{"title": "PDF", "author": "PDF", "url": "https://epub.ub.uni-greifswald.de/files/2631/Dissertation.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "id": "PDF", "license": "PDF", "body": "PDF", "comments": "PDF", "commentsbody": "PDF", "raw_text": "PDF", "text": "\u00a0\n\u00a0 \nHerstellung sicherer und wirksamer \nLebendvakzine gegen die Koi Herpesvirus \nInfektion von Karpfen  \n \nI n a u g u r a l d i s s e r t a t i o n \n \nzur \n \nErlangung des akademischen Grades eines \n \nDoktor der Naturwissenschaften \n(Dr. rer. nat.) \n \nder \nMathematisch-Naturwisse nschaftlichen Fakult\u00e4t \n \nder  \n Universit\u00e4t Greifswald  \n \n \n \n \nvorgelegt von \nLars Schr\u00f6der \ngeboren am 25.02.1988 \nin Schwerin \n \n \nGreifswald, 18.04.2019  \n\u00a0\n\u00a0\u00a0\n\u00a0\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\u00a0\n\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\nDekan:   Prof. Dr. Werner Weitschies \n \n \n1. Gutachter: Prof. Dr. Dr. h.c. Thomas C. Mettenleiter \n 2. Gutachter: Prof. Dr. Dieter Steinhagen \n \nTag der Promotion: 12.04.2019 \n \u00a0\n\u00a0 \n \n \n \n\u201eUm an die Quelle zu kommen, muss man gegen den Strom schwimmen. \u201c  \n               - \u00a0Konfuzius \n \n \n \n \n \n \n  \n  \n \n  \n \n  \n \nIch widme diese Arbeit meiner kleinen Tochter Neele,  \ndie ich \u00fcber alles liebe und f\u00fcr die ich immer da sein werde  \nund allen Menschen, die an mich geglaubt und mich so weit gebracht haben. \n \u00a0\n\u00a0Inhaltsverzeichnis \n \n1. Einleitung .................................................................................... 1 \n1.1. Das Koi-He rpesviru s ................................................................... 2 \n1.1.1. KHV als Vertreter der Familie Alloherpesviridae  ........................... 2 \n1.1.2. \u00dcbertragung und Ausbreitung von KHV ....................................... 3 \n1.1.3. Krankheitsbild einer KHV-In fektion ............................................ 4 \n1.1.4. Wirtsspektrum von KHV .......................................................... 5 \n1.2. Molekulare Struktur und Replikation von KHV .................................... 5 \n1.2.1. Struktur und Ge nomaufbau von KHV .......................................... 5 \n1.2.2. Replikations zyklus vo n KHV ..................................................... 6 \n1.2.3. Virale Enzyme f\u00fcr den Nukleotidstoffwechsel als Virulenzfaktoren ..... 9 1.2.4. Membran-Gl ykoprote ine ....................................................... 10 \n1.3. Herstellung von Impfstoffe n gegen virale Infektionen ........................ 11 \n1.3.1. Lebend vakzin e .................................................................. 11 \n1.3.2. DIVA- Vakzine .................................................................... 11 \n1.3.3. Genetechnik in der Impfstoffentwi cklung .................................. 12 \n1.4. Das Immunsyste m der Fisc he ...................................................... 13 \n2. Zielse tzung ................................................................................ 19 \n3. Publikationen .............................................................................. 21 \n3.1. Publik ation I .......................................................................... 21 \n3.2. Publik ation II ......................................................................... 35 \n3.3. Pubilkat ion III ........................................................................ 67 \n4. Eigenanteil an den zur Dissertat ion eingereichten Publikationen ................ 77 \n4.1. Publik ation I .......................................................................... 77 \n4.2. Publik ation II ......................................................................... 79 \n4.3. Publikat ion III ........................................................................ 81 \n5. Zusammenfassende Diskussion der Ergebnisse ....................................... 85 \n6. Quellen ..................................................................................... 93 7. Zusammenfassung der Dissert ation .................................................... 99 \n8. Summa ry .................................................................................. 101 \n9. Anha ng .................................................................................... 103 \n9.1. Eigenst\u00e4ndigke itserkl\u00e4r ung ....................................................... 103 \n9.2. Publikationen un d Tagungsbei tr\u00e4ge ............................................. 104 \n9.2.1. Tagung sbeitr\u00e4ge ............................................................... 104 \u00a09.2.2. Publik atione n .................................................................. 105 \n9.3 Lebens lauf ........................................................................... 107 \n9.4 Danksa gung .......................................................................... 109 \n \u00a0\n\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n\u00a0\n\u00a0\u00a0 Einleitung \u00a0\n1\u00a0\n\u00a01. Einleitung  \nDer Karpfen z\u00e4hlt neben den Regenbogenforellen zu den bedeutendsten in \nDeutschland gez\u00fcchteten Speisefischarten . Insbesondere in Bayern, Sachsen und \nBrandenburg spielt die Aquakultur von Karp fen eine gro\u00dfe Rolle. Weltweit werden \nnach Angaben der Ern\u00e4hrungs- und Land wirtschaftsorganisation der Vereinten \nNationen (FAO) 4,15 Millionen Tonnen Karp fenfleisch pro Jahr erzeugt (FAQ, 2014; \nF\u00fcllner, Pfeifer, & Langner, 2007). Die Karpfen-Teichwirtschaft wird jedoch seit \nEnde der 90iger Jahre durch da s Koi-Herpesvirus (KHV oder Cyprinid herpesvirus 3 ) \nbedroht, welches Massensterben bei Ko i und Nutzkarpfen verursacht (Ayana \nPerelberg et al., 2003; Hedrick et al., 200 0). Eine KHV-Infektion f\u00fchrt zur schwerer \nklinischer Symptomatik mit Mortalit\u00e4tsr aten zwischen 70 und 80 % (Bretzinger, \nFischer-Scherl, Oumouna, Hoffmann, & Truyen, 1999). Deshalb wurde die KHV \nInfektion in Deutschland im Dezember 2005 in die Verordnung \u00fcber anzeigepflichtige \nKrankheiten aufgenommen. Diese Anzeigepflicht beschr\u00e4nkte sich zun\u00e4chst nur auf \nden Virusnachweis bei Nutzkarpfen, wu rde dann aber im Januar 2006 auch auf \nZierfisch-Zuchtformen der Karpfen, die soge nannten Kois, erweitert (TierSG, \u00a71 VO \n\u00fcber anzeigepflichtige Tierseuchen; Fischseuchen-VO, Richtlinie 91/67/EWG, \nAnhang A). Durch die Fischseuchen-Veror dnung in Verbindung mit der Verordnung \n\u00fcber anzeigepflichtige Krankheiten auf der Grundlage der EU -Richtlinie 2006/88/EG, \nist die Bek\u00e4mpfung und Diagnose von KHV in Deutschland streng geregelt. \u00a0KHV ist \nmittlerweile weltweit verbreitet und ve rursacht Ausbr\u00fcche in Deutschland, \nFrankreich, Italien, \u00d6sterreich, dem Ve reinigten K\u00f6nigreich, Polen Belgien, \nD\u00e4nemark, den Niederlanden, der Schweiz, Indonesien, Japan, S\u00fcdafrika, Taiwan, \nden USA und Thailand (Haenen, Way, Berg mann, & Ariel, 2004; Sano et al., 2004). \nIm Jahre 2016 wurden alleine in Deutschl and wieder 60 KHV- Ausbr\u00fcche angezeigt \n(siehe Abbildung 1). Aus diesem Grund is t die Entwicklung sch\u00fctzender Vakzinen \ndringend notwendig und steht auch im Mittelpunkt dieser Promotionsschrift. \n \n     Einleitung \u00a0\n2\u00a0\n\u00a0\u00a0\nAbbildung 1: Neuausbr\u00fcche der anzeigepflichtigen  Tierseuche KHV in den Jahren 2007 - 2016 nach \nTierseuchen-Nachrichtensystem (TSN) - Tiergesundheitsjahresbericht 2016 \n \n1.1. Das Koi-Herpesvirus \n\u00a0\n1.1.1.  KHV als Vertreter der Familie Alloherpesviridae \nHerpesviren sind die am h\u00e4ufigsten bei Knochenfischen nachgewiesenen DNA-Viren \n(Hedrick, Groff, Okihiro, & Mc Dowell, 1990) und die durch das Cyprinid Herpesvirus \n1 (CyHV-1) verursachten Karpfenpocken stel len die \u00e4lteste bekannte Viruserkrankung \nbei Fischen dar (Waltzek et al., 2005). Da s KHV wurde erstmals im Jahre 1998 in den \nUSA aus einem Koi Karpfen aus Israel isoliert und aufgrund morphologischer und \nbiologischen Charakteristika als Koi-Herp esvirus bezeichnet (Hedrick et al., 2000). \nUm die Verwandtschaft von KHV zu bekannten  Fischviren zu bestimmen, wurden die \nSequenzen von vier vollst\u00e4ndigen Genen an alysiert und dabei gro\u00dfe Homologien zu \nGenen des  Karpfenpockenvirus (CyHV-1) und des H\u00e4matopoetischen Nekrose Virus \nvon Goldfischen (CyHV-2) festgestellt, weshalb KHV als Cyprinid herpesvirus 3  (CyHV-\n3) klassifiziert wurde (Waltzek et al.,  2005). Diese \u00c4hnlichkeit wurde durch die \nErmittlung der vollst\u00e4ndigen Genomsequenzen  dreier KHV-Isolate best\u00e4tigt (Aoki et \nal., 2007). Da jedoch kaum Sequenzhomolog ien zu den zahlreichen Vertretern der \nVirusfamilie Herpesviridae  bei S\u00e4ugetieren, V\u00f6geln und Reptilien erkennbar waren, \nwurde f\u00fcr die Herpesviren von Fischen und Amphibien die neue Virusfamilie \nAlloherpesviridae  geschaffen und mit den Herpesviren von Mollusken \n(Malacoherpesviridae ) und den Herpesviridae  in der Ordnung Herpesvirales  050100150200250\n2007 2008 2009 2010 2011 2012 2013 2014 2015 2016Anzahl\u00a0der\u00a0KHV\u00a0Ausbr\u00fcche \u00a0in\u00a0Deutschland\u00a0 Einleitung \u00a0\n3\u00a0\n\u00a0zusammengefasst (Davison et al., 2009). Die Familie Alloherpesviridae umfasst \nzurzeit 13 Spezies, die aufgrund ihrer Ge nomsequenzen und Wirtsorganismen in 4 \nGattungen Batrachovirus  (Viren der Ranidae ), Cyprinivirus  (Viren der Cyprinidae  und \nAnguillidae ), Ictalurivirus  (Viren der Ictaluridae  und Acipenseridae ) und \nSalmonivirus  (Viren der Salmonidae ) aufgeteilt wurden \n(https://talk.ictvonline.org/taxonomy/ ).  \n \n1.1.2.  \u00dcbertragung und Ausbreitung von KHV \nIm Allgemeinen werden KHV-beding te Krankheitsausbr\u00fcche nur bei \nWassertemperaturen \u00fcber 17\u00b0C beobachtet, doch gibt es Hinweise darauf, dass das \nVirus auch bei einer Temperatur von 10\u00b0C noch vermehrt werden kann (Baumer, \nFabian, Wilkens, Steinhagen, & Ru nge, 2013; Gilad et al., 2004). Bei \nWassertemperaturen unter 13\u00b0C scheint KHV sy mptomlos im Wirt zu \u00fcberdauern und \nerst im optimalen Temperat urbereich beginnen die Tiere infekti\u00f6se Viruspartikel \nauszuscheiden (St-Hilaire et al., 2005). Di e \u00dcbertragung von KHV erfolgt \u00fcber das \nWasser, in dem das Virus \u00fcber mehrere Stunden lang infekti\u00f6s bleiben kann (Ayana \nPerelberg et al., 2003). Normalerweise betr\u00e4gt die Inkubationszeit in Abh\u00e4ngigkeit von Wassertemperatur, Virulenz des Erre gers und Empf\u00e4nglichkeit des Fisches \nzwischen 4 bis 21 Tagen, jedoch kann die KH V-Infektion (KHV-I) bei latent infizierten \nFischen Jahre zur\u00fcckliegen (Hedrick et al ., 2000; Ayana Perelberg et al., 2003). \u00dcber \nsymptomfreie, latent infizierte Fische  konnte das Virus unerkannt weltweit in \nzahlreiche Karpfenbest\u00e4nde eingeschleppt  werden (Walster, 1999). Lebenslange, \nlatente Infektionen sind typisch f\u00fcr Herpesviren. W\u00e4hrend dieses Stadiums ist die virale Replikation und Genexpression erheblich herunterreguliert, was dazu f\u00fchrt, \ndass latente Herpesviren nur sehr schwer nachweisbar sind. In Stresssituationen \nk\u00f6nnen die Viren jedoch jederzeit reaktivier t und auf neue Wirte \u00fcbertragen werden  \n(Fraser, Lawrence, Wroblewska, Gilden, & Koprowski, 1981; Galloway, Fenoglio, & \nMcDougall, 1982). Die ersten KHV Infektio nen wurden in den Jahren 1998 und 1999 \nin Israel, USA und Deutschland dokumentiert  (Bretzinger et al., 1999; Hedrick et al., \n2000; Ayana Perelberg et al., 2003).\n\u00a0Nach der Ver\u00f6ffentlichung dieser Daten wurden \nauch in vielen anderen L\u00e4ndern in Europa, Asien und Nordamerika Ausbr\u00fcche der KHV-I gemeldet (Haenen et al., 2004; Sano et al., 2004; Walster, 1999). \n Einleitung \u00a0\n4\u00a0\n\u00a01.1.3.  Krankheitsbild einer KHV-Infektion  \nDas KHV ist hochinfekti\u00f6s und wird \u00fcber  direkten Hautkontakt oder das Wasser \n\u00fcbertragen. Die Virusausscheidung erfolgt \u00fcb er Haut und Kiemen und wahrscheinlich \nauch \u00fcber den Darm. Dabei l\u00f6st die Infektion eines Bestandes unter nat\u00fcrlichen Bedingungen eine Morbidit\u00e4t von 80-100% und eine Mortalit\u00e4t von 70-80% aus \n(Bretzinger et al., 1999; Walster, 1999). Die Symptomatik kann von Tier zu Tier stark \nvariieren, \u00e4u\u00dfert sich aber oftmal s im Anfangsstadiu m durch vermehrte \nSchleimproduktion auf der Haut und an den Kiemen. In einigen F\u00e4llen wurden aber \nauch Enophthalmus und H\u00e4morrhagien der Haut beobachtet. Im fortgeschrittenen \nStadium treten dann Schwellungen de s Kiemengewebes auf, die bis hin zur \nAusbildungen gro\u00dffl\u00e4chiger Nekrosen f\u00fchr en k\u00f6nnen. Des Weiteren verringert sich \ndie Schleimproduktion und es kommt zur Ausbildung rauer \u201eSandpapier\u201c-artiger Haut. Typische Verhaltens\u00e4nderungen infizierter Tiere sind das Aufsuchen von \nstr\u00f6mungsschwachen Wasserzonen, Anorexie , Koordinationsverlust und Apathie (S. \nM. Bergmann et al., 2010; Hedrick et al ., 2000; Walster, 1999). Ein Hauptproblem \nbei der KHV-Infektion ist die Latenz-Etablierung in \u00fcberlebenden Tieren, die \nlebenslang gesunde Tiere im Umfeld infizi eren k\u00f6nnen (Gilad et  al., 2004; St-Hilaire \net al., 2005). KHV persistier t in den Leukozyten und \u00fcber dauert im latenten Zustand \nin den Kiemen, Haut und Nieren der Tiere bis zum n\u00e4chsten Ausbruch (S. Bergmann \n& Kempter, 2011).  \n \n\u00a0\u00a0 \u00a0\nAbbildung 2: Typisches Krankheitsbild einer KH V Infektion. Gezeigt sind Kiemennekrose und \nHautl\u00e4sionen. Fotos von Dr. Sven Bergmann \n\u00a0\n\u00a0\u00a0\u00a0\n\u00a0 Einleitung \u00a0\n5\u00a0\n\u00a01.1.4.  Wirtsspektrum von KHV \nWie viele andere Herpesviren besitzt au ch KHV ein sehr enges Wirtsspektrum \nbez\u00fcglich der Ausl\u00f6sung einer Erkrankung  (Davison, 2002; Walster, 1999). Dieses \nbeschr\u00e4nkt sich auf Koi- und Karpfenpopulationen, also Fische der Spezies Cyprinus \ncarpio . Dabei sind Karpfen aller Altersklasse n gleicherma\u00dfen f\u00fcr eine KHV-Infektion \nempf\u00e4nglich (Hedrick et al., 2000). Jedoch  wurden deutliche Unterschiede in der \nMortalit\u00e4tsrate bei den verschiedenen Alters gruppen festgestellt. So reagieren Tiere \nmit einem Gewicht von unter 10g, was etwa Karpfen der Altersgruppe K0 bis K1 \nentspricht, empfindlicher auf eine KHV-Infektion als Karpfen mit einem Gewicht von \n\u00fcber 200g ( \u2265 K2) (Ayana Perelberg et al., 2003). In den Altersklassen werden die \nKarpfen anhand der durchlebten Sommer eingeteilt; so steht K2 f\u00fcr einen \n\u201ezweis\u00f6mmerigen Karpfen\u201c. Mehrfach wurden  Versuche durchgef\u00fchrt, in denen KHV-\ninfizierte Karpfen mit anderen Fischspezies zusammen kultiviert wurden, bei denen \njedoch  bisher niemals Anzeichen einer Erkrankung festgestellt wurden (Ayana \nPerelberg et al., 2003; Hedrick et al., 2000; Hedrick, Waltzek, & Mcdowell, 2006; \nWalster, 1999). Allerdings konnte das Virus in anderen Fischspezies (Wie unter \nanderem Hecht, Goldfische und Karausch en) nachgewiesen werden. Diese Fische \nzeigten selbst keinerlei Symptome, waren aber dennoch in der Lage, Karpfen mit \nKHV zu infizieren  (Meyer, 2007).  \n \n1.2. Molekulare Struktur und Replikation von KHV \n\u00a0\n1.2.1.  Struktur und Genomaufbau von KHV \nWie erw\u00e4hnt, wurde das ko mplette KHV Genom erstmals  2007 basierend auf drei \nVirusisolaten aus Israel, Japan und den US A charakterisiert (Aoki et al., 2007). Das \nlineare, doppelstr\u00e4ngige DN A Genom ist etwa 295 kbp gr o\u00df und codiert f\u00fcr ca. 156 \nGene, von denen 8 in zwei Kopien innerhalb  direkter Sequenz-Repetitionen an \nbeiden Genomenden vorliegen (Aoki et al., 2007). \u00c4hnliche  DNA-\nSequenzwiederholungen sind charakteristis ch f\u00fcr die meisten He rpesviren, wobei  \ninterne und terminale, sowie direkte und inverse Repetitionen vorkommen \n(McGeoch, Rixon, & Davison, 2006). A nhand von  Anzahl und Lage der  \nSequenzwiederholungen werden die Geno me der Herpesviren in sechs Klassen \neingeteilt (A-F), wobei das  KHV-Genom der Klasse A entspricht (Aoki et al., 2007; Einleitung \u00a0\n6\u00a0\n\u00a0Brooks, Carroll, Butel, Morse, & Mietzner, 2013). Wie bei allen Herpesviren wird das \nKHV-Genom in ein ikosaedrisches Kapsid ve rpackt, welches von zwei proteinhaltigen \nTegumentschichten umgeben  und mit  ei ner Lipidmembran zellul\u00e4ren Ursprungs \numh\u00fcllt wird, in welche verschiedene virale  Glykoproteine eingelagert sind (Aoki et \nal., 2007; Davison et al., 2009) . Das ikosaedrische Kapsid der Triangulationszahl 16 \nbesteht aus insgesamt 161 Kaps omeren (150 Hexone und 11 Pentone). Dar\u00fcber hinaus \nbefindet sich an einem Kapsidvertex  ei n Portalkomplex, durch welchen die virale \nDNA ins Kapsid geschleust wird (Homa et al., 2013). Das Tegument  enth\u00e4lt zahlreiche \nvirale und einige zellul\u00e4re Proteine und be steht aus einer inneren,  Kapsid-nahen und \neiner \u00e4u\u00dferen Schicht (Bechtel, Winant, & Ganem, 2005; Johannsen et al., 2004; \nMettenleiter, 2008). Die molekulare Zusa mmensetzung der Tegu mentschichten ist \nbei den Alloherpesviridae  noch weitgehend unbekannt.  Besser charakterisiert sind \nhingegen die Membranproteine der Vi rush\u00fclle des KHV, von denen durch \nmassenspektrometrische Proteomanalysen 13 St\u00fcck nachgewiesen wurden (Michel et \nal., 2010). \n\u00a0\n1.2.2.  Replikationszyklus von KHV \nDer Replikationszyklus von humanen und anderen S\u00e4uger-Herpesviren wurde mit \nHilfe ultrastruktureller und molekularbio logischer Analysen bereits detailiert \nuntersucht (Granzow et al., 1997; Mett enleiter, 2002; Mettenleiter, Klupp, & \nGranzow, 2009). Die Infektion beginnt mit der Virusadsorption an Rezeptoren der \nWirtszellmembran und der anschlie\u00dfenden Fusion von Virush\u00fclle und \nPlasmamembran mit Hilfe viraler Fusionsp roteine (Eisenberg et al., 2012). Bei den \nAlphaherpesvirinae  erfolgt die Rezeptorbindung meist \u00fcber das Glykoprotein gD, und \ndie Fusionsmaschinerie besteht aus den viralen Glykoproteinen gB, gH und gL \n(Eisenberg et al., 2012). Die funktionsh omologen Proteine der Alloherpesviren \nwurden bislang nicht eindeutig identifizi ert. Nach erfolgreicher Penetration und \ndamit dem Eintritt des Kapsides in das Zytoplasma l\u00f6st sich die \u00e4u\u00dfere \nTegumentschicht ab, w\u00e4hrend die innere Tegumentschicht mit dem Kapsid verbunden bleibt und f\u00fcr den Transport der Kapside entlang der Mikrotubuli zum \nZellkern ben\u00f6tigt wird (Antinone et al., 2006; Granzow, Klupp, & Mettenleiter, \n2005). Das virale Genom wird durch  Kernpore n in den Zellkern entlassen wo die  die \nvirale DNA zirkularisiert und repliziert wird (Strang & Stow, 2005). Voraussetzung \nhierf\u00fcr ist allerdings zun\u00e4chst die Expr ession viraler Gene durch die zellul\u00e4re \u00a0 Einleitung \u00a0\n7\u00a0\n\u00a0Transkriptions- und Translationsmaschinerie. Die herpesvirale Genexpression ist \nkaskadenartig reguliert, wobei je nach Zeitpunkt ihrer Transkription sehr fr\u00fche \n(immediate early, IE ), fr\u00fche ( early, E ) und sp\u00e4te ( late, L ) Gene unterschieden \nwerden. Die E-Gene werden zus\u00e4tzlich in early  und delayed early  bzw. early-late  \nGene unterteilt (Honess & Roizman, 1974,  1975; Roizman, 2001; Tombacz, Toth, \nPetrovszki, & Boldogkoi, 2009). Die Expression der  IE-Gene wird h\u00e4ufig durch virale  \nTegumentproteine induziert, was jedoch ni cht essenziell ist, da auch gereinigte \nHerpesvirus DNA infekti\u00f6s ist (Feldman, Demarchi, Ben-Porat, & Kaplan, 1982; Fuchs, \nGranzow, Klupp, Kopp, & Mettenleiter, 2002; Ihara, Feldma n, Watanabe, & Ben-\nPorat, 1983; Katan, Haigh, Verrijzer, va n der Vliet, & O'Hare, 1990). Die E-Gene \ncodieren vor allem  f\u00fcr Proteine, welche f\u00fcr die DNA-Replikation (Helikase, Primase, \nDNA-Polymerase) und den Nukleotidstoffw echsel (Thymidinkinase, dUTPase, \nRibonukleotidreduktase) ben\u00f6tigt we rden (Cheung, 1991; Huang & Wu, 2004; \nTaharaguchi et al., 1994; Tombacz et al ., 2009; Watanabe, Ono, Nikami, & Kida, \n1998). Die L-Gene, die als letztes exprimiert werden, kodieren vor allem  f\u00fcr virale \nStrukturproteine (Johnson & Everett, 1986;  Tombacz et al., 2009) . Aus einigen davon \nwerden in einem autokatalytischen Proze ss die Kapside im Zellkern gebildet, in \nwelche dann die replizierte Virus-DNA eingeschleust und auf Genoml\u00e4nge \nzugeschnitten wird \u00a0(Mettenleiter, 2008). Die entstandenen Nukleokapside lagern \nsich an die innere Kernmembran an und gelangen durch Knospung in den \nperinukle\u00e4ren Spalt \u00a0(Mettenleiter, 2008). Die prim\u00e4re Vi rush\u00fclle fusioniert dann mit \nder \u00e4u\u00dferen Kernmembran und die Kapside werden ins Zytoplasma freigesetzt \u00a0\n(Mettenleiter, 2008). Dort lagern sich di e inneren Tegumentproteine an, w\u00e4hrend \ndie \u00e4u\u00dferenen Tegumentproteine erst zusammen mit den Glykoproteinen w\u00e4hrend \nder Knospung im Trans-Golgi-Netzwerk eingebaut werden \u00a0(Mettenleiter, 2008). Die \nsekund\u00e4r umh\u00fcllten, reifen Virionen werden in  Transportvesikeln zur \nPlasmamembran transportiert und gelangen dort durch Fusion der Vesikelmembran mit der Plasmamembran in den extraz ellul\u00e4ren Raum (Mettenleiter, 2008). \n  Einleitung \u00a0\n8\u00a0\n\u00a0\u00a0\nAbbildung 3: Replikationszyklus  von Herpesviren \u2013 Nach der An heftung und Durchdringung der \nZellmembran werden die Kapside durch Wechse lwirkung mit den Mikrotubuli zum Zellkern \ntransportiert, wo sie sich an Kernporen anheften  und das virale Genom in den Zellkern freisetzen. \nHier findet die Transkription der viralen Gene un d die Genomreplikation statt. Konkatemere virale \nDNA wird w\u00e4hrend der Verpackung in vorgeformte Kapside zu Einzelgenomen gespalten. Die \nNukleokapside verlassen den Zellkern durch Knospung an der inneren Kernmembran. Darauf folgt die \nFusion der im perinukle\u00e4ren Spalt befindlichen  prim\u00e4r umh\u00fcllten Virionen mit der \u00e4u\u00dferen \nKernmembran. Die endg\u00fcltige Reifung der ins Zyto plasma entlassenen Nukleokapside erfolgt durch \ndie Anlagerung von Tegumentproteinen und anschlie \u00dfende Knospung in mit viralen Glykoproteinen \nbesetzte Vesikel des Trans-Golgi-Netzwerks, was zu  sekun\u00e4r umh\u00fcllten Partikeln in den Zellvesikeln \nf\u00fchrt. Nach dem Transport zur Zelloberfl\u00e4che ve rschmelzen die Vesikel mit der Plasmamembran, \nwodurch die reifen Virionen aus der Zelle freigesetzt werden.  \n\u00a0\n\u00a0 Einleitung \u00a0\n9\u00a0\n\u00a01.2.3.  Virale Enzyme f\u00fcr den Nukleotids toffwechsel als Virulenzfaktoren \nDie Genome vieler Herpesviren codieren f\u00fcr verschiedene Nukleotid-Stoffwechselenzyme Thymidinki nase (TK), Thymidylatkinase, \nDesoxyuridintriphosphat-Pyroph osphatase (dUTPase, DUT) und \nRibonukleotidreduktase. Da es sich hierbe i um ubiquit\u00e4re Enzyme handelt, die in \nallen teilungsaktiven Zellen exprimiert we rden, sind die viralen Homologen f\u00fcr die \nReplikation in Zellkultur meist entbehrlich.  Allerdings gelten die entsprechenden \nGene bei vielen Herpesviren, einschlie\u00dflich des Katzenwels Virus (channel catfish \nvirus, CCV), als wichtige Virulenzfaktoren (Boivin, Coulombe, & Rivest, 2002; \nEfstathiou, Kemp, Darby, & Minson, 1989; Freuling, M\u00fcller, & Mettenleiter, 2017; \nJ\u00f6ns, Gerdts, Lange, Kaden, & Mettenleite r, 1997; Jons & Mette nleiter, 1996; Zhang \n& Hanson, 1995). Bei KHV wurde die Rolle de r TK f\u00fcr die Virulenzauspr\u00e4gung in \nfr\u00fcheren Studien kontrovers diskutiert.  \nDie Thymidinkinase (TK) ist ein bei fast allen Organismen mit Ausnahme von Pilzen \nvorhandenes Enzym des salvage  pathway  (Bergungsweg) der Nukleotid-Biosynthese, \nwelches Desoxythymidin zu Desoxythymidin monophosphat (dTMP) umwandelt. Auch \ndie meisten DNA-Viren, von Bakteriophagen bis zu humanpathogenen Viren, wie z.B. \ndie Herpes-simplex-Viren (HSV-1/2), codieren  f\u00fcr eigene Thymidinkinasen, die sich \nhinsichtlich ihrer Struktur und Reaktivit\u00e4t teilweise von den zellul\u00e4ren Enzymen \nunterscheidet (Wintersberger, 1997). Auch  KHV besitzt ein TK-Gen, das f\u00fcr ein \nPolypeptid von 224 Aminos\u00e4uren mit einer berechneten Molek\u00fclmasse von 24,6 kDa \nkodiert, und dessen Kinaseaktivit\u00e4t in vitro nachgewiesen werden konnte\n\u00a0(Bercovier \net al., 2005).  \nDie Enzyme der dUTPase-Familie spielen eine wichtige Rolle sowohl f\u00fcr die \nGenomintegrit\u00e4t als auch bei der De-nov o-Thymidylat-Biosynthese. Die dUTPasen \nkatalysieren die Hydrolyse von dUTP zu  dUMP und anorganischem Pyrophosphat. \nDiese Reaktion dient zum einen der Bereitst ellung eines Vorl\u00e4ufers (dUMP) f\u00fcr die \nSynthese von Thymin-Nukleotiden, die f\u00fcr die DNA-Replikation ben\u00f6tigt werden, und \nzum anderen dazu, die intrazellul\u00e4re Konz entration von dUTP zu begrenzen. Ein \nerh\u00f6hter dUTP-Spiegel f\u00fchrt zu einer verst\u00e4 rkten Inkorporation von Uracil in die DNA, \ndie eine durch Uracil-DNA Glycosylase vermittelte Reparatur durch Exzision induziert. Dieser Reparaturprozess kann  zur DNA-Fragmentierung und damit zum \nZelltod f\u00fchren (Rona et al., 2013). Einleitung \u00a0\n10\u00a0\n\u00a01.2.4.  Membran-Glykoproteine  \nDie H\u00fclle von Herpesviren wird von Vesike ln des Trans-Golgi-Netzwerks gebildet, \nwelche die tegumentierten Kapside am Ende der Virusmorphogenese umschlie\u00dfen \n(Granzow et al., 1997; Mettenleiter et al., 2009; Turcotte, Letellier, & Lippe, 2005). \nIn diese Lipidh\u00fclle sind virale, h\u00e4ufig gl ykosylierte Oberfl\u00e4chenproteine eingelagert \n(Mettenleiter et al., 2009; Reske, Pollara , Krummenacher, Chain, & Katz, 2007), die \nvielf\u00e4ltige  Funktionen haben. So erfolgt  das Andocken von Herpesvirus-Partikeln an \ndie Oberfl\u00e4che der Wirtszelle meist durc h die Bindung viraler Glykoproteine (bei \nAlphaherpesviren v.a. des Glykoprote ins gC) an Heparansulfat-tragende \nProteoglykane (Eisenberg et al., 2012; Ra uh, 1990). F\u00fcr die stab ile Virusadsorption \nan die Wirtszelle und die anschlie\u00dfende Fusion der Virush\u00fclle mit der \nPlasmamembran sind weitere virale Glykop roteine notwendig (bei Alphaherpesviren \ngD, gB, gH und gL) (Eisenberg et al ., 2012; Heldwein & Krummenacher, 2008). \nWeitere Glykoproteine sind an der Virusreifung und Freisetzung beteiligt (bei \nAlphaherpesviren gE, gI, gM) (Mettenleiter et al., 2009). Die funktionshomologen \nProteine der Alloherpesviridae  sind bislang nicht bekannt. Dar\u00fcber hinaus sind die \nviralen H\u00fcllproteine wichtige Ziele der Wirtsimmunantwort. \nAls erste Voraussetzung f\u00fcr die Identifizierung und Charakterisierung der \nH\u00fcllproteine von KHV wurden neben mass enspektrometrischen Proteomanalysen \n(Michel et al., 2010) auch monospezifis che Antiseren gegen die von den Genen \nORF25, ORF65, ORF81, ORF99, ORF136,  ORF138, ORF146, ORF148 und ORF149 \ncodierten vorherhergesagten integralen  Membranproteine hergestellt (Fuchs, \nGranzow, Dauber, Fichtner, & Mettenleiter,  2014; Rosenkranz et al., 2008). Mittels \ndieser Seren konnten die Typ I-Membranp roteine pORF25, pORF 65, pORF99, pORF136 \nund pORF149, sowie vor allem das Typ III-Memb ranprotein pORF81 in KHV-infizierten \nZellen eindeutig nachgewiesen werden. Umgekehrt reagierten in indirekten \nImmunfluoreszenztests (IIFT) Seren von nat\u00fcrlich oder experimentell mit KHV \ninfizierten Karpfen und Koi mit Plasmid-tr ansfizierten Zellen, die die Proteine \npORF25, pORF65, pORF148 oder pORF149 exprim ierten (Fuchs et al., 2014). In einer \nweiteren Studie konnte gezeigt werden, da ss die von ORF32, ORF 59, ORF81, ORF83, \nORF99, ORF106, ORF115, und ORF131 co dierten KHV-Membranproteine f\u00fcr die \nVirusreplikation essenziell sind, w\u00e4hrend ORF25, ORF64, ORF65, ORF132, ORF136, \nORF148 oder ORF149 in Zellkultur entbehrlich sind. Allerdings f\u00fchrte die Deletion der \u00a0 Einleitung \u00a0\n11\u00a0\n\u00a0Gene ORF148 oder ORF25 zu einer Abschw\u00e4chung der Virulenz von KHV in vivo  \n(Vancsok et al., 2017). \n \n1.3. Herstellung von Impfstoffen gegen virale Infektionen \n\u00a0\n1.3.1.  Lebendvakzine  \nLebendimpfstoffe sind attenuierte Viren, di e in der Lage sind innerhalb des Wirts zu \nreplizieren, aber keine oder allenfalls eine sehr milde Erkrankung verursachen. \nWichtig dabei ist, dass der Verlust der Vi rulenz,  die immunogenen Eigenschaften der \nViren nicht beeintr\u00e4chtigt (Keystone, Koza rsky, Freedman, Nothdr uft, & and  Conno, \n2013). In den meisten F\u00e4llen zeigen Lebend impfstoffe eine signifikant h\u00f6here \nImmunogenit\u00e4t als inaktivierte Impfsto ffe, da sie eine nat\u00fcrliche Infektion \nnachahmen und so ein breiteres Spektrum an  sowohl humoralen (B-Zellen) als auch \nzellul\u00e4ren (CD8 + und CD4 + T-Zellen) Immunreaktionen hervorgerufen wird \n(Keystone et al., 2013). Eine einmalige Impfung reicht meist aus, um einen \nlangfristigen, manchmal sogar lebenslangen Schutz zu erreichen. Ein Nachteil dieses \nImpfstofftyps kann jedoch das Risiko eine r Virulenzsteigerung durch R\u00fcckmutation \ndes abgeschw\u00e4chten Virus sein. Bei neueren Lebendimpfstoffen, die  genau \ndefinierte und stabile Deletionen aufweise n ,  b e s t e h t  j e d o c h   k e i n   R i s i k o  f \u00fc r  \nR\u00fcckmutationen (Keystone et al., 2013).  \n \n1.3.2.  DIVA-Vakzine \nAls DIVA-Vakzine (engl. differentiation of infected and vaccinated animals ) oder \nMarkervakzine werden Impfstoffe bezeichne t, die es erlauben, geimpfte Tiere von \nFeldvirus-infizierten Tieren zu unterscheid en (van Oirschot, 1999). Dabei geht es \njedoch nicht nur darum, dass sich da s Impfvirus genetisch vom Wildtyp-Virus \nunterscheidet, sondern dass die Antik\u00f6rperan twort von infizierten Tieren von der von \ngeimpften Tieren unterschieden werden ka nn (van Oirschot, Rzih a, Moonen, Pol, & \nvan Zaane, 1986). Die durch eine Virusinfek tion induzierten Antik\u00f6rper k\u00f6nnen mit \nHilfe serologischer Tests, wie zum Beispiel einem ELISA ( Enzyme-linked \nImmunosorbent Assay ), in der Regel weitaus l\u00e4nger nachgewiesen werden als das \nVirus selbst. Bei DIVA-Vakzinen werden deshalb meist ausgew\u00e4hlte immunogene Einleitung \u00a0\n12\u00a0\n\u00a0Proteine deletiert, die f\u00fcr den Immunschutz der Tiere nicht essenziell sind. So kann \nanhand des Fehlens oder Vorhandenseins von Serumantik\u00f6rpern gegen das \nentsprechende Protein unterschieden werden , ob ein Tier lediglich geimpft, oder \nentweder ausschlie\u00dflich oder zus\u00e4tzlich du rch das Wildtypvirus infiziert wurde (M., \n2006; van Oirschot, 1999). Zum Einsatz kommt  diese Art von Impfstoffen vor allem \nin der Nutztierhaltung, wo im Hinblick auf die Tilgung von Seuchen die Verbreitung der Erreger st\u00e4ndig kont rolliert werden muss.  \n \n1.3.3.  Genetechnik in der Impfstoffentwicklung \nDie Verf\u00fcgbarkeit hochwirksamer und sicherer Impfstoffen f\u00fcr die Veterin\u00e4rmedizin \nist eine Grundvoraussetzung f\u00fcr die Tier gesundheitskontrolle (Krishnan, 2000; \nMeeusen, Walker, Peters, Pastoret, & Jungersen, 2007). Mittels revers genetischer \nSysteme ist es m\u00f6glich, Pathogene wie Viren gezielt zu ver\u00e4ndern und  so eine neue \nGeneration von attenuierten Lebendvakzine- Kandidaten zu entwickeln (Freuling et \nal., 2017; van Oirschot, 1999). Gentechnische Methoden erleichtern auch die \nHerstellung von DIVA-Vakzinen, welche ei ne genetische und/oder serologische \nDifferenzierung von Feldvirus-infizierten und geimpften Tieren erm\u00f6glichen (siehe \noben). Auch zur Bek\u00e4mpfung der KHV-Infe ktion wurden neben mittels klassischer \nMethoden abgeschw\u00e4chten Lebendimpfsto ffen aus virulenten Feldisolaten (A. \nPerelberg, Ronen, Hutoran, Smith, & Ko tler, 2005; Ronen et al., 2003) auch bereits \ngentechnisch hergestellte Gendeletionsmutant en erprobt.  Grundlage hierf\u00fcr war die \nKenntnis der Genomsequenz des KHV und der Funktionen und strukturellen Merkmale \neinzelner Virusproteine (Aoki et al., 2007; Boutier et al., 2015; Costes et al., 2008; \nFuchs, Fichtner, Bergmann, & Mettenleite r, 2011; Vancsok et al., 2017). Es konnte \nbereits in fr\u00fcheren Studien belegt  werden, dass virale Enzyme des \nNukleotidstoffelwechsels, wie  die TK und die dUTPase (DUT), Virulenzfaktoren von  \nHerpesviren einschlie\u00dflich des KHV sind (Freuling et al., 2017; Fuchs et al., 2011; \nJons & Mettenleiter, 1996; Kit, Kit, & Pi rtle, 1985). Deshalb wurden auch in der \nvorliegenden Arbeit die TK- und DUT-Gene  mittels homologer Rekombination einzeln \nund in Kombination aus dem KHV-Genom dele tiert. Au\u00dferdem wurden die Gene der \nnicht essenziellen Glykoproteine pORF 148 und pORF 149 deletiert, da diese hoch \nimmunogen sind (Fuchs et al., 2014) und somit als Marker f\u00fcr eine serologische DIVA \nVakzine dienen k\u00f6nnten. Um die Herstellung  der Mutanten und eventuell auch die \u00a0 Einleitung \u00a0\n13\u00a0\n\u00a0sp\u00e4tere Impfstoffproduktion zu erleichter n, wurde der Virusstamm KHV-T (Taiwan) \nverwendet, da dieser an die Zellkultur ad aptiert ist und deutlich h\u00f6here Titer als \nandere KHV-Isolate erreicht (Gao et al., 2 018; Hedrick et al., 2000; Mletzko et al., \n2017). Ein ebenfalls vielversprechender gentechnischer Ansatz sind sogenannte DNA-\nImpfstoffe. Diese basieren auf Expressionsplasmiden f\u00fcr einzelne immunogene \nVirusproteine, im Falle von KHV die Me mbranproteine pORF25 und pORF81, welche \nden Fischen meist mehrmals injiziert werd en (Zhou et al., 2014b). Solche DNA-\nVakzinen unterst\u00fctzen ebenfalls die DIV A-Diagnostik und k\u00f6nnten zum Schutz \nwertvoller Zierfische (Kois) durchaus geeignet sein. Wegen des gro\u00dfen Arbeitsaufwands und der relativ hohen Produktionskosten d\u00fcrfte ein Einsatz bei \nNutzfischen jedoch unwirtschaftlich sein, weshalb dieser Ansatz in der vorliegenden Arbeit nicht verfolgt wurde. \n \n1.4. Das Immunsystem der Fische \nDas Immunsystem umfasst biologische Strukturen und Prozesse innerhalb eines \nOrganismus, die eine Vielzahl von Noxen erkennen und eliminieren k\u00f6nnen. Es sch\u00fctzt insbesondere vor Krankheitserregern und ist in der Lage fremde Zellen, sowie \ninfizierte eigene Zellen von eigenen ge sunden Zellen zu unterscheiden. Alle \nLebewesen verf\u00fcgen \u00fcber Immunsysteme, wobei man bei Vertebraten und so auch \nbei Fischen neben einem angeborenen zus\u00e4tzlich ein klassisches \u201elernf\u00e4higes\u201c, \nadaptives Immunsystem findet (Beck, 2007; Murphy, 2012; Prad ipta, Bismita, & \nSurajit, 2012). Wie neuere Studien jedoch zeigen, verf\u00fcgen bereits Bakterien \u00fcber adaptive Immunmechanismen zur Phagenab wehr (z.B. das CRISPR/Cas9 System), die \ninzwischen auch vielf\u00e4ltig f\u00fcr molekularbio logische Studien in Eukaryoten eingesetzt \nwerden (Jinek et al., 2012). Im Grunde un terscheidet sich die Immunantwort bei \nFischen nicht wesentlich von der h\u00f6herer Ve rtebraten (Pradipta et  al., 2012). Fische \nk\u00f6nnen in ihrem aquatischen Lebensraum, insbesondere bei hoher Bestanddichte und \nschlechten Umweltbedingungen \u00fcber ihre Schleimh\u00e4ute einer hohen Erregerlast \nausgesetzt sein. Dies erfordert ein effekt ives Immunsystem, das auch in der Lage \nsein muss, bei unterschiedlichen Wassertemperaturen eine Abwehr aufrecht zu halten (Ellis, 2001). Einleitung \u00a0\n14\u00a0\n\u00a0Wie bei h\u00f6heren Wirbeltieren besteht das Immunsystem von Fischen aus einer \nangeborenen (engl. innate) und einer adap tiven Komponente, die sich wiederum in \nhumorale und zellul\u00e4re Kompartimente unterteilen. Zu den angeborenen humoralen \nKomponenten des Immunsystems geh\u00f6ren anti mikrobielle Peptide, Lysozyme und das \nKomplement-System. Zu den zellul\u00e4ren Komponenten des angeborenen \nImmunsystems z\u00e4hlen u.a. nat\u00fcrliche Killer- (NK-) Zellen, Makrophagen und \nGranulozyten (Murphy, 2012). Bei den adap tiven humoralen Komp onenten handelt es \nsich um die von B-Zellen gebildeten I mmunglobuline (Antik\u00f6rper), w\u00e4hrend T-\nLymphozyten die zellul\u00e4re Komponente da rstellen (Luttmann, Bratke, K\u00fcpper, & \nMyrtek, 2006; Murphy, 2012). Angeborene Komponenten des Immunsystems werden u.a. durch physikalische Barrieren, z.B. die mukosalen Oberfl\u00e4chen der Haut bzw. \nder Kiemen repr\u00e4sentiert. Diese verhinde rn, dass Krankheitserreger wie Bakterien \nund Viren in den Organismus gelangen (Alberts, 2002; Boyton & Openshaw, 2002). \nSubstanzen im Schleim wie  antimikrobielle Peptide, Lysozym und Komplement-\nKomponenten, welche von den Epithelzellen abgesondert werden, geh\u00f6ren somit zu \nden initialen Abwehrmechanismen von Fischen (Nakao, Tsujikura, Ichiki, Vo, & Somamoto, 2011). Eine weitere physikalisch-chemische Barriere bildet die \nMagens\u00e4ure (Secombes, 1996). Nach der Infe ktion von Fischen mit Viren produzieren \ninfizierte Zellen verschieden Interferone, die antivirale Abwehrmechanismen induzieren. F\u00fcr die angeborene zellul\u00e4re  Immunantwort ist eine Vielzahl von \nunterschiedlichen Leukozyten-Subpopulationen verantwortlich, wie Makrophagen, \nGranulozyten und NK-Zellen (Ellis, 2001; Litman, Cannon, & Dishaw, 2005). Makrophagen dienen als zentrale Schaltstelle des Immunsystems, da sie \nKrankheitserreger aufnehmen und deren Abbauprodukte an Zellen des adaptiven \nImmunsystems pr\u00e4sentieren. Dabei produzie ren sie eine Vielzahl von Botenstoffen \ndie zur Regulation der angeborenen und ad aptiven Immunantwort beitragen (Vallejo \net al., 1992). Gelingt es den Krankheitserregern, die Barrieren der angeborenen \nImmunit\u00e4t zu \u00fcberwinden, greift das adapti ve Immunsystem.  Hierzu geh\u00f6ren die von \nPlasmazellen gebildeten Antigen-spezifisch en Immunglobuline (humorale Immunit\u00e4t) \nsowie zytotoxische T-Zellen und T-Helferzellen mit ihren Antigen-spezifischen T-\nZellrezeptoren (zellvermittelte Immunit\u00e4t). Zytotoxische T-Zellen sind in der Lage, virusinfizierte Zellen, die virale Peptide an  der Oberfl\u00e4che pr\u00e4sentieren, zu lysieren \nund somit die Virusvermehrung zu hemmen (Ellis, 2001). B- und T-Zellen spielen \u00a0 Einleitung \u00a0\n15\u00a0\n\u00a0durch die Generierung von Ged\u00e4chtniszellen  auch eine wichtige Rolle beim Schutz \nvor wiederkehrenden Infektionen (Ellis, 2001).  \nImmunglobuline oder Antik\u00f6rper sind gro\u00df e, Y-f\u00f6rmige Proteine, die haupts\u00e4chlich \nvon Plasmazellen produziert werden und mit ihren variablen Regionen an antigene Strukturen von Krankheitserregern wie Bakt erien und Viren binden. Damit k\u00f6nnen sie \nErreger einerseits direkt oder im Zusa mmenspiel mit Komplement neutralisieren \nbzw. f\u00fcr deren weitere Degradation aufb ereiten (Luttmann et al., 2006; Murphy, \n2012).\n\u00a0 \n\u00a0\n\u00a0\nAbbildung 4: Aufbau von Immunoglobulinen \u00a0(Mashoof & Cris citiello, 2016) \n \nDer humorale Teil des adaptiven Immunsystems wird bei Fischen durch die drei \nImmunglobulin-Klassen IgM, IgD und IgT repr\u00e4sentiert (Whyte, 2007). Bei Fischen \nkommt es allerdings zu keiner gezielten Rekombination in den Genen der schweren \nImmunglobulinketten und damit auch zu keinem sogenanntem \nImmunglobulinklassenswitch w\u00e4hrend der B-Zellreifung. Au\u00dferdem fehlen bei Fischen die Fc \u03b5-, Fc\u03b1- bzw. Fc \u03b3-Rezeptormolek\u00fcle, an welche die Ig-Isotypen von \nS\u00e4ugern mit dem Fc-Teil der schweren Kett e binden, was eine Spezialisierung auf \nantiparasit\u00e4re (IgE), Schleimhaut- (IgA) bzw. serumspezifische (IgG) Effektorfunktionen ausschlie\u00dft. Bei Fischen liegt deshalb wahrscheinlich keine \ngewebe- oder erregerspezifische Spezialisierung der Immunglobuline  vor\n\u00a0(Akula, \nEinleitung \u00a0\n16\u00a0\n\u00a0Mohammadamin, & Hellman, 2014; Wakae et al., 2006). IgM ist eine oligomere Form \nvon Antik\u00f6rpern die \u00fcber Disulfidbr\u00fccke n bei S\u00e4ugern Pentamere und bei Fischen \nTetramere bilden. IgM ist der initiale Antik\u00f6rpertyp, der nach einer  Infektion als \nReaktion auf die Antigen-Exposition auftri tt (Luttmann et al., 2006). Zun\u00e4chst galt \nIgM als die einzige Immunglobulinklasse bei  Knochenfischen, bis bei \nRegenbogenforellen  und Zebrafischen neua rtige, als IgT bzw. IgZ bezeichnete  \nImmunglobuline entdeckt wurden (Hanse n, Landis, & Phillips, 2005; Sunyer, 2013). \nSp\u00e4tere Studien zeigten, dass IgT eine Schl \u00fcsselrolle bei der Immunreaktion der Haut \nund der Kiemenschleimhaut spielt (Parra, Korytar, Takizawa, & Sunyer, 2016). Das \nImmunglobulin D (IgD) ist ein membranst\u00e4ndig er Antik\u00f6rper-Isotyp, der w\u00e4hrend der  \nReifung von  B-Zellen durch alternatives mRNA-Splei\u00dfen mit IgM koexprimiert wird \n(Chen et al., 2009). Die genaue  Funktion von IgD ist bisl ang noch nicht bekannt.  \n \n \nAbbildung 5: Aufbau von Immunoglobulin M - Nach (Hordvik, 2015; Luttmann et al., 2006) \n ? = Art der Wechselwirkungen zwischen den Untereinheiten ist nicht bekannt. \n \nIgM und IgT werden durch sekretierende B- Zellen bzw. Plasmazellen produziert und \n\u00fcber polymere Immunoglobulinrezeptor en aus dem Epithel in die luminale \nSchleimschicht v. a. des Darmes transporti ert (Parra et al., 2016) wo es mit der \nDarmflora interagiert. In der Lamina pr opria der Schleimh\u00e4ute werden Pathogene \noder deren Bestandteile insbesondere von Makrophagen aufgenommen und an T-\n\u00a0 Einleitung \u00a0\n17\u00a0\n\u00a0Helferzellen pr\u00e4sentiert. Gleichfalls k\u00f6nnen B-Zellen \u00fcber ihre \nOberfl\u00e4chenimmunglobuline solche Antigene binden und bei Fischen auch \nphagozytieren (Sunyer, 2013). Dadurch und durch die stimulierende Wirkung von  \nAntigen-spezifischen T-Helferzellen begi nnen B-Zellen sich zu vermehren und zu \nplasmazellen\u00e4hnlichen Zellen zu differenzieren, die antigenspezifische \nImmunglobuline sezernieren (Parra et al., 2016).  \n Die bedeutendsten immunkompetenten Organe bei Fischen sind Thymus, Niere,  Milz, \nDarm assoziertes lymphatisches Gewebe (GAL T, gut associated lymphoid tissue) und \ndas interbranchiale lymphatische Gewebe (i nterbranchial lymphoid tissue) (Fischer, \nKoppang, & Nakanishi, 2013). Der Thymus is t ein weiteres lymphatisches Organ und \nproduziert vor allem T-Lymphozyten, die zu zytotoxischen T-Zellen und T-\nHelferzellen differenzieren (Bowden, Cook , & Rombout, 2005). Die Kopfniere enth\u00e4lt \nein breites Repertoire an I mmunzellen, darunter  die h\u00f6 chste Konzentration an sich \nentwickelnden B-Lymphozyten und auch  geringe Mengen an Antik\u00f6rper-\nsekretierenden Zellen (Whyte, 2007; Zwollo , Cole, Bromage, & Kaattari, 2005). Die \nMilz fungiert wie bei S\u00e4ugern haupts\u00e4chl ich als sekund\u00e4res Immunorgan, das viele \nreife B-Zellen und, IgM-produzierende Zell en enth\u00e4lt (Zwollo et al., 2005; Zwollo, \nHaines, Rosato, & Gumulak-Smith, 2008). Da Fische keine Lymphknoten haben, spielt wahrscheinlich die Milz eine zentrale Rolle beim sogenannten Antigen-Trapping  \n\u00a0\n(Soleto, Fischer, Tafalla, & Granja, 2018). Als Antigen-Trapping  wird die \nKonzentrierung von Antigenen an der Oberfl\u00e4che von dendritischen Zellen der sekund\u00e4ren lymphatischen Organe be zeichnet, sodass eine Erkennung durch \nimmunkompetente Zellen erfolgen kann. Dendritische Zellen sind auch bei Fischen \nbeschrieben worden (Soleto et al., 2018).   \n\u00a0\u00a0 Zielsetzung \u00a0\n19\u00a0\n\u00a02. Zielsetzung \n \nIn den 1990er Jahren wurde die KHV-infektion erstmals in Israel und Europa als eine \nneuartige Infektionskrankheit von Kois und Karpfen beobachtet und hat sich \nmittlerweile weltweit ausgebreitet. Auch in Deutschland wurde die KHV-I im Jahre \n2005 in die Verordnung \u00fcber anzeigepflicht ige Tierseuchen aufgenommen und stellt \neine st\u00e4ndige Bedrohung f\u00fcr die hiesige Karpfen-Population dar, die immer wieder \nzu erheblichen Verlusten f\u00fchrt.  Das Hauptziel dieser Promotionsschrift war es daher, eine stabil abgeschw\u00e4chte, \nsch\u00fctzende und kosteng\u00fcnstige KHV-Lebendvakzine mithilfe gentechnischer \nVerfahren herzustellen. Dar\u00fcber hinaus sollt en Methoden etabliert werden, die eine \ngenetische und serologische Differenzie rung von immunisierten und Wildtyp-KHV \ninfizierten Fischen erlaubten (DIVA-Prinzi p). Die hergestellten Virusrekombinanten \nsollten in vitro  und in vivo  charakterisiert und getestet werden. Hierbei kam es \nbesonders darauf an, dass durch die eingef \u00fcgten Deletionen die Vermehrbarkeit in \nZellkultur nicht signifikant beeintr\u00e4chtigt, die Virulenz in Karpfen jedoch deutlich \nreduziert wurde. Neben diesen praktischen Aspekten sollten die im Rahmen dieser Arbeit gewonnenen Erkenntnisse auch zu einem besseren allgemeinen Verst\u00e4ndnis \nder Biologie der bislang wenig charakterisierten Familie der Alloherpesviridae  \nbeitragen.  \u00a0 Publikationen \u00a0\n21\u00a0\n\u00a03. Publikationen \n\u00a0\n3.1. Publikation I \n\u00a0\n\u201cGeneration of a potential koi herpesvirus live vaccine by \nsimultaneous deletion of the vi ral thymdine kinase and dUTPase \ngenes\u201d \nLars Schr\u00f6der, Sandro Klafack, Sv en M. Bergmann, Dieter Fichtner, \nYeonhwa Jin, Pei-Yu Lee, Dirk H\u00f6pe r, Thomas C. Mettenleiter, Walter \nFuchs \n \nPubliziert in Journal of General Virology \n  Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39Generation of a potential koi herpesvirus live vaccine by\nsimultaneous deletion of the viral thymidine kinase and\ndUTPase genes\nLars Schr\u00f6der,1Sandro Klafack,2Sven M. Bergmann,2Dieter Fichtner,2Yeonhwa Jin,2Pei-Yu Lee,3Dirk H\u00f6per,4\nThomas C. Mettenleiter1and Walter Fuchs1,*\nAbstract\nKoi herpesvirus (KHV, Cyprinidherpesvirus 3 ) causes a fatal disease of koi and common carp. To obtain safe and efficacious\nlive vaccines, we generated deletion mutants of KHV lacking the nonessential genes encoding two enzymes of nucleotide\nmetabolism, thymidine kinase (TK, ORF55) and deoxyuridine-triphosphatase (DUT, ORF123). Since single-deletion mutants\nbased on a KHV isolate from Israel (KHV-I) only exhibited partial attenuation (Fuchs W, Fichtner D, Bergmann SM,\nMettenleiter TC. Arch Virol 2011;156 : 1059 \u20131063), a corresponding double mutant was generated and tested in vivo , and\nshown to be almost avirulent but still protective. To overcome the low in vitro virus titres of KHV-I ( /C20105p.f.u. ml/C01), single\nand double TK and DUT deletions were also introduced into a cell culture-adapted KHV strain from Taiwan (KHV-T). The\ndeletions did not affect in vitro virus replication, and all KHV-T mutants exhibited wild-type-like plaque sizes and titres\nexceeding 107p.f.u. ml/C01, as a prerequisite for economic vaccine production. Compared to wild-type and revertant viruses,\nthe single-deletion mutants of KHV-T were significantly attenuated in vivo , and immersion of juvenile carp in water containing\nhigh doses of the double mutant caused almost no fatalities. Nevertheless, the deletion mutants induced similar levels of\nKHV-specific serum antibodies to the parental wild-type virus, and conferred solid protection against disease after challenge\nwith wild-type KHV. For the convenient differentiation of DNA samples prepared from gill swabs of carp infected with wild-\ntype and TK-deleted KHV we developed a triplex real-time PCR. Thus, KHV-T DDUT/TK might be suitable as a genetic DIVA\nvaccine in the field.\nINTRODUCTION\nIn the late 20th century a previously unknown virus infec-\ntion led to mass mortality of koi and common carp ( Cypri-\nnus carpio ) in Israel and Europe. The causative agent was\nidentified as a herpesvirus and designated as carp nephritis\nand gill necrosis virus (CNGNV) or koi herpesvirus (KHV)\n[1\u20134]. During the following years this virus spread across\nmajor parts of the world and caused considerable losses in\nfood and ornamental fish [5]. DNA sequencing of three\nvirus isolates from the United States, Israel and Japan\nrevealed an approximately 295 kbp type A herpesvirus\ngenome containing 22 kbp direct repeat sequences at both\ntermini and 156 different open reading frames (ORFs) [6].\nSequence analyses further demonstrated a close relationship\nto carp pox virus ( Cyprinid herpesvirus 1 ) and goldfishhaematopoietic necrosis virus ( Cyprinid herpesvirus 2 ), and,\ntherefore, KHV was classified as Cyprinid herpesvirus 3\n(CyHV-3 ) within the genus Cyprinivirus in the family Allo-\nherpesviridae and the order Herpesvirale s [7] (https://talk.\nictvonline.org/taxonomy/).\nBecause of the economic relevance of KHV disease, safe,\nefficacious and, at least for common carp, affordable vac-\ncines are urgently needed. In the first attempts, inactivated\nKHV preparations and attenuated live virus vaccines\nobtained after cell culture passage and/or UV irradiation of\nvirulent KHV were evaluated [4, 8]. Although the latter\nproved to be useful, the molecular basis for their attenuation\nremained unclear, which meant that there was a risk of\nreversion to a more virulent phenotype. Furthermore, these\nvaccines did not support the differentiation of naturally\nReceived 27 June 2018; Accepted 23 August 2018\nAuthor affiliations:1Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany;2Institute of\nInfectology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany;3GeneReach Biotechnology Corporation, Taichung, Taiwan, ROC;4Institute of\nDiagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.\n*Correspondence: Walter Fuchs, walter.fuchs@fli.de\nKeywords: koi herpesvirus; Cyprinid herpesvirus 3; vaccine; thymidine kinase; dUTPase.\nAbbreviations: CCB, common carp brain cells; Ct, cycle threshold; CyHV-3, Cyprinid herpesvirus 3; DIVA, differentiation of infected from vaccinated ani-\nmals; DUT, dUTPase; FBS, foetal bovine serum; IIF, indirect immunofluorescence; KHV, koi herpesvirus; KHV-T, KHV strain Taiwan; MEM, minimum\nessential medium; qPCR, quantitative real-time PCR; TK, thymidine kinase.RESEARCH ARTICLE\nSchr\u00f6der et al.,Journal of General Virology\nDOI 10.1099/jgv.0.001148\n001148 \u00e32018 The Authors\n1Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39infected from vaccinated animals (the DIVA principle [9]).\nTherefore, candidate subunit or DNA vaccines containing\nor encoding single envelope glycoproteins of KHV, such as\npORF25 or pORF81, have been developed, and have been\nshown to induce protective immune responses [10 \u201312]. On\nthe other hand, defined gene deletions have been introduced\nby targeted mutagenesis of the KHV genome cloned as a\nbacterial artificial chromosome in Escherichia coli [13], or\nby homologous recombination in permissive carp cell cul-\ntures [14], to obtain engineered live vaccines. Interestingly,\nthe deletion of several genes encoding nonessential envelope\nglycoproteins of KHV did not lead to sufficient attenuation\nof the virus in carp, while in the case of pORF25 it signifi-\ncantly reduced its protective efficacy against wild-type chal-\nlenge [15]. In contrast, the deletion of two nonessential\nKHV genes of unknown function, ORF56 and ORF57, or of\nORF57 alone, led to complete attenuation and efficient pro-\ntection against challenge [16, 17].\nIn many mammalian and avian herpesviruses homologues\nof cellular enzymes involved in nucleotide metabolism such\nas thymidine kinase (TK) and deoxyuridine triphosphatase\n(DUT) have been shown to be dispensable for virus replica-\ntion in vitro , but identified as important virulence factors in\nvivo [18\u201322]. Attenuation was also demonstrated for a TK\ngene-deleted mutant of channel catfish virus, which is a\nmember of the Alloherpesviridae [23]. TK (ORF55) and\nDUT (ORF123) gene-deleted KHV recombinants were also\nshown to be unaffected in cell culture and attenuated in\nvivo. However, attenuation was incomplete, and single-\ndeletion mutants still caused significant mortality in juvenile\ncarp [13, 14]. We therefore generated a TK and DUT gene\ndouble-deletion mutant of a virulent KHV isolate from\nIsrael (KHV-I) [2], which retained wild-type-like in vitro\nreplication [14]. However, the parental virus and its deriva-\ntives, like most field isolates of KHV, only reached titres of\nless than 105p.f.u. ml/C01in cell culture, and the stability of\nthe infectious virus at 25/C14C, as well as after freeze-thawing,\nwas very limited [14].\nSince these properties would not permit economical vaccine\nproduction, we introduced the same TK and DUT gene\ndeletions into the genome of a cell culture-adapted, but still\nconsiderably virulent, KHV strain from Taiwan (KHV-T)\n[24]. The in vitro replication properties of the new single-\nand double-deletion mutants of KHV-T were analysed, and\nanimal experiments were performed to determine virulence\nand protective efficacy of the KHV-T-derived viruses, as\nwell as of the KHV-I-derived double-deletion mutant in\ncommon carp. Sera collected after vaccination and challenge\ninfection were investigated for KHV-specific antibodies\nusing a recently developed KHV antibody enzyme-linked\nimmunosorbent assay (ELISA) [25]. We further developed a\nnew TK gene-specific quantitative real-time PCR (qPCR)\nthat could be combined with the described ORF89-specific\n[26] and control qPCRs [27]. Using this triplex qPCR the\nsuitability of TK plus DUT gene-deleted KHV recombinants\nas genetic DIVA vaccines was evaluated.RESULTS AND DISCUSSION\nGeneration and genomic characterization of KHV\nTK and DUT gene mutants\nWe have previously generated and characterized TK\n(ORF55) and DUT (ORF123) single- and double-gene dele-\ntion mutants of one of the first described KHV isolates from\nIsrael (KHV-I) [14, 28]. In the present study, we introduced\nidentical deletions into the genome of the cell culture-\nadapted strain KHV-T [24]. To this end, a non-neuronal\ncommon carp brain (CCB) cell line [3] was cotransfected\nwith genomic KHV-T DNA and transfer plasmids contain-\ning PCR-amplified and subsequently mutagenized genome\nfragments of the same virus strain (Fig. 1a \u2013c). To facilitate\nthe selection of virus mutants resulting from homologous\nrecombination, a GFP reporter gene cassette was inserted\ninstead of the deleted viral sequences, and fluorescent foci\nof cells infected with the transfection progenies were iso-\nlated. To allow additional gene deletions using the same\nreporter gene and to avoid possible adverse effects of the\ntransgene, DNA of the plaque-purified GFP-expressing\nKHV mutants was prepared and used for cotransfections of\nCCB cells together with TK and DUT gene deletion plas-\nmids lacking foreign sequences (Fig. 1b, c), and non-\nfluorescent progeny virus plaques were selected. In a similar\nmanner, TK and DUT rescuants were generated from the\nGFP-expressing single-gene deletion mutants. To obtain the\nTK and DUT double-deletion mutants of KHV-T and\nKHV-I, the GFP cassette was consecutively inserted and\nremoved at both loci. All of the desired virus recombinants\ncould be purified to homogeneity after a few ( /C204) rounds of\nplaque isolation. To verify the desired mutations of the TK\nand/or DUT genes, the affected genome regions were ampli-\nfied from viral DNA by PCR and sequenced using the\nprimer pairs KTK-PSF/PSR and KDUT-PSF/PSR (Table 1)\n[14]. The obtained PCR products of all KHV mutants\nexhibited the expected sizes (Fig. 1d, e) and sequences.\nThese studies confirmed that all of the respective deletion\nmutants lacked codons 36 to 270 of the DUT gene (Fig. 1c),\nencoding major parts of the conserved functional domain of\ntrimeric dUTPases (amino acids 30 to 119) [29]. The dele-\ntion from the TK gene included codons 43 to 187 and, thus,\nthe predicted (https://prosite.expasy.org) ATP-binding site\n(amino acids 9 to 16) was retained, but the highly conserved\nC-terminal TK signature domain (amino acids 162 to 175)\nwas missing (Fig. 1b). Furthermore, after removal of the\nGFP-cassette, the short retained 3 \u00a2parts of both ORFs were\nfused out of frame to the 5 \u00a2parts. Therefore, no functional\nthymidine kinase and/or dUTPase could be expressed by\nany of the generated KHV mutants. The presence of the\ndesired mutations and the genetic homogeneity of the KHV\nrecombinants was further confirmed by restriction endonu-\nclease digestions of genomic DNA and Southern blot\nhybridization with TK and DUT gene-specific probes\n(results not shown).Schr\u00f6der et al.,Journal of General Virology\n2Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39Genome sequence of KHV-T DDUT/TK\nNext-generation sequencing of the genome of KHV-\nTDDUT/TK confirmed that it is a derivative KHV-T, whose\ncomplete genome sequence has been published recently\n(GenBank accession # MG925491) [30]. Whereas theterminal direct repeat sequences of both viruses proved to\nbe identical, few alterations or ambiguities were found\nwithin the central unique region (Table 2). Two of them\naffected the length of presumably noncoding homopoly-\nmeric G stretches (positions 102598 and 124177), and seven\nothers represented altered copy numbers of perfect or\nFig. 1. Construction and genetic characterization of KHV-T recombinants. (a) Map of the KHV genome, with arrows indicating the local-\nizations of direct terminal repeat sequences, and of the TK (ORF55) and DUT (ORF123) genes. Enlarged maps of the (b) TK and (c) DUT\ngene regions illustrate plasmid cloning and mutagenesis. Viral ORFs (pointed rectangles) and predicted transcripts (dotted arrows), as\nwell as relevant restriction sites. are shown. Major parts of the TK (red) or DUT (blue) ORFs were either deleted or replaced by an\nEGFP (green) expression cassette containing the human cytomegalovirus immediate early promoter (P-CMV) and bidirectional polyade-\nnylation signal of simian virus 40 (A+). The precise extensions of the deletions and the codon ranges of conserved functional thymidine\nkinase and dUTPase domains (see text) are indicated. Designations of plasmids and resulting virus recombinants (in Italics) are given\nat the right. The (d) TK and (e) DUT genes of relevant KHV-T recombinants were amplified from genomic DNA by PCR using the pri-\nmers KTK-PSF and -PSR, or KDUT-PSF and -PSR (Table 1), and separated on a 1.5 % agarose gel. The sizes of the 1 kb Plus DNA lad-\nder (Thermo Fisher Scientific) and the calculated sizes of the expected products are indicated.Schr\u00f6der et al.,Journal of General Virology\n3Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39imperfect tandem repetitions of short sequence elements\n(Table 2). Three of these alterations were located within the\nviral ORFs 45, 52 and 149, and therefore enlarged or short-\nened the deduced proteins. However, since the length of the\ninserted or deleted repeat elements was always a multiple of\nthree, no frameshifts occurred. It has long been known that\nvariable numbers of tandem repeats (VNTRs) are present in\nmany herpesvirus genomes and they have also been found\nby the comparison of different KHV strains and isolates [6,\n30]. The analysis of individual sequence reads from theKHV-T DDUT/TK genome strongly indicated that the used\ntemplate DNA prepared from a plaque-purified virus\nrecombinant already contained different variants of most of\nthese repetitive sequences. Thus, the suitability of such poly-\nmorphisms for the differentiation of KHV isolates might be\nlimited, although the predominant repeat copy numbers\nappear to be stable over several in vitro orin vivo virus pas-\nsages [31, 32]. In contrast to the ambiguities regarding tan-\ndem repeats, two single base substitutions were\nunambiguously found in KHV-T DDUT/TK whenTable 1. PCR and sequencing primers and TaqMan probes used in this study\nSequences refer to the sequences of the KHV TUMST1 genome [6] (GenBank accession no. AP008984) or of pEGFP-1 [43] (GenBank accession no.\nU55761). Reverse strand primers (r) and modifications are indicated.\nName Sequence Genome position Modifications\nKTKR-F 5 \u00a2-TAGCCGTACAGGGGACAC-3 \u00a2 94 386 \u201394 403 \u2013\nKTK-PSF 5 \u00a2-TGGAGCGTCTGTCCTACAGC-3 \u00a2 96 073 \u201396 092 \u2013\nKTKR-R 5 \u00a2-AGGTGATTTCGGTCATGAGC-3 \u00a2 98 473 \u201398 492 (r) \u2013\nKTK-PSR 5 \u00a2-ACAAGAACGAGGTGGAGCG-3 \u00a2 96 620 \u201396 638 (r) \u2013\nKDUTR-F 5 \u00a2-CCTACACCGCTCTGTTCG-3 \u00a2 214 403 \u2013214 420 \u2013\nKDUT-PSF 5 \u00a2-AGTTTTCAATGTGGCAGGC-3 \u00a2 216 565 \u2013216 583 \u2013\nKDUTR-R 5 \u00a2-AGAAACTGAGATCATCGCGG-3 \u00a2 219 310 \u2013219 329 (r) \u2013\nKDUT-PSR 5 \u00a2-AATACAGCTACAATTGCGGG-3 \u00a2 217 402 \u2013217 421 (r) \u2013\nKHV-86F 5 \u00a2-GACGCCGGAGACCTTGTG-3 \u00a2 165 351 \u2013165 368 \u2013\nKHV-163R 5 \u00a2-CGGGTTCTTATTTTTGTCCTTGTT-3 \u00a2 165 405 \u2013165 428 (r) \u2013\nKHV-109P 5 \u00a2-CTTCCTCTGCTCGGCGAGCACG-3 \u00a2 165 374 \u2013165 395 (r) 5 \u00a2: FAM, 3 \u00a2: TAMRA\nKHVTKQ-F 5 \u00a2-ACTTTATGCAGCAGCCCTTC-3 \u00a2 96 340 \u201396 359 \u2013\nKHVTKQ-R 5 \u00a2-CACTTCATGCACACCGCC-3 \u00a2 96 410 \u201396 427 (r) \u2013\nKHVTKQ-S 5 \u00a2-CCCATGGCGGACAAGCTGGACAAG-3 \u00a2 96 381 \u201396 404 5 \u00a2: Cy 5, 3 : BHQ-2\nEGFP15-F 5 \u00a2-GAGCAAGGGCGAGGAGC-3 \u00a2 102 \u2013118 \u2013\nEGFP10-R 5 \u00a2-CTTGTACAGCTCGTCCATGC-3 \u00a2 794 \u2013813 (r) \u2013\nEGFP-HEX 5 \u00a2-AGCACCCAGTCCGCCCTGAGCA-3 \u00a2 703 \u2013724 5 \u00a2: HEX, 3 \u00a2: BHQ-1\nTable 2. Sequence analysis KHV-T DDUT/TK compared to KHV-T\nNucleotide positions of alterations in KHV-T DDUT/TK refer to the sequence of the KHV-T genome (GenBank accession no. MG925491) [30]. The\ndeleted nucleotide rages are indicated, and the two flanking nucleotides are provided at insertion sites. The designations of affected ORFs, nucleotide\nsequences of insertions (+) or deletions ( D) and consequences for deduced amino acid sequences, including codon positions, are given. Targeted\nmutations that are unique to KHV-T DDUT/TK are in bold.\nPosition in KHV-T ORF Alteration\n37986 \u201338 007 \u2013 DGTGTGTGTGTGTGTGTGTGTGT\n75907 \u201375 915 45 DAGGAGGTGG ( DGGG at codon 336)\n91247/91248 52 +AACCACCGAGGA (+TTEE at codon 158)\n96099 \u201396 532 55 DTK gene (from codon 43)\n102598 \u2013 +G\n124177 \u2013 +G\n138261 72 A \ufb01C (K \ufb01N at codon 103)\n177575 \u2013177594 \u2013 DAGAGAGAGAGAGAGAGAGAG\n216478/216479 \u2013 +CTCAGCACCTTCAGCACCTTCAGCACCTTCAGCACCTTCAGCAC\n216585 \u2013217288 123 DDUT gene (from codon 36)\n256452/256453 149 +TGTCGTGCTTGGTGTGGTTGGGGTCGAAGTCGTACTTGG (+PSTTSTPTTPSTT at codon 513)\n257991 \u2013 T\ufb01C\n270671 \u2013270685 \u2013 DCGACACAGACTACAGSchr\u00f6der et al.,Journal of General Virology\n4Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39compared to the published KHV-T sequence (positions\n1238261 and 257991), with one of them leading to an amino\nacid substitution in the ORF72 product (Table 2). Remark-\nably, the same bases that had been found in KHV-T DDUT/\nTK were also found in other KHV-T derivatives in our labo-\nratory, and in the closely related Japanese isolate KHV-J or\nTUMST1 (GenBank accession no. AP008984) [6]. Thus, the\nbase substitutions obviously occurred during propagation of\nKHV-T by Guo and coworkers. Nevertheless, the only sig-\nnificant differences between KHV-T DDUT/TK and the\npublished sequence of KHV-T were the expected deletions\nof ORFs 55 and 123, encoding TK or DUT, respectively\n(Table 2). Taken together, our sequence analyses did not\nprovide any evidence for unwanted mutations affecting the\nin vitro orin vivo phenotype of KHV-T DDUT/TK com-\npared to KHV-T. Furthermore, we were able to confirm\nmost of the gene alterations in KHV-T acquired during cell\nculture adaptation, including the frameshift in ORF27,\nwhich is considered to be relevant for its lower virulence\ncompared to certain field isolates [30]. However, since sev-\neral other KHV strains and isolates possess similar muta-\ntions, the precise reason for the exceptional replication of\nKHV-T in cell culture remains to be elucidated.\nIn vitro replication properties of KHV TK and DUT\ngene mutants\nTo investigate the cell-to-cell spread of the KHV-T derived\nmutants compared to the parental strain, CCB cells were\ngrown to monolayers in 24-well plates, infected in parallel\nwith serial dilutions of all viruses and incubated for 4 days\nunder plaque assay conditions at 25/C14C. The infected cells\nwere identified by indirect immunofluorescence (IIF) tests\nand the plaque areas were determined microscopically,\nrevealing that all TK and/or DUT deletion mutants, irre-\nspective of the presence or absence of the GFP reporter\ngene, as well as the rescuants, formed plaques ranging from\napproximately 85 to 95 % of the wild-type size (Fig. 2a). The\nobserved minor differences were not statistically significant.\nAfter the synchronized infection of CCB cells at an m.o.i. of\n0.1 the replication kinetics also showed wild-type-like\ncourses for all of the investigated KHV-T recombinants and\nresulted in maximum titres of between 5 /C2106and 2/C2107p.\nf.u. ml/C01in total cell lysates (Fig. 2b). Thus, in line with pre-\nvious in vitro investigations of TK and DUT gene-deleted\nKHV mutants [13, 14], our present studies confirmed that\nboth genes are fully dispensable for virus replication in tis-\nsue culture. The newly prepared GFPless TK and DUT gene\ndouble-deletion mutant of KHV-I also exhibited similar\ngrowth properties to the corresponding wild-type virus and\nthe described deletion mutants (results not shown). How-\never, the maximum titres of all KHV-I-derived viruses on\nCCB cells were only approximately 105p.f.u. ml/C01, and\ndecreased rapidly if incubation at 25/C14C was further contin-\nued [14]. The molecular reasons for these differences in rep-\nlication rates and virion stability in vitro remain to be\nelucidated. However, for economic reasons, KHV-T derivedrecombinants are apparently more suitable as putative live\nvaccines than derivatives of KHV-I.\nVirulence and protective efficacy of TK and DUT\ngene deleted KHV mutants\nPrevious animal experiments have shown that single dele-\ntions of the TK or DUT genes of KHV lead to significant\nbut insufficient attenuation [13, 14]. Since both genes\nseemed to contribute to the virulence of KHV-I, we tested a\ncorresponding double-deletion mutant of KHV-I in vivo .\nTo this end, groups of 48 1-year-old specific pathogen-free\ncarp were infected either by immersion in water containing\n1.5/C2102plaque-forming units (p.f.u.) ml/C01or by intraperi-\ntoneal (i.p.) administration of 2 /C2103p.f.u. of either KHV-\nIDTK/DUT or KHV-I per animal. Whereas no clinical signs\nwere observed after immersion, few fish developed moder-\nate symptoms (mainly skin lesions) after the injection of\nKHV-I DTK/DUT, and three of them (6 %) died (Fig. 3a). In\ncontrast, control animals infected with similar doses of viru-\nlent KHV-I developed severe clinical signs, including gill\nnecrosis, haemorrhages at the fins and neurological disor-\nders, and 48 or 60 % of the carp succumbed to infection\n(Fig. 3a). As expected, these differences between the mortal-\nity rates caused KHV-I DTK/DUT and wild-type virus\nproved to be statistically significant according to Fisher \u2019s\nexact test ( P<0.001). After 50 days, all carp that had sur-\nvived primary infection, as well as the mock-infected con-\ntrol animals, were challenged by immersion in water\ncontaining 1.5 /C2102p.f.u. ml/C01KHV-I. Whereas the na\u00efve\ncarp groups developed severe disease leading to mortality\nrates of 50 %, the wild-type-primed fish were widely pro-\ntected, and only one, representing 4 or 5.5 % of each group,\ndied after challenge, possibly still as a consequence of the\nprimary infection with KHV-I (Fig. 3b). The results\nobtained with the KHV-I DTK/DUT-vaccinated animals\nwere more inhomogeneous. Whereas the i.p. immunized\ncarp were completely protected, the group immunized by\nimmersion exhibited nearly 15 % mortality. Although the\nprotection level of this group compared to non-vaccinated\ncontrol animals was still significant ( P<0.001), it was also\nsignificantly ( P<0.05) lower than that of the i.p.-immunized\ngroup. Thus, the virus dose used for vaccination by immer-\nsion might have been too low to achieve a sufficient\nimmune response in all animals. However, in view of the\nlow titres of KHV-I-derived viruses in cell culture (see\nabove), production of the virus for the administration of\nhigher live vaccine doses to huge carp populations by\nimmersion would be prohibitively expensive. On the other\nhand, individual administration of the vaccines by injection\nrequires less virus, but is more laborious.\nTherefore, we tested the novel TK and DUT gene double-\ndeletion mutant based on the cell culture-adapted strain\nKHV-T (KHV-T DDUT/TK). To verify the previously\ndescribed effects of single deletions of TK or DUT on the\nvirulence of KHV [13, 14] corresponding deletion mutants\n(KHV-T DTK, KHV-T DDUT) and rescuants (KHV-TTKR,\nKHV-TDUTR) of KHV-T were also included in the secondSchr\u00f6der et al.,Journal of General Virology\n5Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39animal trial. Six groups consisting of 40 9-month-old and 5\n2-year-old carp each were infected by immersion in water\ncontaining 5 /C2103p.f.u. ml/C01of the virus mutants or KHV-\nT. Between days 8 and 26 after wild-type infection 17 of the\njuvenile carp died, resulting in a total mortality rate of\n42.5 % (Fig. 4a, b). In contrast, only three fish, representing\n7.5 % of each of the groups infected with KHV-T DTK or\nKHV-T DDUT, perished, and in KHV-T DDUT/TK-infected\nanimals the mortality rate was further reduced to 5 %, or\ntwo individuals (Fig. 4a, b). These differences were statisti-\ncally significant according to Fisher \u2019s exact test ( P<0.001).\nIn line with this, only a few of the KHV-T DDUT/TK-\ninfected fish exhibited moderate skin alterations and\nenhanced mucus production, whereas the KHV-T-infected\ngroup developed clinical symptoms that were similar to\nthose observed after KHV-I infection (see above). Therelevance of the TK and/or DUT gene deletions for the\nobserved attenuation was demonstrated by significantly\nincreased mortality rates [22.5 % ( P<0.1) or 35 % ( P<0.05)]\ninduced by the rescuants KHV-TTKR or KHV-TDUTR,\nrespectively. The moderate reduction of mortality compared\nto wild-type infection was not significant ( P=0.49) in the\ncase of KHV-TDUTR, and only weakly significant ( P=0.06)\nin the case of KHV-TTKR. However, a slight attenuation\ncaused by accidental mutations at other gene loci cannot be\nruled out at the moment. The 2-year-old fish used for the\npreparation of gill swab and serum samples seemed to be\nmore resistant against lethal KHV infection, since only one\nof the five KHV-T- and KHV-TDUTR-infected ones died,\nand no fatalities were observed in the other groups.\nFour weeks after immunization or primary infection all sur-\nviving fish were challenged by immersion in water\nFig. 2. Replication of the generated KHV-T recombinants in CCB cells. (a) Plaque areas were determined 4 days after infection and\ncompared to those of the parental KHV-T (WT), which were set as 100 %. The mean sizes of 30 plaques per virus and standard devia-\ntions are indicated. (b) For growth kinetic studies the cells were infected at an m.o.i. of 0.1, and at indicated times after infection total\nprogeny virus titres were determined by plaque assays. The mean results of three independent experiments, including two parallel\nsamples of each virus, are shown. The same colours were used for the individual viruses in (a) and (b), as well as in Fig. 4.Schr\u00f6der et al.,Journal of General Virology\n6Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39containing 5 /C2103p.f.u. ml/C01of wild-type KHV-T. None of\nthe immunized groups developed apparent clinical symp-\ntoms, and no fatalities were observed (Fig. 4c). Only one\nmore carp of the wild-type control group died soon (4 days)\nafter challenge, presumably still as a consequence of primaryinfection. Thus, unlike in the first trial with KHV-I DTK/\nDUT, a single vaccination of juvenile carp by immersion\nwith a 20-fold higher dose of KHV-T DDUT/TK, as well as\nwith the corresponding single mutants, conferred complete\nprotection against homologous challenge infection. At the\nchosen age (approximately 9 months) carp are usually dis-\ntributed to ponds after the first hibernation, providing an\nexcellent opportunity for vaccination.\nInterestingly, the single mutants KHV-T DTK and KHV-\nTDDUT proved to be less virulent than the corresponding\nmutants of KHV-I [14], which might be due to the generally\nlower virulence of KHV-T [30]. Although in our studies the\nattenuation of KHV-T appeared to be less pronounced (see\nFigs 3 and 4) than that described by others, it remains to be\ninvestigated whether the protection achieved by KHV-T\nmutants against challenge with heterologous, more virulent\nKHV isolates (e.g. KHV-I) is also sufficient. However, in\nview of the high degree of genetic identity (>99 %) between\nthese KHV isolates [6, 30], cross-protection is to be\nexpected.\nELISA detection of KHV-specific serum antibodies\nSera were prepared from blood samples from the 2-year-old\ncarp in the second animal trial, taken prior to, and 2 as well\nas 4 weeks after, primary infection with the different KHV\nrecombinants and KHV-T challenge, respectively. The sera\nwere tested at dilutions of 1 : 300 by a previously described\n[25] in-house antibody ELISA using sucrose gradient-\npurified KHV virions as the antigen (Fig. 5). As in previous\nexperiments, the substrate reactions of sera from uninfected\ncarp were below 0.2 OD 450nm units, which was defined as\nthe cut-off level. In contrast, all tested sera from carp\ninfected with either virus mutant showed positive reactions,\nindicating the presence of KHV-specific antibodies. The\nmean antibody titres increased from 2 to 4 weeks after pri-\nmary infection (Fig. 5). Although the titres varied moder-\nately between the different groups, no clear correlation with\nthe virulence of the respective KHV variants could be\nobserved. After 2 weeks, similar amounts of antibodies were\nfound in carp immunized with the most attenuated mutant\nKHV-T DDUT/TK and in wild-type KHV-T-infected fish\n(Fig. 5). The antibody titres detected 2 (Fig. 5) and 4 weeks\n(not shown) after challenge were similar to those detected\nbefore. This indicated that replication of the challenge virus\nwas limited and did not further enhance the humoral\nimmune response. Thus, at least with respect to antibody-\nmediated protection, a single live virus vaccination seems to\nbe sufficient.\nAnalysis of gill swabs with a KHV-specific\nmultiplex real-time PCR\nPrevious studies have demonstrated that considerable\namounts of KHV DNA can be isolated from the gills of\ninfected carp, and that PCR detection after non-lethal swab\nsampling is feasible [26, 33]. Therefore, gill swabs were\ntaken from the 2-year-old carp prior to infection, as well as\n2 weeks after primary infections with either virus, and\nFig. 3. Attenuation and protective efficacy of KHV-I DTK/DUT. (a) Juve-\nnile carp were primarily infected with KHV-I (WT) or KHV-I DTK/DUT by\nimmersion (imm.) in water containing 1.5 /C2102p.f.u. ml/C01(grey bars)\nor by intraperitoneal (i.p.) injection of 2 /C2103p.f.u./animal (black bars).\nControl groups (N.I.) were treated in the same manner with cell culture\nmedium. (b) After 50 days all surviving fish were challenged by\nimmersion in water containing 1.5 /C2102p.f.u. ml/C01of KHV-I. The mor-\ntality rates (%) and the dead and total animal numbers in each group\nare shown.Schr\u00f6der et al.,Journal of General Virology\n7Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39challenge infection with KHV-T, respectively. The extracted\nDNAs were analysed by a newly developed triplex real-time\nPCR, including a described internal control [27], a KHV\nORF89-specific PCR [26] and a novel KHV TK gene-\nspecific reaction. For quantitation of the latter two reactions,\ndefined amounts of DNA prepared from sucrose gradient-\npurified KHV-T particles were used, and the determined\nstandard curves revealed similar sensitivities of /C2030 genomecopies per sample at cycle threshold (Ct) values <32\n(Fig. 6a, b). Ct values >36 were considered to be negative.\nKHV DNA could be detected in all of the four analysed\nswab samples taken after the primary and challenge infec-\ntion of each animal group, whereas the samples from unin-\nfected fish were negative, as expected (Fig. 6c). Two weeks\nafter primary infection with wild-type KHV-T and the\nFig. 4. Attenuation and protective efficacy of KHV-T recombinants. Juvenile carp were primarily infected with KHV-T (WT) or the indi-\ncated virus mutants by immersion in water containing 5 /C2103p.f.u. ml/C01. (a) The survival rates (%) of infected and uninfected animals\n(N.I.) at the indicated times and (b) the cumulative mortalities (%) are shown. (c) After 28 days all surviving fish were challenged by\nimmersion in water containing 5 /C2103p.f.u. ml/C01of KHV-T, and the mortality rates are shown. The numbers of deceased and total ani-\nmals in each group are also indicated.Schr\u00f6der et al.,Journal of General Virology\n8Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39rescuants KHV-TTKR or KHV-TDUTR, the calculated\nmean DNA amounts were approximately 105virus genome\ncopies in reactions, whereas only approximately 104copies\nof KHV-T DDUT, and little more than 102genome copies of\nthe TK gene-deleted mutants KHV-T DTK and KHV-\nTDDUT/TK were detectable (Fig. 6c). This indicated less\nefficient replication of the deletion mutants, and correlated\nwith the observed attenuation of virulence. As expected,\nonly the ORF89-specific qPCR was positive in samples from\ncarp immunized with the TK-negative KHV mutants,\nwhereas in the other samples both the ORF89 and the TK\ngene-specific qPCRs detected similar amounts of viral DNA\n(Fig. 6c). Thus, the newly developed triplex qPCR differenti-\nates animals infected with wild-type KHV from fish immu-\nnized with the TK-negative or doubly deleted virus\nrecombinants, which, therefore, might be used as genetic\nDIVA vaccines.\nTwo weeks after challenge infection the detected amounts of\nviral DNA were generally lower (102to 103genome copies\nin reaction) than after primary infection with virulent KHV\n(Fig. 6c), demonstrating that acquired immune responses\ninhibited KHV replication. However, the viral DNA\ndetected in gill swabs from animals that had been immu-\nnized with KHV-T DTK and KHV-T DDUT/TK not only\nshowed positive reactions in the ORF89-, but also, at asimilar level, in the TK gene-specific PCR. This might have\nbeen due to a non-productive challenge infection with TK-\npositive KHV-T, or, more likely, to limited replication of\nthe challenge virus. Thus, vaccination with TK-negative\nKHV obviously does not confer sterilizing immunity, but is\nsufficient to prevent disease and fatalities after challenge.\nThis would facilitate the detection of inapparent wild-type\ninfections by qPCR even in carp populations that had been\npreviously vaccinated. On the other hand, persistent or\nlatent infection of vaccinated animals with virulent KHV\nmight bear the risk of transmission to na\u00efve carp, which has\nto be evaluated in future cohabitation studies.\nIn summary, our present results confirm earlier studies\nshowing that the TK (ORF55) and DUT (ORF123) genes of\nKHV are completely dispensable for efficient virus replica-\ntion in cell culture, but contribute to virulence in vivo [13,\n14]. Furthermore, our results show that the contributions of\nTK and DUT to virulence of KHV are additive, and that the\ncombined deletion of both proteins results in sufficient\nattenuation of KHV to make it suitable as a live virus vac-\ncine. Presumably, the few fatalities observed after immer-\nsion in high doses of KHV-T DDUT/TK can be overcome by\noptimization of the immunization protocol. Unlike in previ-\nously described classically attenuated KHV live vaccines [4,\n8], the molecular basis for the attenuation of our vaccine\nFig. 5. Detection of KHV-specific antibodies by an ELISA on plates coated with purified virions [25]. Sera of 2-year-old carp were ana-\nlysed before (n.i.), and 2 and 4 weeks after, primary infection (p.i.) with the indicated viruses, as well as 2 weeks after challenge (p.c.)\nwith KHV-T (WT). The mean substrate reaction values (OD 450nm ) and standard deviations of sera from four animals per group, each\nanalysed in duplicate, are shown. Samples showing an OD 450nm of >0.2 (bold line) were considered to be positive. The results from fish\nimmunized with the vaccine candidate KHV-T DDUT/TK are highlighted in dark grey.Schr\u00f6der et al.,Journal of General Virology\n9Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39candidates is unambiguously known, since the relevance of\nTK and DUT for the virulence of KHV has been demon-\nstrated by the generation and in vivo testing of correspond-\ning rescuants. However, similar rescuants cannot arise\nunder natural conditions, since functionally essential parts\nof the coding sequences of both enzymes of nucleotide\nmetabolism have been completely removed from the\ngenomes of our KHV recombinants. Only recombination\nwith wild-type virus could lead to the restoration of the\nDUT and TK genes. For convenient differentiation of the\nmutants from wild-type KHV, we have developedconventional PCR reactions [14], as well as a highly sensi-\ntive TK gene-specific real-time PCR (this study), which is\nsuitable for DNA samples prepared after non-lethal sam-\npling. Thus, KHV-T DDUT/TK supports DIVA diagnosis.\nThis could be also achieved by subunit or DNA vaccines\nagainst KHV [10 \u201312], which might be even safer than stably\nattenuated live vaccines and affordable for ornamental fish.\nHowever, they are not suitable for cost-efficient production\nand mass application to common carp in fish farms. We\nhave now achieved this by using the cell culture-adapted\nvirus strain KHV-T as the backbone for our live vaccine\nFig. 6. Detection of KHV DNA in gill swabs by quantitative multiplex real-time PCR. Standard curves of (a) an ORF89-specific [26], and\n(b) a newly developed TK gene-specific PCR were determined using defined genome copy numbers of KHV-T DNA prepared from puri-\nfied particles. (c) Approximately 200 ng of total DNA prepared from swab samples taken from uninfected carp (n.i.), 2 weeks after pri-\nmary infection (p.i.) with the indicated viruses, and 2 weeks after subsequent challenge (p.c.) with KHV-T (WT), were analysed. The\nmean genome copy numbers in samples from four animals, each calculated from the Ct values of the ORF89- (grey bars) and the TK\ngene-specific (black bars) reactions, are shown.Schr\u00f6der et al.,Journal of General Virology\n10Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39candidates, which grow to significantly higher titres than\nother KHV isolates in different cell culture systems [24].\nThus, the production of sufficient amounts of e.g. KHV-\nTDDUT/TK for vaccination in the field of juvenile carp by\nimmersion should be no problem. Recently, other nonessen-\ntial KHV genes contributing to virulence have been identi-\nfied [15 \u201317]. Although the attenuation achieved by the\nsingle deletion of several genes encoding highly immuno-\ngenic viral envelope glycoproteins [34, 35] was not sufficient\n[15], it is conceivable that the additional deletion of these\ngenes from KHV-T DDUT/TK would abolish its minor\nresidual virulence, and make it suitable as a serological\nDIVA vaccine by the use of available monoclonal antibodies\n[34, 36].\nMETHODS\nViruses and cells\nKHV-I [2], KHV-T [24] and their derivatives were propa-\ngated in CCB cells [3] at 25/C14C in minimum essential\nmedium (MEM) supplemented with 10 % foetal bovine\nserum (FBS). After the appearance of cytopathogenic effects,\nthe infected cultures were lysed by freeze-thawing and\nstored in aliquots at /C080/C14C. For plaque assays, CCB cell\nmonolayers were incubated with serial virus dilutions for\n2 h. Then, the inoculum was replaced by MEM containing\n5 % FBS and 6 g of methylcellulose per litre, and incubation\nat 25/C14C was continued for 3 to 7 days.\nConstruction of deletion plasmids and virus\nrecombinants\nGenomic KHV-T DNA was prepared from infected cell\nlysates as described previously [37]. For the generation of\ntransfer plasmids the TK (ORF55) and DUT (ORF123)\ngene regions were amplified from genomic KHV-T DNA by\nPCR using Pfx DNA polymerase (Thermo Fisher Scientific)\nand the primers KTKR-F and KTKR-R or KDUTR-F and\nKDUTR-R, respectively (Table 1). The obtained 4107 and\n4927 bp PCR products were treated with Klenow polymer-\nase and T4 polynucleotide kinase, and inserted into the\nSmaI-digested vector pBluescript SK( /C0) (Agilent Technolo-\ngies). For inactivation of the TK gene (ORF55, 217 codons),\ncodons 43 to 187 were deleted by CpoI/Eco47III digestion of\npBl-KTTKR (Fig. 1b). Subsequently, the plasmid was either\ndirectly religated, or modified by the insertion of an expres-\nsion cassette for enhanced green fluorescent protein (GFP),\nwhich had been isolated as an 1607 bp BamHI/EcoRI frag-\nment from the plasmid pBl-GFP [38], resulting in pBl-\nKTDTK and pBl-KT DTKGFP, respectively (Fig. 1b). To\nremove an unwanted NcoI restriction site, the insert of pBl-\nKTDUTR (Fig. 1c) was shortened by 133 nucleotides by\nHindIII/ BspEI double digestion and religation. Subse-\nquently, the DUT gene (ORF123, 274 codons) was deleted\nfrom codon 36 to 270 by double digestion with NcoI and\nSbfI, and deletion plasmids with and without reporter gene\ninsertion (pBl-KT DDUTGFP, pBl-KT DDUT) were gener-\nated as above (Fig. 1c). In all cloning experiments, non-compatible ends were blunted by Klenow treatment prior to\nligation.\nCCB cells were cotransfected (K2 Transfection System,\nBiontex) with genomic KHV-T DNA and the deletion plas-\nmids pBl-KT DTKGFP or pBl-KT DDUTGFP, and homolo-\ngous recombination led to the GFP-expressing virus\nmutants KHV-T DTKGFP or KHV-T DDUTGFP, which\nwere plaque-purified to homogeneity. Genomic DNA from\nthese mutants was then used for cotransfection with\nreporter geneless deletion (pBl-KT DTK, pBl-KT DDUT) or\nrescue plasmids (pBl-KTTKR, pBl-KTDUTR), resulting in\nthe isolation of KHV-T DTK, KHV-T DDUT, KHV-TTKR\nand KHV-TDUTR from non-fluorescent virus plaques\n(Fig. 1). To obtain the double-mutant KHV-T DDUT/TK,\nKHV-T DDUT was subsequently mutated as above with the\nplasmids KHV-T DTKGFP and KHV-T DTK. From the\ndescribed KHV-I mutant KHV- DTKDUTG [14] the GFP\ninsertion at the DUT gene locus was removed by mutagene-\nsis with a transfer plasmid derived from pBl-KB5836NB\n[14] by deletion of the above mentioned NcoI/SbfI fragment,\nresulting in KHV-I DTK/DUT. Genomic DNA of all gener-\nated KHV recombinants was prepared, and the presence of\nthe desired mutations was confirmed by restriction analyses\nand Southern blot hybridization (not shown), as well as by\nPCR amplification and sequencing of the mutated TK and\nDUT gene regions with the primers KTK-PSF, KTK-PSR,\nKDUT-PSF and KDUT-PSR (Table 1) as described previ-\nously [14].\nIn vitro replication studies\nFor the comparative analysis of virus spread, CCB cells\ngrown in 24-well plates were infected with serial dilutions of\nKHV-T, KHV-T DDUTGFP, KHV-T DTKGFP, KHV-\nTDDUT/TKGFP, KHV-T DDUT, KHV-T DTK, KHV-\nTDDUT/TK, KHV-TDUTR, or KHV-TTKR and incubated\nunder semisolid medium for 96 h at 25/C14C. Then the cells\nwere washed with phosphate-buffered saline (PBS) and\nfixed with 50 % methanol/50 % acetone for 30 min at\n/C020/C14C. The infected cells were visualized by IIF reactions\nof a monospecific rabbit antiserum raised against the viral\nenvelope protein pORF81 as described previously [39].\nAreas of 30 plaques per virus were measured by fluores-\ncence microscopy (Eclipse Ti-S with software NIS-elements,\nversion 4, Nikon), and the average sizes as well as standard\ndeviations were calculated as percentages of the mean pla-\nque areas induced by KHV-T.\nFor the investigation of replication kinetics, CCB cells\ngrown in 24-well plates were infected with the same virus\nmutants at an m.o.i. of 0.1 at 4/C14C to permit virus adsorption\nand, after 1 h, shifted to 25/C14C for penetration. After an addi-\ntional 2 h non-penetrated virus was inactivated by treatment\nwith citric acid [40], and incubation at 25/C14C was continued.\nAt different times after the temperature shift the infected\ncell cultures were frozen at /C080/C14C. For the determination\nof progeny virus titres the cell lysates were thawed at 25/C14C\nand plaque assays followed by IIF tests were performed as\nabove. The mean titres of two parallel wells per virus inSchr\u00f6der et al.,Journal of General Virology\n11Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39three independent experiments were calculated. Student \u2019st-\ntest was applied to evaluate the statistical significance of dif-\nferences between the virus titres and plaque sizes of the\nKHV mutants.\nAnimal trials\nPrior to the animal experiments, the used carp were con-\nfirmed to be free of cyprinid herpesviruses (CyHV-1, -2 and\n-3), carp edema virus (CEV) and the causative agent of\nspring viraemia of carp (SVCV) by PCR or RT-PCR analysis\nof swab and blood samples. Furthermore, the animals were\nnegatively checked for ectoparasites.\nTo test the in vivo attenuation and protective efficacy of\nKHV-I DTK/DUT, 2 groups of 48 1-year-old (approximately\n10 g/6 cm) specific pathogen-free carp (obtained from S.H.\nLeenstra, Wageningen, The Netherlands) were infected\neither by immersion in a bucket with 10 l water containing\n1.5/C2106p.f.u. of virus for 2 h, or by i.p. administration of\n2/C2103p.f.u. of virus per animal. Control groups were\ninfected with the same doses of wild-type KHV-I, or mock-\ninfected with cell culture medium. The six groups were kept\nin separate tanks at a constant temperature of 22/C14C and\nobserved daily for clinical symptoms. Fifty days after pri-\nmary or mock infection, all surviving fish were challenged\nby immersion in 10 l water containing 1.5 /C2106p.f.u. KHV-\nI, returned to their aquaria and observed for an additional\n61 days.\nIn a second trial, 7 groups consisting of 40 9-month-old\n(approximately 8 g/5 \u20137 cm) and 5 2-year-old (approxi-\nmately 200 g/20 \u201323 cm) carp from a commercial fish farm\nin Germany (Fischzucht Tra\u00dfdorf 1967 e.V., Tra\u00dfdorf) each\nwere kept in individual aquaria at a constant temperature of\n20/C14C. To avoid cannibalism, the small fish were separated\nfrom the larger ones by permeable grids. The carp were\ninfected by immersion for 1 h in 5 l water containing\n2.5/C2107p.f.u. of either KHV-T, KHV-T DDUT, KHV-\nTDTK, KHV-T DDUT/TK, KHV-TDUTR, KHV-TTKR or\ncell culture medium. After 28 days all carp that had survived\nprimary KHV infection were challenged by immersion for\n1 h in 5 l water containing 2.5 /C2107p.f.u. of KHV-T,\nreturned to their aquaria and observed for another 28 days.\nTwo and 4 weeks after primary, as well as after challenge\ninfection, blood samples and gill swabs were taken from the\nolder carp, whereas only the young ones were considered\nfor the evaluation of mortality rates. The statistical signifi-\ncance of the differences was determined using a two-sided\nFisher \u2019s exact test [41].\nEnzyme-linked immunosorbent assay (ELISA)\nBlood samples from infected and uninfected carp were\nstored overnight at 4/C14C and centrifuged at 600 gfor 15 min,\nand sera were taken from the supernatant. Nunc-Immu-\nnoTMMircoWellTMPolySorpTMF96 plates (Thermo Fisher\nScientific) were coated with sucrose gradient-purified KHV\nparticles, blocked and incubated with the 1 : 300 diluted sera\nin two replicas, an anti-carp IgM monoclonal antibody\n(Aquatic diagnostics) and horseradish peroxidase-conjugated anti-mouse IgG (Jackson ImmunoResearch) as\ndescribed previously [25]. Substrate reactions were mea-\nsured in an Infinite F200 microplate reader (Tecan), and\nOD 450nm values >0.2 were considered to be positive.\nQuantitative real time PCR (qPCR)\nTotal DNA from the gill swabs of infected and control carp\nwas prepared using the QIAamp DNA Mini kit (Qiagen).\nTo this end, the Q-tips used for sampling were incubated\nfor/C211 h at 56/C14C in 180 \u00b5l buffer ATL until the samples\nwere completely lysed and further processed as recom-\nmended by the manufacturer. The DNA was finally eluted\nin 50 \u00b5l of water. The 25 \u00b5l TaqMan triplex qPCR reaction\nmixes using the QuantiTect Multiplex PCR NoROX kit\n(Qiagen) contained approximately 200 ng of swab DNA\nsample, 2 /C2103copies of plasmid pEGFP-1 (Clontech) as an\ninternal control, a control-specific primer/probe set (10 \u00b5M\nEGFP15-F, 10 \u00b5M EGFP10-R and 1.5 \u00b5M EGFP-HEX) [27],\na KHV ORF89-specific primer/probe set (10 \u00b5M KHV-86F,\n10 \u00b5M KHV-163R and 1.25 \u00b5M KHV-109P) [26] and a\nnewly designed KHV TK gene (ORF 55)-specific set, con-\nsisting of 10 \u00b5M KHVTKQ-F, 10 \u00b5M KHVTKQ-R and 2 \u00b5M\nKHVTKQ-P (Table 1). For quantitation, reaction mixes\ncontaining 200 ng swab DNA sample from an uninfected\nfish and 1 fg (3.14 genome copies) to 1 ng (3.14 /C2106\ngenome copies) of DNA from sucrose gradient-purified\n[39] KHV-T particles were used. The approximate genome\ncopy number per \u00b5g virion DNA was calculated (http://cels.\nuri.edu/gsc/cndna.html) based on a randomly composed\ndouble-stranded 295 kbp molecule. Reactions were per-\nformed in an AriaMx Real-Time PCR System (Agilent\nTechnologies) for 15 min at 95/C14C, followed by 40 cycles of\n1 min 95/C14C, 1 min 95/C14C, 30 s 60/C14C and 30 s 72/C14C, and the\nKHV genome copy numbers in the samples were calculated\nfrom Ct values based on the standard curve.\nSequence analyses\nThe inserts of transfer plasmids and the modified genome\nregions of virus recombinants were analysed by sequencing\nusing the BigDye Terminator v1.1 cycle sequencing kit and\na 3130 Genetic Analyzer (Applied Biosystems). The results\nwere evaluated with the Geneious software package in ver-\nsion 10.2.3 (Biomatters). Furthermore, genomic DNA of\nKHV-T DDUT/TK was prepared [37] from infected CCB\ncells and used to prepare shotgun sequencing libraries for\nsequencing with the Ion Torrent PGM as described previ-\nously [42] with minor modifications. In brief, DNA was\nfragmented using the Covaris ultrasonicator M220 and sub-\nsequently converted to sequencing libraries with the aid of a\nGeneRead Library L core kit (Qiagen) according to the\nmanufacturer \u2019s instructions using barcoded IonXpress\nadapters (Thermo Fisher). Before clonal amplification and\nsequencing with HiQ reagents following the manufacturer \u2019s\ninstructions, the libraries were size selected as described.\nThe data were analysed by mapping the obtained sequence\nreads along the reference sequence (GenBank accession no.\nAP008984) [6] using the Genome Sequencer software suite\n(v3.0; Roche) with a minimum overlap identity of 99 % andSchr\u00f6der et al.,Journal of General Virology\n12Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:39a minimum alignment between the reads and the reference\nof 95 %. In total, >700 000 KHV-specific reads were consid-\nered. The few remaining ambiguities were clarified by the\nexamination of individual reads and/or by Sanger sequenc-\ning PCR-amplified DNA fragments (see above).\nFunding information\nThis study was supported by the German Federal Ministry of Food and\nAgriculture (BMEL).\nAcknowledgements\nThe authors thank G. Strebelow and Patrick Zitzow for help with\nsequence analyses. The technical assistance of A. Landmesser, I.\nWerner and J. Lange is greatly appreciated.\nConflicts of interest\nThe authors declare that there are no conflicts of interest.\nEthical statement\nThe carp used in this study were kept in accordance with the German\nprotection of animals act. The infection trials were approved by the\nanimal experiment commission of the federal state Mecklenburg-West\nPomerania (Az 7221.3-2-002/15, FLI TV 02/15 KHV-att.). The suffering\nof the fish was minimized.\nReferences\n1.Bretzinger A, Fischer-Scherl T, Oumouna M, Hoffmann R, Truyen\nU.Mass mortalities in koi, Cyprinus carpio , associated with gill and\nskin disease. Bull Eur Ass Fish Pathol 1999;5:182.\n2.Hedrick RP, Marty GD, Nordhausen Rw MJK, Bercovier H et al. A\nherpesvirus associated with mass mortality of juvenile and adult\nkoi, a strain of a common carp. Fish Health Newsletter 1999;7:44 \u2013\n57.\n3.Neukirch M, B\u00f6ttcher K, Bunnajirakul S. Isolation of a virus from\nkoi with altered gills. Bull Eur Assoc Fish Pathol 1999;19:221 \u2013224.\n4.Ronen A, Perelberg A, Abramowitz J, Hutoran M, Tinman S et al.\nEfficient vaccine against the virus causing a lethal disease in cul-\ntured Cyprinus carpio .Vaccine 2003;21:4677 \u20134684.\n5.Gotesman M, Kattlun J, Bergmann SM, El-Matbouli M. CyHV-3:\nthe third cyprinid herpesvirus. Dis Aquat Organ 2013;105:163 \u2013174.\n6.Aoki T, Hirono I, Kurokawa K, Fukuda H, Nahary R et al. Genome\nsequences of three koi herpesvirus isolates representing the\nexpanding distribution of an emerging disease threatening koi and\ncommon carp worldwide. J Virol 2007;81:5058 \u20135065.\n7.Davison AJ, Eberle R, Ehlers B, Hayward GS, McGeoch DJ et al.\nThe order Herpesvirales. Arch Virol 2009;154:171 \u2013177.\n8.Perelberg A, Ronen A, Hutoran M, Smith Y, Kotler M. Protection\nof cultured Cyprinus carpio against a lethal viral disease by an\nattenuated virus vaccine. Vaccine 2005;23:3396 \u20133403.\n9.van Oirschot JT. Diva vaccines that reduce virus transmission. J\nBiotechnol 1999;73:195 \u2013205.\n10.Cui LC, Guan XT, Liu ZM, Tian CY, Xu YG. Recombinant lactobacil-\nlus expressing G protein of spring viremia of carp virus (SVCV)\ncombined with ORF81 protein of koi herpesvirus (KHV): a promis-\ning way to induce protective immunity against SVCV and KHV\ninfection in cyprinid fish via oral vaccination. Vaccine 2015;33:\n3092 \u20133099.\n11.Zhou J, Xue J, Wang Q, Zhu X, Li X et al. Vaccination of plasmid\nDNA encoding ORF81 gene of CJ strains of KHV provides protec-\ntion to immunized carp. In Vitro Cell Dev Biol Anim 2014;50:489 \u2013\n495.\n12.Zhou JX, Wang H, Li XW, Zhu X, Lu WL et al. Construction of KHV-\nCJ ORF25 DNA vaccine and immune challenge test. J Fish Dis\n2014;37:319 \u2013325.\n13.Costes B, Fournier G, Michel B, Delforge C, Raj VS et al. Cloning\nof the koi herpesvirus genome as an infectious bacterial artificial\nchromosome demonstrates that disruption of the thymidinekinase locus induces partial attenuation in Cyprinus carpio koi. J\nVirol 2008;82:4955 \u20134964.\n14.Fuchs W, Fichtner D, Bergmann SM, Mettenleiter TC. Generation\nand characterization of koi herpesvirus recombinants lacking viral\nenzymes of nucleotide metabolism. Arch Virol 2011;156:1059 \u2013\n1063.\n15.Vancsok C, Pe\u00f1aranda MMD, Raj VS, Leroy B, Jazowiecka-Rakus\nJet al. Proteomic and functional analyses of the virion transmem-\nbrane proteome of cyprinid herpesvirus 3. J Virol 2017;91:\ne01209-17.\n16.Boutier M, Ronsmans M, Ouyang P, Fournier G, Reschner A et al.\nRational development of an attenuated recombinant cyprinid her-\npesvirus 3 vaccine using prokaryotic mutagenesis and in vivo bio-\nluminescent imaging. PLoS Pathog 2015;11:e1004690.\n17.Boutier M, Gao Y, Vancsok C, Su /C19arez NM, Davison AJ et al. Identi-\nfication of an essential virulence gene of cyprinid herpesvirus 3.\nAntiviral Res 2017;145:60 \u201369.\n18.Efstathiou S, Kemp S, Darby G, Minson AC. The role of herpes\nsimplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol\n1989;70:869 \u2013879.\n19.J\u00f6ns A, Gerdts V, Lange E, Kaden V, Mettenleiter TC. Attenuation\nof dUTPase-deficient pseudorabies virus for the natural host. Vet\nMicrobiol 1997;56:47 \u201354.\n20.Kit S. Recombinant-derived modified-live herpesvirus vaccines.\nAdv Exp Med Biol 1989;251:219 \u2013236.\n21.Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W. Protection\nof chickens against H5N1 highly pathogenic avian influenza virus\ninfection by live vaccination with infectious laryngotracheitis virus\nrecombinants expressing H5 hemagglutinin and N1 neuramini-\ndase. Vaccine 2009;27:773 \u2013785.\n22.Schnitzlein WM, Winans R, Ellsworth S, Tripathy DN. Generation\nof thymidine kinase-deficient mutants of infectious laryngotrachei-\ntis virus. Virology 1995;209:304 \u2013314.\n23.Zhang HG, Hanson LA. Deletion of thymidine kinase gene attenu-\nates channel catfish herpesvirus while maintaining infectivity.\nVirology 1995;209:658 \u2013663.\n24.Mletzko A, Amtmann A, Bergmann S, Lee P, Christian J et al.\nInoculation of cyprinid herpesvirus 3 (CyHV-3) on common carp\nbrain cells-influence of process parameters on virus yield. In Vitro\nCell Dev Biol Anim 2017;53:579 \u2013585.\n25.Bergmann SM, Wang Q, Zeng W, Li Y, Wang Y et al. Validation of a\nKHV antibody enzyme-linked immunosorbent assay (ELISA). J Fish\nDis2017;40:1511 \u20131527.\n26.Gilad O, Yun S, Zagmutt-Vergara FJ, Leutenegger CM, Bercovier\nHet al. Concentrations of a Koi herpesvirus (KHV) in tissues of\nexperimentally infected Cyprinus carpio koi as assessed by real-\ntime TaqMan PCR. Dis Aquat Organ 2004;60:179 \u2013187.\n27.Hoffmann B, Depner K, Schirrmeier H, Beer M. A universal heter-\nologous internal control system for duplex real-time RT-PCR\nassays used in a detection system for pestiviruses. J Virol\nMethods 2006;136:200 \u2013209.\n28.Hedrick RP, Gilad O, Yun S, Spangenberg JV, Marty GD et al. A\nherpesvirus associated with mass mortality of juvenile and adult\nkoi, a strain of common carp. J Aquat Anim Health 2000;12:44 \u201357.\n29.Marchler-Bauer A, Bo Y, Han L, He J, Lanczycki CJ et al. CDD/\nSPARCLE: functional classification of proteins via subfamily\ndomain architectures. Nucleic Acids Res 2017;45:D200 \u2013D203.\n30.Gao Y, Su /C19arez NM, Wilkie GS, Dong C, Bergmann S et al. Genomic\nand biologic comparisons of cyprinid herpesvirus 3 strains. Vet\nRes2018;49:40.\n31.Avarre JC, Madeira JP, Santika A, Zainun Z, Baud M et al. Investi-\ngation of cyprinid herpesvirus-3 genetic diversity by a multi-locus\nvariable number of tandem repeats analysis. J Virol Methods\n2011;173:320 \u2013327.\n32.Klafack S, Wang Q, Zeng W, Wang Y, Li Y et al. Genetic variability\nof koi herpesvirus in vitro -a natural event? Front Microbiol 2017;8:\n982.Schr\u00f6der et al.,Journal of General Virology\n13Downloaded from www.microbiologyresearch.org by\nIP:  193.22.115.2\nOn: Thu, 08 Nov 2018 12:47:3933.Monaghan SJ, Thompson KD, Adams A, Bergmann SM. Sensitivity\nof seven PCRs for early detection of koi herpesvirus in experimen-\ntally infected carp, Cyprinus carpio L., by lethal and non-lethal\nsampling methods. J Fish Dis 2015;38:303 \u2013319.\n34.Fuchs W, Granzow H, Dauber M, Fichtner D, Mettenleiter TC.\nIdentification of structural proteins of koi herpesvirus. Arch Virol\n2014;159:3257 \u20133268.\n35.Michel B, Leroy B, Stalin Raj V, Lieffrig F, Mast J et al. The\ngenome of cyprinid herpesvirus 3 encodes 40 proteins incorpo-\nrated in mature virions. J Gen Virol 2010;91:452 \u2013462.\n36.Vrancken R, Boutier M, Ronsmans M, Reschner A, Leclipteux T\net al. Laboratory validation of a lateral flow device for the detec-\ntion of CyHV-3 antigens in gill swabs. J Virol Methods 2013;193:\n679 \u2013682.\n37.Fuchs W, Mettenleiter TC. DNA sequence and transcriptional anal-\nysis of the UL1 to UL5 gene cluster of infectious laryngotracheitis\nvirus. J Gen Virol 1996;77:2221 \u20132229.38.Fuchs W, Mettenleiter TC. DNA sequence of the UL6 to UL20\ngenes of infectious laryngotracheitis virus and characterization of\nthe UL10 gene product as a nonglycosylated and nonessential\nvirion protein. J Gen Virol 1999;80:2173 \u20132182.\n39.Rosenkranz D, Klupp BG, Teifke JP, Granzow H, Fichtner D et al.\nIdentification of envelope protein pORF81 of koi herpesvirus. J Gen\nVirol 2008;89:896 \u2013900.\n40.Mettenleiter TC. Glycoprotein gIII deletion mutants of pseudora-\nbies virus are impaired in virus entry. Virology 1989;171:623 \u2013625.\n41.Agresti A. A survey of exact inference for contingency tables.\nStatistical Science 1992;7:131 \u2013153.\n42.H\u00f6per D, Freuling CM, M\u00fcller T, Hanke D, von Messling V et al.\nHigh definition viral vaccine strain identity and stability testing\nusing full-genome population data \u2013The next generation of vaccine\nquality control. Vaccine 2015;33:5829 \u20135837.\n43.Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of\nthe green fluorescent protein (GFP). Gene 1996;173:33 \u201338.Schr\u00f6der et al.,Journal of General Virology\n14Five reasons to publish your next article with a Microbiology Society journal\n1. The Microbiology Society is a not-for-profit organization.\n2. We offer fast and rigorous peer review \u2013average time to first decision is 4 \u20136 weeks.\n3. Our journals have a global readership with subscriptions held in research institutions around\nthe world.\n4. 80% of our authors rate our submission process as \u2018excellent \u2019or \u2018very good \u2019.\n5. Your article will be published on an interactive journal platform with advanced metrics.\nFind out more and submit your article at microbiologyresearch.org.Publikationen \u00a0\n22\u00a0\n\u00a0 \u00a0 Publikationen \u00a0\n35\u00a0\n\u00a03.2. Publikation II \n\u00a0\n\u201cCharacterization of gene deletion mutants of Cyprinid herpesvirus 3 \n(koi herpesvirus) lacking the immunogenic envelope glycoproteins pORF25, pORF65, pORF148 and pORF149\u201d  \n Lars Schr\u00f6der, Sandro Klafack, Sven M.  Bergmann, Pei-Yu Alison Lee, Kati \nFranzke, Dirk H\u00f6per, Thomas C.  Mettenleiter, Walter Fuchs \n Publiziert in Virus Research \n  Accepted Manuscript\nTitle: Characterization of gene deletion mutants of Cyprinid\nherpesvirus 3 (koi herpesvirus) lacking the immunogenic\nenvelope glycoproteins pORF25, pORF65, pORF148 andpORF149\nAuthors: Lars Schr\u00a8 oder, Sandro Klafack, Sven M. Bergmann,\nPei-Yu Alison Lee, Kati Franzke, Dirk H\u00a8 oper, Thomas C.\nMettenleiter, Walter Fuchs\nPII: S0168-1702(18)30474-X\nDOI: https://doi.org/10.1016/j.virusres.2018.12.004Reference: VIRUS 97537\nTo appear in: Virus Research\nReceived date: 3 August 2018\nRevised date: 7 December 2018Accepted date: 8 December 2018\nPlease cite this article as: Schr\u00a8 oder L, Klafack S, Bergmann SM, Lee P-YuA,\nFranzke K, H\u00a8 oper D, Mettenleiter TC, Fuchs W, Characterization of gene deletion\nmutants of Cyprinid herpesvirus 3 (koi herpesvirus) lacking the immunogenic envelope\nglycoproteins pORF25, pORF65, pORF148 and pORF149, Virus Research (2018),\nhttps://doi.org/10.1016/j.virusres.2018.12.004\nThis is a PDF \ufb01le of an unedited manuscript that has been accepted for publication.\nAs a service to our customers we are providing this early version of the manuscript.The manuscript will undergo copyediting, typesetting, and review of the resulting proofbefore it is published in its \ufb01nal form. Please note that during the production processerrors may be discovered which could affect the content, and all legal disclaimers thatapply to the journal pertain.1 \n 2nd revision  of Virus Research manuscript VIRUS_2018_394  \nCharacterization  of gene deletion mutants of Cyprinid \nherpesvirus 3  (koi herpesvirus ) lacking the immunogenic \nenvelope g lycoproteins pORF25, pORF65, pORF148 and \npORF149  \n \nLars Schr\u00f6dera, Sandro Klafackb, Sven M. Bergmannb, Pei -Yu Alison Leed, Kati \nFranzkeb, Dirk  H\u00f6perc, Thomas C. Mettenleitera, Walter Fuchsa* \n \na Institute of Molecular Virology and Cell Biology, Friedrich -Loeffler -Institut, \nGreifswald -Insel Riems, Germany  \nb Institute of Infectology, Friedrich -Loeffler -Institut, Greifswald -Insel Riems, Germany  \nc Institute of Diagnostic Virology, Friedrich -Loeffler -Institut, Greifswald -Insel Riems, \nGermany  \nd GeneReach Biotechnology Corporation, Taichung, Taiwan  \n \n*Corresponding  author: Walter Fuchs  \ne-mail: walter.fuchs@fli.de  \nphone: +49 38351 71258  \n \n \nKeywords : Cyprinid herpesvirus 3 , Koi herpesvirus, Envelope glycoproteins, Gene \ndeletion mutants, Virus replication in vitro , Virulence  in carp  \n \nHighlights : \n\uf0b7 CyhV -3 glycoproteins pORF25, pORF65, pORF148, pORF149 are \ndispensable for replication  \n\uf0b7 pORF25 and pORF149 are relevant for efficient virus entry and cell -to-cell \nspread  \nACCEPTED MANUSCRIPT\n2 \n \uf0b7 The adverse effect of ORF149 deletion is compensated by additional ORF148 \ndeletion  \n\uf0b7 Deletion of ORF148 and/or ORF14 9 does not signi ficantly reduce virulence of \nCyHV -3 \n\uf0b7 Deletion of ORF148 and/or ORF149 does not affect protective efficacy of \nCyHV -3 \n \n \n \n \nAbstract  \nCyprinid herpesvirus 3 (CyHV -3) or koi herpesvirus  is a global pathogen causing \nmass m ortality in koi and common carp, against which improved vaccines are \nurgently needed.  In this study we investigated the role of four nonessential, but \nimmunogenic envelope glycoproteins encoded by members of the ORF25 gene \nfamily (ORF 25, ORF65, ORF148 and ORF149 ) during CyHV -3 replication. Single \ndeletion of ORF65 did not affect in vitro  replication, and deletion of ORF148 even \nslightly enhanced virus growth on common carp brain (CCB) cells, deletions of \nORF25 or ORF149 led to reduced plaque sizes and virus titers, which was due to \ndelayed entry into host cells. An ORF148/ORF149 double deletion mutant exhibited \nwild-type like growth indicating oppos ing functions of the two proteins. Electron \nmicroscopy of CCB cells infected with either mutant did not indicate any effects on \nvirion formation and maturation in nucleus or cytoplasm, nor on release of enveloped \nparticles. The ORF148, ORF149 and double deleti on mutants were also tested in \nanimal experiments  using juvenile carp , and proved to be insufficiently attenuated for \nuse as live virus vaccines . However, surviving fish were protected agai nst challenge \nwith wild -type CyHV -3, demonstrating that  these antibody inducing protei ns are \ndispensable for an efficient immune response in vivo . \n \n1. Introduction  \nCultivation of common carp has a long tradition in Europe and Asia, and in several \nregions provides a key source of protein for human consumption.  Furthermore, the \nbreeding of colored carp varieties ( koi) as ornamental fish has become a popular ACCEPTED MANUSCRIPT\n3 \n hobby, and a profitable business worldwide  (Balon, 199 5). In the 1990 ies, a \npreviously unknown virus infection led to mass mortality of common  and koi carp in \nIsrael and Europe . The causative agent was identified as a herpesvirus and \ndesignated as carp interstitial nephritis and gill necrosis virus  (CNGV) , or koi \nherpesvirus (KHV)  (Bretzinger et al., 1999; Hedrick et al., 1999; Neukirch et al., 1999; \nRonen et al., 2003) . Due to the severity of the infection, the development of \nattenuated vaccines was rapidly initiated  (Bretzinger et al., 1999; Hedrick et al., 1999; \nNeukirch et al., 1999; Ronen et al., 2003) . \nAnalyses of genome sequences demonstrated a close relationship to carp pox virus \n(Cyprinid herpesvirus  1), and goldfish haematopoietic necrosis virus ( Cyprinid \nherpesvirus  2), leading to classification  as Cyprinid herpesvirus  3 (CyHV -3) within the \ngenus Cyprinivirus  in the family Alloherpesvirida e and the order Herpesvirales  \n(Davison et al., 2009) . The CyHV -3 genome has a  size of 295 kbp including 22 kbp of \ndirect repeat sequences at  both ends, and contains approximately 155 open reading \nframes (ORFs) predicted to encode proteins  (Aoki et al., 2007) . Some  of these ORFs \nare conserved in other herpesviruses of fish or amphibians, but homologies to \nmammalian and avian herpesviruses (family Herpesviridae ) are very limited.  Analysis \nof purified virus particles by mass spectrometry identified 40 different CyHV -3 \nencoded proteins, including 3 capsid components, and 13 membrane proteins \n(Michel et al., 2010) . \nThe integral membrane proteins  pORF25,  pORF65 , pORF81 , pORF99, pORF136 , \npORF148  and pORF149  were also identified and characterized by specific antisera \nor monoclonal antibod ies (mAb ), and, except  pORF81 and pORF136, proved to be \nmodified by N -linked glycosylation  (Rosenkranz et al., 2008; Vrancken et al., 2013) . \nORF s 25, 65, 148, and 149 constitute members of a family of distantly related genes \nwhich is conserved in  cyprinid herpesviruses, and might have evolved from a \ncommon ancestor  (Andrew J. Davison et al., 2013; Aoki et al., 2007) . Indirect \nimmunofluorescence (IF) tests of eukaryotic cells transfected with expression \nplasmids fo r ORF25, ORF65, ORF99, ORF148 or  ORF149 revealed specific \nreactions of the respective glycoproteins with serum antibodies from experimentally \nand naturally KHV -infected carp  (Fuchs et al., 2014) . Therefore, vaccines based on \nKHV mutants lacking these genes might be suitable for serological differ entiation \nbetween infected and vaccinated animals (DIVA)  (van Oirschot, 1999) . On the other \nhand, candidate subunit or DNA vaccines containing or encodi ng single CyHV -3 ACCEPTED MANUSCRIPT\n4 \n envelope proteins  like pORF25 or pORF81 have been shown to induce protective \nimmune responses (Cui et al., 2015; Zhou et al., 2014a; Zhou et al., 2014b) , \nsuggesting that their deletion might affect the protective efficacy of CyHV -3 live \nvaccines . Recent studies demonstrated, that the four ORF25 family genes including \nORF65, ORF148, and ORF149 are not essential for CyHV -3 replication in cell \nculture, and that deletion of ORF25  attenuated the virus in vivo, but significantly \nreduced  its protective ef ficacy against wild -type challenge (Vancsok et al., 2017) . In \ncontrast, single deletions of ORF65, ORF148, o r ORF149  did not lead to sufficient \nattenuatio n of a virulent CyHV -3 strain in carp (Vancsok et al., 2017) . Thus, other \nCyHV -3 recombinants possessing e.g. d ouble deletions of the viral thymidine kinase \n(TK, ORF55 ) and d eoxyuridine triphosphatase (d UTPase , ORF123) genes or of the \nadjacent ORFs 56 and 57 appeared to be more promising (Boutier et al., 2017 ; \nSchr\u00f6der et al., 2018 ). \nWhereas the previous functional analyses of CyHV -3 envelope proteins were \nperformed with a member of the European virus lineage isolated in Belgium (Vancsok \net al., 2017) , we reanalyzed the potential of ORF25, ORF65, ORF14 8, and ORF149 \ndeletions for vaccine  development by using a less  virulent, but highly cell -culture \nadapted East Asian type CyHV -3 strain from Taiwan  (KHV -T) (Mletzko et al., 2017 ; \nGao et al., 2018) . To investigate possible additive effects on virulence , or functional \nredundancy we  also generated an ORF148  and ORF149 double deletion mutant. \nFurthermore, t he cell culture adaptation of KHV -T facilitat ed in vitro  investigation of \nindividual viral gene functions. The crucial roles  and interactions of envelope \n(glyco) proteins during virus entry, virion formation, spread and release have been \nextensively investigated for mammalian herpesviruses (reviewed by (Mettenleiter, \n2002; Sathiyamoorthy et al., 2017) , but little is known about their functional \nhomologues in Alloherpesviruses. We therefore studied the roles of pORF25, \npORF65, pORF148, and pORF149 in entry and vir us morphogenesis by penetration  \nkinetics and electron  microscopy of infected common carp brain (CCB) cells  \n(Neukirch et al., 1999) . \n \n \n2. Materials and m ethods  \n \nACCEPTED MANUSCRIPT\n5 \n 2.1. Viruses and cells  \nKHV-T (Mletzko et al., 2017) , and its derivatives were propagated in CCB cells \n(Neukirch et al., 1999) , which were grown in minimum essential medium (MEM) \nsupplemented with 10 % fetal bovine serum (FBS) at 25\u00b0C. Infected cells were \nincubated in medium containing only 5 % FBS, and, after appearance of \ncytopathogenic effects, lysed by freeze -thawing and stored in aliquots at -80\u00b0C. For \nplaque assays, CCB cell monolayers were incubated with serial virus dilutions for 2 h. \nSubsequently, the inoculum was replaced by MEM containing 5 % FBS and 6 g/l of \nmethylcellulose, and incubation at 25\u00b0C was cont inued for 3 to 7 days.  \n \n2.2. Construction of deletion plasmids and virus recombinants  \nGenomic KHV -T DNA was prepared from infected cell lysates as described (Fuchs \nand Mettenleiter, 1996) . For the generation of deletion mutan ts, transfer plasmids \nwere prepared after amplification of the target ed glycoprotein gene regions  from \nKHV-T DNA by PCR using Pfx DNA polymerase (Thermo Fisher Scientific), with the \nrespective  primer pairs (Table  1). The obtained 6005  bp (ORF148/149) , 3629 bp \n(ORF25), 3210 bp (ORF65) , and  6005 bp (ORF148/149), PCR products  were \ndigested at engineered EcoRI and HindIII sites, and inserted into the correspondingly \ndigested vector pUC19 (New England Biolabs ), resulting in plasmids pUC -KT25R, \npUC-KT65R, and pUC -KT149R (Fig. 1 B-D) From the latter plasmid, major parts of \nORF 148 and ORF 149 were deleted either singly,  or in combination  (Fig. 1D ). For the \ndouble deletion a 3048  bp HpaI/PstI fragment of pUC -KT149R was either removed  or \nreplaced by an expression cassette  for enhanced green fluorescent protein (EGFP) , \nwhich had been isolated as a 1607 bp BamHI/EcoRI  fragment from plasmid pBl -GFP  \n(Fuchs and Mettenleiter, 1999) . Single deletions of ORF148 or ORF149 were \nintroduced by removal  or EGFP -substitutions of 63 5 bp HpaI/NotI, or 1252  bp \nXcmI/Pst I fragments, respectively , resulting in transfer plasmids pUC -KT\u2206148 (G), \npUC-KT\u2206149 (G), pUC -KT\u2206148/149(G ). In a similar manner, major parts of ORF2 5 \n(Fig. 1B ) and ORF 65 (Fig. 1C ) were removed  from the original plasmids by digestion \nwith BamHI or BsiWI , resulting in deletions of 1220 bp or 1169 bp, respectively . \nOptionally, the deleted fragments were replaced by the EGFP expression cassette, \nyielding plasmids pUC -KT\u039425 (G) and pUC -KT\u039465 (G). In all cloning experiments \nACCEPTED MANUSCRIPT\n6 \n non-compatible fragment ends were blunted by treatment with Klenow polymerase \nprior to ligation.  \nIn a first series of experiments CCB cells were cotransfected (K2 Transfection \nSystem, Biontex) with genomic KHV -T DNA and the GFP -gene containing deletion \nplasmids  Homologous recombination led to t he corresponding G FP-expressing virus \nmutants KHV-T\u2206148G, KHV -T\u2206149G, KHV -T\u2206148/149G, KHV -T\u039425G and KHV -\nT\u039465G (Fig. 1) which could be purified to homogeneity  by plaque assays on CCB \ncells, and subsequent aspiration of gree n fluorescent cell foci. Subsequently, \ngenomic DNA of these KHV -T recombinants was prepared and used for \ncotransfection s with deletion or rescue plasmids  lacking a reporter gene . From t he \nresulting non -fluorescent virus plaques  deletion mutants KHV-T\u0394148, KHV-T\u0394149, \nKHV-T\u0394148/149, KHV -T\u039425, and KHV-T\u039465, as well the revertants KHV-T148R, \nKHV-T149R, KHV -T148/149R, KHV -T25R and KHV-T65R (Fig. 1) were isolated . \nGenomic DNA of all generated CyHV -3 recombinants  was analyzed by restriction \nand Southern blot analy ses (not shown), and the modified genome regions were \nfurther characterized by PCR and sequencing using the specific primers described \nhere (Table 1) , and previously  (Fuchs et al., 2014) . \n \n2.3. In vitro  replication studies  and indirect immunofluorescence (IIF) tests  \nFor determination of replication kinetics CCB cells were  grown in 24well plates and \ninfected with KHV -T and the generated virus recombinants at a multiplicity (MOI) of \n0.1 at 4\u00b0C to permit virus adsorption. After 1 h, pre -warmed medium was added and \nincubation was continued for 2 h at 25\u00b0C to allow penetration. Subsequently, non -\npenetrated virus was inactivated by treatment with citric acid -buffered  saline (pH 3.0) \n(Mettenleiter, 1989) , and incubation at 25\u00b0C was continued under fresh  medium. At \ndifferent ti mes after the temperature shift, individual plates were frozen at -80\u00b0C.  For \ndetermination of progeny virus titers, the plates were thawed at 25\u00b0C, and serial \ndilutions of the cell lysates were analyzed by plaque assays on CCB cells. After 4 d  \nat 25\u00b0C, the cells were washed with phosphate -buffered saline (PBS), and fixed with \n50 % methanol / 50 % acetone for 3 0 min at -20\u00b0C. The fixed cells were incubated \nwith a monospecific rabbit a ntiserum detecting the  envelope protein pORF81  of \nCyHV -3, and fluorochrome -conjugated secondary antibodies as described \n(Rosenkranz et al., 2008) , and investigated by fluorescence microsc opy (Eclipse Ti -S \nACCEPTED MANUSCRIPT\n7 \n with software NIS -elements, version 4, Nikon). Mean titers of four  replicates per virus \nmutant were calculated. Furthermore , the area s of 30 plaques per virus were  \nmeasured , and average sizes as well as standard deviations were calculated as \npercentages of the mean plaque areas induced by KHV -T. Unpaired two -sided  \nStudent\u2019s t -tests were  applied to evaluate the statistical significance of differences \nbetween plaque sizes and titers of the CyHV -3 mutants.  \n \n2.4. In vitro  penetration kinetics  \nCCB cells grown in 6well plates were  infected with approximately  250 plaque -forming \nunits (PFU) of t he GFP-expressing virus mutants KHV-T\u0394148 G, KHV -T\u0394149 G, KHV -\nT\u0394148/149 G, KHV -T\u039425 G, and KHV-T\u039465 G, or, as wild -type like control,  KHV-\nT\u0394DUTGFP  (Schr\u00f6der et al., 2018 ). After 1 h  at 4\u00b0C , prewarmed medium was \nadde d, and incubation was continued at 25\u00b0C . Before and 10, 20, 30, 60 and 120 \nminutes after the temperature shift, remaining extracellular virus particles were \ninactivated by low pH treatment (Mettenleiter, 1989) . Subsequently, the cells were \nwashed  with PBS, overlaid with semisolid medium, and incubated for 3 d at 25\u00b0C.  \nThe plaques of the penetrated viruses after different times were counted by \nfluorescence microscopy, and compared to plaque numbers obtained in we lls which \nwere not acid -treated, and overlaid  with semisolid medium after 120 minutes  at 25\u00b0C  \n(Vallbracht et al., 2017) . Mean percentage values, and standard deviations were \ndetermined in three independent expe riments.  Unpaired two -sided  Student\u2019s t -tests \nwere applied to evaluate the statistical significance of differences between \npenetration rates of the CyHV -3 mutants.  \n \n2.5. Western blot analyses  \nCCB cells were infected with KHV -T or the generated virus recombinants at an MOI \nof 1, and incubated for two days at 25\u00b0C. The cells were lysed and proteins were \nseparated by discontinuous sodium dodecyl sulfate -polyacrylamide gel \nelectrophoresis (SDS -PAGE). Transfer to nitrocellulose membranes, and subsequent \nincubation of the blots was done as described  (Pavlova et al., 2009 ). Monospecific \nrabbit antisera against CyHV -3 pORF25, pORF149, and the major capsid protein \npORF92 (Fuchs et al., 2014)  were used at dilutions of 1 : 10,000. Binding of \nperoxidase -conjugated secondary antibodies (Jackson ImmunoResearch) was \nACCEPTED MANUSCRIPT\n8 \n detected and recorded (Clarity Western ECL Substrate, and VersaDoc 4000 MP, Bio -\nRad).  \n \n2.6. U ltrastructural analyses  \nCCB cells were infected with KHV -T or the generated virus recombinants at an MOI \nof 1, and incubated for 20 h at 25\u00b0C.  The samples were fixed and processed for \ntransmission electron microscopy as described previously  (Klupp et al., 2000) , and \nexamined using a Tecnai Spirit electron microscope (FEI) and an acceleration \nvoltage of 80 kV.  \n \n2.7. Sequence analyses  \nThe inserts of transfer plasmids, and the modified genome regions of virus \nrecombinants were analyzed by sequencing us ing the BigDye Terminator v1.1 cycle \nsequencing kit, and a 3130 Genetic Analyzer (Applied Biosystems). Results were \nevaluated with the GeneiousTM software package in version 10.2.3 (Biomatters).  \nFurthermore, the full genome sequence of KHV -T\uf044148/149 was de termined as \ndescribed recently (H\u00f6per et al., 2015; Schr\u00f6der et al., 2018 ). \n \n2.8. Animal trial  \nIn vivo  attenuation and protective efficacy of the generated ORF148 and ORF 149 \nmutants of KHV -T was tested using  five groups  of carp , each consistin g of 40 nine \nmonths -old (approximately  8 g / 5 -7 cm) and 5 two years -old (approximately  200 g / \n20-23 cm) fish (Fischzucht Tra\u00dfdorf  1967  e.V., Tra\u00dfdorf , Germany ). The animals \nwere kept at a constant te mperature of 20\u00b0C, and  infected by immersion for 1 h in 5 l \nwater containing 2.5 x 107 PFU of either KHV -T, KHV-T\u0394148, KHV -T\u0394149, KHV -\nT\u0394148/14 9, or cell culture medium. After 35 d, a ll carp  that had survived primary \nCyHV -3 infection  were challenged by immersion for 1 h in 5 l water containing 2.5 x \n107 PFU of KHV-T. The fish were examined for additional 28 days for clinic al \nsymptoms. Blood samples and gill swabs were taken from the two years -old carp \nbefore, and two and four weeks after primary  infection , as w ell as after challenge. \nThe young carps were considered for evaluation of the mortality rates.  Statistical \nsignifican ce of differences between the groups was evaluated using two -sided \nFisher\u2019s exact tests (Agresti A., 1992) . ACCEPTED MANUSCRIPT\n9 \n  \n2.9. Enzyme -linked immunosorbent assay (ELISA)  \nBlood samples from infected and uninfected carp were centrifuged at 600 x g for 15 \nmin and the supernatant was used in the ELISA. NUNC POLYSORP immuno -plates \n(Thermo Fisher Scientific) were coated with sucrose -gradient purified KHV-T \nparticles, blocked, in cubated with t he 1 : 300 diluted sera in two replicates. An anti -\ncarp IgM monoclonal antibody (Aquatic diagnostics), and horseradish peroxidase -\nconjugated anti -mouse IgG (Jackson ImmunoResearch) were added as described \n(Bergmann et al., 2017) . Substrate reactions were measured in an Infinite F200 \nmicroplate reader (Tecan), and OD 450nm values > 0.2 were consi dered as positive.  \n  \nACCEPTED MANUSCRIPT\n10 \n 3. Results  and discussion  \n \n3.1. Generation and genetic  characterization of glycoprotein deletion mutants \nof KHV -T \nPrevious studies  have shown  that sera from naturally or experimentally CyHV -3 \ninfected carp and koi specifically reacted with cells transfected with expression \nplasmids encoding pORF25, pORF65, pORF148, and pORF149, which are distantly \nrelated members of a family of type I envelope glyco proteins  (Fuchs et al., 2014) . \nDespite their immunogenicity, the four glyco proteins have recently been shown to be \ndispensable for in vitro  replication of a highly virulent CyHV -3 isolate from Belgium, \nwhich has been cloned and engineered as a bacterial chromosome  (Costes et al., \n2008; Vancsok et al., 2017) . In the present study, we generated similar gene deletion \nmutants of the cell culture -adapted strain KHV -T (Mletzko et al., 2017 ). \nLike in our previous studies i solation of the gene deletion mutants, and of \ncorresponding revertants was  facilitated by transient insertion of a GFP reporter \ncassette (Schr\u00f6der et al., 2018 ). The deletion of ORF25 (609 codons, Fig. 1B ) \nencompassed codons  138 to 545 , whereas from  ORF65 (595 codons, Fig. 1C ), \ncodons 36 to 425  were removed, and the remaining  5\u2019 and 3\u2019 ends were fused out -of-\nframe  in the final deletion mutants KHV -T\uf04425 and KHV -T\uf04465. The single deletions of \nORF148 (602 codons) and ORF149 (700 codons), removed codons 70 to 281  and 17 \nto 434, respectively (Fig. 1D), and frameshifted the retained parts of the ORFs  in \nKHV-T\uf044148 and KHV -T\uf044149. Consequently, t he double deletion ranged from codon \n17 of ORF 149 to codon 281  of ORF148 , but in this case the deletion was in frame. \nHowever, expression of a chimeric membrane protein by KHV -T\uf044148/149 is unlikely, \nsince the predicted signal peptide of pORF149 was affected by the deletion (Fig. 1D).  \nGenomic DNA of all generated CyHV -3 recombinants was analyzed by restriction \nenzyme digestions and Southern blot hybridizations, which confirmed the desired, \nand indicated no unwanted alterations ( see supplementary figure S1 ). Furthermore, \nthe mutated gen es were amplified  from viral DNA by PCR and subsequently \nsequenced using the primer pairs CyHV -3O25 -F and -R, CyHV -3O65-F and -R, or \nCyHV -3O148 -R and CyHV3 -O149-F, respectively  (Fuchs et al., 2014) . The PCR \nproducts of all CyHV -3 mutants exhibited the expected sizes (Fig. 2 ) and sequen ces. \nAnalysis of the complete genome sequence was performed only for the recombinant \nACCEPTED MANUSCRIPT\n11 \n KHV-T\uf044148/149. As expected, this sequence was very similar to that of the  parental \nvirus strain KHV -T (Gao et al., 2018) , except the deletion within ORFs 148 and 149 \n(Table 2). Nine of the 1 1 other observed alterations affected homopolymeric \nnucleotide stretches or tandem repetitions of short motifs which tend to be hi ghly \nvariable (highlighted in gr ey). Although few  of these regions were localized in ORFs \n45 and 52, no frameshifts or stop codons were introduced (Table 2). We found similar \ndifferences to the published sequence , including two single base substitutions,  and a \nconsiderable elongation of ORF52 also in another recently sequenced recombinant \nof KHV -T which lacked the viral thym idine kinase and dUTPase genes  (Schr\u00f6der et \nal., 2018 ). Thus, these alterations are presumably present in the KHV -T variants \nused in different labs, and not due to accidental mutations which occurred during \npreparation of the virus recombinants.  \n \n3.2. Protein  expression of the CyHV -3 mutants  \nProtein expression of the generated glycoprotein gene del etion mutants of KHV -T \nwas analyzed using available antisera  (Fuchs et al., 2014) . CCB cells were harvested \nfor Western blotting 2 d after infection at an MOI of 1  with the respective CyHV -3 \nmutants . Glycoprotein pORF25  was detectable in cells infected with KHV -T or the \nrevertant  KHV-T25R, but not in cells infected with KHV -T\uf04425 (Fig. 3A). Like the \ncorresponding protein of KHV -I (Fuchs et al., 2014) , pPORF25 of KHV -T (calculated \nmass of the primary translation product of 66.1 kDa) , exhibited an apparent molecular \nmass of approximately  125 kDa, indicating presence of several carbohydrate chains , \ni.a. at 5 predicted N -linked glycosylation sites  (asparagine -X-serine/ threonine ). In \ncontrast, pORF149 (calculated mass 72.0 kDa) contains only one potential N -\nglycosylation site, but three protein bands of approximately  100, 120 and 160 kDa \nwere detected by the antiserum (Fig. 3B). The specificity of these reactions was \nconfirmed by the absence of the se signals in cells infected with the deletion mutants \nKHV-T\uf044149 and KHV -T\uf044148/149, and their reappearance in ORF149 rescu ants (Fig. \n3B). It remains to be elucidated whether the large forms of pORF149, which contains \n74 serine (10.6 %) and 143 threonine (20.5 %) residues, are due to O -linked \nglycosylation, other post -translational modifications, or stable protein -protein \ninteractions. An antiserum against the major capsid protein pORF92 of CyHV -3 \n(Fuchs et al., 2014)  served as control, and similar amounts of the approximately  140 \nACCEPTED MANUSCRIPT\n12 \n kDa gene product (calculated mass 139.6 kDa) were detected in all infected samples \n(Fig. 3, lower panels). Our available pORF65 - and pORF148 -specific sera (Fuchs et \nal., 2014)  did not permit unambiguous detection of their target proteins by Western \nblot or IF analyses of  CyHV -3 infected cells, but expression of p ORF25 and \npORF149 was  demonstrated  to be unaffected in ORF65 and ORF148 mutants of \nKHV-T (results not shown).  \nAlthough we cannot identify pORF148 directly, previous studies showed that its \nexpression in another CyHV -3 strain was not affected by deletion of the upstream \nORF149 (Vancsok et al., 2017 ), and , therefore, it appears likely that ORF148 is also \nexpressed by KHV -T\uf044149. This assumption is supported by the different phenotypes \nof our ORF148, ORF149, and double deletion mutants (see below).  \nThe absence of pORF65 from cell lysates  infected with KHV -T\uf04465 or KHV -\uf04465G, as \nwell as its rescue in KHV -T65R,  could be demonstrated by lateral flow tests \n(FASTest\u00ae KOI HV, Megacor) based on pORF65 -specifc mAb (Vrancken et al., \n2013)  (see supplementary figure S2 ). This test might also permit fast differentiation of \npotential CyHV -3 vaccines lacking OR F65 from wild -type virus in carp. \n \n3.3. In vitro  replication properties of the CyHV -3 mutants  \nCell-to-cell spread of KHV-T and the derived mutants was compared by plaque \nassays on CCB cells , which were evaluated 4 d after infection  (Fig. 4). Infected cells \nwere identified by IIF  tests and plaque areas were determined microscopically.  The \nplaque sizes of the ORF65 and ORF148 mutants ranged between 95 % and 99 % of \nwild-type levels , which was statistically not significant.  In contrast, plaque sizes of \nKHV-T\u220625 G, KHV -T\u220625, KHV -T\u2206149G , and KHV-T\u2206149  were sign ificantly (p < \n0.005) reduced by approximately  50 % compared to wild  type KHV -T. These \nspreading defects were corrected in the rescue mutants KHV -T25R and KHV -T149R. \nInterestingly , the double  gene deletions in KHV -T\u2206148/149G and KHV -T\u2206148/149 \nalso resulted in almost wild -type sized plaques (Fig. 4), indicating that the adverse \neffect of ORF149 deletion is compensated by the additional removal of ORF148.  \nAlthough plaques of KHV -T\u2206148/149 appear ed significantly (p < 0.05) smaller than \nthose of KHV -T, no significant size differences were observed between the deletion \nmutant and the rescuant  KHV-T148/149R.  \nACCEPTED MANUSCRIPT\n13 \n Growth kinetics analyzed after synchronized infection at a MOI of 0.1 confirmed that \nORF25, O RF65, ORF148 and ORF149 are dispensable for productive replication of \nCyHV -3 in CCB cells (Fig. 5A). Singl e deletions of ORF25 (blue bars) or ORF149 \n(red bars) resulted in delayed replication compared to wild -type KHV -T and the \ncorresponding revertants. Th e observed differences were statistically significant  (p < \n0.05) at nearly all times after infection. The ORF25 -deleted, but not the ORF149 -\ndeleted virus also exhibited  a significant,  approximately  10fold reduction of final titers. \nWhereas deletion of ORF65 (orange  bars) , and ORF148/149 (yellow bars) had no \ndistinct effect, single deletion of ORF148 ( green  bars) slightly enh anced replication . \nThis enh ancement was significant (p < 0. 05) at 6 of the 7 analyzed times after \ninfection when compared to  wild-type KHV -T, and at 5 time points  when compared to \nthe revertant KHV -T148R  (Fig. 5A) . Apart from few outliers at single times, all \nrevertant viruses exhibited wild -type like grow th properties  (Fig. 5A) . The GFP -\nexpressing gene deletion mutants exhibited similar replication kinetics as the \ncorresponding reporter -less mutants  (results not shown) , and were omitted to reduce \ncomplexity of the diagram.  However, to confirm t he effects of ORF148 and ORF149 \ndeletion , the corresponding subset of CyHV -3 recombinant s was reanalyzed in a \nsecond series of growth kinetic studies at lower MOI (0.01) (see supplementary figure \nS3). These studies confirmed that, independent of presence or absence of a GFP \nreporter gene, the ORF149 deletion delayed, and the ORF148 deletion e nhanced \nreplication of KHV -T. Again the effects appeared additive, resulting in wild -type like \ngrowth of the double deletion mutants.  \nIn general, these  results are in line with those of previous investigations of similar \nsingle gene deletion mutants genera ted by mutagenesis of a BAC -cloned CyHV -3 \nisolate from Belgium  (Vancsok et al., 2017) . These studies also showed wild-type like \ngrowth of the ORF65 -deleted virus,  but delayed replication and cell -to-cell spread of \nORF25 - and ORF149 -deleted mutants on CCB cells, as well as reduced final titers of \nORF25 -negative virus. However, unlike in our experiments a beneficial effect of \nORF148 deletion was not observed, and ORF148/149 double mutants were not \ninvestigated  in the previous study (Vancsok et al., 2017) . \nTo further elucidate the functions of the ORF25 gene family members of CyHV -3, we \nanalyzed in vitro  penetration kinetics of the different deletion mutants using acid-\ninactivation protocols established for another herpesvirus, Pseudorabies virus ( PrV, \nSuid alphaherpesvirus 1 ) (Mettenleiter, 1989; Vallbracht et al., 2017) . To facilitate ACCEPTED MANUSCRIPT\n14 \n evaluation  by direct fluorescence microscopy , the GFP -expressing CyHV -3 \nglycoprotein deletion mutants  were used  for these experime nts, and a GFP -\nexpressing dUTPase - deletion mutant of KHV -T (KHV -T\uf044DUTG ) served as \u201cwild \ntype\u201d control. This virus had been shown to exhibit wild type -like replication properties \nin CCB cells (Schr\u00f6der et al., 2018 ). After synchronized adsorption to CCB cells on \nice, i nfectious particles of KHV -T\uf044DUTG, KHV -T\uf04465G and KHV-T\uf044148G  were \nshown to enter cells almost completely within two hours at 25\u00b0C  (Fig. 5B). In \ncontrast, only 58 %  of the KHV -T\uf04425G and 36 %  of the KHV-T\uf044149G particles \nbecame insensitive  to acid treatment within this time, and also at earlier times lower \nproportions of these two mutants had penetrated into the cells (Fig. 5B).  For \nORF149 -deleted CyHV -3 the observed penetration defect is statistical ly highly \nsignificant (p < 0,005 ). These findings explain the delayed replication (Fig. 5A), and \nthe reduced plaque sizes (Fig. 4) of ORF25 and ORF149 -deleted CyHV -3. \nInterestingly, the double mutant KHV -T\uf044148/149G exhibited wild type -like penetration \nkinetics (Fig. 5B).  \nTo exclude relevance of the envelope glycoproteins pORF25, pORF65, pORF148, \nand pORF14 9 for virion morphogenesis, CCB cells were analyzed by electron \nmicroscopy 20 h after infection with KHV -T or the single and double mutants at a MOI \nof 1 (Fig. 6). As exemplarily shown  for KHV -T\uf04425 and KHV -T\uf044149, all stages of \nmorphogenesis, including nucleocapsid formation in the nucleus (Fig. 6A, 6C, 6E , \nasterisks ), nuclear egress b y transit through the nuclear membrane (Fig. 6A, 6C, 6E, \narrows ), final envelopment of nucleocapsi ds in the cytoplasm (Fig. 6B, 6D , 6F, \nsquares ), and released mature virus particles (Fig. 6A, 6B, 6E, 6F , triangles ) were \nfound in cells infected with either virus. Thus, we found no evidence for a role of the \ninvestigated glycoproteins in matu ration or egress of CyHV -3 virions, although it \ncannot be excluded considering a potential functional redundancy within the \nparalogous ORF25 family proteins.  \nHowever, b ased on our results the ORF25 family members pORF25 and pORF149 \nplay an accessory role during virus entry into host cells. This process and the \ninvolved proteins have been extensively investigated for mammalian \nalphaherpesviruses like herpes simplex virus type 1 ( HSV-1, Human \nalphaherpesvirus 1 ) (Eisenberg et al., 2012; Sathiyamoorthy et al., 2017) , whereas \nlittle is known about the corresponding gene products of alloherpesviruses. In most \nACCEPTED MANUSCRIPT\n15 \n alphaherpesviruses  four en velope glycoproteins (gB, gD, gH, gL) are required for \nspecific receptor binding and subsequent fusion of the viral envelope with the ho st \ncell plasma membrane. However, except gD, the former proteins are conserved \nthroughout the Herpesviridae , whereas the ORF25 family seems to be restricted to \nthe Cyprinivirus genus of the Alloherpesviridae  (Aoki et al., 2007; Davison et al., \n2013) . Moreover, at least the core fusion protein gB, and gH are absolutely essential \nfor productive replication  of the Herpesviridae , whereas the ORF25 family members \nof CyHV -3 are dispensable (Vancsok et al., 2017 ; this study ). Therefore , the proteins \ninvestigated in this study are presumably not required for the membrane fusion \nprocess per se. However, it appears conceivable that the structurally related gene \nproducts of the ORF25 family represent redundant receptor binding proteins of \nCyHV -3, which are able to bind  the same or diff erent host cell membrane proteins, \nand to activate the hitherto unknown alloherpesvirus fusion protein(s). Therefore, it \nhas to  be test ed whether combined deletion of all ORF25 family members  from the \nCyHV -3 genome , i.e. of ORF25, ORF65, OR F148, ORF149, an d the often  \nspontaneously deleted or frameshifted ORF s 26 and 27, still results in a replication \ncompetent virus.  \nAn inter esting  finding was the positive effect of ORF148 deletion , which compensate d \nthe adverse effects of ORF149 deletion in the double deletion mutants. Although \nKHV-T\uf044148/149 might  express a chimeric  membrane protein containing the C -\nterminal part of pORF148 , and a modified N -terminal signal sequence originating \nfrom pORF149 , this was  not possible in KHV -T\uf044148/149 G, where the two gene \nremnants we re separated by the GFP cassette (Fig. 1D). Nevertheless both double \nmutants exhibited similar, almost wild type like in vitro  replication properties, which \nwere clearly improved compared to those of the ORF149 single deletion mutants \n(Fig. 4, 5 ). Furthermore, full genome sequencing of KHV -T\uf044148/149 revealed no \naccidental mutations compared to KHV -T which could compensate for ORF149 \ndeletion. However, pORF148 and pORF149 exhibit an amino acid sequence identity \nof 37.5 %, suggesting related \u201cfunct ions\u201d. Possibly, pORF148 represents  a \nnonfunctional \u201ccopy\u201d of pORF149 , which is expressed and able to bind cellular \nreceptors, but not to trigger subsequent virus entry.  Thus, absence of pORF148 \nmight facilitate receptor binding of pORF149, which seems to be the most relevant \nORF25 family member for efficient entry  (Fig. 5) . In the absence of both proteins, \nother  receptor binding proteins, e.g. pORF25 or pORF65, might be able to  ACCEPTED MANUSCRIPT\n16 \n compensate . This hypothesis is supported by the moderately delayed penetration of \nORF25 -deleted CyHV -3 (Fig. 5).  \n \n3.4. Virulence and protective efficacy of ORF148 and ORF 149 gene deleted \nCyHV -3 mutants  in carp  \nPrevious experiments have shown that deletion of ORF25 leads to attenuation of \nCyHV -3, but interferes with protection against subsequent wild type challenge  \n(Vancsok et al., 2017) . This might have been either due to the relevance of pORF25 -\nspecific immune reactions for protection (Zhou et al., 2014b) , or to an inefficient in \nvivo replication of the de letion mutant. In contrast, ORF65, ORF148, and ORF149 \nsingle gene deletion mutants of the BAC -cloned Belgian CyHV -3 isolate were not \nsufficiently attenuated (Vancsok et al., 2017) . However, previously  we have shown \nthat combined d eletion of the TK and d UTPase  genes of CyHV -3 leads to an \nimproved attenuation compared to the corresponding single deletions without \naffecting protective efficacy of the candidate vaccine (Fuchs et al., 2011; Schr\u00f6der et \nal., 2018 ). Therefore , we now examined the virulence  of, and the immune responses \ninduced by the double mutant KHV-T\uf044148/149. The corresponding single mutants \nKHV-T\uf044148 or  KHV-T\uf044149 were  also evaluated , and compared to the parental strain \nKHV-T, which has been considered to be much less virulent than the virus used for  \nprevious in vivo  testing  of glyco protein deletion mutan ts of CyHV -3 (Gao et al., 2018) . \nIn the present animal trial , five  groups  consisting of 40 nine months - and 5 two years -\nold carp , were infected by immersion in 5 l water containing 2.5 x 107 PFU of the \nvirus mutants, KHV -T or cell culture medium. Between day 6 and 31 after wild -type \ninfection , 17 of the juvenile carp died, resulting in a total mortality rate of 4 2.5 % (Fig. \n7A). This rate  was twice as high as observed by others using the corresponding virus \nstrain (Gao et al., 2018) , but in line with the results of previous animal experiments \nwith KHV -T in our institute (Schr\u00f6der et al., 2018) . It remains to be elucidated \nwhether this difference is due to different susceptibilities of the used carp breeds, \ndifferent virus doses  or water temperatures , or to the few d etermined sequence \nalterations  between the KHV -T preparations  used in the different laboratories (Table \n2)(Schr\u00f6der et al., 2018) . \nInfection with KHV-T\u2206148 or  KHV-T\u2206149 led to loss of 9 (22.5 %) or 8  (20 %) \nanimals, respectively (Fig. 7A) . Mortality caused by the double deletion mutant KHV -\nACCEPTED MANUSCRIPT\n17 \n T\u2206148/149  was slightly higher  (10 of 40 carp or 25  %). According to Fisher\u2019s exact \ntests the observed reductions of mortality rates compared to wild type infection were \nnot significant (p > 0.05), and the animals of all infected groups developed one or \nmore signs of CyHV -3 infection like fatigue, skin lesion and excess mucus \nproduction . This applied also to the  two year -old fish , which, however, survived \ninfection with wild -type or mutant KHV -T. Thus, in line with previous results (Vancsok \net al., 2017)  deletion of ORF148 and ORF149 did not sufficiently  attenuate  CyHV -3 \nfor use as a live vaccine. Unlike the TK and dUTPase double deletions  (Schr\u00f6der et \nal., 2018 ), combined removal of ORF148 and ORF149 did not improve  in vivo  \nattenuation of the virus , correlat ing with the enhanced in vitro  growth of KHV -\nT\u2206148/149 compared to KHV -T\u2206149 (Figs. 4, 5).  \nFive weeks after primary infection all surviving fish and na\u00efve control animals were \nchallenged by immersion in 5 l water containing 2.5 x 107 PFU of wild -type KHV -T. \nThe mock -immunized carp developed severe clinical signs, and 15 of them (37.5 %) \ndied (Fig. 7A). In contrast, no symptoms were observed in any of the immunized \ncarp, and all of them survived challenge infection (Fig 7A ). Although responses to \nheterologous, more virulent, challenge virus strains remain to be evaluated, the \npresent results indicate that even combined deletion of the highly immunogenic \nenvelope glycoproteins pORF148 and pORF149 (Fuchs et al., 2014)  did not \nsubstantially affect protective efficacy of CyHV -3. In line with this, an ELISA using \nplates coated with purified CyHV -3 virions  (Bergmann et al., 2017) , indicated  similar \nor even higher titers of specific serum antibodies in animals infected with the deletion \nmutants than in wild type infected carp (Fig. 7B) . We have shown previously that \nseveral ot her CyHV -3 proteins, including g lycoproteins pORF25, pORF65, pORF99, \nand the major capsid protein pORF9 2 also induce humoral immune responses  in \ncarp (Fuchs et al., 2014) , which might have covered the  lack of  pORF148 and /or \npORF149 specific antibodies in the present animal experiments. Since all \nglycoproteins encoded by the ORF25 gene family of CyHV -3 are obviously \ndispensable for in vitro  virus replication (Vancsok et al., 2017 , and this study ), their \ndeletion might support the development of D IVA vaccines (van Oirschot, 1999)  which \npermit serological differentiation between immuniz ed and wild type -infected fish.  \n \n \nConflicts of interest  ACCEPTED MANUSCRIPT\n18 \n The authors declare  that there are no conflicts of interest  \n \nEthical statement  \nThe carp used in this study were kept in accordance with the German protection of \nanimal act. The experiments were approved by the animal experiment commission of \nthe federal state Mecklenburg -West Pomerania. Suff ering of animals was minimized.  \n \nAcknowledgments  \nThe studies were supported by the German Federal Ministry of Food and Agriculture. \nThe authors thank G. Strebelow for help with sequence analyses , and  M. J\u00f6rn for \ngraphical design of the EM micrographs . The technical help o f A. Landmesser, I. \nWerner, J. Lange , P. Zitzow, and P. Meyer is greatly appreciated.  \n \n  \nACCEPTED MANUSCRIPT\n19 \n References  \n \nAgresti A., 1992. A Survey of Exact Inference for Contingency Tables. Statistical Science 7(1), 131 -177.  \nAndrew J. Davison, Tomofumi Kurobe, Derek Gatherer, Charles Cunningham, Ian Korf, Hideo Fukuda, \nRonald P. Hedrick, Waltzek, T.B., 2013. Comparative Genomics of Carp Herpesviruses. Journal \nof Virology 87, 2908 -2922.  \nAoki, T., Hirono, I., Kurokawa, K., Fukuda, H., Nahary, R., Eldar, A., Davison, A.J., Waltzek, T.B., \nBercovier, H., Hedrick, R.P., 2007. Genome sequences of three koi herpesvirus isolates \nrepresenting the expanding distribution of an emerging disease threatening koi and common \ncarp worldwide. J Virol 81(10), 5058 -5065.  \nBalon, E.K., 1995. Origin and domest ication of the wild carp, Cyprinus carpio: from Roman gourmets \nto the swimming flowers. Aquaculture 129, 3 \u201348. \nBergmann, S.M., Wang, Q., Zeng, W., Li, Y., Wang, Y., Matras, M., Reichert, M., Fichtner, D., Lenk, M., \nMorin, T., Olesen, N.J., Skall, H.F., Lee , P.Y., Zheng, S., Monaghan, S., Reiche, S., Fuchs, W., \nKotler, M., Way, K., Brauer, G., Bottcher, K., Kappe, A., Kielpinska, J., 2017. Validation of a \nKHV antibody enzyme -linked immunosorbent assay (ELISA). J Fish Dis 40(11), 1511 -1527.  \nBoutier, M., Gao, Y., Vancsok, C., Suarez, N.M., Davison, A.J., Vanderplasschen, A., 2017. \nIdentification of an essential virulence gene of cyprinid herpesvirus 3. Antiviral Res 145, 60 -\n69. \nBretzinger, A., Fischer -Scherl, T., Oumouna, M., Hoffmann, R., Truyen, U., 1999. Mas s mortalities in \nkoi, Cyprinus carpio, associated with gill and skin disease. Bull. Eur. Ass. Fish Pathol 5(19), \n182.  \nCostes, B., Fournier, G., Michel, B., Delforge, C., Raj, V.S., Dewals, B., Gillet, L., Drion, P., Body, A., \nSchynts, F., Lieffrig, F., Van derplasschen, A., 2008. Cloning of the koi herpesvirus genome as \nan infectious bacterial artificial chromosome demonstrates that disruption of the thymidine \nkinase locus induces partial attenuation in Cyprinus carpio koi. J Virol 82(10), 4955 -4964.  \nCui, L. C., Guan, X.T., Liu, Z.M., Tian, C.Y., Xu, Y.G., 2015. Recombinant lactobacillus expressing G \nprotein of spring viremia of carp virus (SVCV) combined with ORF81 protein of koi \nherpesvirus (KHV): A promising way to induce protective immunity against SVCV an d KHV \ninfection in cyprinid fish via oral vaccination. Vaccine 33(27), 3092 -3099.  \nDavison, A.J., Eberle, R., Ehlers, B., Hayward, G.S., McGeoch, D.J., Minson, A.C., Pellett, P.E., Roizman, \nB., Studdert, M.J., Thiry, E., 2009. The order Herpesvirales. Arch Virol 154(1), 171 -177.  \nDavison, A.J., Kurobe, T., Gatherer, D., Cunningham, C., Korf, I., Fukuda, H., Hedrick, R.P., Waltzek, \nT.B., 2013. Comparative genomics of carp herpesviruses. J Virol 87(5), 2908 -2922.  \nEisenberg, R.J., Atanasiu, D., Cairns, T.M., Gal lagher, J.R., Krummenacher, C., Cohen, G.H., 2012. \nHerpes virus fusion and entry: a story with many characters. Viruses 4(5), 800 -832.  \nFuchs, W., Fichtner, D., Bergmann, S.M., Mettenleiter, T.C., 2011. Generation and characterization of \nkoi herpesvirus rec ombinants lacking viral enzymes of nucleotide metabolism. Arch Virol \n156(6), 1059 -1063.  \nFuchs, W., Granzow, H., Dauber, M., Fichtner, D., Mettenleiter, T.C., 2014. Identification of structural \nproteins of koi herpesvirus. Arch Virol 159(12), 3257 -3268.  \nFuchs, W., Mettenleiter, T.C., 1996. DNA sequence and transcriptional analysis of the UL1 to UL5 \ngene cluster of infectious laryngotracheitis virus. J Gen Virol 77 ( Pt 9), 2221 -2229.  \nFuchs, W., Mettenleiter, T.C., 1999. DNA sequence of the UL6 to UL20 genes of infectious \nlaryngotracheitis virus and characterization of the UL10 gene product as a nonglycosylated \nand nonessential virion protein. J Gen Virol 80 ( Pt 8), 2173 -2182.  \nGao, Y., Suarez, N.M., Wilkie, G.S., Dong, C., Bergmann, S., Lee, P.A., Davison, A. J., Vanderplasschen, \nA.F.C., Boutier, M., 2018. Genomic and biologic comparisons of cyprinid herpesvirus 3 strains. \nVet Res 49(1), 40.  \nACCEPTED MANUSCRIPT\n20 \n Hedrick, R.P., Marty, G.D., Nordhausen, R.W., M.J., K., Bercovier, H., Eldar, A., 1999. A herpesvirus \nassociated with mass mortality of juvenile and adult koi, a strain of a common carp. Fish \nHealth Newsletter 7(27), 44 -57. \nHoper, D., Freuling, C.M., Muller, T., Hanke, D., von Messling, V., Duchow, K., Beer, M., Mettenleiter, \nT.C., 2015. High definition viral vaccine stra in identity and stability testing using full -genome \npopulation data --The next generation of vaccine quality control. Vaccine 33(43), 5829 -5837.  \nKlupp, B.G., Granzow, H., Mettenleiter, T.C., 2000. Primary envelopment of pseudorabies virus at the \nnuclear mem brane requires the UL34 gene product. J Virol 74(21), 10063 -10073.  \nMettenleiter, T.C., 1989. Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in \nvirus entry. Virology 171(2), 623 -625.  \nMettenleiter, T.C., 2002. Herpesvirus assembly and egress. J Virol 76(4), 1537 -1547.  \nMichel, B., Leroy, B., Stalin Raj, V., Lieffrig, F., Mast, J., Wattiez, R., Vanderplasschen, A.F., Costes, B., \n2010. The genome of cyprinid herpesvirus 3 encodes 40 proteins incorporated in mature \nvirions. J Gen Virol 91(P t 2), 452 -462.  \nMletzko, A., Amtmann, A., Bergmann, S., Lee, P., Christian, J., Buchholz, R., Becker, A., 2017. \nInoculation of cyprinid herpesvirus 3 (CyHV -3) on common carp brain cells -influence of \nprocess parameters on virus yield. In Vitro Cell Dev Biol Anim 53(7), 579 -585.  \nNeukirch, M., B\u00f6ttcher, K., Bunnajirakul, S., 1999. Isolation of a virus from koi with altered gills. \nBulletin of the European Association of Fish Pathologists 19, 221 \u2013224.  \nPavlova, S.P., Veits, J., Keil, G.M., Mettenleiter, T.C., Fuch s, W., 2009. Protection of chickens against \nH5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious \nlaryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. \nVaccine 27(5), 773 -785.  \nRonen, A., Perelberg, A., Abramowitz, J., Hutoran, M., Tinman, S., Bejerano, I., Steinitz, M., Kotler, M., \n2003. Efficient vaccine against the virus causing a lethal disease in cultured Cyprinus carpio. \nVaccine 21(32), 4677 -4684.  \nRosenkranz, D., Klupp, B.G ., Teifke, J.P., Granzow, H., Fichtner, D., Mettenleiter, T.C., Fuchs, W., 2008. \nIdentification of envelope protein pORF81 of koi herpesvirus. J Gen Virol 89(Pt 4), 896 -900.  \nSathiyamoorthy, K., Chen, J., Longnecker, R., Jardetzky, T.S., 2017. The COMPLEXit y in herpesvirus \nentry. Curr Opin Virol 24, 97 -104.  \nSchr\u00f6der, L., Klafack, S., Bergmann, S., Fichtner, D., Lee, P., Mettenleiter, T.C., Fuchs, W., 2018. \nGeneration of potential koi herpesvirus live vaccines by simultaneous deletion of the viral \nthymdine ki nase and dUTPase genes.  J Gen Virol , doi: 10.1099/jgv.0.001148 . \nVallbracht, M., Rehwaldt, S., Klupp, B.G., Mettenleiter, T.C., Fuchs, W., 2017. Functional Relevance of \nthe N -Terminal Domain of Pseudorabies Virus Envelope Glycoprotein H and Its Interaction \nwith Glycoprotein L. J Virol 91(9).  \nvan Oirschot, J.T., 1999. Diva vaccines that reduce virus transmission. J Biotechnol 73(2 -3), 195 -205.  \nVancsok, C., Penaranda, M.M.D., Raj, V.S., Leroy, B., Jazowiecka -Rakus, J., Boutier, M., Gao, Y., Wilkie, \nG.S., Suare z, N.M., Wattiez, R., Gillet, L., Davison, A.J., Vanderplasschen, A.F.C., 2017. \nProteomic and Functional Analyses of the Virion Transmembrane Proteome of Cyprinid \nHerpesvirus 3. J Virol 91(21).  \nVrancken, R., Boutier, M., Ronsmans, M., Reschner, A., Leclipt eux, T., Lieffrig, F., Collard, A., Melard, \nC., Wera, S., Neyts, J., Goris, N., Vanderplasschen, A., 2013. Laboratory validation of a lateral \nflow device for the detection of CyHV -3 antigens in gill swabs. J Virol Methods 193(2), 679 -\n682.  \nZhou, J., Xue, J. , Wang, Q., Zhu, X., Li, X., Lv, W., Zhang, D., 2014a. Vaccination of plasmid DNA \nencoding ORF81 gene of CJ strains of KHV provides protection to immunized carp. In Vitro \nCell Dev Biol Anim 50(6), 489 -495.  \nZhou, J.X., Wang, H., Li, X.W., Zhu, X., Lu, W.L.,  Zhang, D.M., 2014b. Construction of KHV -CJ ORF25 \nDNA vaccine and immune challenge test. J Fish Dis 37(4), 319 -325.  \n  \nACCEPTED MANUSCRIPT\n21 \n Figure legends  \n \nFig. 1  \nConstruction of CyHV -3 recombinants. (A) Map of the KHV -T genome with \nlocalizations of ORF25, ORF65 , ORF 148, ORF 149 and direct terminal repeat \nsequences (rectangles) . Enlarged maps of the (B) ORF 25, (C) ORF 65, and (D) \nORF148/ORF 149 gene regions illustrate cloning and mutagenesis.  Viral ORFs \n(pointe d rectangles) and  relevant restriction sites are shown. Non-functional, \nfragmented or frameshifted ORFs are indicated by dotted  lines and different shading. \nEngineered restriction sites are printed in Italics. Black rectangles indicate encoded \nsignal peptides and transmembrane d omains of the CyHV -3 glycoprotein  genes. \nMajor parts of them  were either repl aced by a GFP expression cassette containing \nthe human cytomegalovirus immediate early promoter (P -CMV) , and a \npolyadenylation signal (A+), or deleted without substitution. T he deleted codon \nACCEPTED MANUSCRIPT\n22 \n ranges are given . Designations of plasmids and resulting virus recombinants (printed \nin Italics) are given at the right.  \n  \nACCEPTED MANUSCRIPT\n23 \n  \nFig. 2  \nPCR products of the authentic or mutated CyHV -3 genes (A) ORF25, (B) ORF 65, \nand (C) ORF148/ORF149 amplified from genomic DNA  of the generated \nrecombinants obtained with primer pairs CyHV -3O25 -F/R, CyHV -3O65 -F/R, or \nCyHV -3O148 -R and CyHV -3O149 -F (Fuchs et al., 2014) . Marker DNAs (1 kb Plus \nDNA ladder, Thermo Fisher Scientific) , and calculated product sizes are indicate d at \nleft and right , respectively.  \n  \nACCEPTED MANUSCRIPT\n24 \n  \nFig. 3  \nWestern blot analyses of CCB cells infected with the indicated CyHV -3 recombinants \n(MOI 1, 2 d p.i.). Blots of infected and uninfected cells were probed with monospecific \nrabbit antisera against (A) pORF2 5, (B) pORF149, and the major capsid protein \npORF92 (lower panels). Marker proteins (PageRuler Plus Prestained Protein Ladder, \nThermo Fisher Scientific), and specifically detected viral proteins are indicated at the \nleft and right, respectively.  \n  \nACCEPTED MANUSCRIPT\n25 \n  \nFig. 4  \nPlaque sizes of CyHV -3 recombinants on CCB cells. A reas of 30 plaques per virus \nwere determined after 4 days at 25\u00b0C , and com pared to plaques of parental KHV -T, \nwhich were set as 100 %. Me an sizes  and sta ndard deviations are shown . Asteri sks \nindicate significant (\uf02a p < 0. 05 % , \uf02a\uf02a p < 0,005 ) reduction compared to wild-type \nplaques sizes . \n  \nACCEPTED MANUSCRIPT\n26 \n  \nFig. 5  \nReplication and penetration kinetics of CyHV -3 recombinants on CCB cells (A) For \ndetermination of replication kinetics  the cells were infected at a MOI of 0.1, and \nincubated for the indicated times at 25\u00b0C. T otal progeny virus titers were determined \nby plaque assays  on CCB cells . Shown are the mean results of four experiments . \nAsterisks indicate significant (p < 0. 05) titer differences compared to wild -type virus \n(\uf0b9 KHV-T), and to the corresponding rescue mutants ( \uf0b9 Rev.)  at the same time after \ninfection . (B) For determination of p enetration  kinetics CCB cells were infected with \napproximately 250 PFU of the GFP-expressing KHV -T recombinants, using the \ndescribed GFP -expressing dUTPase -negative mutant KHV-T\uf044DUTG (Schr\u00f6der et \nal., 2018 ) as wild type -like control.  After adsorption at 4\u00b0C, the cells were  incubate d \nfor indicated times at 25\u00b0C prior to acid inactivation of non -penetrated virus. Then \nincubation at  25\u00b0C was continued under plaque assay conditions for 3 d. Numbers of  \nplaques were compared to those obtained without acid inactivation  of the same virus \nmutant . Mean percentages of three independent experiments and standard \nACCEPTED MANUSCRIPT\n27 \n deviations are shown.  Asterisks indica te significantly reduced ( \uf02a p < 0.1, \uf02a\uf02a p < 0.05, \n\uf02a\uf02a p < 0.005) penetration rates . \n  \nACCEPTED MANUSCRIPT\n28 \n  \nFig. 6  \nVirion morphogenesis of CyHV -3 glycoprotein mutants. CCB cells were infected at an \nMOI of 1 with KHV -T (A, B), KHV -T\uf044149 (C, D) or KHV -T\uf04425 (E, F) at an MOI of 1, \nand fixed and processed for transmission electron microscopy after 20 h at 25\u00b0C . \nEmpty capsids and nucleocapsids in the nucleus (asterisks) , nuclear egress (arrows), \nfinal envelopment in the cytoplasm (squares), and extracellular virus particles \n(triangles) are indicated.  Bars represen t 500 n m. \n  \nACCEPTED MANUSCRIPT\n29 \n  \nFig. 7  \nAttenuation and protective efficacy of CyHV -3 recombinants. Nine months and two \nyears -old carp were infected with KHV -T or the indicated virus mutants by immersion \nin 5 l water containing 5 x 103 PFU/ml. After 35 d all surviving fish and mock -infected \ncontrol animals (N.I.) were challenged with the same dose of  KHV-T. (A) Shown are \nthe time courses of survival rates (%)  of the nine months -old fish , and total numbers \nof deceased and infected  animals i n each group. (B) KHV-specific antibodies were \ndetected by an ELISA  (Bergmann et al., 2017)  in sera  of two years -old carp 28 days  \nafter primary infection ( p.i.) with the indicated viruses or mock infection (N.I.) , as well \nas 28 day s after challenge ( p.c.) with KHV -T. The mean substrate reaction values \n(OD 450nm) of two replicas each of sera from four animals per group and standard \ndeviations are indicated. Samples showing an OD 450nm of > 0.2 (red line) were \nconsidered as positive.  \n  \nACCEPTED MANUSCRIPT\n30 \n Tables  \n \nTable 1:  PCR and sequencing primers used in this study  \nname Sequence  nucleotide  position  \nKTO25F  5\u2018-CAC GAATT CTCATGTACGAGTACCTGCG -3\u2018 44,755  - 44,774  \nKTO25R  5\u2019-CAC AAGCTT CGGAGAGCATGATGAAGAGG -3\u2019 48,347 - 48,366 (r) \nKTO65F  5\u00b4-CAC GAAT TCTTTCAGTTCAACGACCCG -3\u00b4 121,758  - 121,777  \nKTO65R  5\u00b4-CAC AAG CTTTACCTTCTACGGCGTGG -3\u00b4 124,935 - 124,954  (r) \nKTO149R -F 5\u00b4-CAC GAATTC CGAGGGAGATCAGAGTTC -3\u00b4 253,07 6 - 253,094  \nKTO149R -R 5`-CAC AAGCT TGGGATGATGTCAGCGTTG -3\u00b4 259,046  - 259,064  (r) \nNucleotide  positions refer to the sequence  of the CyHV -3 TUMST1 genome  \n(GenBank accession # AP008984)  (Aoki et al., 2007) . Additional, nonmatching \nnucleotides ( in Italics) , engineered restriction sites (bold) , and reverse strand primers \n(r), are indicated.  \n  \nACCEPTED MANUSCRIPT\n31 \n Table 2: Sequence analysis KHV -T\uf044148/149  compared to KHV -T \nPosition in KHV -T ORF  Alteration  \n37986 - 38007  - \uf044 GTGTGTGTGTGTGTGTGTGTGT  \n75907 - 75915  45 \uf044 AGGAGGTGG ( \uf044GGG at codon 336)  \n91174/91175  52 + TAACCACCGAGGAAACCACCGAGGAAACCACC  \n   GAGGAAACCACCGAGGAAACCACCGAGGTAAC  \n   CACCGAGGAAACCACCGAGG  (+ VTTEETTEETT  \n   EETTEETTEVTTEETTE at codon 133 ) \n91222/91223  52 + AAACCACCGAGG (+ ETTE at codon 149)  \n91247/91248  52 + AACCACCGAGGA  (+ TTE E at codon 158) \n102598  - + GGGG  \n138261  72 A \uf0ae C (K \uf0ae N at codon 103)  \n177575 - 177594  - \uf044 AGAGAGAGAGAGAGAGAGAG  \n216478/216479  - + CTTCAGCACCTTCAGCACCTTCAGCACCTTCAG  \n   CACCTTCAGCACCTTCAGCACCTTCAGCACCTT  \n   CAGCACCTTCAGCACCTTCAGCAC  \n254891 - 257899  148/149  \uf044 ORF149 / ORF148 (from codon 17 to 281)  \n257991  - T \uf0ae C \n270671 - 270685  - \uf044 CGACACAGACTACAG  \nNucleotide positions of alterations in KHV -T\uf044148/149 refer to the published genome \nsequence of the CyHV -3 strain KHV -T (GenBank accession number # MG925491) \n(Gao et al., 2018) . Deleted nucleotide rages are indicated, and the two flanking \nnucleotides are provided at insertion sites. Designations of affect ed ORFs, nucleotide \nsequences of insertions (+) or deletions ( \uf044), and consequences on deduced amino \nacid sequences includi ng codon positions are given . Alterations affecting repetitive \nsequences are highlighted by shading. The targeted mutation unique  to KHV -\nT\uf044148/149  is printed in bold letters.  \nACCEPTED MANUSCRIPT\nPublikationen \u00a0\n36\u00a0\n\u00a0 \n \u00a0 Publikationen \u00a0\n67\u00a0\n\u00a03.3. Pubilkation III \n\u00a0\n\u201cIn cellulo evolution of Cyprinid herpesvirus 3 seems to follow a \nviral quasispecies-like model\u201d \n Sandro Klafack, Anna-Sophie Fiston -Lavier, Sven M. Bergmann, Saliha \nHammoumi, Lars Schr\u00f6der, Walter Fuchs, Angela Lusiastuti, Pei-Yu Lee, \nMaster students, Anne-Sophie Gosse lin-Grenet and Jean-Christophe \nAvarre  \n Eingereicht bei Viruses - Animal Viruses \n  \u00a0\nViruses\u00a02018,\u00a010,\u00a0x;\u00a0doi:\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 www.mdpi.com/jou rnal/viruses \u00a0\nArticle\u00a0 1 \nIn\u00a0cellulo\u00a0evolution \u00a0of\u00a0Cyprinid \u00a0herpesvirus \u00a03\u00a0seems\u00a0 2 \nto\u00a0follow\u00a0a\u00a0viral\u00a0quasispecies \u2010like\u00a0model\u00a0\u00a0 3 \nRunning \u00a0title:\u00a0Evolution \u00a0of\u00a0CyHV\u20103\u00a0in\u00a0vitro\u00a0 4 \nSandro\u00a0Klafack1, \u00a0Anna\u2010Sophie\u00a0Fiston\u2010Lavier2,\u00a0Sven\u00a0M.\u00a0Bergmann1*, \u00a0Saliha\u00a0Hammoumi2, \u00a0Lars\u00a0 5 \nSchr\u00f6der3, \u00a0Walter\u00a0Fuchs3,\u00a0Angela\u00a0Lusiastuti4, \u00a0Pei\u2010Yu\u00a0Lee5,\u00a0Master\u00a0students6**, \u00a0Anne\u2010Sophie\u00a0 6 \nGosselin \u2010Grenet7\u00a0and\u00a0Jean\u2010Christophe \u00a0Avarre2* \u00a0 7 \n1\u00a0Institute\u00a0of\u00a0Infectology, \u00a0Friedrich \u2010Loeffer\u2010Institut,\u00a0Federal\u00a0Research \u00a0Institute\u00a0for\u00a0Animal\u00a0Health,\u00a0 8 \nGreifswald \u2010Insel\u00a0Riems,\u00a0Germany \u00a0 9 \n2\u00a0ISEM,\u00a0IRD,\u00a0CNRS,\u00a0EPHE,\u00a0University \u00a0of\u00a0Montpellier, \u00a0Montpellier, \u00a0France\u00a0 10 \n3\u00a0Institute\u00a0of\u00a0Molecular \u00a0Virology \u00a0and\u00a0Cell\u00a0Biology,\u00a0Friedrich \u00a0Loeffer\u00a0Institut,\u00a0Federal\u00a0Research \u00a0Institute\u00a0for\u00a0 11 \nAnimal\u00a0Health,\u00a0Greifswald \u2010Insel\u00a0Riems,\u00a0Germany \u00a0 12 \n4\u00a0Research \u00a0Institute\u00a0for\u00a0Freshwater \u00a0Aquaculture \u00a0and\u00a0Fisheries \u00a0Extension, \u00a0Bogor,\u00a0Indonesia \u00a0 13 \n5\u00a0GenReach \u00a0Biotechnology, \u00a0Taichung \u00a0City,\u00a0Taiwan\u00a0 14 \n6\u00a0Master\u00a0Interactions \u00a0Microorganisms/Hosts \u00a0and\u00a0Environment \u00a0(IMHE),\u00a0and\u00a0Master\u00a0of\u00a0Sciences\u00a0and\u00a0Digital\u00a0 15 \nTechnology \u00a0for\u00a0Healthcare \u00a0(SDTH),\u00a0specialty \u00a0Bioinformatics, \u00a0Knowledge \u00a0and\u00a0Data\u00a0(BKD),\u00a0University \u00a0of\u00a0 16 \nMontpellier, \u00a0Montpellier, \u00a0France\u00a0 17 \n7\u00a0DGIMI,\u00a0INRA,\u00a0University \u00a0of\u00a0Montpellier, \u00a0Montpellier, \u00a0France\u00a0 18 \n*\u00a0Corresponding \u00a0authors:\u00a0Jean\u2010Christophe \u00a0Avarre\uff1bInstitut\u00a0des\u00a0Sciences\u00a0de\u00a0l\u2019Evolution \u00a0de\u00a0Montpellier \uff0c 19 \nUniversity \u00a0of\u00a0Montpellier, \u00a0Place\u00a0Eug\u00e8ne\u00a0Bataillon, \u00a0cc065\u00a034095\u00a0Montpellier \u00a0cedex\u00a05,\u00a0France\uff1bJean\u2010 20 \nchristophe.avarre@ird.fr \u00a0\u00a0 21 \nSven\u00a0Bergmann \uff1bFederal\u00a0Research \u00a0Institute\u00a0for\u00a0Animal\u00a0Health\uff0cS\u00fcdufer\u00a010,\u00a017493\u00a0Greifswald \u2010Insel\u00a0Riems,\u00a0 22 \nGermany \uff1bsven.bergmann@fli.de \u00a0 23 \n**Master \u00a0IMHE:\u00a0Charles\u00a0Amoyal, \u00a0Hajar\u00a0Amraoui, \u00a0Audrey\u00a0Bigourdan, \u00a0In\u00e8s\u00a0Boujandir, \u00a0Oceane\u00a0Bueno,\u00a0Betty\u00a0 24 \nCotteux, \u00a0No\u00ebmie\u00a0De\u00a0San\u00a0Nicolas,\u00a0Romain\u00a0Delattre, \u00a0Mame\u00a0Boucar\u00a0Diouf,\u00a0R\u00e9my\u00a0Dussaut, \u00a0K\u00e9vin\u00a0Gawron, \u00a0 25 \nJean\u2010Baptiste\u00a0Imbert,\u00a0Halima\u00a0Mouilhi, \u00a0Emilie\u00a0Nifaut,\u00a0Anais\u00a0Pages,\u00a0Lucien\u00a0Platon,\u00a0Sandrine \u00a0Sanchez, \u00a0Lena\u00a0 26 \nSimon,\u00a0H\u00e9l\u00e8ne\u00a0Sobry,\u00a0Mathilde \u00a0Souche,\u00a0Boris\u00a0Taillefer. \u00a0 27 \n**Master \u00a0SDTH\u2010BKD:\u00a0Edith\u00a0Ndiesseu \u00a0Guemgne, \u00a0Olivier\u00a0Sacchi,\u00a0Amad\u00a0Diouf,\u00a0Amirouche \u00a0Labib\u00a0Ouzerdine, \u00a0 28 \nFaustine \u00a0Durand,\u00a0Julie\u00a0Brooke,\u00a0Julie\u00a0Cremaschi, \u00a0Mathieu\u00a0Massaviol, \u00a0Mickael\u00a0Hamouma, \u00a0Mohammad \u00a0 29 \nSalma,\u00a0Morgan\u00a0Souli\u00e9,\u00a0Quentin\u00a0Delorme, \u00a0Thimoth\u00e9e \u00a0Virgoulay, \u00a0Valentin \u00a0Klein,\u00a0Yannick\u00a0Antoine, \u00a0Aurore\u00a0 30 \nBerne,\u00a0Camille\u00a0Gaal.\u00a0\u00a0 31 \n\u00a0 32 \nAbstract \uff1aViruses\u00a0are\u00a0able\u00a0to\u00a0evolve\u00a0in\u00a0vitro\u00a0by\u00a0mutation \u00a0after\u00a0serial\u00a0passages \u00a0on\u00a0cell\u00a0cultures, \u00a0which\u00a0 33 \ncan\u00a0lead\u00a0to\u00a0either\u00a0a\u00a0loss\u00a0or\u00a0an\u00a0increase\u00a0of\u00a0virulence. \u00a0Cyprinid \u00a0herpesvirus \u00a03\u00a0(CyHV\u20103),\u00a0a\u00a0295\u2010kb\u00a0 34 \ndouble\u00a0stranded \u00a0DNA\u00a0virus,\u00a0is\u00a0the\u00a0etiological \u00a0agent\u00a0of\u00a0the\u00a0koi\u00a0herpesvirus \u00a0disease\u00a0(KHVD). \u00a0To\u00a0 35 \nassess\u00a0the\u00a0influence \u00a0of\u00a0serial\u00a0passages, \u00a0an\u00a0isolate\u00a0of\u00a0CyHV\u20103\u00a0(KHV\u2010T)\u00a0was\u00a0passaged \u00a099\u00a0times\u00a0onto\u00a0 36 \ncommon \u00a0carp\u00a0brain\u00a0(CCB)\u00a0cells,\u00a0and\u00a0virus\u00a0virulence \u00a0was\u00a0evaluated \u00a0during\u00a0passages \u00a0through\u00a0 37 \nexperimental \u00a0infections \u00a0of\u00a0common \u00a0carp.\u00a0After\u00a078\u00a0CCB\u00a0passages, \u00a0the\u00a0isolate\u00a0was\u00a0much\u00a0less\u00a0virulent\u00a0 38 \nthan\u00a0the\u00a0original\u00a0form;\u00a0however, \u00a0it\u00a0partially\u00a0recovered \u00a0its\u00a0virulence \u00a0after\u00a099\u00a0passages. \u00a0A\u00a0comparative \u00a0 39 \ngenomic \u00a0analysis\u00a0of\u00a0these\u00a0three\u00a0forms\u00a0of\u00a0KHV\u2010T\u00a0(P0,\u00a0P78\u00a0and\u00a0P99)\u00a0revealed \u00a0a\u00a0limited\u00a0number\u00a0of\u00a0 40 \nvariations. \u00a0The\u00a0largest\u00a0one\u00a0was\u00a0a\u00a0deletion\u00a0of\u00a01\u00a0363\u00a0bp\u00a0in\u00a0the\u00a0predicted \u00a0ORF150,\u00a0which\u00a0was\u00a0detected\u00a0 41 \nin\u00a0P78\u00a0but\u00a0not\u00a0in\u00a0P99.\u00a0This\u00a0unexpected \u00a0finding\u00a0was\u00a0confirmed \u00a0by\u00a0PCR.\u00a0ORF150\u00a0thus\u00a0appears\u00a0as\u00a0a\u00a0 42 \npotential \u00a0key\u00a0player\u00a0for\u00a0the\u00a0virulence \u00a0of\u00a0CyHV\u20103.\u00a0In\u00a0addition, \u00a0the\u00a0results\u00a0presented \u00a0here\u00a0primarily \u00a0 43 \nsuggest\u00a0that\u00a0CyHV\u20103\u00a0evolves,\u00a0at\u00a0least\u00a0in\u00a0vitro,\u00a0through\u00a0an\u00a0assemblage \u00a0of\u00a0haplotypes \u00a0that\u00a0 44 \nalternatively \u00a0become\u00a0dominant \u00a0or\u00a0under\u2010represented. \u00a0 45 \nKeywords: \u00a0Cyprinid \u00a0herpesvirus \u00a03;\u00a0cell\u00a0culture\u00a0passages; \u00a0genome\u00a0evolution; \u00a0haplotype \u00a0 46 \n\u00a0 47 Viruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 2\u00a0of\u00a010\u00a0\n 1.\u00a0Introduction \u00a0 48 \nCommon \u00a0carp\u00a0(Cyprinus \u00a0carpio\u00a0L.)\u00a0is\u00a0the\u00a0most\u00a0produced \u00a0fish\u00a0in\u00a0the\u00a0world.\u00a0With\u00a0its\u00a0ornamental \u00a0 49 \nbreed,\u00a0the\u00a0koi,\u00a0it\u00a0is\u00a0also\u00a0one\u00a0of\u00a0the\u00a0most\u00a0expensive \u00a0fish.\u00a0This\u00a0fish\u00a0is\u00a0highly\u00a0threatened \u00a0by\u00a0the\u00a0Cyprinid \u00a0 50 \nherpesvirus \u00a03\u00a0(CyHV\u20103),\u00a0also\u00a0called\u00a0Koi\u00a0Herpesvirus \u00a0(KHV).\u00a0Since\u00a0its\u00a0first\u00a0report\u00a0in\u00a0the\u00a0late\u00a01990s\u00a0[1],\u00a0 51 \nKHV\u00a0disease\u00a0(KHVD)\u00a0has\u00a0spread\u00a0to\u00a0many\u00a0countries \u00a0worldwide \u00a0[2],\u00a0and\u00a0is\u00a0recognized \u00a0as\u00a0a\u00a0significant \u00a0 52 \nproblem\u00a0for\u00a0the\u00a0common \u00a0carp\u00a0and\u00a0koi\u00a0aquaculture \u00a0industries \u00a0[3,\u00a04].\u00a0Together \u00a0with\u00a0carp\u00a0pox\u00a0virus\u00a0 53 \n(Cyprinid \u00a0herpesvirus \u00a01),\u00a0goldfish\u00a0herpesvirus \u00a0(Cyprinid \u00a0herpesvirus \u00a02)\u00a0and\u00a0eel\u00a0herpesvirus \u00a0 54 \n(Anguillid \u00a0herpesvirus \u00a01),\u00a0CyHV\u20103\u00a0clusters\u00a0as\u00a0a\u00a0member\u00a0of\u00a0the\u00a0genus\u00a0Cyprinivirus \u00a0in\u00a0the\u00a0family\u00a0 55 \nAlloherpesviridae \u00a0[5].\u00a0It\u00a0causes\u00a0mass\u00a0mortality \u00a0in\u00a0carp\u00a0aquaculture, \u00a0often\u00a0with\u00a0more\u00a0than\u00a080%\u00a0losses\u00a0 56 \nand\u00a0severe\u00a0symptoms. \u00a0Most\u00a0common \u00a0symptoms \u00a0are\u00a0gill\u00a0necrosis, \u00a0skin\u00a0hemorrhage, \u00a0a\u00a0massive\u00a0mucus\u00a0 57 \nproduction, \u00a0later\u00a0on\u00a0sandpaper \u00a0skin\u00a0and\u00a0/\u00a0or\u00a0sunken\u00a0eyes\u00a0[1,\u00a06].\u00a0Once\u00a0infected\u00a0with\u00a0KHV,\u00a0carps\u00a0bear\u00a0 58 \nthe\u00a0virus\u00a0lifelong\u00a0and\u00a0will\u00a0therefore \u00a0act\u00a0as\u00a0carriers\u00a0[7\u20109].\u00a0Moreover, \u00a0persistent \u00a0infected\u00a0carp\u00a0can\u00a0shed\u00a0 59 \nthe\u00a0virus\u00a0for\u00a0the\u00a0rest\u00a0of\u00a0their\u00a0life.\u00a0Then\u00a0those\u00a0carp\u00a0or\u00a0koi\u00a0can\u00a0infect\u00a0naive\u00a0fish\u00a0and\u00a0spread\u00a0the\u00a0virus.\u00a0\u00a0 60 \nThe\u00a0genome\u00a0of\u00a0CyHV\u20103\u00a0was\u00a0sequenced \u00a0multiple \u00a0times\u00a0[10\u201013].\u00a0With\u00a0156\u00a0open\u00a0reading\u00a0frames\u00a0 61 \n(ORF)\u00a0and\u00a0a\u00a0length\u00a0of\u00a0295\u00a0kb,\u00a0KHV\u00a0has\u00a0the\u00a0biggest\u00a0genome\u00a0known\u00a0in\u00a0herpesviruses \u00a0[14].\u00a0 62 \nUnfortunately, \u00a0little\u00a0is\u00a0known\u00a0about\u00a0the\u00a0function\u00a0of\u00a0the\u00a0156\u00a0ORFs\u00a0or\u00a0their\u00a0importance \u00a0for\u00a0the\u00a0 63 \nvirulence. \u00a0Because\u00a0of\u00a0this\u00a0knowledge \u00a0gap,\u00a0it\u00a0is\u00a0difficult\u00a0to\u00a0target\u00a0a\u00a0particular \u00a0ORF\u00a0for\u00a0vaccine\u00a0 64 \nproduction \u00a0[15,\u00a016].\u00a0Thus,\u00a0classical\u00a0methods, \u00a0like\u00a0attenuation \u00a0along\u00a0cell\u00a0culture\u00a0passages \u00a0[17],\u00a0were\u00a0 65 \nused\u00a0to\u00a0generate \u00a0vaccine\u00a0strains.\u00a0Although \u00a0virus\u00a0attenuation \u00a0by\u00a0successive \u00a0passages \u00a0on\u00a0cell\u00a0culture\u00a0 66 \nhas\u00a0proven\u00a0efficient\u00a0[18],\u00a0no\u00a0genomic \u00a0and/or\u00a0transcriptomic \u00a0comparisons \u00a0between\u00a0original\u00a0and\u00a0 67 \nattenuated \u00a0viral\u00a0strains\u00a0have\u00a0been\u00a0carried\u00a0out\u00a0so\u00a0far\u00a0in\u00a0view\u00a0of\u00a0understanding \u00a0the\u00a0molecular \u00a0 68 \nmechanisms \u00a0of\u00a0virus\u00a0attenuation. \u00a0It\u00a0was\u00a0recently\u00a0shown\u00a0that\u00a0mutations \u00a0occurring \u00a0in\u00a0the\u00a0genome\u00a0of\u00a0 69 \nCyHV\u20103\u00a0during\u00a0cell\u00a0culture\u00a0passages \u00a0could\u00a0be\u00a0reverted\u00a0after\u00a0additional \u00a0passages \u00a0[19].\u00a0The\u00a0occurrence \u00a0 70 \nof\u00a0multiple \u00a0haplotypes \u00a0within\u00a0a\u00a0same\u00a0viral\u00a0specimen \u00a0is\u00a0now\u00a0well\u00a0documented \u00a0[12,\u00a020,\u00a021],\u00a0and\u00a0these\u00a0 71 \ngenetic\u00a0reversions \u00a0could\u00a0be\u00a0the\u00a0result\u00a0of\u00a0a\u00a0switching \u00a0dominance \u00a0of\u00a0one\u00a0or\u00a0several\u00a0haplotypes \u00a0over\u00a0the\u00a0 72 \nothers.\u00a0The\u00a0present\u00a0study\u00a0aimed\u00a0at\u00a0testing\u00a0this\u00a0hypothesis, \u00a0by\u00a0the\u00a0phenotypic \u00a0and\u00a0genomic \u00a0 73 \ncomparison \u00a0of\u00a0a\u00a0same\u00a0specimen \u00a0before\u00a0passage\u00a0on\u00a0cell\u00a0cultures\u00a0(P0)\u00a0and\u00a0after\u00a078\u00a0passages \u00a0(P78)\u00a0and\u00a0 74 \n99\u00a0passages \u00a0(P99).\u00a0The\u00a0results\u00a0presented \u00a0below\u00a0prove,\u00a0for\u00a0the\u00a0first\u00a0time,\u00a0that\u00a0CyHV\u20103\u00a0evolves,\u00a0at\u00a0least\u00a0 75 \nin\u00a0vitro,\u00a0through\u00a0an\u00a0assemblage \u00a0of\u00a0haplotypes \u00a0that\u00a0alternatively \u00a0become\u00a0dominant \u00a0and\u00a0under\u2010 76 \nrepresented. \u00a0This\u00a0finding\u00a0may\u00a0have\u00a0important \u00a0consequences \u00a0for\u00a0the\u00a0understanding \u00a0of\u00a0the\u00a0evolution \u00a0 77 \nof\u00a0this\u00a0virus,\u00a0as\u00a0well\u00a0as\u00a0for\u00a0the\u00a0development \u00a0of\u00a0a\u00a0vaccine\u00a0virus.\u00a0\u00a0 78 \n2.\u00a0Materials \u00a0and\u00a0Methods \u00a0 79 \n2.1.\u00a0CyHV\u20103\u00a0propagation \u00a0onto\u00a0CCB\u00a0cells\u00a0and\u00a0virus\u00a0harvest\u00a0and\u00a0storage\u00a0 80 \nCommon \u00a0carp\u00a0brain\u00a0(CCB)\u00a0cells\u00a0[22]\u00a0were\u00a0grown\u00a0at\u00a020\u00b0C\u00a0in\u00a0minimal\u00a0essential \u00a0medium\u00a0with\u00a0 81 \nEarls\u2019\u00a0salts\u00a0(Invitrogen) \u00a0supplemented \u00a0with\u00a010%\u00a0FBS,\u00a010mM\u00a0HEPES,\u00a02.2\u00a0g/l\u00a0NaHCO\u00a0(Roth),\u00a01%\u00a0non\u2010 82 \nessential \u00a0amino\u00a0acids\u00a0(Biochrom) \u00a0and\u00a00.12\u00a0g/l\u00a0pyruvic\u00a0acid\u00a0sodium\u00a0salt\u00a0(Merck).\u00a0Twenty\u00a0four\u2010hour\u00a0 83 \nold\u00a0CCB\u00a0cell\u00a0monolayers \u00a0were\u00a0adsorbed \u00a0for\u00a01\u00a0hour\u00a0at\u00a020\u00b0C\u00a0with\u00a0an\u00a0isolate\u00a0of\u00a0CyHV\u20103\u00a0collected \u00a0from\u00a0 84 \nan\u00a0infected\u00a0koi\u00a0in\u00a0Taiwan\u00a0(KHV\u2010T)\u00a0[19].\u00a0Culture\u00a0medium\u00a0was\u00a0then\u00a0added\u00a0to\u00a0the\u00a0KHV\u2010T\u00a0inoculated \u00a0 85 \ncells,\u00a0which\u00a0were\u00a0subsequently \u00a0incubated \u00a0at\u00a020\u00b0C.\u00a0KHV\u2010T\u00a0was\u00a0serially\u00a0passaged \u00a0over\u00a0100\u00a0times.\u00a0Viral\u00a0 86 \nsuspensions \u00a0were\u00a0collected \u00a0after\u00a0consecutive \u00a0passages \u00a0when\u00a090%\u00a0of\u00a0cells\u00a0showed\u00a0cytopathic \u00a0effects\u00a0 87 \n(CPE),\u00a0usually\u00a0after\u00a07\u00a0days.\u00a0For\u00a0virus\u00a0harvest,\u00a0flasks\u00a0were\u00a0frozen\u00a0at\u00a0\u201080\u00b0C\u00a0and\u00a0thawed\u00a0once\u00a0at\u00a0room\u00a0 88 \ntemperature. \u00a0The\u00a0remaining \u00a0suspensions \u00a0were\u00a0stored\u00a0at\u00a0\u201080\u00b0C\u00a0or\u00a0used\u00a0directly\u00a0for\u00a0new\u00a0inoculation \u00a0 89 \nand\u00a0adsorption. \u00a0 90 \n2.2.\u00a0Experimental \u00a0infections \u00a0of\u00a0carp\u00a0 91 \nThe\u00a0wild\u2010type\u00a0KHV\u2010T\u00a0(P0)\u00a0and\u00a0the\u00a0resulting \u00a0viruses\u00a0after\u00a078\u00a0(P78)\u00a0and\u00a099\u00a0(P99)\u00a0passages \u00a0were\u00a0 92 \nexamined \u00a0for\u00a0their\u00a0ability\u00a0to\u00a0elicit\u00a0both\u00a0mortality \u00a0and\u00a0morbidity \u00a0in\u00a0common \u00a0carp.\u00a0For\u00a0this\u00a0purpose, \u00a0 93 \nforty\u00a06\u2010month\u00a0old\u00a0carp\u00a0were\u00a0placed\u00a0in\u00a0250\u2010L\u00a0aquaria.\u00a0Prior\u00a0to\u00a0challenge, \u00a0fish\u00a0were\u00a0adapted\u00a0to\u00a0the\u00a0re\u2010 94 \ncirculating \u00a0systems\u00a0for\u00a014\u00a0days\u00a0at\u00a020\u00b0C\u00a0(+/\u2010\u00a01\u00b0C).\u00a0First,\u00a0samples\u00a0consisting \u00a0of\u00a0gill\u00a0swap\u00a0and\u00a0blood\u00a0for\u00a0 95 Viruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 3\u00a0of\u00a010\u00a0\n serum\u00a0preparation \u00a0were\u00a0collected \u00a0before\u00a0infection. \u00a0Carp\u00a0were\u00a0then\u00a0immersed \u00a0for\u00a01\u00a0hour\u00a0in\u00a010\u2010L\u00a0tanks\u00a0 96 \ncontaining \u00a0the\u00a0respective \u00a0virus\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0105\u00a0TCID50/ml. \u00a0After\u00a0that,\u00a0they\u00a0were\u00a0transferred \u00a0back\u00a0to\u00a0 97 \ntheir\u00a0original\u00a0aquaria.\u00a0Gill\u00a0swaps\u00a0and\u00a0sera\u00a0were\u00a0collected \u00a0every\u00a014\u00a0days\u00a0from\u00a0five\u00a0fish\u00a0per\u00a0aquarium. \u00a0 98 \nMortality \u00a0and\u00a0morbidity \u00a0was\u00a0recorded \u00a0daily\u00a0by\u00a0counting \u00a0dead\u00a0fish\u00a0and\u00a0carp\u00a0with\u00a0symptoms, \u00a0mainly\u00a0 99 \nincreased \u00a0mucus\u00a0production \u00a0and\u00a0local\u00a0necrosis\u00a0on\u00a0the\u00a0skin\u00a0and\u00a0the\u00a0gill,\u00a0respectively. \u00a0Dead\u00a0fish\u00a0were\u00a0 100 \nimmediately \u00a0examined \u00a0for\u00a0the\u00a0presence \u00a0of\u00a0KHV\u00a0by\u00a0PCR.\u00a0All\u00a0experiments \u00a0on\u00a0animals\u00a0were\u00a0proceeded \u00a0 101 \nunder\u00a0the\u00a0strict\u00a0German\u00a0rules\u00a0for\u00a0animal\u00a0welfare\u00a0and\u00a0legally\u00a0authorized \u00a0by\u00a0the\u00a0animal\u00a0protection \u00a0 102 \ncommission \u00a0of\u00a0Mecklenburg, \u00a0Western\u00a0Pomerania, \u00a0with\u00a0the\u00a0allowance \u00a0no.\u00a07221.3\u20101\u2010008/18\u00a0(TV\u00a002/18\u00a0 103 \nKHV\u2010att\u00a04).\u00a0 104 \n2.3.\u00a0Extraction \u00a0of\u00a0viral\u00a0DNA,\u00a0library\u00a0preparation \u00a0and\u00a0genome\u00a0sequencing \u00a0of\u00a0P78\u00a0and\u00a0P99\u00a0 105 \nGenomic \u00a0DNA\u00a0was\u00a0extracted \u00a0from\u00a0both\u00a0the\u00a0cell\u00a0pellets\u00a0and\u00a0cell\u00a0supernatants, \u00a0using\u00a0the\u00a0 106 \nNucleospin \u00a0virus\u00a0extraction \u00a0kit\u00a0(Macherey \u00a0Nagel).\u00a0Cell\u00a0cultures\u00a0were\u00a0thawed\u00a0on\u00a0ice,\u00a0aliquoted \u00a0in\u00a0 107 \nvolumes \u00a0of\u00a0450\u00a0\u03bcL\u00a0and\u00a0centrifuged \u00a0at\u00a03000\u00a0rpm\u00a0for\u00a01\u00a0min.\u00a0Supernatants \u00a0were\u00a0transferred \u00a0into\u00a0new\u00a0 108 \ntubes\u00a0and\u00a0mixed\u00a0with\u00a0400\u00a0\u03bcL\u00a0of\u00a0lysis\u00a0buffer\u00a0supplemented \u00a0with\u00a010\u00a0\u03bcL\u00a0of\u00a0proteinase \u00a0K,\u00a0whereas\u00a0cell\u00a0 109 \npellets\u00a0were\u00a0resuspended \u00a0in\u00a0400\u00a0\u03bcL\u00a0of\u00a0lysis\u00a0buffer\u00a0supplemented \u00a0with\u00a010\u00a0\u03bcL\u00a0of\u00a0proteinase \u00a0K.\u00a0Viral\u00a0 110 \nlysis\u00a0was\u00a0obtained \u00a0by\u00a0a\u00a015\u2010min\u00a0incubation \u00a0at\u00a070\u00b0C.\u00a0DNA\u00a0was\u00a0then\u00a0purified\u00a0following \u00a0the\u00a0 111 \nmanufacturer \u02b9s\u00a0instructions, \u00a0and\u00a0eluted\u00a0in\u00a030\u00a0\u03bcL\u00a0of\u00a0PCR\u2010grade\u00a0H2O.\u00a0Purity\u00a0of\u00a0the\u00a0obtained \u00a0DNAs\u00a0 112 \nwas\u00a0checked\u00a0by\u00a0spectrophotometry \u00a0(Nanodrop \u00a02100)\u00a0while\u00a0their\u00a0quantity\u00a0was\u00a0measured \u00a0using\u00a0a\u00a0 113 \nQubit\u00a0(ThermoFisher \u00a0Scientific). \u00a0\u00a0 114 \nDNA\u00a0libraries\u00a0were\u00a0prepared \u00a0with\u00a0the\u00a0Nextera\u00a0XT\u00a0DNA\u00a0Library\u00a0Prep\u00a0kit\u00a0(Illumina), \u00a0using\u00a01\u00a0ng\u00a0 115 \nof\u00a0input\u00a0DNA.\u00a0DNA\u00a0tagmentation, \u00a0amplification \u00a0and\u00a0purification \u00a0were\u00a0carried\u00a0out\u00a0exactly\u00a0as\u00a0 116 \nspecified \u00a0by\u00a0the\u00a0provider. \u00a0The\u00a0average\u00a0size\u00a0distribution \u00a0of\u00a0DNA\u00a0fragments \u00a0was\u00a0verified\u00a0with\u00a0a\u00a0 117 \nBioAnalyzer \u00a02100\u00a0(Agilent\u00a0Technologies), \u00a0and\u00a0the\u00a0concentration \u00a0of\u00a0each\u00a0DNA\u00a0library\u00a0was\u00a0measured \u00a0 118 \nby\u00a0qPCR,\u00a0according \u00a0to\u00a0Illumina\u2019s \u00a0recommendations. \u00a0Six\u00a0replicates \u00a0of\u00a0samples\u00a0P78\u00a0and\u00a0P99\u00a0were\u00a0 119 \nprepared \u00a0by\u00a0the\u00a0IMHE\u00a0Master\u00a0students. \u00a0Among\u00a0these\u00a0replicates, \u00a0two\u00a0from\u00a0P78\u00a0cell\u00a0pellets\u00a0(P78\u20101c\u00a0 120 \nand\u00a0P78\u20102c),\u00a0two\u00a0from\u00a0P78\u00a0cell\u00a0supernatants \u00a0(P78\u20101s\u00a0and\u00a0P78\u20102s)\u00a0and\u00a0two\u00a0from\u00a0P99\u00a0cell\u00a0pellets\u00a0(P99\u2010 121 \n1c\u00a0and\u00a0P99\u20102c),\u00a0chosen\u00a0according \u00a0to\u00a0their\u00a0comparable \u00a0final\u00a0concentration \u00a0(comprised \u00a0between\u00a011.3\u00a0 122 \nand\u00a033.7\u00a0nM),\u00a0were\u00a0sequenced \u00a0at\u00a0Montpellier \u00a0Genomix \u00a0platform \u00a0(Montpellier, \u00a0France)\u00a0on\u00a0a\u00a0single\u00a0 123 \nlane\u00a0of\u00a0a\u00a0MiSeq\u00a0instrument \u00a0with\u00a0MiSeq\u00a0Reagent\u00a0Kit\u00a0v2\u00a0(Illumina), \u00a0using\u00a0500\u00a0cycles\u00a0(2\u00a0x\u00a0250\u00a0bases,\u00a0 124 \npaired\u2010ends).\u00a0 125 \n2.4.\u00a0Preparation \u00a0and\u00a0genome\u00a0sequencing \u00a0of\u00a0KHV\u2010T\u00a0(P0)\u00a0 126 \nThe\u00a0wild\u2010type\u00a0form\u00a0of\u00a0KHV\u2010T\u00a0had\u00a0already\u00a0been\u00a0sequenced \u00a0in\u00a0a\u00a0previous \u00a0project\u00a0(unpublished \u00a0 127 \ndata),\u00a0and\u00a0was\u00a0used\u00a0here\u00a0for\u00a0genome\u00a0comparisons. \u00a0After\u00a0extraction \u00a0with\u00a0the\u00a0Wizard\u00a0Genomic \u00a0DNA\u00a0 128 \npurification \u00a0kit\u00a0(Promega), \u00a0DNA\u00a0was\u00a0subjected \u00a0to\u00a0a\u00a0specific\u00a0target\u00a0enrichment, \u00a0as\u00a0described \u00a0in\u00a0[12],\u00a0 129 \nand\u00a0sequenced \u00a0on\u00a0a\u00a0HiSeq2000 \u00a0platform \u00a0(Illumina) \u00a0together\u00a0with\u00a07\u00a0other\u00a0specimens \u00a0in\u00a0a\u00a0paired\u2010end\u00a0 130 \n(2x100\u00a0bases)\u00a0format,\u00a0at\u00a0Montpellier \u00a0Genomix \u00a0platform \u00a0(Montpellier, \u00a0France).\u00a0\u00a0 131 \n2.5.\u00a0Genomic\u00a0sequence\u00a0analysis\u00a0 132 \nThe\u00a0seven\u00a0sequence \u00a0datasets\u00a0(P78\u20101c,\u00a0P78\u20102c,\u00a0P78\u20101s,\u00a0P78\u20102s,\u00a0P99\u20101c,\u00a0P99\u20102c\u00a0and\u00a0P0)\u00a0were\u00a0first\u00a0 133 \nanalyzed \u00a0by\u00a0the\u00a0students, \u00a0with\u00a0the\u00a0help\u00a0of\u00a0the\u00a0authors.\u00a0Quality\u00a0of\u00a0the\u00a0raw\u00a0sequencing \u00a0data\u00a0was\u00a0 134 \nevaluated \u00a0using\u00a0fastQC\u00a0(version\u00a00.11.8;\u00a0https://github.com/s \u2010andrews/FastQC). \u00a0Potential \u00a0adaptor\u00a0 135 \nsequences \u00a0were\u00a0removed \u00a0with\u00a0Trimmomatic \u00a0(version\u00a00.35)\u00a0[23]\u00a0and\u00a0bases\u00a0with\u00a0a\u00a0quality\u00a0score\u00a0>\u00a030\u00a0 136 \nwere\u00a0selected\u00a0using\u00a0SeqTk\u00a0(version\u00a01.3\u2010r106;\u00a0\u2010q\u00a00.001;\u00a0https://github.com/lh3/seqtk). \u00a0The\u00a0reads\u00a0were\u00a0 137 \nthen\u00a0mapped\u00a0to\u00a0the\u00a0KHV\u2010J\u00a0strain\u00a0reference \u00a0genome\u00a0(accession \u00a0number\u00a0AP008984) \u00a0with\u00a0BWA\u2010mem\u00a0 138 \n(version\u00a0bwa\u00a0V0.7.9a)\u00a0[24],\u00a0using\u00a0the\u00a0default\u00a0parameters. \u00a0Reads\u00a0aligning\u00a0with\u00a0a\u00a0quality\u00a0lower\u00a0than\u00a030\u00a0 139 \n(except\u00a0those\u00a0aligning\u00a0twice\u00a0in\u00a0the\u00a0terminal\u00a0repeats\u00a0of\u00a0the\u00a0reference \u00a0genome) \u00a0were\u00a0filtered\u00a0out.\u00a0Since\u00a0 140 \nthe\u00a0mapping \u00a0quality\u00a0of\u00a0P78\u00a0and\u00a0P99\u00a0replicates \u00a0was\u00a0comparable, \u00a0replicate \u00a0data\u00a0were\u00a0merged\u00a0to\u00a0end\u00a0 141 \nup\u00a0with\u00a0three\u00a0unique\u00a0sets:\u00a0P78,\u00a0P99\u00a0and\u00a0P0.\u00a0To\u00a0search\u00a0for\u00a0differences \u00a0between\u00a0the\u00a03\u00a0genomes, \u00a0calling\u00a0 142 \nof\u00a0variants\u00a0was\u00a0performed \u00a0for\u00a0the\u00a0three\u00a0datasets. \u00a0Single\u00a0nucleotide \u00a0polymorphisms \u00a0(SNPs)\u00a0and\u00a0short\u00a0 143 Viruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 4\u00a0of\u00a010\u00a0\n indels\u00a0(<\u00a0100\u00a0bp\u00a0were\u00a0called\u00a0combining \u00a0Picard\u00a0(version\u00a01.61)\u00a0and\u00a0GATK\u00a0(version\u00a03.5),\u00a0with\u00a0a\u00a0minimum \u00a0 144 \nquality\u00a0filter\u00a0at\u00a0Q20.\u00a0The\u00a0effect\u00a0of\u00a0each\u00a0variant\u00a0was\u00a0then\u00a0assessed \u00a0using\u00a0the\u00a0\u02babedtools \u00a0intersect\u02ba\u00a0 145 \n(v2.27.0)\u00a0and\u00a0\u02baSnpEff\u02ba\u00a0(v4.3)\u00a0tools.\u00a0For\u00a0both\u00a0tools,\u00a0the\u00a0annotation \u00a0version\u00a01\u00a0from\u00a0the\u00a0reference \u00a0genome\u00a0 146 \n(AP008984), \u00a0downloaded \u00a0from\u00a0https://www.ncbi.nlm.nih.g ov/nuccore/AP008984.1/, \u00a0was\u00a0used.\u00a0For\u00a0 147 \nlarge\u00a0variant\u00a0calling\u00a0(>\u00a0100\u00a0bp),\u00a0read\u00a0depth\u00a0along\u00a0the\u00a0reference \u00a0genome\u00a0was\u00a0first\u00a0computed \u00a0using\u00a0 148 \nSamtools \u00a0with\u00a0the\u00a0command \u00a0\u201cdepth\u201d\u00a0(version\u00a01.9)\u00a0[25]\u00a0and\u00a0then\u00a0compared \u00a0between\u00a0P78,\u00a0P99\u00a0and\u00a0P0.\u00a0 149 \nDetected \u00a0large\u00a0variations \u00a0were\u00a0confirmed \u00a0by\u00a0visualization \u00a0of\u00a0the\u00a0read\u00a0mapping \u00a0with\u00a0the\u00a0Integrative \u00a0 150 \nGenomics \u00a0Viewer\u00a0(IGV,\u00a0V2.4.7)\u00a0[26],\u00a0and\u00a0manual\u00a0curation\u00a0allowed\u00a0to\u00a0precise\u00a0their\u00a0boundaries. \u00a0 151 \nRegions\u00a0of\u00a0interest\u00a0were\u00a0finally\u00a0annotated \u00a0using\u00a0KHV\u2010J\u00a0reference \u00a0genome\u00a0(annotation \u00a0release\u00a01),\u00a0and\u00a0 152 \nputative\u00a0protein\u00a0motives\u00a0within\u00a0predicted \u00a0open\u00a0reading\u00a0frames\u00a0(ORFs)\u00a0were\u00a0searched \u00a0with\u00a0the\u00a0NCBI\u00a0 153 \nConserved \u00a0Domains \u00a0(CD)\u00a0search\u00a0tool\u00a0(https://www.ncbi.nlm.nih.gov/cdd/) \u00a0[27].\u00a0\u00a0 154 \n2.6.\u00a0PCR\u00a0assays\u00a0 155 \nTwo\u00a0PCR\u00a0assays\u00a0targeting \u00a0the\u00a0regions\u00a0comprised \u00a0between\u00a0nt\u00a0258055\u2010260647\u00a0(encompassing \u00a0the\u00a0 156 \nwhole\u00a0ORF150) \u00a0and\u00a0between\u00a0nt\u00a0258428\u2010258927\u00a0(inside\u00a0the\u00a0deletion) \u00a0were\u00a0carried\u00a0out\u00a0using\u00a0the\u00a0 157 \nfollowing \u00a0primer\u00a0pairs\u00a0designed \u00a0from\u00a0P0\u00a0sequence: \u00a05\u2019\u2010GCGTCGACGGAGCATG \u20103\u2019\u00a0/\u00a05\u2019\u2010 158 \nCGAAAGAGTAAGCCGTTGCC \u20103\u2019\u00a0 and\u00a0 5\u00b4\u2010CACAAGAGATGGACGCTCAG \u20103\u00b4\u00a0 /\u00a0 5\u00b4\u2010 159 \nGTTCTCGCCCAGCACCA \u20103\u00b4.\u00a0DNA\u00a0extracted \u00a0from\u00a0P0,\u00a0P78\u00a0and\u00a0P99\u00a0was\u00a0amplified \u00a0using\u00a0the\u00a0GoTaq\u00a0 160 \nG2\u00a0kit\u00a0(Promega), \u00a0under\u00a0the\u00a0following \u00a0conditions: \u00a095\u00b0C\u00a0for\u00a05\u00a0minutes, \u00a030\u00a0cycles\u00a0of\u00a095\u00b0C\u00a0for\u00a030\u00a0seconds,\u00a0 161 \n60\u00b0C\u00a0for\u00a030\u00a0seconds\u00a0and\u00a075\u00b0C\u00a0for\u00a03\u00a0minutes, \u00a0followed \u00a0by\u00a0a\u00a0final\u00a0extension \u00a0at\u00a075\u00b0C\u00a0for\u00a05\u00a0minutes. \u00a0PCR\u00a0 162 \nproducts \u00a0were\u00a0run\u00a0onto\u00a0agarose\u00a0gels,\u00a0visualized \u00a0with\u00a0ethidium \u00a0bromide\u00a0under\u00a0a\u00a0UV\u00a0transilluminator \u00a0 163 \nand\u00a0recovered \u00a0from\u00a0the\u00a0gel\u00a0for\u00a0further\u00a0Sanger\u00a0sequencing. \u00a0\u00a0 164 \n2.7.\u00a0Nucleotide \u00a0sequence\u00a0accession\u00a0numbers\u00a0 165 \nRaw\u00a0sequences \u00a0(fastq\u00a0files)\u00a0were\u00a0stored\u00a0in\u00a0the\u00a0public\u00a0Sequence \u00a0Read\u00a0Archive\u00a0(SRA)\u00a0repository \u00a0 166 \nand\u00a0can\u00a0be\u00a0accessed \u00a0under\u00a0the\u00a0SRP\u00a0study\u00a0accession \u00a0XXX.\u00a0\u00a0 167 \n3.\u00a0Results\u00a0and\u00a0discussion \u00a0 168 \nIn\u00a0view\u00a0of\u00a0obtaining \u00a0a\u00a0natural\u00a0attenuated \u00a0live\u00a0vaccine,\u00a0KHV\u2010T\u00a0was\u00a0serially\u00a0passaged \u00a0on\u00a0CCB\u00a0 169 \ncells\u00a0over\u00a0100\u00a0times\u00a0at\u00a020\u00b0C,\u00a0and\u00a0selected\u00a0passages \u00a0were\u00a0tested\u00a0for\u00a0attenuation \u00a0with\u00a0common \u00a0carp.\u00a0 170 \nAmong\u00a0the\u00a0selected\u00a0passages, \u00a0P78\u00a0and\u00a0P99\u00a0exhibited \u00a0the\u00a0most\u00a0interesting \u00a0features. \u00a0Firstly,\u00a0P78\u00a0elicited\u00a0 171 \nlower\u00a0mortality \u00a0and\u00a0morbidity \u00a0rates\u00a0than\u00a0the\u00a0P0\u00a0(wild\u2010type)\u00a0or\u00a0P99\u00a0viruses\u00a0(Figure\u00a01).\u00a0Indeed,\u00a0the\u00a0 172 \nmortality \u00a0induced\u00a0by\u00a0P78\u00a0during\u00a0an\u00a0experimental \u00a0infection \u00a0dropped \u00a0from\u00a090%\u00a0(P0)\u00a0to\u00a018%\u00a0with\u00a0an\u00a0 173 \ninfection \u00a0dose\u00a0of\u00a0105\u00a0TCID50/ml \u00a0and\u00a0to\u00a00\u00a0with\u00a0104\u00a0TCID50/ml \u00a0infection \u00a0dose\u00a0(Fig.\u00a01A\u00a0&\u00a01C).\u00a0Likewise, \u00a0 174 \nsymptoms \u00a0were\u00a0completely \u00a0absent\u00a0in\u00a0the\u00a0P78\u00a0group\u00a0at\u00a0105\u00a0TCID50/ml, \u00a0while\u00a0the\u00a0morbidity \u00a0induced\u00a0 175 \nby\u00a0P0\u00a0at\u00a0the\u00a0same\u00a0dose\u00a0reached\u00a090%\u00a0and\u00a0was\u00a0mostly\u00a0associated \u00a0with\u00a0severe\u00a0symptoms \u00a0(Fig.\u00a01B\u00a0&\u00a01D),\u00a0 176 \nconsistent \u00a0with\u00a0what\u00a0is\u00a0usually\u00a0observed \u00a0for\u00a0naturally \u00a0occurring \u00a0CyHV\u20103\u00a0isolates\u00a0[28].\u00a0The\u00a0mortality \u00a0 177 \ninduced\u00a0by\u00a0P99\u00a0(28%)\u00a0was\u00a0higher\u00a0than\u00a0that\u00a0obtained \u00a0with\u00a0P78.\u00a0Likewise, \u00a0morbidity \u00a0was\u00a0also\u00a0much\u00a0 178 \nhigher\u00a0than\u00a0that\u00a0recorded \u00a0for\u00a0P78,\u00a0with\u00a0a\u00a0peak\u00a0of\u00a0100%\u00a0at\u00a09\u00a0dpi;\u00a0however, \u00a0the\u00a0symptoms \u00a0caused\u00a0by\u00a0 179 \nP99\u00a0did\u00a0not\u00a0last\u00a0long\u00a0and\u00a0essentially \u00a0consisted \u00a0of\u00a0increased \u00a0mucus\u00a0(Fig.\u00a01F).\u00a0Even\u00a0though\u00a0in\u00a0the\u00a0 180 \nabsence\u00a0of\u00a0replicates, \u00a0it\u00a0is\u00a0not\u00a0possible\u00a0to\u00a0infer\u00a0whether\u00a0these\u00a0differences \u00a0are\u00a0significant, \u00a0it\u00a0seems\u00a0that\u00a0 181 \nP99\u00a0has\u00a0partially\u00a0recovered \u00a0its\u00a0virulence \u00a0ability.\u00a0 182 Viruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 5\u00a0of\u00a010\u00a0\n \u00a0 183 \nFigure\u00a01.\u00a0Mortality \u00a0and\u00a0morbidity \u00a0elicited\u00a0by\u00a0the\u00a0three\u00a0forms\u00a0of\u00a0KHV\u2010T.\u00a0Carp\u00a0were\u00a0experimentally \u00a0 184 \ninfected\u00a0with\u00a0P0\u00a0and\u00a0P99\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0105\u00a0TCID 50/ml,\u00a0and\u00a0with\u00a0P78\u00a0at\u00a0doses\u00a0of\u00a0104\u00a0TCID 50/ml,\u00a0105\u00a0 185 \nTCID 50/ml\u00a0and\u00a0106\u00a0TCID 50/ml.\u00a0Mortality \u00a0(A,\u00a0B,\u00a0C)\u00a0and\u00a0morbidity \u00a0(D,\u00a0E,\u00a0F)\u00a0were\u00a0recorded \u00a0during\u00a028\u00a0 186 \ndays\u00a0post\u2010infection \u00a0(dpi)\u00a0and\u00a0plotted\u00a0at\u00a0scale.\u00a0 187 \nSequencing \u00a0of\u00a0the\u00a0six\u00a0passaged \u00a0samples\u00a0led\u00a0to\u00a0a\u00a0number\u00a0of\u00a0reads\u00a0comprised \u00a0between\u00a01\u00a0297\u00a0956\u00a0 188 \nand\u00a03\u00a0315\u00a0745,\u00a0resulting \u00a0in\u00a0a\u00a0mean\u00a0depth\u00a0of\u00a0coverage \u00a0ranging\u00a0between\u00a0262x\u00a0and\u00a0568x\u00a0(Table\u00a01).\u00a0These\u00a0 189 \nvalues\u00a0were\u00a0much\u00a0higher\u00a0for\u00a0P0\u00a0(60\u00a0049\u00a0308\u00a0reads\u00a0and\u00a07802x\u00a0of\u00a0mean\u00a0depth\u00a0coverage) \u00a0because\u00a0it\u00a0had\u00a0 190 \nbeen\u00a0subjected \u00a0to\u00a0specific\u00a0target\u00a0enrichment \u00a0prior\u00a0to\u00a0sequencing \u00a0on\u00a0a\u00a0HiSeq\u00a0platform. \u00a0KHV\u2010J\u00a0was\u00a0 191 \nused\u00a0as\u00a0mapping \u00a0reference \u00a0because\u00a0KHV\u2010T\u00a0had\u00a0previously \u00a0been\u00a0shown\u00a0to\u00a0belong\u00a0to\u00a0the\u00a0Asian\u00a0lineage\u00a0 192 \n[19].\u00a0As\u00a0one\u00a0could\u00a0expect,\u00a0the\u00a0number\u00a0of\u00a0variations \u00a0identified \u00a0at\u00a0the\u00a0genome\u00a0scale\u00a0between\u00a0the\u00a0three\u00a0 193 \nforms\u00a0of\u00a0KHV\u2010T\u00a0and\u00a0KHV\u2010J\u00a0was\u00a0very\u00a0low\u00a0(Table\u00a01).\u00a0Variations \u00a0were\u00a0conserved \u00a0among\u00a0replicates, \u00a0and\u00a0 194 \nthe\u00a0slight\u00a0discrepancies \u00a0observed \u00a0between\u00a0the\u00a0four\u00a0P78\u00a0replicates \u00a0(46\u201054,\u00a0Table\u00a01)\u00a0mostly\u00a0concerned \u00a0 195 \ntandem\u00a0repeated \u00a0regions.\u00a0Comparison \u00a0of\u00a0P78\u00a0and\u00a0P99\u00a0with\u00a0P0\u00a0revealed \u00a0a\u00a0limited\u00a0number\u00a0of\u00a0 196 \nvariations, \u00a0which\u00a0increased \u00a0with\u00a0the\u00a0passages \u00a0(Table\u00a01).\u00a0The\u00a0majority\u00a0of\u00a0these\u00a0variations \u00a0consisted \u00a0of\u00a0 197 \nsingle\u00a0nucleotide \u00a0substitutions \u00a0or\u00a0short\u00a0insertions/deletions \u00a0of\u00a0repeated \u00a0motifs\u00a0within\u00a0variable\u00a0 198 \nnumbers \u00a0of\u00a0tandem\u00a0repeats,\u00a0without\u00a0any\u00a0incidence \u00a0on\u00a0the\u00a0reading\u00a0frame.\u00a0Only\u00a0three\u00a0of\u00a0these\u00a0 199 \nmutations \u00a0elicited\u00a0a\u00a0frameshift \u00a0in\u00a0a\u00a0predicted \u00a0ORF\u00a0of\u00a0P78\u00a0(Supplementary \u00a0Table\u00a01)\u00a0and\u00a0of\u00a0P99\u00a0 200 \n(Supplementary \u00a0Table\u00a02).\u00a0With\u00a0a\u00a0few\u00a0exceptions, \u00a0most\u00a0of\u00a0these\u00a0variations \u00a0had\u00a0a\u00a0frequency \u00a0lower\u00a0than\u00a0 201 \n1,\u00a0indicating \u00a0the\u00a0presence \u00a0of\u00a0more\u00a0than\u00a0one\u00a0variant.\u00a0The\u00a0only\u00a0large\u00a0variation \u00a0(>100\u00a0bp)\u00a0observed \u00a0 202 \nbetween\u00a0the\u00a03\u00a0KHV\u2010T\u00a0forms\u00a0corresponded \u00a0to\u00a0a\u00a01\u00a0363\u2010bp\u00a0deletion\u00a0located\u00a0in\u00a0KHVJ160 \u00a0(corresponding \u00a0 203 \nto\u00a0the\u00a0ORF150) \u00a0of\u00a0P78.\u00a0This\u00a0deletion\u00a0was\u00a0observed \u00a0in\u00a0the\u00a04\u00a0replicates \u00a0of\u00a0P78.\u00a0Most\u00a0notably,\u00a0the\u00a0read\u00a0 204 \ndepth\u00a0that\u00a0was\u00a0comprised \u00a0between\u00a0~200x\u00a0and\u00a0~450x\u00a0at\u00a0positions \u00a0258\u00a0153\u00a0and\u00a0259\u00a0517\u00a0(depending \u00a0on\u00a0 205 \nthe\u00a0replicate), \u00a0suddenly \u00a0dropped \u00a0to\u00a00x\u00a0between\u00a0these\u00a0positions, \u00a0indicating \u00a0that\u00a0no\u00a0reads\u00a0were\u00a0 206 \nrecovered \u00a0from\u00a0this\u00a0region\u00a0during\u00a0sequencing, \u00a0in\u00a0none\u00a0of\u00a0the\u00a0four\u00a0replicates. \u00a0Most\u00a0surprisingly, \u00a0this\u00a0 207 \ndeletion\u00a0was\u00a0totally\u00a0absent\u00a0in\u00a0the\u00a0two\u00a0replicates \u00a0of\u00a0P99,\u00a0as\u00a0indicated \u00a0by\u00a0an\u00a0even\u00a0read\u00a0depth\u00a0upstream, \u00a0 208 \nalong\u00a0and\u00a0downstream \u00a0of\u00a0the\u00a01\u00a0363\u2010bp\u00a0deleted\u00a0region\u00a0(Figure\u00a02).\u00a0Though\u00a0it\u00a0is\u00a0acknowledged \u00a0that\u00a0the\u00a0 209 \nrate\u00a0of\u00a0read\u00a0missassignments \u00a0in\u00a0multiplexed \u00a0sequencing \u00a0runs\u00a0may\u00a0account\u00a0for\u00a00.06\u00a0to\u00a00.29%\u00a0of\u00a0the\u00a0 210 \ntotal\u00a0number\u00a0of\u00a0reads\u00a0[29\u201031],\u00a0this\u00a0cannot\u00a0explain\u00a0the\u00a0complete \u00a0absence\u00a0of\u00a0reads\u00a0in\u00a0the\u00a0deleted\u00a0region\u00a0 211 \nof\u00a0P78.\u00a0Since\u00a0the\u00a0possibility \u00a0of\u00a0a\u00a0\u2018reverse\u00a0mutation\u2019 \u00a0of\u00a0the\u00a0same\u00a0length\u00a0and\u00a0at\u00a0the\u00a0same\u00a0location\u00a0can\u00a0be\u00a0 212 \nruled\u00a0out,\u00a0it\u00a0is\u00a0likely\u00a0that\u00a0P78\u00a0and\u00a0P99\u00a0both\u00a0contained \u00a0the\u00a0two\u00a0variants\u00a0(ORF150 \u00a0and\u00a0ORF150\u2010del).\u00a0The\u00a0 213 \npresence \u00a0of\u00a0mixed\u00a0genotypes \u00a0has\u00a0been\u00a0demonstrated \u00a0to\u00a0be\u00a0a\u00a0common \u00a0feature\u00a0of\u00a0CyHV\u20103\u00a0infections \u00a0 214 \nin\u00a0vivo\u00a0[12,\u00a020,\u00a021],\u00a0but\u00a0also\u00a0in\u00a0vitro\u00a0[19].\u00a0One\u00a0can\u00a0therefore \u00a0assume\u00a0that\u00a0the\u00a0haplotype \u00a0carrying\u00a0the\u00a0 215 \nfull\u00a0ORF150\u00a0was\u00a0present\u00a0in\u00a0P78,\u00a0but\u00a0in\u00a0a\u00a0too\u00a0low\u00a0proportion \u00a0for\u00a0being\u00a0detected\u00a0through\u00a0the\u00a0 216 \nsequencing \u00a0and/or\u00a0analysis\u00a0protocol\u00a0we\u00a0used.\u00a0Errors\u00a0accumulate \u00a0during\u00a0every\u00a0step\u00a0of\u00a0a\u00a0sequencing \u00a0 217 \nprotocol, \u00a0including \u00a0library\u00a0preparation, \u00a0sequencing, \u00a0and\u00a0read\u00a0alignment. \u00a0For\u00a0illustration, \u00a0it\u00a0was\u00a0 218 \nViruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 6\u00a0of\u00a010\u00a0\n shown\u00a0that\u00a0a\u00a0variant\u00a0present\u00a0at\u00a0a\u00a0frequency \u00a0of\u00a02.5%\u00a0in\u00a0the\u00a0initial\u00a0sample\u00a0will\u00a0not\u00a0be\u00a0accurately \u00a0 219 \ndetected\u00a0at\u00a0a\u00a0read\u00a0depth\u00a0lower\u00a0than\u00a01000x\u00a0[32,\u00a033].\u00a0\u00a0 220 \n\u00a0 221 \nFigure\u00a02.\u00a0IGV\u00a0screenshot \u00a0of\u00a0the\u00a0region\u00a0containing \u00a0the\u00a0large\u00a0deletion\u00a0for\u00a0the\u00a0seven\u00a0sequenced \u00a0samples. \u00a0 222 \nEach\u00a0horizontal \u00a0track\u00a0corresponds \u00a0to\u00a0the\u00a0reads\u00a0mapped\u00a0on\u00a0the\u00a0KHV\u2010J\u00a0reference \u00a0genome\u00a0(AP008984). \u00a0 223 \nWhite\u00a0areas\u00a0correspond \u00a0to\u00a0an\u00a0absence\u00a0of\u00a0reads\u00a0and\u00a0dashed\u00a0lines\u00a0indicate\u00a0the\u00a0boundaries \u00a0of\u00a0the\u00a0 224 \ndeletion. \u00a0Gene\u00a0annotation \u00a0of\u00a0KHV\u2010J\u00a0is\u00a0shown\u00a0at\u00a0the\u00a0bottom.\u00a0KHVJ159 \u00a0corresponds \u00a0to\u00a0ORF149\u00a0and\u00a0 225 \nKHVJ160 \u00a0to\u00a0ORF150, \u00a0according \u00a0to\u00a0Aoki\u00a0et\u00a0al\u00a0[10].\u00a0 226 \nTable\u00a01.\u00a0Main\u00a0features\u00a0of\u00a0genome\u00a0comparisons. \u00a0 227 \nSample # readsa % mapped reads  Mean coverage \n[1st-3rd quartile] # variants against KHV-Jb  # variants against P0b \nP0 60 049 308 98.62 7802 [7868-7932] 80  - \nP78-1c 1 297 956 37.86 262 [202-292] 46  21 \nP78-2c 2 179 255 37.07 418 [301-466] 54  26 \nP78-1s 3 002 298 27.08 356 [248-398] 50  25 \nP78-2s 3 315 745 32.28 568 [448-634] 49  23 \nP99-1c 3 280 716 30.30 559 [404-633] 103  58 \nP99-2c 2 227 886 31.94 395 [302-451] 103  57 \na All reads with a quality  < Q30 were removed  228 \nb Only variations < 100 bp were considered here. 229 \nTo\u00a0verify\u00a0these\u00a0sequencing \u00a0results,\u00a0two\u00a0PCR\u00a0assays\u00a0designed \u00a0to\u00a0target\u00a0the\u00a0full\u00a0ORF150\u00a0and\u00a0its\u00a0 230 \ndeleted\u00a0region\u00a0were\u00a0applied\u00a0on\u00a0the\u00a0three\u00a0KHV\u2010T\u00a0samples. \u00a0Using\u00a0the\u00a0first\u00a0set\u00a0of\u00a0primers\u00a0targeting \u00a0the\u00a0 231 \nfull\u00a0ORF150, \u00a0a\u00a0unique\u00a0band\u00a0was\u00a0observed \u00a0around\u00a01200\u00a0bp\u00a0for\u00a0P78,\u00a0whereas\u00a0for\u00a0P0\u00a0and\u00a0P99,\u00a0the\u00a0PCR\u00a0 232 \nproduct\u00a0had\u00a0the\u00a0expected \u00a0length\u00a0around\u00a02593\u00a0bp\u00a0(Fig.\u00a03).\u00a0Additionally, \u00a0the\u00a0second\u00a0set\u00a0of\u00a0primers\u00a0did\u00a0 233 \nnot\u00a0yield\u00a0any\u00a0amplification \u00a0in\u00a0P78\u00a0while\u00a0a\u00a0500\u2010bp\u00a0fragment \u00a0was\u00a0amplified \u00a0in\u00a0P0\u00a0and\u00a0P99,\u00a0as\u00a0was\u00a0 234 \nexpected \u00a0with\u00a0this\u00a0primer\u00a0set\u00a0(Figure\u00a03).\u00a0Sanger\u00a0sequencing \u00a0of\u00a0all\u00a0the\u00a0obtained \u00a0amplicons \u00a0showed\u00a0 235 \n100%\u00a0identity\u00a0with\u00a0P0\u00a0sequence. \u00a0These\u00a0PCR\u00a0results\u00a0clearly\u00a0confirmed \u00a0that\u00a0this\u00a0deletion\u00a0did\u00a0not\u00a0result\u00a0 236 \nfrom\u00a0a\u00a0sequencing \u00a0artefact.\u00a0Though\u00a0often\u00a0overlooked, \u00a0the\u00a0extent\u00a0of\u00a0information \u00a0available \u00a0in\u00a0a\u00a0sample\u00a0 237 \nis\u00a0limited\u00a0by\u00a0the\u00a0quantity\u00a0of\u00a0biological \u00a0material\u00a0the\u00a0sample\u00a0contains\u00a0prior\u00a0to\u00a0its\u00a0amplification \u00a0[34].\u00a0 238 \nMoreover, \u00a0it\u00a0is\u00a0also\u00a0known\u00a0that\u00a0amplification \u00a0by\u00a0PCR\u00a0may\u00a0distort\u00a0the\u00a0content\u00a0of\u00a0a\u00a0sample\u00a0through\u00a0 239 \ndifferent \u00a0sources\u00a0of\u00a0errors\u00a0such\u00a0as\u00a0efficiency \u00a0biases,\u00a0stochasticity, \u00a0template \u00a0switches \u00a0or\u00a0polymerase \u00a0 240 \nerrors\u00a0[35].\u00a0These\u00a0errors\u00a0may\u00a0have\u00a0a\u00a0significant \u00a0impact\u00a0on\u00a0sequence \u00a0representation, \u00a0especially \u00a0for\u00a0 241 \nsequences \u00a0that\u00a0are\u00a0present\u00a0at\u00a0very\u00a0low\u00a0copy\u00a0numbers \u00a0[35,\u00a036].\u00a0As\u00a0reflected \u00a0by\u00a0the\u00a0weak\u00a0percent\u00a0of\u00a0 242 \nmapped\u00a0reads,\u00a0the\u00a0amount\u00a0of\u00a0viral\u00a0sequences \u00a0in\u00a0the\u00a0input\u00a0DNA\u00a0(ratio\u00a0of\u00a0CyHV\u20103\u00a0/\u00a0host\u00a0reads)\u00a0was\u00a0 243 \nrelatively \u00a0low.\u00a0Taking\u00a0all\u00a0these\u00a0elements \u00a0together, \u00a0the\u00a0results\u00a0obtained \u00a0here\u00a0indicate\u00a0that\u00a0the\u00a0deleted\u00a0 244 \nViruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 7\u00a0of\u00a010\u00a0\n variant\u00a0was\u00a0very\u00a0abundant \u00a0in\u00a0P78\u00a0but\u00a0under\u00a0the\u00a0detection \u00a0threshold \u00a0in\u00a0P99.\u00a0In\u00a0other\u00a0words,\u00a0the\u00a0main\u00a0 245 \nhaplotype \u00a0of\u00a0P78\u00a0carried\u00a0the\u00a0deletion\u00a0of\u00a01\u00a0363\u00a0bp\u00a0whereas\u00a0the\u00a0dominant \u00a0haplotype \u00a0in\u00a0P99\u00a0was\u00a0the\u00a0 246 \nsame\u00a0as\u00a0in\u00a0P0,\u00a0the\u00a0wild\u2010type\u00a0KHV\u2010T.\u00a0However, \u00a0whether\u00a0this\u00a0deleted\u00a0variant\u00a0was\u00a0already\u00a0present\u00a0in\u00a0 247 \nP0\u00a0or\u00a0arose\u00a0by\u00a0mutation \u00a0during\u00a0the\u00a0successive \u00a0passages \u00a0needs\u00a0to\u00a0be\u00a0further\u00a0investigated. \u00a0 248 \n\u00a0 249 \nFigure\u00a03.\u00a0PCR\u00a0results\u00a0using\u00a0the\u00a0primer\u00a0set\u00a0covering \u00a0the\u00a0whole\u00a0ORF150\u00a0(1)\u00a0and\u00a0the\u00a0primer\u00a0set\u00a0designed \u00a0 250 \ninside\u00a0the\u00a0deletion\u00a0(2).\u00a0The\u00a0expected \u00a0amplicon \u00a0sizes\u00a0according \u00a0to\u00a0P0\u00a0are\u00a02593\u00a0bp\u00a0and\u00a0500\u00a0bp\u00a0using\u00a0the\u00a0 251 \ntwo\u00a0primer\u00a0set,\u00a0respectively. \u00a0The\u00a0two\u00a0external\u00a0lanes\u00a0were\u00a0loaded\u00a0with\u00a0a\u00a0100\u2010bp\u00a0molecular \u00a0weight\u00a0 252 \nmarker,\u00a0and\u00a0the\u00a0corresponding \u00a0sizes\u00a0are\u00a0indicated \u00a0on\u00a0the\u00a0left.\u00a0.\u00a0 253 \nThe\u00a01\u00a0363\u2010bp\u00a0deletion\u00a0starts\u00a0between\u00a0genes\u00a0KHVJ159 \u00a0(ORF149) \u00a0and\u00a0KHVJ160 \u00a0(ORF150), \u00a0and\u00a0 254 \nspans\u00a0more\u00a0than\u00a0half\u00a0of\u00a0ORF150\u00a0(see\u00a0Figure\u00a02).\u00a0As\u00a0a\u00a0result,\u00a0the\u00a0original\u00a0initiation \u00a0codon\u00a0is\u00a0missing,\u00a0 255 \nand\u00a0an\u00a0alternative \u00a0ORF150\u00a0could\u00a0potentially \u00a0begin\u00a0at\u00a0position\u00a0259570,\u00a0providing \u00a0this\u00a0resulting \u00a0 256 \ntruncated \u00a0ORF\u00a0is\u00a0transcribed. \u00a0As\u00a0already\u00a0identified \u00a0by\u00a0Aoki\u00a0et\u00a0al\u00a0[10],\u00a0and\u00a0confirmed \u00a0by\u00a0a\u00a0new\u00a0search\u00a0 257 \nagainst\u00a0the\u00a0conserved \u00a0domains \u00a0database, \u00a0ORF150\u00a0contains\u00a0a\u00a0RING\u2010HC\u00a0(Really\u00a0Interesting \u00a0New\u00a0Gene)\u00a0 258 \nfinger\u00a0 domain\u00a0 in\u00a0 its\u00a0 N\u2010terminal\u00a0 region\u00a0 (e\u2010value\u00a0 =\u00a0 1.23x10\u20107;\u00a0 259 \nhttps://www.ncbi.nlm.nih.g ov/protein/129560669). \u00a0RING\u00a0fingers,\u00a0and\u00a0especially \u00a0of\u00a0HC\u00a0(C3HC4) \u00a0 260 \ntypes,\u00a0bind\u00a0two\u00a0zinc\u00a0cations\u00a0and\u00a0are\u00a0involved \u00a0in\u00a0ubiquitination, \u00a0a\u00a0potent\u00a0regulator \u00a0of\u00a0cellular\u00a0protein\u00a0 261 \nfunctions \u00a0such\u00a0as\u00a0oncogenesis, \u00a0viral\u00a0replication \u00a0or\u00a0apoptosis \u00a0[37\u201039].\u00a0As\u00a0this\u00a0RING\u00a0motif\u00a0is\u00a0missing\u00a0in\u00a0 262 \nthe\u00a0truncated \u00a0form\u00a0of\u00a0ORF150, \u00a0and\u00a0since\u00a0this\u00a0deletion\u00a0is\u00a0the\u00a0major\u00a0difference \u00a0between\u00a0P78\u00a0and\u00a0P99,\u00a0it\u00a0 263 \nis\u00a0tempting \u00a0to\u00a0associate \u00a0this\u00a0absence\u00a0to\u00a0the\u00a0drop\u00a0of\u00a0virulence, \u00a0or\u00a0partial\u00a0attenuation, \u00a0observed \u00a0for\u00a0P78.\u00a0 264 \nFurther\u00a0studies\u00a0need\u00a0to\u00a0be\u00a0done\u00a0to\u00a0evaluate\u00a0the\u00a0potential \u00a0role\u00a0of\u00a0ORF150\u00a0in\u00a0CyHV\u20103\u00a0virulence. \u00a0\u00a0 265 \nTo\u00a0conclude, \u00a0our\u00a0results\u00a0demonstrate \u00a0that\u00a0an\u00a0in\u00a0vitro\u00a0infection \u00a0by\u00a0CyHV\u20103\u00a0is\u00a0the\u00a0result\u00a0of\u00a0a\u00a0 266 \nmixture\u00a0of\u00a0haplotypes \u00a0that\u00a0co\u2010occur,\u00a0and\u00a0that\u00a0the\u00a0ratio\u00a0between\u00a0these\u00a0latter\u00a0may\u00a0dramatically \u00a0varies\u00a0 267 \nalong\u00a0infection \u00a0cycles.\u00a0To\u00a0study\u00a0what\u00a0drives\u00a0the\u00a0haplotype \u00a0composition \u00a0during\u00a0an\u00a0infection \u00a0will\u00a0imply\u00a0 268 \nto\u00a0use\u00a0other\u00a0computational \u00a0and/or\u00a0sequencing \u00a0approaches, \u00a0as\u00a0for\u00a0instance\u00a0those\u00a0developed \u00a0for\u00a0 269 \nhaplotype \u00a0reconstruction \u00a0in\u00a0RNA\u00a0viruses\u00a0[40\u201042].\u00a0Finally,\u00a0our\u00a0results\u00a0also\u00a0support\u00a0increasing \u00a0 270 \nevidence \u00a0that\u00a0large\u00a0DNA\u00a0viruses,\u00a0and\u00a0especially \u00a0herpesviruses, \u00a0may\u00a0behave\u00a0like\u00a0viral\u00a0quasispecies \u00a0 271 \n[43]\u00a0in\u00a0the\u00a0way\u00a0that\u00a0they\u00a0are\u00a0also\u00a0composed \u00a0of\u00a0a\u00a0mixture\u00a0of\u00a0haplotypes \u00a0that\u00a0evolve\u00a0during\u00a0infections. \u00a0 272 \nThis\u00a0study\u00a0lays\u00a0the\u00a0basis\u00a0for\u00a0better\u00a0understanding \u00a0the\u00a0mechanisms \u00a0of\u00a0in\u00a0vitro\u00a0and\u00a0in\u00a0vivo\u00a0evolution \u00a0 273 \nof\u00a0this\u00a0very\u00a0successful \u00a0virus.\u00a0 274 \nSupplementary \u00a0Materials: \u00a0The\u00a0following \u00a0are\u00a0available \u00a0online\u00a0at\u00a0www.mdpi.com/xxx/s1, \u00a0Table\u00a0S1:\u00a0Nature\u00a0and\u00a0 275 \nposition\u00a0of\u00a0variants\u00a0between\u00a0P78\u00a0and\u00a0P0.\u00a0All\u00a0variations \u00a0located\u00a0in\u00a0the\u00a0terminal\u00a0repeats\u00a0appear\u00a0only\u00a0once.\u00a0 276 \nViruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 8\u00a0of\u00a010\u00a0\n Predicted \u00a0ORFs\u00a0were\u00a0deduced \u00a0from\u00a0the\u00a0genome\u00a0annotation \u00a0of\u00a0KHV\u2010J\u00a0(AP008984). \u00a0Missense \u00a0variant\u00a0indicates \u00a0a\u00a0 277 \nnucleotide \u00a0substitution \u00a0that\u00a0modifies \u00a0the\u00a0amino\u00a0acid;\u00a0synonymous \u00a0variant\u00a0denotes\u00a0a\u00a0nucleotide \u00a0substitution \u00a0that\u00a0 278 \ndoes\u00a0not\u00a0modify\u00a0the\u00a0amino\u00a0acid;\u00a0frameshift \u00a0variant\u00a0indicates \u00a0an\u00a0insertion \u00a0or\u00a0a\u00a0deletion\u00a0that\u00a0changes\u00a0the\u00a0reading\u00a0 279 \nframe;\u00a0intergenic \u00a0variant\u00a0points\u00a0to\u00a0a\u00a0mutation \u00a0located\u00a0between\u00a0two\u00a0predicted \u00a0open\u00a0reading\u00a0frames.\u00a0When\u00a0more\u00a0 280 \nthan\u00a0two\u00a0variants\u00a0co\u2010occur\u00a0at\u00a0a\u00a0single\u00a0position, \u00a0only\u00a0the\u00a0frequency \u00a0of\u00a0the\u00a0most\u00a0abundant \u00a0alternate \u00a0(from\u00a0all\u00a0 281 \nreplicates) \u00a0is\u00a0indicated. \u00a0Only\u00a0variations \u00a0<100\u00a0bp\u00a0were\u00a0listed.\u00a0\u00a0 282 \nTable\u00a0S2:\u00a0Nature\u00a0and\u00a0position\u00a0of\u00a0variants\u00a0between\u00a0P99\u00a0and\u00a0P0.\u00a0All\u00a0variations \u00a0located\u00a0in\u00a0the\u00a0terminal\u00a0repeats\u00a0 283 \nappear\u00a0only\u00a0once.\u00a0Predicted \u00a0ORFs\u00a0were\u00a0deduced \u00a0from\u00a0the\u00a0genome\u00a0annotation \u00a0of\u00a0KHV\u2010J\u00a0(AP008984). \u00a0Missense \u00a0 284 \nvariant\u00a0indicates \u00a0a\u00a0nucleotide \u00a0substitution \u00a0that\u00a0modifies \u00a0the\u00a0amino\u00a0acid;\u00a0synonymous \u00a0variant\u00a0denotes\u00a0a\u00a0 285 \nnucleotide \u00a0substitution \u00a0that\u00a0does\u00a0not\u00a0modify\u00a0the\u00a0amino\u00a0acid;\u00a0frameshift \u00a0variant\u00a0indicates \u00a0an\u00a0insertion \u00a0or\u00a0a\u00a0 286 \ndeletion\u00a0that\u00a0changes\u00a0the\u00a0reading\u00a0frame;\u00a0intergenic \u00a0variant\u00a0points\u00a0to\u00a0a\u00a0mutation \u00a0located\u00a0between\u00a0two\u00a0predicted \u00a0 287 \nopen\u00a0reading\u00a0frames.\u00a0Only\u00a0variations \u00a0<100\u00a0bp\u00a0were\u00a0listed.\u00a0 288 \nAcknowledgments \uff1aPart\u00a0of\u00a0this\u00a0work\u00a0was\u00a0supported \u00a0by\u00a0the\u00a0ERA\u2010NET\u00a0EMIDA\u00a0funded\u00a0project\u00a0MOLTRAQ \u00a0 289 \n(ANR\u201011\u2010EMIDA\u2010006).\u00a0Data\u00a0presented \u00a0in\u00a0this\u00a0work\u00a0were\u00a0produced \u00a0through\u00a0the\u00a0genotyping \u00a0and\u00a0sequencing \u00a0 290 \nfacilities\u00a0of\u00a0ISEM\u00a0(Institut\u00a0des\u00a0Sciences\u00a0de\u00a0l\u2019Evolution \u00a0\u2010Montpellier), \u00a0the\u00a0MBB\u00a0platform \u00a0and\u00a0Labex\u00a0CeMEB\u00a0(Centre\u00a0 291 \nM\u00e9diterran\u00e9en \u00a0Environnement \u00a0Biodiversit\u00e9). \u00a0Part\u00a0of\u00a0the\u00a0data\u00a0presented \u00a0here\u00a0was\u00a0generated \u00a0during\u00a0a\u00a0training\u00a0 292 \nsession\u00a0of\u00a0the\u00a0IMHE\u00a0Master\u00a0students \u00a0of\u00a0Montpellier \u00a0University. \u00a0The\u00a0first\u00a0bioinformatics \u00a0analyses \u00a0were\u00a0realized\u00a0 293 \nby\u00a0the\u00a0students \u00a0from\u00a0the\u00a0Master\u00a0Sciences\u00a0and\u00a0Digital\u00a0Technology \u00a0for\u00a0Healthcare, \u00a0specialty \u00a0Bioinformatics, \u00a0 294 \nKnowledge, \u00a0Data\u00a0of\u00a0Montpellier \u00a0University \u00a0during\u00a0the\u00a0Montpellier \u00a0Omics\u00a0Days\u00a02018.\u00a0This\u00a0is\u00a0publication \u00a0IRD\u2010 295 \nDIVA\u2010ISEM\u00a02018\u2010XXX.\u00a0 296 \nConflicts \u00a0of\u00a0Interest\uff1aAuthors\u00a0declare\u00a0no\u00a0conflict\u00a0of\u00a0interest.\u00a0\u00a0 297 \nReferences \u00a0 298 \n1. Hedrick, \u00a0R.\u00a0P.;\u00a0Gilad,\u00a0O.;\u00a0Yun,\u00a0S.;\u00a0Spangenberg, \u00a0J.\u00a0V.;\u00a0Marty,\u00a0G.\u00a0D.;\u00a0Nordhausen, \u00a0R.\u00a0W.;\u00a0Kebus,\u00a0M.\u00a0J.;\u00a0 299 \nBercovier, \u00a0H.;\u00a0Eldar,\u00a0A.,\u00a0A\u00a0herpesvirus \u00a0associated \u00a0with\u00a0mass\u00a0mortality \u00a0of\u00a0juvenile\u00a0and\u00a0adult\u00a0koi,\u00a0a\u00a0strain\u00a0of\u00a0 300 \ncommon \u00a0carp.\u00a0Journal\u00a0of\u00a0Aquatic\u00a0Animal\u00a0Health\u00a02000,\u00a012,\u00a0(1),\u00a044\u201057.\u00a0 301 \n2. Pokorova, \u00a0D.;\u00a0Vesely,\u00a0T.;\u00a0Piackova, \u00a0V.;\u00a0Reschova, \u00a0S.;\u00a0Hulova,\u00a0J.,\u00a0Current\u00a0knowledge \u00a0on\u00a0koi\u00a0herpesvirus \u00a0 302 \n(KHV):\u00a0a\u00a0review.\u00a0Veterinarni \u00a0Medicina \u00a02005,\u00a050,\u00a0(4),\u00a0139\u2010147.\u00a0 303 \n3. Donohoe, \u00a0O.\u00a0H.;\u00a0Henshilwood, \u00a0K.;\u00a0Way,\u00a0K.;\u00a0Hakimjavadi, \u00a0R.;\u00a0Stone,\u00a0D.\u00a0M.;\u00a0Walls,\u00a0D.,\u00a0Identification \u00a0and\u00a0 304 \nCharacterization \u00a0of\u00a0Cyprinid \u00a0Herpesvirus \u20103\u00a0(CyHV\u20103)\u00a0Encoded \u00a0MicroRNAs. \u00a0PLoS\u00a0ONE\u00a02015,\u00a010,\u00a0(4),\u00a0 305 \ne0125434. \u00a0 306 \n4. Haenen,\u00a0O.\u00a0L.\u00a0M.;\u00a0Way,\u00a0K.;\u00a0Bergmann, \u00a0S.\u00a0M.;\u00a0Ariel,\u00a0E.,\u00a0The\u00a0emergence \u00a0of\u00a0koi\u00a0herpesvirus \u00a0and\u00a0its\u00a0significance \u00a0 307 \nto\u00a0European \u00a0aquaculture. \u00a0Bull.\u00a0Eur.\u00a0Assoc.\u00a0Fish\u00a0Pathol.\u00a02004,\u00a024,\u00a0(6),\u00a0293\u2010307.\u00a0 308 \n5. Waltzek, \u00a0T.\u00a0B.;\u00a0Kelley,\u00a0G.\u00a0O.;\u00a0Alfaro,\u00a0M.\u00a0E.;\u00a0Kurobe,\u00a0T.;\u00a0Davison, \u00a0A.\u00a0J.;\u00a0Hedrick, \u00a0R.\u00a0P.,\u00a0Phylogenetic \u00a0 309 \nrelationships \u00a0in\u00a0the\u00a0family\u00a0Alloherpesviridae. \u00a0Dis.\u00a0Aquat.\u00a0Org.\u00a02009,\u00a084,\u00a0(3),\u00a0179\u2010194.\u00a0 310 \n6. Bretzinger, \u00a0A.;\u00a0Fischer\u2010Scherl,\u00a0T.;\u00a0Oumouna, \u00a0M.;\u00a0Hoffmann, \u00a0R.;\u00a0Truyen,\u00a0U.,\u00a0Mass\u00a0mortalities \u00a0in\u00a0Koi\u00a0carp,\u00a0 311 \nCyprinus \u00a0carpio,\u00a0associated \u00a0with\u00a0gill\u00a0and\u00a0skin\u00a0disease.\u00a0Bull.\u00a0Eur.\u00a0Assoc.\u00a0Fish\u00a0Pathol.\u00a01999,\u00a019,\u00a0(5),\u00a0182\u2010185.\u00a0 312 \n7. Eide,\u00a0K.;\u00a0Miller\u2010Morgan, \u00a0T.;\u00a0Heidel,\u00a0J.;\u00a0Bildfell,\u00a0R.;\u00a0Jin,\u00a0L.,\u00a0Results\u00a0of\u00a0total\u00a0DNA\u00a0measurement \u00a0in\u00a0koi\u00a0tissue\u00a0 313 \nby\u00a0Koi\u00a0Herpes\u00a0Virus\u00a0real\u2010time\u00a0PCR.\u00a0Journal\u00a0of\u00a0virological \u00a0methods \u00a02011,\u00a0172,\u00a0(1\u20102),\u00a081\u20104.\u00a0 314 \n8. Eide,\u00a0K.\u00a0E.;\u00a0Miller\u2010Morgan, \u00a0T.;\u00a0Heidel,\u00a0J.\u00a0R.;\u00a0Kent,\u00a0M.\u00a0L.;\u00a0Bildfell,\u00a0R.\u00a0J.;\u00a0Lapatra,\u00a0S.;\u00a0Watson,\u00a0G.;\u00a0Jin,\u00a0L.,\u00a0 315 \nInvestigation \u00a0of\u00a0koi\u00a0herpesvirus \u00a0latency\u00a0in\u00a0koi.\u00a0Journal\u00a0of\u00a0virology\u00a02011,\u00a085,\u00a0(10),\u00a04954\u201062.\u00a0 316 \n9. Reed,\u00a0A.\u00a0N.;\u00a0Putman,\u00a0T.;\u00a0Sullivan, \u00a0C.;\u00a0Jin,\u00a0L.,\u00a0Application \u00a0of\u00a0a\u00a0nanoflare \u00a0probe\u00a0specific\u00a0to\u00a0a\u00a0latency\u00a0associated \u00a0 317 \ntranscript \u00a0for\u00a0isolation \u00a0of\u00a0KHV\u00a0latently\u00a0infected\u00a0cells.\u00a0Virus\u00a0research\u00a02015,\u00a0208,\u00a0129\u201035.\u00a0 318 \n10. Aoki,\u00a0T.;\u00a0Hirono,\u00a0I.;\u00a0Kurokawa, \u00a0K.;\u00a0Fukuda,\u00a0H.;\u00a0Nahary,\u00a0R.;\u00a0Eldar,\u00a0A.;\u00a0Davison, \u00a0A.\u00a0J.;\u00a0Waltzek, \u00a0T.\u00a0B.;\u00a0 319 \nBercovier, \u00a0H.;\u00a0Hedrick, \u00a0R.\u00a0P.,\u00a0Genome\u00a0sequences \u00a0of\u00a0three\u00a0koi\u00a0herpesvirus \u00a0isolates\u00a0representing \u00a0the\u00a0 320 \nexpanding \u00a0distribution \u00a0of\u00a0an\u00a0emerging \u00a0disease\u00a0threatening \u00a0koi\u00a0and\u00a0common \u00a0carp\u00a0worldwide. \u00a0J.\u00a0Virol.\u00a02007,\u00a0 321 \n81,\u00a0(10),\u00a05058\u20105065.\u00a0 322 \n11. Gao,\u00a0Y.;\u00a0Su\u00e1rez,\u00a0N.\u00a0M.;\u00a0Wilkie,\u00a0G.\u00a0S.;\u00a0Dong,\u00a0C.;\u00a0Bergmann, \u00a0S.;\u00a0Lee,\u00a0P.\u2010Y.\u00a0A.;\u00a0Davison, \u00a0A.\u00a0J.;\u00a0Vanderplasschen, \u00a0 323 \nA.\u00a0F.\u00a0C.;\u00a0Boutier,\u00a0M.,\u00a0Genomic \u00a0and\u00a0biologic\u00a0comparisons \u00a0of\u00a0cyprinid \u00a0herpesvirus \u00a03\u00a0strains.\u00a0Veterinary \u00a0 324 \nResearch \u00a02018,\u00a049,\u00a0(1),\u00a040.\u00a0 325 \n12. Hammoumi, \u00a0S.;\u00a0Vallaeys, \u00a0T.;\u00a0Santika,\u00a0A.;\u00a0Leleux,\u00a0P.;\u00a0Borzym,\u00a0E.;\u00a0Klopp,\u00a0C.;\u00a0Avarre,\u00a0J.\u00a0C.,\u00a0Targeted \u00a0genomic \u00a0 326 \nenrichment \u00a0and\u00a0sequencing \u00a0of\u00a0CyHV\u20103\u00a0from\u00a0carp\u00a0tissues\u00a0confirms \u00a0low\u00a0nucleotide \u00a0diversity \u00a0and\u00a0mixed\u00a0 327 \ngenotype \u00a0infections. \u00a0Peerj\u00a02016,\u00a04.\u00a0 328 Viruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 9\u00a0of\u00a010\u00a0\n 13. Li,\u00a0W.;\u00a0Lee,\u00a0X.;\u00a0Weng,\u00a0S.;\u00a0He,\u00a0J.;\u00a0Dong,\u00a0C.,\u00a0Whole\u2010genome\u00a0sequence \u00a0of\u00a0a\u00a0novel\u00a0Chinese\u00a0cyprinid \u00a0herpesvirus \u00a0 329 \n3\u00a0isolate\u00a0reveals\u00a0the\u00a0existence \u00a0of\u00a0a\u00a0distinct\u00a0European \u00a0genotype \u00a0in\u00a0East\u00a0Asia.\u00a0Veterinary \u00a0Microbiology \u00a02015,\u00a0 330 \n175,\u00a0(2\u20134),\u00a0185\u2010194.\u00a0 331 \n14. Davison, \u00a0A.\u00a0J.;\u00a0Kurobe,\u00a0T.;\u00a0Gatherer, \u00a0D.;\u00a0Cunningham, \u00a0C.;\u00a0Korf,\u00a0I.;\u00a0Fukuda,\u00a0H.;\u00a0Hedrick, \u00a0R.\u00a0P.;\u00a0Waltzek, \u00a0T.\u00a0 332 \nB.,\u00a0Comparative \u00a0genomics \u00a0of\u00a0carp\u00a0herpesviruses. \u00a0Journal\u00a0of\u00a0virology\u00a02013,\u00a087,\u00a0(5),\u00a02908\u201022.\u00a0 333 \n15. Costes,\u00a0B.;\u00a0Fournier, \u00a0G.;\u00a0Michel,\u00a0B.;\u00a0Delforge, \u00a0C.;\u00a0Raj,\u00a0V.\u00a0S.;\u00a0Dewals,\u00a0B.;\u00a0Gillet,\u00a0L.;\u00a0Drion,\u00a0P.;\u00a0Body,\u00a0A.;\u00a0Schynts,\u00a0 334 \nF.;\u00a0Lieffrig,\u00a0F.;\u00a0Vanderplasschen, \u00a0A.,\u00a0Cloning\u00a0of\u00a0the\u00a0koi\u00a0herpesvirus \u00a0genome\u00a0as\u00a0an\u00a0infectious \u00a0bacterial \u00a0 335 \nartificial\u00a0chromosome \u00a0demonstrates \u00a0that\u00a0disruption \u00a0of\u00a0the\u00a0thymidine \u00a0kinase\u00a0locus\u00a0induces\u00a0partial\u00a0 336 \nattenuation \u00a0in\u00a0Cyprinus \u00a0carpio\u00a0koi.\u00a0Journal\u00a0of\u00a0virology\u00a02008,\u00a082,\u00a0(10),\u00a04955\u201064.\u00a0 337 \n16. Boutier,\u00a0M.;\u00a0Ronsmans, \u00a0M.;\u00a0Ouyang, \u00a0P.;\u00a0Fournier, \u00a0G.;\u00a0Reschner, \u00a0A.;\u00a0Rakus,\u00a0K.;\u00a0Wilkie,\u00a0G.\u00a0S.;\u00a0Farnir,\u00a0F.;\u00a0 338 \nBayrou,\u00a0C.;\u00a0Lieffrig,\u00a0F.;\u00a0Li,\u00a0H.;\u00a0Desmecht, \u00a0D.;\u00a0Davison, \u00a0A.\u00a0J.;\u00a0Vanderplasschen, \u00a0A.,\u00a0Rational\u00a0development \u00a0of\u00a0 339 \nan\u00a0attenuated \u00a0recombinant \u00a0cyprinid \u00a0herpesvirus \u00a03\u00a0vaccine\u00a0using\u00a0prokaryotic \u00a0mutagenesis \u00a0and\u00a0in\u00a0vivo\u00a0 340 \nbioluminescent \u00a0imaging. \u00a0PLoS\u00a0pathogens \u00a02015,\u00a011,\u00a0(2),\u00a0e1004690. \u00a0 341 \n17. Ronen,\u00a0A.;\u00a0Perelberg, \u00a0A.;\u00a0Abramowitz, \u00a0J.;\u00a0Hutoran, \u00a0M.;\u00a0Tinman,\u00a0S.;\u00a0Bejerano, \u00a0I.;\u00a0Steinitz,\u00a0M.;\u00a0Kotler,\u00a0M.,\u00a0 342 \nEfficient\u00a0vaccine\u00a0against\u00a0the\u00a0virus\u00a0causing\u00a0a\u00a0lethal\u00a0disease\u00a0in\u00a0cultured \u00a0Cyprinus \u00a0carpio.\u00a0Vaccine\u00a02003,\u00a021,\u00a0 343 \n(32),\u00a04677\u20104684.\u00a0 344 \n18. Enzmann, \u00a0P.\u2010J.;\u00a0Fichtner, \u00a0D.;\u00a0Sch\u00fctze,\u00a0H.;\u00a0Walliser, \u00a0G.,\u00a0Development \u00a0of\u00a0vaccines\u00a0against\u00a0VHS\u00a0and\u00a0IHN:\u00a0oral\u00a0 345 \napplication, \u00a0molecular \u00a0marker\u00a0and\u00a0discrimination \u00a0of\u00a0vaccinated \u00a0fish\u00a0from\u00a0infected\u00a0populations. \u00a0Journal\u00a0of\u00a0 346 \nApplied\u00a0Ichthyology \u00a01998,\u00a014,\u00a0(3\u20104),\u00a0179\u2010183.\u00a0 347 \n19. Klafack,\u00a0S.;\u00a0Wang,\u00a0Q.;\u00a0Zeng,\u00a0W.\u00a0W.;\u00a0Wang,\u00a0Y.\u00a0Y.;\u00a0Li,\u00a0Y.\u00a0Y.;\u00a0Zheng,\u00a0S.\u00a0C.;\u00a0Kempter, \u00a0J.;\u00a0Lee,\u00a0P.\u00a0Y.;\u00a0Matras,\u00a0M.;\u00a0 348 \nBergmann, \u00a0S.\u00a0M.,\u00a0Genetic\u00a0Variability \u00a0of\u00a0Koi\u00a0Herpesvirus \u00a0In\u00a0vitro\u2010A\u00a0Natural\u00a0Event?\u00a0Front\u00a0Microbiol \u00a02017,\u00a0 349 \n8.\u00a0 350 \n20. Avarre,\u00a0J.\u00a0C.;\u00a0Santika,\u00a0A.;\u00a0Bentenni, \u00a0A.;\u00a0Zainun,\u00a0Z.;\u00a0Madeira, \u00a0J.\u00a0P.;\u00a0Maskur,\u00a0M.;\u00a0Bigarr\u00e9,\u00a0L.;\u00a0Caruso,\u00a0D.,\u00a0Spatio\u2010 351 \ntemporal \u00a0analysis\u00a0of\u00a0Cyprinid \u00a0herpesvirus \u00a03\u00a0genetic\u00a0diversity \u00a0at\u00a0a\u00a0local\u00a0scale.\u00a0Journal\u00a0of\u00a0Fish\u00a0Diseases \u00a02012,\u00a0 352 \n35,\u00a0(10),\u00a0767\u2010774.\u00a0 353 \n21. Sunarto,\u00a0A.;\u00a0McColl,\u00a0K.\u00a0A.;\u00a0Crane,\u00a0M.\u00a0S.;\u00a0Sumiati,\u00a0T.;\u00a0Hyatt,\u00a0A.\u00a0D.;\u00a0Barnes,\u00a0A.\u00a0C.;\u00a0Walker,\u00a0P.\u00a0J.,\u00a0Isolation \u00a0and\u00a0 354 \ncharacterization \u00a0of\u00a0koi\u00a0herpesvirus \u00a0(KHV)\u00a0from\u00a0Indonesia: \u00a0identification \u00a0of\u00a0a\u00a0new\u00a0genetic\u00a0lineage.\u00a0Journal\u00a0 355 \nof\u00a0Fish\u00a0Diseases \u00a02011,\u00a034,\u00a0(2),\u00a087\u2010101.\u00a0 356 \n22. Neukirch, \u00a0M.;\u00a0B\u00f6ttcher, \u00a0K.;\u00a0Bunnajirakul, \u00a0S.,\u00a0Isolation \u00a0of\u00a0a\u00a0virus\u00a0from\u00a0koi\u00a0with\u00a0altered\u00a0gills.\u00a0Bull.\u00a0Eur.\u00a0Assoc.\u00a0 357 \nFish\u00a0Pathol.\u00a01999,\u00a019,\u00a0(5),\u00a0221\u2010224.\u00a0 358 \n23. Bolger,\u00a0A.\u00a0M.;\u00a0Lohse,\u00a0M.;\u00a0Usadel,\u00a0B.,\u00a0Trimmomatic: \u00a0a\u00a0flexible\u00a0trimmer\u00a0for\u00a0Illumina \u00a0sequence \u00a0data.\u00a0 359 \nBioinformatics \u00a02014,\u00a030,\u00a0(15),\u00a02114\u20102120.\u00a0 360 \n24. Li,\u00a0H.;\u00a0Durbin,\u00a0R.,\u00a0Fast\u00a0and\u00a0accurate\u00a0short\u00a0read\u00a0alignment \u00a0with\u00a0Burrows \u2010Wheeler\u00a0transform. \u00a0Bioinformatics \u00a0 361 \n2009,\u00a025,\u00a0(14),\u00a01754\u201060.\u00a0 362 \n25. Li,\u00a0H.;\u00a0Handsaker, \u00a0B.;\u00a0Wysoker, \u00a0A.;\u00a0Fennell,\u00a0T.;\u00a0Ruan,\u00a0J.;\u00a0Homer,\u00a0N.;\u00a0Marth,\u00a0G.;\u00a0Abecasis, \u00a0G.;\u00a0Durbin,\u00a0R.;\u00a0 363 \nGenome\u00a0Project\u00a0Data\u00a0Processing, \u00a0S.,\u00a0The\u00a0Sequence \u00a0Alignment/Map \u00a0format\u00a0and\u00a0SAMtools. \u00a0Bioinformatics \u00a0 364 \n2009,\u00a025,\u00a0(16),\u00a02078\u20102079.\u00a0 365 \n26. Thorvaldsd\u00f3ttir, \u00a0H.;\u00a0Robinson, \u00a0J.\u00a0T.;\u00a0Mesirov, \u00a0J.\u00a0P.,\u00a0Integrative \u00a0Genomics \u00a0Viewer\u00a0(IGV):\u00a0high\u2010performance \u00a0 366 \ngenomics \u00a0data\u00a0visualization \u00a0and\u00a0exploration. \u00a0Briefings \u00a0in\u00a0Bioinformatics \u00a02013,\u00a014,\u00a0(2),\u00a0178\u2010192.\u00a0 367 \n27. Marchler \u2010Bauer,\u00a0A.;\u00a0Bryant,\u00a0S.\u00a0H.,\u00a0CD\u2010Search:\u00a0protein\u00a0domain\u00a0annotations \u00a0on\u00a0the\u00a0fly.\u00a0Nucleic\u00a0Acids\u00a0Res.\u00a0 368 \n2004,\u00a032,\u00a0(suppl_2), \u00a0W327\u2010W331.\u00a0 369 \n28. Bergmann, \u00a0S.\u00a0M.;\u00a0Sadowski, \u00a0J.;\u00a0Kie\u0142pi\u0144ski,\u00a0M.;\u00a0Bart\u0142omiejczyk, \u00a0M.;\u00a0Fichtner, \u00a0D.;\u00a0Riebe,\u00a0R.;\u00a0Lenk,\u00a0M.;\u00a0 370 \nKempter, \u00a0J.,\u00a0Susceptibility \u00a0of\u00a0koi\u00a0\u00d7\u00a0crucian\u00a0carp\u00a0and\u00a0koi\u00a0\u00d7\u00a0goldfish\u00a0hybrids\u00a0to\u00a0koi\u00a0herpesvirus \u00a0(KHV)\u00a0 371 \nand\u00a0the\u00a0development \u00a0of\u00a0KHV\u00a0disease\u00a0(KHVD). \u00a0Journal\u00a0of\u00a0Fish\u00a0Diseases \u00a02010,\u00a033,\u00a0(3),\u00a0267\u2010272.\u00a0 372 \n29. D\u2019Amore, \u00a0R.;\u00a0Ijaz,\u00a0U.\u00a0Z.;\u00a0Schirmer, \u00a0M.;\u00a0Kenny,\u00a0J.\u00a0G.;\u00a0Gregory, \u00a0R.;\u00a0Darby,\u00a0A.\u00a0C.;\u00a0Shakya,\u00a0M.;\u00a0Podar,\u00a0M.;\u00a0 373 \nQuince,\u00a0C.;\u00a0Hall,\u00a0N.,\u00a0A\u00a0comprehensive \u00a0benchmarking \u00a0study\u00a0of\u00a0protocols \u00a0and\u00a0sequencing \u00a0platforms \u00a0for\u00a016S\u00a0 374 \nrRNA\u00a0community \u00a0profiling. \u00a0BMC\u00a0Genomics \u00a02016,\u00a017,\u00a0(1),\u00a055.\u00a0 375 \n30. MacConaill, \u00a0L.\u00a0E.;\u00a0Burns,\u00a0R.\u00a0T.;\u00a0Nag,\u00a0A.;\u00a0Coleman, \u00a0H.\u00a0A.;\u00a0Slevin,\u00a0M.\u00a0K.;\u00a0Giorda,\u00a0K.;\u00a0Light,\u00a0M.;\u00a0Lai,\u00a0K.;\u00a0Jarosz,\u00a0 376 \nM.;\u00a0McNeill, \u00a0M.\u00a0S.;\u00a0Ducar,\u00a0M.\u00a0D.;\u00a0Meyerson, \u00a0M.;\u00a0Thorner, \u00a0A.\u00a0R.,\u00a0Unique,\u00a0dual\u2010indexed\u00a0sequencing \u00a0adapters \u00a0 377 \nwith\u00a0UMIs\u00a0effectively \u00a0eliminate \u00a0index\u00a0cross\u2010talk\u00a0and\u00a0significantly \u00a0improve \u00a0sensitivity \u00a0of\u00a0massively \u00a0parallel\u00a0 378 \nsequencing. \u00a0BMC\u00a0Genomics \u00a02018,\u00a019,\u00a030.\u00a0 379 \n31. Wright,\u00a0E.\u00a0S.;\u00a0Vetsigian, \u00a0K.\u00a0H.,\u00a0Quality\u00a0filtering\u00a0of\u00a0Illumina \u00a0index\u00a0reads\u00a0mitigates \u00a0sample\u00a0cross\u2010talk.\u00a0BMC\u00a0 380 \nGenomics \u00a02016,\u00a017,\u00a0876.\u00a0 381 Viruses\u00a02018,\u00a010,\u00a0x\u00a0FOR\u00a0PEER\u00a0REVIEW \u00a0\u00a0 10\u00a0of\u00a010\u00a0\n 32. Spencer, \u00a0D.\u00a0H.;\u00a0Tyagi,\u00a0M.;\u00a0Vallania, \u00a0F.;\u00a0Bredemeyer, \u00a0A.\u00a0J.;\u00a0Pfeifer,\u00a0J.\u00a0D.;\u00a0Mitra,\u00a0R.\u00a0D.;\u00a0Duncavage, \u00a0E.\u00a0J.,\u00a0 382 \nPerformance \u00a0of\u00a0Common \u00a0Analysis \u00a0Methods \u00a0for\u00a0Detecting \u00a0Low\u2010Frequency \u00a0Single\u00a0Nucleotide \u00a0Variants\u00a0in\u00a0 383 \nTargeted \u00a0Next\u2010Generation \u00a0Sequence \u00a0Data.\u00a0The\u00a0Journal\u00a0of\u00a0Molecular \u00a0Diagnostics \u00a0:\u00a0JMD\u00a02014,\u00a016,\u00a0(1),\u00a075\u201088.\u00a0 384 \n33. Xu,\u00a0C.;\u00a0Nezami\u00a0Ranjbar,\u00a0M.\u00a0R.;\u00a0Wu,\u00a0Z.;\u00a0DiCarlo, \u00a0J.;\u00a0Wang,\u00a0Y.,\u00a0Detecting \u00a0very\u00a0low\u00a0allele\u00a0fraction\u00a0variants\u00a0 385 \nusing\u00a0targeted\u00a0DNA\u00a0sequencing \u00a0and\u00a0a\u00a0novel\u00a0molecular \u00a0barcode\u2010aware\u00a0variant\u00a0caller.\u00a0BMC\u00a0Genomics \u00a02017,\u00a0 386 \n18,\u00a0(1),\u00a05.\u00a0 387 \n34. Liu,\u00a0S.\u2010L.;\u00a0Rodrigo, \u00a0A.\u00a0G.;\u00a0Shankarappa, \u00a0R.;\u00a0Learn,\u00a0G.\u00a0H.;\u00a0Hsu,\u00a0L.;\u00a0Davidov, \u00a0O.;\u00a0Zhao,\u00a0L.\u00a0P.;\u00a0Mullins,\u00a0J.\u00a0I.,\u00a0 388 \nHIV\u00a0Quasispecies \u00a0and\u00a0Resampling. \u00a0Science\u00a01996,\u00a0273,\u00a0(5274),\u00a0415\u2010416.\u00a0 389 \n35. Kebschull, \u00a0J.\u00a0M.;\u00a0Zador,\u00a0A.\u00a0M.,\u00a0Sources\u00a0of\u00a0PCR\u2010induced\u00a0distortions \u00a0in\u00a0high\u2010throughput \u00a0sequencing \u00a0data\u00a0 390 \nsets.\u00a0Nucleic\u00a0Acids\u00a0Res.\u00a02015,\u00a043,\u00a0(21),\u00a0e143\u2010e143.\u00a0 391 \n36. Illingworth, \u00a0C.\u00a0J.\u00a0R.;\u00a0Roy,\u00a0S.;\u00a0Beale,\u00a0M.\u00a0A.;\u00a0Tutill,\u00a0H.;\u00a0Williams, \u00a0R.;\u00a0Breuer,\u00a0J.,\u00a0On\u00a0the\u00a0effective\u00a0depth\u00a0of\u00a0viral\u00a0 392 \nsequence \u00a0data.\u00a0Virus\u00a0Evolution \u00a02017,\u00a03,\u00a0(2),\u00a0vex030.\u00a0 393 \n37. Freemont, \u00a0P.\u00a0S.,\u00a0Ubiquitination: \u00a0RING\u00a0for\u00a0destruction? \u00a0Current\u00a0Biology\u00a02000,\u00a010,\u00a0(2),\u00a0R84\u2010R87.\u00a0 394 \n38. Lorick,\u00a0K.\u00a0L.;\u00a0Jensen,\u00a0J.\u00a0P.;\u00a0Fang,\u00a0S.;\u00a0Ong,\u00a0A.\u00a0M.;\u00a0Hatakeyama, \u00a0S.;\u00a0Weissman, \u00a0A.\u00a0M.,\u00a0RING\u00a0fingers\u00a0mediate\u00a0 395 \nubiquitin \u2010conjugating \u00a0enzyme\u00a0(E2)\u2010dependent \u00a0ubiquitination. \u00a0Proceedings \u00a0of\u00a0the\u00a0National \u00a0Academy \u00a0of\u00a0 396 \nSciences\u00a0of\u00a0the\u00a0United\u00a0States\u00a0of\u00a0America \u00a01999,\u00a096,\u00a0(20),\u00a011364\u201011369.\u00a0 397 \n39. Zhang,\u00a0Y.;\u00a0Li,\u00a0L.\u2010F.;\u00a0Munir,\u00a0M.;\u00a0Qiu,\u00a0H.\u2010J.,\u00a0RING\u2010Domain\u00a0E3\u00a0Ligase\u2010Mediated \u00a0Host\u2013Virus \u00a0Interactions: \u00a0 398 \nOrchestrating \u00a0Immune \u00a0Responses \u00a0by\u00a0the\u00a0Host\u00a0and\u00a0Antagonizing \u00a0Immune \u00a0Defense\u00a0by\u00a0Viruses.\u00a0Frontiers \u00a0in\u00a0 399 \nImmunology \u00a02018,\u00a09,\u00a0(1083).\u00a0 400 \n40. Nkili\u2010Meyong, \u00a0A.\u00a0A.;\u00a0Bigarr\u00e9,\u00a0L.;\u00a0Labouba, \u00a0I.;\u00a0Vallaeys, \u00a0T.;\u00a0Avarre,\u00a0J.\u00a0C.;\u00a0Berthet,\u00a0N.,\u00a0Contribution \u00a0of\u00a0Next\u2010 401 \nGeneration \u00a0Sequencing \u00a0to\u00a0Aquatic\u00a0and\u00a0Fish\u00a0Virology. \u00a0Intervirology \u00a02016,\u00a059,\u00a0(5\u20106),\u00a0285\u2010300.\u00a0 402 \n41. Posada\u2010Cespedes, \u00a0S.;\u00a0Seifert,\u00a0D.;\u00a0Beerenwinkel, \u00a0N.,\u00a0Recent\u00a0advances \u00a0in\u00a0inferring \u00a0viral\u00a0diversity \u00a0from\u00a0high\u2010 403 \nthroughput \u00a0sequencing \u00a0data.\u00a0Virus\u00a0Research \u00a02017,\u00a0239,\u00a017\u201032.\u00a0 404 \n42. Xue,\u00a0K.\u00a0S.;\u00a0Moncla,\u00a0L.\u00a0H.;\u00a0Bedford, \u00a0T.;\u00a0Bloom,\u00a0J.\u00a0D.,\u00a0Within\u2010Host\u00a0Evolution \u00a0of\u00a0Human\u00a0Influenza \u00a0Virus.\u00a0 405 \nTrends\u00a0Microbiol. \u00a02018,\u00a026,\u00a0(9),\u00a0781\u2010793.\u00a0 406 \n43. Andino,\u00a0R.;\u00a0Domingo, \u00a0E.,\u00a0Viral\u00a0quasispecies. \u00a0Virology \u00a02015,\u00a0479\u2010480,\u00a046\u201051.\u00a0 407 \n\u00a0 408 \n\u00a9\u00a02018\u00a0by\u00a0the\u00a0authors.\u00a0Submitted \u00a0for\u00a0possible\u00a0open\u00a0access\u00a0publication \u00a0under\u00a0the\u00a0\u00a0 409 \nterms\u00a0and\u00a0conditions \u00a0of\u00a0the\u00a0Creative\u00a0Commons \u00a0Attribution \u00a0(CC\u00a0BY)\u00a0license\u00a0 410 \n(http://creativecommons.org/licenses/by/4.0/). \u00a0 411 \nPublikationen \u00a0\n68\u00a0\n\u00a0 \n \u00a0 Eigenanteil \u00a0an\u00a0den\u00a0zur\u00a0Dissertation \u00a0eingereichten \u00a0Publikationen \u00a0\n77\u00a0\n\u00a04. Eigenanteil an den zur Dissertation eingereichten \nPublikationen \n \n4.1. Publikation I \n\u00a0\n\u201cGeneration of a potential koi herpesvirus live vaccine by simu ltaneous deletion \nof the viral thymdine ki nase and dUTPase genes\u201d \n \nLars Schr\u00f6der, Sandro Klafack, Sven M. Be rgmann, Dieter Fichtner, Yeonhwa Jin, Pei-\nYu Lee, Dirk H\u00f6per, Thomas C. Mettenleiter, Walter Fuchs \n \nPubliziert in Journal of General Virology  \nLars Schr\u00f6der \n\uf0b7 Herstellung der Deletionsplasmide  \n\uf0b7 Herstellung der KHV-T Mutanten \n\uf0b7 Durchf\u00fchrung der in vitro  Replikationsstudien  \n\uf0b7 Durchf\u00fchrung des Tierversuches mit den KHV-T Mutanten unter \nfachlicher Anleitung \n\uf0b7 Probennahme und Auswertung der Ti erversuchsproben mittels qPCR \nund ELISA von den Tierversuchsproben \n\uf0b7 Erstellung der Arbeitsversion un d Fertigstellung des Manuskripts \n \nSandro Klafack \n\uf0b7 Beteiligung am Tierversuch mit den KHV-T Mutanten und der \nProbennahme \n\uf0b7 Hilfe beim Generieren der qPCR und ELISA Daten \n \nSven M. Bergmann \n\uf0b7 Versuchsleiter und Koordinator des Tierversuches mit den KHV-T \nMutanten \n\uf0b7 Beteiligung an der Auswertung des Tierversuchs der KHV-T Mutanten Eigenanteil \u00a0an\u00a0den\u00a0zur\u00a0Dissertation \u00a0eingereichten \u00a0Publikationen \u00a0\n78\u00a0\n\u00a0\u00a0Dieter Fichtner  \n\uf0b7 Versuchsleiter und Koordinator des Tierversuches mit den KHV-I \nMutanten \n\uf0b7 Auswertung des Tierversuchs der KHV-I Mutanten \n \nYeonhwa Jin  \n\uf0b7 Beteiligung beim Tierversuch der KHV-T Mutanten \n \nPei-Yu Alison Lee  \n\uf0b7 Bereitstellung des parent alen Virusisolates KHV-T \n \nDirk H\u00f6per \n\uf0b7 Durchf\u00fchrung und Auswertung der Sequenzanalyse des Virusgenoms \nder TK- und dUTPase-negativen KHV-T Mutante \n \nThomas C. Mettenleiter \n\uf0b7 Grundkonzeption des Forschungsprojektes \n\uf0b7 Mitarbeit an der Fertigst ellung der Publikation \nWalter Fuchs  \n\uf0b7 Herstellung und in vitro  Charakterisierung der KHV-I Mutanten \n\uf0b7 Planung des Forschungsprojektes \n\uf0b7 Mitarbeit an der Auswertung der Ergebnisse \n\uf0b7 Mitarbeit an der Fertigst ellung der Publikation \n \n  \n \n  \n \n  \u00a0 Eigenanteil \u00a0an\u00a0den\u00a0zur\u00a0Dissertation \u00a0eingereichten \u00a0Publikationen \u00a0\n79\u00a0\n\u00a04.2. Publikation II \n\u00a0\n\u201cCharacterization of gene deletion mu tants of Cyprinid herpesvirus 3 (koi \nherpesvirus) lacking the immunogenic en velope glycoproteins pORF25, pORF65, \npORF148 and pORF149\u201d \n\u00a0\nLars Schr\u00f6der, Sandro Klafack, Sven M.  Bergmann, Pei-Yu Alison Lee, Kati \nFranzke, Dirk H\u00f6per, Thomas C. Mettenleiter, Walter Fuchs \n\u00a0\nPubliziert in Virus Research  \n\u00a0\nLars Schr\u00f6der \n\uf0b7 Herstellung der Deletionsplasmide und Virusmutanten \n\uf0b7 Durchf\u00fchrung der in vitro  Replikationsstudien  \n\uf0b7 Durchf\u00fchrung des Tierversuches unter fachlicher Anleitung \n\uf0b7 Probenentnahme und Durchf\u00fchrung des ELISA von den \nTierversuchsproben \n\uf0b7 Erstellung der Arbeitsversion un d Fertigstellung des Manuskripts \n \nSandro Klafack \n\uf0b7 Beteiligung beim Tierversuch und der Probennahme  \n \nSven M. Bergmann \n\uf0b7 Versuchsleiter und Koordinator des Tierversuches  \n\uf0b7 Beteiligung an der Auswertung des Tierversuchs  \n \nPei-Yu Alison Lee  \n\uf0b7 Bereitstellung des parent alen Virusisolates KHV-T \n \nKati Franzke  \n\uf0b7 Elektronenmikroskopische Untersuchungen \n  Eigenanteil \u00a0an\u00a0den\u00a0zur\u00a0Dissertation \u00a0eingereichten \u00a0Publikationen \u00a0\n80\u00a0\n\u00a0\u00a0Dirk H\u00f6per \n\uf0b7 Durchf\u00fchrung und Auswertung der Sequenzanalyse  \n \nThomas C. Mettenleiter \n\uf0b7 Grundkonzeption des Forschungsprojektes  \n\uf0b7 Mitarbeit an der Fertigst ellung der Publikation \n \nWalter Fuchs  \n\uf0b7 Planung des Forschungsprojektes \n\uf0b7 Mitarbeit an der Auswertung der Ergebnisse \n\uf0b7 Mitarbeit an der Fertigst ellung der Publikation \u00a0 Eigenanteil \u00a0an\u00a0den\u00a0zur\u00a0Dissertation \u00a0eingereichten \u00a0Publikationen \u00a0\n81\u00a0\n\u00a04.3. Publikation III \n\u201cIn cellulo evolution of Cyprinid herpesvirus 3 seems to follow a viral \nquasispecies-like model\u201d  \n \nSandro Klafack, Anna-Sophie Fiston-Lavie r, Sven M. Bergmann,  Saliha Hammoumi, \nLars Schr\u00f6der, Walter Fuchs, Angela Lusiastuti, Pei-Yu Lee, Master students, Anne-\nSophie Gosselin-Grenet and Jean-Christophe Avarre   \nEingereicht bei Viruses - Animal Viruses \n Sandro Klafack \n\uf0b7 Durchf\u00fchrung der Experimente \n\uf0b7 Generierung der Daten  \n\uf0b7 Validierung der Sequenzierungsergebnisse  \n\uf0b7 Mitgestaltung der Arbeit \n\uf0b7 Erstellung der Arbeitsversion des Manuskriptes  \n\uf0b7 Fertigstellung des Manuskripts \n \nAnne-Sophie Gosselin-Grenet \n\uf0b7 Durchf\u00fchrung der Experimente \n\uf0b7 Analyse der Sequenzdaten  \n\uf0b7 Fertigstellung des Manuskripts \n Sven M. Bergmann \n\uf0b7 Analyse der Sequenzdaten  \n\uf0b7 Auswertung der Daten \n\uf0b7 Mitgestaltung der Arbeit \n\uf0b7 Fertigstellung des Manuskripts \n \nSaliha Hammoumi \n\uf0b7 Analyse der Sequenzdaten  \n\uf0b7 Bearbeitung der Sequenzdaten \n  Eigenanteil \u00a0an\u00a0den\u00a0zur\u00a0Dissertation \u00a0eingereichten \u00a0Publikationen \u00a0\n82\u00a0\n\u00a0\u00a0Lars Schr\u00f6der \n\uf0b7 Durchf\u00fchrung der Experimente \n\uf0b7 Generierung der Daten  \n\uf0b7 Mitgestaltung der Arbeit \n Walter Fuchs  \n\uf0b7 Mitgestaltung der Arbeit \n\uf0b7 Generierung der Daten  \n Angela Lusiastuti \n\uf0b7 Charakterisierung von KHV \n\uf0b7 Durchf\u00fchrung der Experimente  \n Pei-Yu Lee  \n\uf0b7 Bereitstellung des parent alen Virusisolates KHV-T \n\uf0b7 Fertigstellung des Manuskripts \n Master students  \n\uf0b7 Hilfe bei der Durchf\u00fchrung der Experimente \n\uf0b7 Analyse der Sequenzdaten  \n Anna-Sophie Fiston-Lavier \n\uf0b7 Analyse der Sequenzdaten  \n\uf0b7 Bearbeitung der Sequenzdaten \n\uf0b7 Fertigstellung des Manuskripts \n \nJean-Christophe Avarre  \n\uf0b7 Durchf\u00fchrung der Experimente \n\uf0b7 Auswertung der Daten \n\uf0b7 Bearbeitung der Sequenzdaten \n\uf0b7 Erstellung der Arbeitsversion des Manuskriptes  \n\uf0b7 Fertigstellung des Manuskripts \n \u00a0 Eigenanteil \u00a0an\u00a0den\u00a0zur\u00a0Dissertation \u00a0eingereichten \u00a0Publikationen \u00a0\n83\u00a0\n\u00a0 \n     \n____________________________________\n\u00a0\nProf. Dr. Dr. h.c. Thomas C. Mettenleiter  Datum: \n \u00a0 Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n85\u00a0\n\u00a05. Zusammenfassende Diskussion der Ergebnisse          \nDurch den unkontrollierten Handel mit infizi erten Kois konnte sich das KHV weltweit \nausbreiten und stellt zunehmend eine Bedr ohung f\u00fcr die Produktion von Nutzkarpfen, \nKois als auch f\u00fcr Wildfische dar. Aus diesem Grund ist die Herstellung eines \nImpfstoffes von gro\u00dfer Bedeutung. Bislang g i b t  e s  k e i n e n  i n  d e r  E U  z u g e l a s s e n  \nImpfstoff gegen die KHV Infektion. Generell ist zwar eine Impfung gegen KHV m\u00f6glich, jedoch wird die Sicherheit der ve rf\u00fcgbaren, auf konventionell attenuierten \nKHV-Isolaten basierenden Lebendimpfstoffen kritisch beurteilt. Deshalb waren wir \ndaran interessiert, ein kosteng\u00fcnstiges, sc h\u00fctzendes und genetisch stabiles Impfvirus \nherzustellen (siehe Publikation I). Der Grundgedanke bestand darin, die f\u00fcr den \nNukleotidstoffwechsel relevanten Gene der viralen Thymidinkinase (TK) und \nDesoxyuridintriphosphatase (DUT) au s dem KHV-Genom mittels homologer \nRekombination zu deletieren, um dadurch di e Virulenz des Erregers zu vermindern. \nIn vergleichbaren Studien mit anderen Herp esviren konnte gezeigt werden, dass   TK \nund DUT einen erheblichen Einfluss auf die Virulenz in vivo  haben, aber entbehrlich \nf\u00fcr die Virusreplikation in Zellkultur sind (Efstathiou et al., 198 9; J\u00f6ns et al., 1997; \nKit, 1989; Schnitzlein, Winans, Ellsworth, & Tripathy, 1995). In Publikation I konnten \nwir zeigen, dass auch bei KHV die Deleti on der TK- und/oder DUT-Gene zu einer \nsignifikanten Attenuierung f\u00fchrt. Obwohl die generierten Virusmutanten in Zellkultur \nkeinerlei Replikationsdefizite im Vergleic h zum Wildtypvirus zeigten, erwiesen sie \nsich in Tierversuchen mit Jungkarpfen als deutlich abgeschw\u00e4cht. Vor allem die mit \nder Doppel-Deletionsmutante zweier unterschiedlicher KHV-Isolate, KHV-I \u2206TK/DUT \noder KHV-T \uf044DUT/TK, infizierten Karpfen zeigte n nur noch vereinzelt schwache \nklinische Symptome wie  Hautl\u00e4sionen und allenfalls minimale  Mortalit\u00e4tsraten (< \n5%). Im Gegensatz dazu entwickelten Kontrolltiere, die mit den entsprechenden Wildtypviren infizierten worden waren, fast durchweg schwere Symptome der KHV-\nInfektion, die zu Mortalit\u00e4tsraten vo n 40-60% f\u00fchrten. Nach anschlie\u00dfenden \nBelastungsinfektionen mit dem Wildtypvirus erwiesen sich die immunisierten Karpfen \nals gesch\u00fctzt und zeigten keinerlei Anzeichen einer akuten KHV-Infektion. Mit einem \nf\u00fcr den Nachweis KHV-spezifischer Antik\u00f6rper entwickelten ELISA (S. M. Bergmann et al., 2017) konnte in den getestet en Seren aus mit den abgeschw\u00e4chten \nVirusmutanten  immunisierten und  mit Wildtyp-KHV infizierten Karpfen eine Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n86\u00a0\n\u00a0\u00a0vergleichbar starke  humorale Immunant wort nachgewiesen werden, was mit der \nguten Schutzwirkung der Impfung korrelierte. \nDar\u00fcber hinaus wurde aus Kiemenabstrichen DNA extrahiert und mittels einer KHV-\nspezifischen quantitativen real time PCR (qPCR) untersucht. Mit dieser fr\u00fcher beschriebenen Methode wird ein Teil des KHV-Gens ORF89 detektiert und \namplifiziert (Gilad et al., 2004), wodurch wir in der Lage ware n, nicht infizierte \nKarpfen von infizierten zu unterscheiden. Hier bei fiel auf, dass in den Abstrichen von \nFischen, die mit TK-negativen Deletionsmutanten infiziert waren, weniger \nVirusgenome detektiert werden  konnten, als in den Abstri chen von Fischen, die mit \nWildtypvirus oder TK-Revertanten infiziert waren. Dies wies auf eine weniger effiziente Replikation der Deletionsmutanten hin und korrelierte mit der \nbeobachteten Abschw\u00e4chung der Virulenz. Mittels einer Multiplex-qPCR, die \nzus\u00e4tzlich einen zweiten, neu generierten Primer-Mix zur Amplifikation eines Abschnitts des TK-Gens ORF55 enthielt, sollt e eine Differenzierung der mit den KHV-\nMutanten immunisierten Karpfen von Wildty p-infizierten Tieren erm\u00f6glicht werden \n(genetische DIVA). Wie erwartet waren in dieser Testkomponente alle DNA-Proben \naus mit den TK- oder Doppel mutanten infizierten Fische n negativ, w\u00e4hrend in den \nanderen Proben vergleichbare Virusgenom-Mengen wie bei der ORF89 Amplifikation \ndetektiert wurden. Zwei Wochen nach der Belastungsinfektion mit dem Wildtypvirus \nwaren die nachgewiesenen Mengen an viraler DNA geringer als nach einer \nPrim\u00e4rinfektion mit virulentem  KHV, was belegte, dass die Virusreplikation durch das \nadaptive Immunsystem gehemmt wu rde. Jedoch zeigten nach der \nBelastungsinfektion auch die mit TK-negat ivem KHV immunisierten Karpfen positive \nReaktionen in denORF89- und TK-Gen-s pezifischen PCR-Komponenten. Dieses \nResultat zeigte, dass die Impfung mit TK-negativem KHV keine sterile Immunit\u00e4t vermittelte, aber ausreichte, um eine  Erkrankung und Todesf\u00e4lle nach der \nBelastungsinfektion zu verhindern. Somit sollte die neu entwickelte Multiplex-qPCR \nauch den Nachweis inapparenter Wildtyp-Infektionen in geimpften \nKarpfenpopulationen erlauben. Dies ist im  Hinblick auf die Kontrolle und eine \nm\u00f6gliche Tilgung der Seuche sehr wichtig, da persistierende oder latente Infektionen \ngeimpfter Tiere mit virulentem KHV das Ri siko einer \u00dcbertragung auf naive Karpfen \nbeinhalten. Zusammenfassend zeigen die Erge bnisse aus Publikation I, dass die Gene \nORF55 (TK) und ORF123 (DUT) des KHV-Genoms f\u00fcr eine effiziente Virusreplikation \nin der Zellkultur nicht ben\u00f6tigt werden, aber wichtige in vivo  Virulenzfaktoren \u00a0 Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n87\u00a0\n\u00a0darstellen. Dar\u00fcber hinaus zeigten unsere Untersuchungen, dass die kombinierte \nDeletion beider Gene zu einer ausreichenden Abschw\u00e4chung des KHV f\u00fchrt, um die \nentsprechende Mutante als Lebendvirusimp fstoff einzusetzen. Durch Nutzung des \nZellkultur-adaptierten KHV-T als Ausgangsstamm k\u00f6nnte ein solcher Impfstoff auch kosteng\u00fcnstig produziert werden. \nZur weiteren Verbesserung der in Publik ation I beschriebenen KHV-Mutanten wurde \nversucht, auch eine serologisch differe nzierbare Markervakzine gegen die KHV-\nInfektion zu generieren. Hierf\u00fcr wurden die Gene immunogener H\u00fcllglykoproteine \nder ORF25-Genfamilie ausgew\u00e4hlt (siehe Pu blikation II). Die Gene ORF25, 26, 27, 65, \n148 und 149 stellen Mitglieder einer Familie von entfernt verwandten Genen dar, die \nin den Cyprinid Herpesviren konserviert sind und sich vermutlich aus einem \ngemeinsamen Vorfahren entwickelt haben (A oki et al., 2007; Davison et al., 2013). \nDie Gene ORF26 und ORF27 sind jedo ch in manchen KHV-Isolaten durch \nLeserasterverschiebungen inaktiviert\n\u00a0(Gao et al., 2018) und wurden deshalb nicht \nweiter untersucht. In Vorversuchen zeigten eukaryotische Zellen, die mit \nExpressionsplasmiden f\u00fcr die von ORF25,  ORF65, ORF148 oder ORF149 codierten \nintegralen TypI-Membranproteine tr ansfiziert waren, in indirekten \nImmunfluoreszenztests spezifische Reaktionen mit verschiedenen Seren aus \nexperimentell und nat\u00fcrlich KHV-infizierte n Karpfen und Kois (F uchs et al., 2014). \nAus diesem Grund wurde versucht, KHV- Deletionsmutanten f\u00fcr die vier Gene \nherzustellen, die dann auf ihre Eignung als Markerimpfstoffe (serologische DIVA) \ngepr\u00fcft werden sollten. Die Versuche bele gten, dass keines der vier Gene f\u00fcr die \nVermehrung des KHV in Zellkultur essentiell ist, da jedes von ihnen zumindest einzeln \naus dem Virusgenom deletiert werden konnte. In vitro  Replikationsstudien zeigten, \ndass Deletionen der Gene ORF25 oder ORF 149 eine verz\u00f6gerte Virusreplikation und \neine verlangsamte Ausbreitung von Zelle zu Zelle zur Folge hatten, w\u00e4hrend die \nDeletion von ORF65 keinen erkennbaren Effe kt hatte. Diese Ergebnisse stimmten im \nWesentlichen mit denen fr\u00fcherer Untersuchungen \u00e4hnlicher Mutanten \u00fcberein, die durch Mutagenese eines als artifizielles Bakterienchromosom (BAC) klonierten KHV-\nIsolates aus Belgien hergestellt  worden  waren (Vancsok et al., 2017). Ein vorher \nnicht beschriebenes interessantes Ergebnis dieser Arbeit war jedoch die replikationsf\u00f6rdernde Wirkung der OR F148-Deletion, die in einer Doppel-\nDeletionsmutante die nachteiligen Effekte der ORF149-Deletion fast vollst\u00e4ndig \nkompensierte. Beide Proteine weisen eine  Aminos\u00e4uresequenzidentit\u00e4t von 37,5% Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n88\u00a0\n\u00a0\u00a0auf, was auf \u00e4hnliche Funktionen hindeu tet und die Erkl\u00e4rung der gegens\u00e4tzlichen \nDeletions-Effekte erschwert. Um die Funktionen der Mitglieder der ORF25-\nGenfamilie des KHV weiter aufzukl\u00e4ren, analysierten wir die in vitro  \nPenetrationskinetik der verschiedenen Deletionsmutanten unter Verwendung von S\u00e4ureinaktivierungsprotokollen, wie sie f\u00fcr ein anderes Herpesvirus, das \nPseudorabiesvirus, etabliert wurden (M ettenleiter, 1989). Diese Untersuchungen \nzeigten, dass die Deletion der ORF25-Fa milienmitglieder pORF25 oder pORF149, \nnicht jedoch von pORF65 oder pORF148 zu ei nem deutlich verlangsamten Eindringen \nder Viren in die Wirtszellen f\u00fchrt, was auch die verz\u00f6gerte Replikation und die \nreduzierten Plaquegr\u00f6\u00dfen von ORF25- un d ORF149-negativem KHV erkl\u00e4ren k\u00f6nnte. \nAuch der beobachtete Penetrationsdefe kt der ORF149-Deletionsmutante wurde \ndurch die zus\u00e4tzliche Deletion von ORF 148 korrigiert, was eventuell auf eine \nkompetitive Hemmung von Virus-Wirtsze llinteraktionen durch pORF148 hindeuten \nk\u00f6nnte. Bei S\u00e4ugetier-Alphaherpesviren wi e dem Herpes-Simplex-Virus Typ 1 (HSV-\n1) wurden der Viruseintritt in die Zelle durch Membranfusion und die daran \nbeteiligten viralen Glycoproteine (gB, gD, gH, gL) bereits intensiv untersucht \n(Eisenberg et al., 2012; Sathiyamoorthy, Chen, Longnecker, & Jardetzky, 2017). Bei \nden Alloherpesviren hingegen sind die bete iligten Proteine bislang nicht bekannt.  \nEine zentrale Rolle der Produkte der ORF25-Genfamilie bei der Membranfusion erscheint unwahrscheinlich, da sie im  Gegensatz zu den hochkonservierten \nFusionsproteinen der Herpesviridae  auf die Cyprinivirus-Gattung der \nAlloherpesviridae  beschr\u00e4nkt zu sein scheinen (Aok i et al., 2007; Davison et al., \n2013) und f\u00fcr die produktive Virusreplikation  entbehrlich sind (Vancsok et al., 2017). \nEs erscheint jedoch denkbar, dass die strukturell verwandten Genprodukte der \nORF25-Familie redundante Rezeptorbindungsp roteine des KHV darstellen, die in der \nLage sind, die gleichen oder unterschiedl iche Wirtszellmembranproteine zu binden \nund die bisher unbekannten Alloherpesvi rus-Fusionsproteine zu aktivieren. Die \nH\u00fcllglykoproteine pORF148 und pORF149 k\u00f6nnten m\u00f6glicherweise um denselben zellul\u00e4ren Rezeptor konkurrieren, wobei nur pORF149 zur anschlie\u00dfenden \nAktivierung der Fusionsproteine in der La ge ist. Daher k\u00f6nnte die Abwesenheit von \npORF148 den Eintritt in die Wirtszelle erleic htern. In Abwesenheit beider Proteine \nk\u00f6nnten eventuell andere Rezeptor-Bindung sproteine, wie pORF25 oder pORF65, die \nFunktion von pORF149 \u00fcbernehmen. \u00a0 Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n89\u00a0\n\u00a0K\u00fcrzlich ver\u00f6ffentlichte Studien zeigten,  dass eine ORF25-Deletionsmutante zwar \neine deutlich reduzierte Virulenz, jedoch nicht gegen Belastungsinfektionen mit \nWildtyp-KHV sch\u00fctzte. Im Gegensatz dazu  erwiesen sich ORF65-, ORF148- und \nORF149-negative Deletionsmutanten als unzureichend attenuiert (Vancsok et al., 2017). In der vorliegenden Arbeit wurde nun die Virulenz und Schutzwirkung der \nDoppeldeletionsmutante KHV-T \u2206148/149 und der entsprechenden Einzelmutanten \nKHV-T\u2206148 und KHV-T \u2206149 vergleichend in Karpfen untersucht. Leider stellte sich \ndabei heraus, dass auch die kombinierte Deletion von pORF148 und pORF149 keine \nausreichende Abschw\u00e4chung der Virulenz vo n KHV bewirkte, sondern im Vergleich zu \nden Einzelmutanten sogar zu einer leichten  Virulenz-Steigerung f\u00fchrte. Ein positives \nResultat war jedoch, dass die beiden H\u00fcllglykoproteine f\u00fcr die Induktion einer \nsch\u00fctzenden Immunantwort gegen eine na chfolgende KHV-Belastungsinfektion der \n\u00fcberlebenden Fische entbehrlich waren. Auch im ELISA konnte keine Reduktion der \nKHV-spezifischen Serumantik\u00f6rpert iter nach Infektion mit KHV-T \uf044148/149 oder den \nEinzelmutanten im Vergleich zur Wildtypi nfektion festgestellt werden. Aufgrund \ndieser Daten erscheint es m\u00f6glich, dass ei ne kombinierte Deletion von immunogenen, \naber f\u00fcr die Schutzwirkung nicht essentiellen Glykoproteingenen der ORF25 Familie mit echten Virulenzfaktoren wie de n TK- und DUT-Genen die Entwicklung \nfunktionierender DIVA-Impfstoffe erlaubt. F\u00fcr die differentielle serologische \nDiagnostik k\u00f6nnten eventuell  kompetitiv e ELISA Tests unter Nutzung verf\u00fcgbarer \nmonoklonaler Antik\u00f6rper (mAb) gegen pO RF65 oder pORF149  (Fuchs et al., 2014) \nentwickelt werden. Ob solche Mehrfach mutanten immer noch eine sch\u00fctzende \nImmunit\u00e4t gegen die KHV-Infektion vermitte ln, und ob die Entwicklung zuverl\u00e4ssiger \nund praxistauglicher Tests f\u00fcr eine serolo gische Differenzierung von geimpften und \nWildtypvirus-infizierten Karpfen prinzi piell m\u00f6glich ist, muss durch weitere \nTierversuche und in vitro  Experimente gekl\u00e4rt werden. \nParallel zu den Versuchen, mit gentechnischen Methoden einen abgeschw\u00e4chten \nKHV-Lebendimpfstoff zu generieren, wurde auch versucht, das gleiche Ziel durch \nserielle Zellkulturpassage des virulenten Wi ldtypvirus zu erreichen. Hierzu wurde in \nder in Publikation III dargestellten Studie ein Isolat von KHV-T \u00fcber hundertmal bei \n20\u00b0C in einer aus dem Karpfe ngehirn gewonnenen, nicht-ne uronalen Zelllinie (CCB = \ncommon carp brain) passagiert. Anschlie\u00dfend wurde die Virulenz des Virus nach unterschiedlicher Passagenzahl durch experimentelle Infektionen von Karpfen \ngetestet. Bedingt durch die Homogenit\u00e4t de r Zellkulturen und die Abwesenheit einer Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n90\u00a0\n\u00a0\u00a0Immunabwehr k\u00f6nnen sich Viren in vitro durch spontane Mutationen anders \nentwickeln als im nat\u00fcrlichen Wirtsorganismus, was zu einem Verlust oder in \nEinzelf\u00e4llen auch zu einer Erh\u00f6hung der Virulenz f\u00fchren kann. Durch eine \nvergleichende genomische Analyse verschiedener Passagen sollten solche Ver\u00e4nderungen festgestellt und so m\u00f6gliche, bislang unbekannte Virulenzfaktoren \ndes KHV identifiziert werden. Schon in fr\u00fcheren Studien wurde  diese klassische \nMethode zur Attenuierung von KHV und anderen Fischpathogenen durch \nZellkulturpassagen angewandt, um potenzielle Impfstoffe gegen die entsprechenden \nErreger zu erhalten (Enzmann, Fichtner, Sch\u00fctze, & Walliser, 1998; Ronen et al., \n2003). Allerdings wurden bislang ka um Genomvergleiche zwischen den \nurspr\u00fcnglichen und den nach Passage abge schw\u00e4chten KHV Isolaten durchgef\u00fchrt, \num die molekularen Mechanismen der Attenuierung zu verstehen. Von den in \nPublikation III durch Infektion von Karpfe n gepr\u00fcften CCB-Zellpassagen von KHV-T \nzeigten P78 und P99 die interessantesten ph\u00e4notypischen Ver\u00e4nderungen. Die \nPassage 78 verursachte deutlich niedrigere Mortalit\u00e4ts- und Morbidit\u00e4tsraten als das \nAusgangsisolat P0 (Wildtypvirus). In eine m Parallelversuch lag durch P78 induzierte \nMortalit\u00e4t bei 18% gegen\u00fcber 90% mit P0. Allerdings verursachte P99 wieder eine \nh\u00f6here Mortalit\u00e4t von 28 %, sowie auch ei ne erh\u00f6hte Morbidit\u00e4t der Fische, was auf \neine Virulenzsteigerung hindeutete. Die vergleichende Genomanalyse dieser drei KHV-T-Passagen (P0, P78 und P99) zeigte eine begrenzte Anzahl von Ver\u00e4nderungen \ngegen\u00fcber dem virulenten Ausgangsvirus. Am auff\u00e4lligsten war eine Deletion von \n1363 bp, die einen gro\u00dfen Teil des ORF150 eins chloss, und in P78, aber nicht in P99 \noder P0 nachgewiesen wurde. Dieser unerw artete Befund der NGS (next generation \nsequencing) Analyse des KHV Genoms konnte durch PCR-Amplifikation des \nauthentischen und mutierten ORF150 aus Viru s DNA der jeweiligen Passagen best\u00e4tigt \nwerden. Vor kurzem konnte schon einmal gezeigt werden, dass Mutationen, die im \nGenom von KHV w\u00e4hrend Zellkulturpassagen aufgetreten waren, nach weiteren \nPassagen wieder verschwanden (Klafack et  al., 2017). Da im aktuellen Fall jedoch \neine irreversible Deletion singul\u00e4rer KH V-Genomsequenzen festgestellt wurde, ist \ndavon auszugehen, dass auch in der Viruspopulation von Passage 78 noch geringe, \nnicht detektierbare Mengen des Wildtypg enoms vorhanden waren, welches in der \nFolge wieder die Oberhand gewann. Dennoch deuten die Ergebnisse darauf hin, dass \nORF150 f\u00fcr einen Virulenzfaktor von KH V codieren k\u00f6nnte. Die Funktion des \nvorhergesagten  ORF150 Proteins ist bislan g nicht bekannt, jedoch enth\u00e4lt es eine \u00a0 Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n91\u00a0\n\u00a0RING Finger-Dom\u00e4ne (Aoki et al., 2007), wie sie vor allem  in regulatorischen \nProteinen gefunden wird, die \u00fcber ihren Zi nkfinger mit Nukleins\u00e4uren oder anderen \nProteinen interagieren. Daher erscheint eine Rolle von ORF150 bei der \nVirusreplikation von KHV ebenso vorstellbar wie eine Interaktion mit der Immunabwehr der Wirtszelle. Da die das RING-Motiv umfassende ORF150Deletion der \nmarkanteste Unterschied zwischen P78 und P99 von KHV-T ist, liegt die Vermutung \nnahe, dass die Funktion des Proteins mit der Virulenz von KHV korreliert. Um dies zu \npr\u00fcfen, sollen nun wieder mit gentechnisc hen Methoden definierte ORF150 Mutanten \nvon KHV hergestellt und sowohl in vitro  als auch in vivo  charakterisiert werden. \n  \n \n  \n \n  \n \n  \n \n  \n \n  \n \n  \n \n  \n\u00a0  Zusammenfassende \u00a0Diskussion \u00a0der\u00a0Ergebnisse \u00a0\n92\u00a0\n\u00a0\u00a0\u00a0  \u00a0 Quellen\u00a0\n93\u00a0\n\u00a06. Quellen \n \nAkula,\u00a0S.,\u00a0Mohammadamin, \u00a0S.,\u00a0&\u00a0Hellman,\u00a0L.\u00a0(2014).\u00a0Fc\u00a0receptors \u00a0for\u00a0immunoglobulins \u00a0and\u00a0their\u00a0\nappearance \u00a0during\u00a0vertebrate \u00a0evolution. \u00a0PLoS\u00a0One,\u00a09(5),\u00a0e96903.\u00a0\ndoi:10.1371/journal.pone.0096903 \u00a0\nAlberts,\u00a0B.,\u00a0Johnson,\u00a0A.,\u00a0Lewis,\u00a0J.,\u00a0Raff,\u00a0M.,\u00a0Roberts,\u00a0K.\u00a0and\u00a0Walter,\u00a0P.\u00a0(2002).\u00a0Molecular \u00a0biology\u00a0of\u00a0the\u00a0\ncell\u00a0(Vol.\u00a04).\u00a0New\u00a0York:\u00a0\u00a0Garland\u00a0Science.\u00a0\nAntinone, \u00a0S.\u00a0E.,\u00a0Shubeita, \u00a0G.\u00a0T.,\u00a0Coller,\u00a0K.\u00a0E.,\u00a0Lee,\u00a0J.\u00a0I.,\u00a0Haverlock \u2010Moyns,\u00a0S.,\u00a0Gross,\u00a0S.\u00a0P.,\u00a0&\u00a0Smith,\u00a0G.\u00a0A.\u00a0\n(2006).\u00a0The\u00a0Herpesvirus \u00a0capsid\u00a0surface\u00a0protein,\u00a0VP26,\u00a0and\u00a0the\u00a0majority\u00a0of\u00a0the\u00a0tegument \u00a0\nproteins\u00a0are\u00a0dispensable \u00a0for\u00a0capsid\u00a0transport \u00a0toward\u00a0the\u00a0nucleus.\u00a0J\u00a0Virol,\u00a080(11),\u00a05494\u20105498.\u00a0\ndoi:10.1128/JVI.00026 \u201006\u00a0\nAoki,\u00a0T.,\u00a0Hirono,\u00a0I.,\u00a0Kurokawa, \u00a0K.,\u00a0Fukuda,\u00a0H.,\u00a0Nahary,\u00a0R.,\u00a0Eldar,\u00a0A.,\u00a0.\u00a0.\u00a0.\u00a0Hedrick,\u00a0R.\u00a0P.\u00a0(2007).\u00a0Genome\u00a0\nsequences \u00a0of\u00a0three\u00a0koi\u00a0herpesvirus \u00a0isolates\u00a0representing \u00a0the\u00a0expanding \u00a0distribution \u00a0of\u00a0an\u00a0\nemerging \u00a0disease\u00a0threatening \u00a0koi\u00a0and\u00a0common\u00a0carp\u00a0worldwide. \u00a0J\u00a0Virol,\u00a081(10),\u00a05058\u20105065.\u00a0\ndoi:10.1128/JVI.00146 \u201007\u00a0\nAyana\u00a0Perelberg, \u00a0Margarita \u00a0Smirnov,\u00a0Marina\u00a0Hutoran,\u00a0Ariel\u00a0Diamant,\u00a0Yitzhak\u00a0Bejerano, \u00a0&\u00a0Kotler,\u00a0M.\u00a0\n(2003).\u00a0Epidemiological \u00a0description \u00a0of\u00a0an\u00a0new\u00a0viral\u00a0disease\u00a0afflicting\u00a0cultured\u00a0Cyprinus\u00a0carpio\u00a0\nin\u00a0Israel.\u00a0The\u00a0Israeli\u00a0Journal\u00a0of\u00a0Aquaculture, \u00a01(55),\u00a05\u201012.\u00a0\u00a0\nBaumer,\u00a0A.,\u00a0Fabian,\u00a0M.,\u00a0Wilkens,\u00a0M.\u00a0R.,\u00a0Steinhagen, \u00a0D.,\u00a0&\u00a0Runge,\u00a0M.\u00a0(2013).\u00a0Epidemiology \u00a0of\u00a0cyprinid\u00a0\nherpesvirus \u20103\u00a0infection\u00a0in\u00a0latently\u00a0infected\u00a0carp\u00a0from\u00a0aquaculture. \u00a0Dis\u00a0Aquat\u00a0Organ,\u00a0105(2),\u00a0\n101\u2010108.\u00a0doi:10.3354/dao02604 \u00a0\nBechtel,\u00a0J.\u00a0T.,\u00a0Winant,\u00a0R.\u00a0C.,\u00a0&\u00a0Ganem,\u00a0D.\u00a0(2005).\u00a0Host\u00a0and\u00a0viral\u00a0proteins\u00a0in\u00a0the\u00a0virion\u00a0of\u00a0Kaposi's\u00a0\nsarcoma\u2010associated \u00a0herpesvirus. \u00a0J\u00a0Virol,\u00a079(8),\u00a04952\u20104964.\u00a0doi:10.1128/JVI.79.8.4952 \u2010\n4964.2005 \u00a0\nBeck,\u00a0G.\u00a0a.\u00a0G.\u00a0S.\u00a0H.\u00a0(2007).\u00a0Immunity \u00a0and\u00a0the\u00a0invertebrates \u00a0(pp.\u00a060\u201066).\u00a0\nBercovier, \u00a0H.,\u00a0Fishman,\u00a0Y.,\u00a0Nahary,\u00a0R.,\u00a0Sinai,\u00a0S.,\u00a0Zlotkin,\u00a0A.,\u00a0Eyngor,\u00a0M.,\u00a0.\u00a0.\u00a0.\u00a0Hedrick,\u00a0R.\u00a0P.\u00a0(2005).\u00a0\nCloning\u00a0of\u00a0the\u00a0koi\u00a0herpesvirus \u00a0(KHV)\u00a0gene\u00a0encoding\u00a0thymidine \u00a0kinase\u00a0and\u00a0its\u00a0use\u00a0for\u00a0a\u00a0highly\u00a0\nsensitive\u00a0PCR\u00a0based\u00a0diagnosis. \u00a0BMC\u00a0Microbiol, \u00a05,\u00a013.\u00a0doi:10.1186/1471 \u20102180\u20105\u201013\u00a0\nBergmann, \u00a0S.,\u00a0&\u00a0Kempter, \u00a0J.\u00a0(2011).\u00a0Detection \u00a0of\u00a0koi\u00a0herpesvirus \u00a0(KHV)\u00a0after\u00a0re\u2010activation \u00a0in\u00a0\npersistently \u00a0infected\u00a0common\u00a0carp\u00a0(Cyprinus \u00a0carpio\u00a0L.)\u00a0using\u00a0non\u2010lethal\u00a0sampling\u00a0methods. \u00a0\nBulletin\u2010\u00a0European \u00a0Association \u00a0of\u00a0Fish\u00a0Pathologists, \u00a031(3),\u00a092\u2010100.\u00a0\u00a0\nBergmann, \u00a0S.\u00a0M.,\u00a0Sadowski, \u00a0J.,\u00a0Kielpinski, \u00a0M.,\u00a0Bartlomiejczyk, \u00a0M.,\u00a0Fichtner,\u00a0D.,\u00a0Riebe,\u00a0R.,\u00a0.\u00a0.\u00a0.\u00a0Kempter, \u00a0\nJ.\u00a0(2010).\u00a0Susceptibility \u00a0of\u00a0koi\u00a0x\u00a0crucian\u00a0carp\u00a0and\u00a0koi\u00a0x\u00a0goldfish\u00a0hybrids\u00a0to\u00a0koi\u00a0herpesvirus \u00a0\n(KHV)\u00a0and\u00a0the\u00a0development \u00a0of\u00a0KHV\u00a0disease\u00a0(KHVD).\u00a0J\u00a0Fish\u00a0Dis,\u00a033(3),\u00a0267\u2010272.\u00a0\ndoi:10.1111/j.1365 \u20102761.2009.01127.x \u00a0\nBergmann, \u00a0S.\u00a0M.,\u00a0Wang,\u00a0Q.,\u00a0Zeng,\u00a0W.,\u00a0Li,\u00a0Y.,\u00a0Wang,\u00a0Y.,\u00a0Matras,\u00a0M.,\u00a0.\u00a0.\u00a0.\u00a0Kielpinska, \u00a0J.\u00a0(2017).\u00a0Validation \u00a0\nof\u00a0a\u00a0KHV\u00a0antibody\u00a0enzyme\u2010linked\u00a0immunosorbent \u00a0assay\u00a0(ELISA).\u00a0J\u00a0Fish\u00a0Dis,\u00a040(11),\u00a01511\u2010\n1527.\u00a0doi:10.1111/jfd.12621 \u00a0\nBoivin,\u00a0G.,\u00a0Coulombe, \u00a0Z.,\u00a0&\u00a0Rivest,\u00a0S.\u00a0(2002).\u00a0Intranasal \u00a0herpes\u00a0simplex\u00a0virus\u00a0type\u00a02\u00a0inoculation \u00a0causes\u00a0\na\u00a0profound \u00a0thymidine \u00a0kinase\u00a0dependent \u00a0cerebral\u00a0inflammatory \u00a0response\u00a0in\u00a0the\u00a0mouse\u00a0\nhindbrain. \u00a0Eur\u00a0J\u00a0Neurosci, \u00a016(1),\u00a029\u201043.\u00a0\u00a0\nBoutier,\u00a0M.,\u00a0Ronsmans, \u00a0M.,\u00a0Ouyang,\u00a0P.,\u00a0Fournier,\u00a0G.,\u00a0Reschner, \u00a0A.,\u00a0Rakus,\u00a0K.,\u00a0.\u00a0.\u00a0.\u00a0Vanderplasschen, \u00a0A.\u00a0\n(2015).\u00a0Rational\u00a0development \u00a0of\u00a0an\u00a0attenuated \u00a0recombinant \u00a0cyprinid\u00a0herpesvirus \u00a03\u00a0vaccine\u00a0\nusing\u00a0prokaryotic \u00a0mutagenesis \u00a0and\u00a0in\u00a0vivo\u00a0bioluminescent \u00a0imaging.\u00a0PLoS\u00a0Pathog,\u00a011(2),\u00a0\ne1004690. \u00a0doi:10.1371/journal.ppat.1004690 \u00a0\nBowden,\u00a0T.\u00a0J.,\u00a0Cook,\u00a0P.,\u00a0&\u00a0Rombout, \u00a0J.\u00a0H.\u00a0(2005).\u00a0Development \u00a0and\u00a0function\u00a0of\u00a0the\u00a0thymus\u00a0in\u00a0teleosts.\u00a0\nFish\u00a0Shellfish\u00a0Immunol, \u00a019(5),\u00a0413\u2010427.\u00a0doi:10.1016/j.fsi.2005.02.003 \u00a0\nBoyton,\u00a0R.\u00a0J.,\u00a0&\u00a0Openshaw, \u00a0P.\u00a0J.\u00a0(2002).\u00a0Pulmonary \u00a0defences\u00a0to\u00a0acute\u00a0respiratory \u00a0infection. \u00a0Br\u00a0Med\u00a0\nBull,\u00a061,\u00a01\u201012.\u00a0\u00a0Quellen\u00a0\n94\u00a0\n\u00a0\u00a0Bretzinger, \u00a0A.,\u00a0Fischer\u2010Scherl,\u00a0T.,\u00a0Oumouna, \u00a0M.,\u00a0Hoffmann, \u00a0R.,\u00a0&\u00a0Truyen,\u00a0U.\u00a0(1999).\u00a0Mass\u00a0mortalities \u00a0\nin\u00a0koi,\u00a0Cyprinus\u00a0carpio,\u00a0associated \u00a0with\u00a0gill\u00a0and\u00a0skin\u00a0disease.\u00a0Bull.\u00a0Eur.\u00a0Ass.\u00a0Fish\u00a0Pathol,\u00a05(19),\u00a0\n182.\u00a0\u00a0\nBrooks,\u00a0G.\u00a0F.,\u00a0Carroll,\u00a0K.\u00a0C.,\u00a0Butel,\u00a0J.\u00a0S.,\u00a0Morse,\u00a0S.\u00a0A.,\u00a0&\u00a0Mietzner, \u00a0T.\u00a0A.\u00a0(2013).\u00a0Jawetz,\u00a0Melnick\u00a0and\u00a0\u00a0\nAdelberg's \u00a0Medical\u00a0Microbiology \u00a0(Vol.\u00a026).\u00a0\nChen,\u00a0K.,\u00a0Xu,\u00a0W.,\u00a0Wilson,\u00a0M.,\u00a0He,\u00a0B.,\u00a0Miller,\u00a0N.\u00a0W.,\u00a0Bengten,\u00a0E.,\u00a0.\u00a0.\u00a0.\u00a0Cerutti,\u00a0A.\u00a0(2009).\u00a0Immunoglobulin \u00a0\nD\u00a0enhances \u00a0immune\u00a0surveillance \u00a0by\u00a0activating \u00a0antimicrobial, \u00a0proinflammatory \u00a0and\u00a0B\u00a0cell\u2010\nstimulating \u00a0programs \u00a0in\u00a0basophils. \u00a0Nat\u00a0Immunol, \u00a010(8),\u00a0889\u2010898.\u00a0doi:10.1038/ni.1748 \u00a0\nCheung,\u00a0A.\u00a0K.\u00a0(1991).\u00a0Cloning\u00a0of\u00a0the\u00a0latency\u00a0gene\u00a0and\u00a0the\u00a0early\u00a0protein\u00a00\u00a0gene\u00a0of\u00a0pseudorabies \u00a0virus.\u00a0\nJ\u00a0Virol,\u00a065(10),\u00a05260\u20105271.\u00a0\u00a0\nCostes,\u00a0B.,\u00a0Fournier,\u00a0G.,\u00a0Michel,\u00a0B.,\u00a0Delforge, \u00a0C.,\u00a0Raj,\u00a0V.\u00a0S.,\u00a0Dewals,\u00a0B.,\u00a0.\u00a0.\u00a0.\u00a0Vanderplasschen, \u00a0A.\u00a0(2008).\u00a0\nCloning\u00a0of\u00a0the\u00a0koi\u00a0herpesvirus \u00a0genome\u00a0as\u00a0an\u00a0infectious \u00a0bacterial\u00a0artificial\u00a0chromosome \u00a0\ndemonstrates \u00a0that\u00a0disruption \u00a0of\u00a0the\u00a0thymidine \u00a0kinase\u00a0locus\u00a0induces\u00a0partial\u00a0attenuation \u00a0in\u00a0\nCyprinus\u00a0carpio\u00a0koi.\u00a0J\u00a0Virol,\u00a082(10),\u00a04955\u20104964.\u00a0doi:10.1128/JVI.00211 \u201008\u00a0\nDavison,\u00a0A.\u00a0J.\u00a0(2002).\u00a0Evolution \u00a0of\u00a0the\u00a0herpesviruses. \u00a0Vet\u00a0Microbiol, \u00a086(1\u20102),\u00a069\u201088.\u00a0\u00a0\nDavison,\u00a0A.\u00a0J.,\u00a0Eberle,\u00a0R.,\u00a0Ehlers,\u00a0B.,\u00a0Hayward, \u00a0G.\u00a0S.,\u00a0McGeoch, \u00a0D.\u00a0J.,\u00a0Minson,\u00a0A.\u00a0C.,\u00a0.\u00a0.\u00a0.\u00a0Thiry,\u00a0E.\u00a0(2009).\u00a0\nThe\u00a0order\u00a0Herpesvirales. \u00a0Arch\u00a0Virol,\u00a0154(1),\u00a0171\u2010177.\u00a0doi:10.1007/s00705 \u2010008\u20100278\u20104\u00a0\nDavison,\u00a0A.\u00a0J.,\u00a0Kurobe,\u00a0T.,\u00a0Gatherer, \u00a0D.,\u00a0Cunningham, \u00a0C.,\u00a0Korf,\u00a0I.,\u00a0Fukuda,\u00a0H.,\u00a0.\u00a0.\u00a0.\u00a0Waltzek,\u00a0T.\u00a0B.\u00a0(2013).\u00a0\nComparative \u00a0genomics \u00a0of\u00a0carp\u00a0herpesviruses. \u00a0J\u00a0Virol,\u00a087(5),\u00a02908\u20102922.\u00a0\ndoi:10.1128/JVI.03206 \u201012\u00a0\nEfstathiou, \u00a0S.,\u00a0Kemp,\u00a0S.,\u00a0Darby,\u00a0G.,\u00a0&\u00a0Minson,\u00a0A.\u00a0C.\u00a0(1989).\u00a0The\u00a0role\u00a0of\u00a0herpes\u00a0simplex\u00a0virus\u00a0type\u00a01\u00a0\nthymidine \u00a0kinase\u00a0in\u00a0pathogenesis. \u00a0J\u00a0Gen\u00a0Virol,\u00a070\u00a0(\u00a0Pt\u00a04),\u00a0869\u2010879.\u00a0doi:10.1099/0022 \u20101317\u201070\u2010\n4\u2010869\u00a0\nEisenberg, \u00a0R.\u00a0J.,\u00a0Atanasiu, \u00a0D.,\u00a0Cairns,\u00a0T.\u00a0M.,\u00a0Gallagher, \u00a0J.\u00a0R.,\u00a0Krummenacher, \u00a0C.,\u00a0&\u00a0Cohen,\u00a0G.\u00a0H.\u00a0(2012).\u00a0\nHerpes\u00a0virus\u00a0fusion\u00a0and\u00a0entry:\u00a0a\u00a0story\u00a0with\u00a0many\u00a0characters. \u00a0Viruses,\u00a04(5),\u00a0800\u2010832.\u00a0\ndoi:10.3390/v4050800 \u00a0\nEllis,\u00a0A.\u00a0E.\u00a0(2001).\u00a0Innate\u00a0host\u00a0defense\u00a0mechanisms \u00a0of\u00a0fish\u00a0against\u00a0viruses\u00a0and\u00a0bacteria.\u00a0Dev\u00a0Comp\u00a0\nImmunol, \u00a025(8\u20109),\u00a0827\u2010839.\u00a0\u00a0\nEnzmann, \u00a0P.\u2010J.,\u00a0Fichtner,\u00a0D.,\u00a0Sch\u00fctze,\u00a0H.,\u00a0&\u00a0Walliser,\u00a0G.\u00a0(1998).\u00a0Development \u00a0of\u00a0vaccines\u00a0against\u00a0VHS\u00a0\nand\u00a0IHN:\u00a0oral\u00a0application, \u00a0molecular \u00a0marker\u00a0and\u00a0discrimination \u00a0of\u00a0vaccinated \u00a0fish\u00a0from\u00a0\ninfected\u00a0populations. \u00a0Journal\u00a0of\u00a0Applied\u00a0Ichthyology, \u00a014((3\u20104)),\u00a0179\u2010183.\u00a0\u00a0\nFAQ.\u00a0(2014).\u00a0Fishery\u00a0and\u00a0Aquaculture \u00a0Statics.\u00a0\u00a0\u00a0\u00a0\nFeldman, \u00a0L.\u00a0T.,\u00a0Demarchi, \u00a0J.\u00a0M.,\u00a0Ben\u2010Porat,\u00a0T.,\u00a0&\u00a0Kaplan,\u00a0A.\u00a0S.\u00a0(1982).\u00a0Control\u00a0of\u00a0abundance \u00a0of\u00a0\nimmediate \u2010early\u00a0mRNA\u00a0in\u00a0herpesvirus \u00a0(pseudorabies) \u2010infected\u00a0cells.\u00a0Virology,\u00a0116(1),\u00a0250\u2010\n263.\u00a0\u00a0\nFischer,\u00a0U.,\u00a0Koppang, \u00a0E.\u00a0O.,\u00a0&\u00a0Nakanishi, \u00a0T.\u00a0(2013).\u00a0Teleost\u00a0T\u00a0and\u00a0NK\u00a0cell\u00a0immunity. \u00a0Fish\u00a0Shellfish\u00a0\nImmunol, \u00a035(2),\u00a0197\u2010206.\u00a0doi:10.1016/j.fsi.2013.04.018 \u00a0\nFraser,\u00a0N.\u00a0W.,\u00a0Lawrence, \u00a0W.\u00a0C.,\u00a0Wroblewska, \u00a0Z.,\u00a0Gilden,\u00a0D.\u00a0H.,\u00a0&\u00a0Koprowski, \u00a0H.\u00a0(1981).\u00a0Herpes\u00a0simplex\u00a0\ntype\u00a01\u00a0DNA\u00a0in\u00a0human\u00a0brain\u00a0tissue.\u00a0Proc\u00a0Natl\u00a0Acad\u00a0Sci\u00a0U\u00a0S\u00a0A,\u00a078(10),\u00a06461\u20106465.\u00a0\u00a0\nFreuling,\u00a0C.\u00a0M.,\u00a0M\u00fcller,\u00a0T.\u00a0F.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(2017).\u00a0Vaccines\u00a0against\u00a0pseudorabies \u00a0virus\u00a0(PrV).\u00a0\nVet\u00a0Microbiol, \u00a0206,\u00a03\u20109.\u00a0doi:10.1016/j.vetmic.2016.11.019 \u00a0\nFuchs,\u00a0W.,\u00a0Fichtner,\u00a0D.,\u00a0Bergmann, \u00a0S.\u00a0M.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(2011).\u00a0Generation \u00a0and\u00a0\ncharacterization \u00a0of\u00a0koi\u00a0herpesvirus \u00a0recombinants \u00a0lacking\u00a0viral\u00a0enzymes\u00a0of\u00a0nucleotide \u00a0\nmetabolism. \u00a0Arch\u00a0Virol,\u00a0156(6),\u00a01059\u20101063.\u00a0doi:10.1007/s00705 \u2010011\u20100953\u20108\u00a0\nFuchs,\u00a0W.,\u00a0Granzow, \u00a0H.,\u00a0Dauber,\u00a0M.,\u00a0Fichtner,\u00a0D.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(2014).\u00a0Identification \u00a0of\u00a0\nstructural \u00a0proteins\u00a0of\u00a0koi\u00a0herpesvirus. \u00a0Arch\u00a0Virol,\u00a0159(12),\u00a03257\u20103268.\u00a0doi:10.1007/s00705 \u2010\n014\u20102190\u20104\u00a0\nFuchs,\u00a0W.,\u00a0Granzow, \u00a0H.,\u00a0Klupp,\u00a0B.\u00a0G.,\u00a0Kopp,\u00a0M.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(2002).\u00a0The\u00a0UL48\u00a0tegument \u00a0\nprotein\u00a0of\u00a0pseudorabies \u00a0virus\u00a0is\u00a0critical\u00a0for\u00a0intracytoplasmic \u00a0assembly \u00a0of\u00a0infectious \u00a0virions.\u00a0J\u00a0\nVirol,\u00a076(13),\u00a06729\u20106742.\u00a0\u00a0\nF\u00fcllner,\u00a0D.\u00a0G.,\u00a0Pfeifer,\u00a0M.,\u00a0&\u00a0Langner,\u00a0N.\u00a0(2007).\u00a0Karpfenteichwirtschaft \u2010Bewirtschaftung \u00a0von\u00a0\nKarpfenteichen. \u00a0Gute\u00a0fachliche\u00a0Praxis :\u00a0S\u00e4chsische \u00a0Landesanstalt \u00a0f\u00fcr\u00a0Landwirtschaft. \u00a0\u00a0 Quellen\u00a0\n95\u00a0\n\u00a0Galloway, \u00a0D.\u00a0A.,\u00a0Fenoglio,\u00a0C.\u00a0M.,\u00a0&\u00a0McDougall, \u00a0J.\u00a0K.\u00a0(1982).\u00a0Limited\u00a0transcription \u00a0of\u00a0the\u00a0herpes\u00a0\nsimplex\u00a0virus\u00a0genome\u00a0when\u00a0latent\u00a0in\u00a0human\u00a0sensory\u00a0ganglia.\u00a0J\u00a0Virol,\u00a041(2),\u00a0686\u2010691.\u00a0\u00a0\nGao,\u00a0Y.,\u00a0Suarez,\u00a0N.\u00a0M.,\u00a0Wilkie,\u00a0G.\u00a0S.,\u00a0Dong,\u00a0C.,\u00a0Bergmann, \u00a0S.,\u00a0Lee,\u00a0P.\u00a0A.,\u00a0.\u00a0.\u00a0.\u00a0Boutier,\u00a0M.\u00a0(2018).\u00a0\nGenomic\u00a0and\u00a0biologic\u00a0comparisons \u00a0of\u00a0cyprinid\u00a0herpesvirus \u00a03\u00a0strains.\u00a0Vet\u00a0Res,\u00a049(1),\u00a040.\u00a0\ndoi:10.1186/s13567 \u2010018\u20100532\u2010z\u00a0\nGilad,\u00a0O.,\u00a0Yun,\u00a0S.,\u00a0Zagmutt\u2010Vergara,\u00a0F.\u00a0J.,\u00a0Leutenegger, \u00a0C.\u00a0M.,\u00a0Bercovier, \u00a0H.,\u00a0&\u00a0Hedrick,\u00a0R.\u00a0P.\u00a0(2004).\u00a0\nConcentrations \u00a0of\u00a0a\u00a0Koi\u00a0herpesvirus \u00a0(KHV)\u00a0in\u00a0tissues\u00a0of\u00a0experimentally \u00a0infected\u00a0Cyprinus\u00a0\ncarpio\u00a0koi\u00a0as\u00a0assessed\u00a0by\u00a0real\u2010time\u00a0TaqMan\u00a0PCR.\u00a0Dis\u00a0Aquat\u00a0Organ,\u00a060(3),\u00a0179\u2010187.\u00a0\ndoi:10.3354/dao060179 \u00a0\nGranzow, \u00a0H.,\u00a0Klupp,\u00a0B.\u00a0G.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(2005).\u00a0Entry\u00a0of\u00a0pseudorabies \u00a0virus:\u00a0an\u00a0immunogold \u2010\nlabeling\u00a0study.\u00a0J\u00a0Virol,\u00a079(5),\u00a03200\u20103205.\u00a0doi:10.1128/JVI.79.5.3200 \u20103205.2005 \u00a0\nGranzow, \u00a0H.,\u00a0Weiland,\u00a0F.,\u00a0Jons,\u00a0A.,\u00a0Klupp,\u00a0B.\u00a0G.,\u00a0Karger,\u00a0A.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(1997).\u00a0\nUltrastructural \u00a0analysis\u00a0of\u00a0the\u00a0replication \u00a0cycle\u00a0of\u00a0pseudorabies \u00a0virus\u00a0in\u00a0cell\u00a0culture:\u00a0a\u00a0\nreassessment. \u00a0J\u00a0Virol,\u00a071(3),\u00a02072\u20102082.\u00a0\u00a0\nHaenen,\u00a0O.,\u00a0Way,\u00a0K.,\u00a0Bergmann, \u00a0S.,\u00a0&\u00a0Ariel,\u00a0E.\u00a0(2004).\u00a0The\u00a0emergence \u00a0of\u00a0koi\u00a0herpesvirus \u00a0and\u00a0its\u00a0\nsignificance \u00a0to\u00a0European \u00a0aquaculture. \u00a0Bulletin\u2010\u00a0European \u00a0Association \u00a0of\u00a0Fish\u00a0Pathologists, \u00a0\n6(24).\u00a0\u00a0\nHansen,\u00a0J.\u00a0D.,\u00a0Landis,\u00a0E.\u00a0D.,\u00a0&\u00a0Phillips,\u00a0R.\u00a0B.\u00a0(2005).\u00a0Discovery \u00a0of\u00a0a\u00a0unique\u00a0Ig\u00a0heavy\u2010chain\u00a0isotype\u00a0(IgT)\u00a0\nin\u00a0rainbow\u00a0trout:\u00a0Implications \u00a0for\u00a0a\u00a0distinctive \u00a0B\u00a0cell\u00a0developmental \u00a0pathway\u00a0in\u00a0teleost\u00a0fish.\u00a0\nProc\u00a0Natl\u00a0Acad\u00a0Sci\u00a0U\u00a0S\u00a0A,\u00a0102(19),\u00a06919\u20106924.\u00a0doi:10.1073/pnas.0500027102 \u00a0\nHedrick,\u00a0R.\u00a0P.,\u00a0Gilad,\u00a0O.,\u00a0Yun,\u00a0S.,\u00a0Spangenberg, \u00a0J.\u00a0V.,\u00a0Marty,\u00a0G.\u00a0D.,\u00a0Nordhausen, \u00a0R.\u00a0W.,\u00a0.\u00a0.\u00a0.\u00a0Eldar,\u00a0A.\u00a0\n(2000).\u00a0A\u00a0Herpesvirus \u00a0Associated \u00a0with\u00a0Mass\u00a0Mortality \u00a0of\u00a0Juvenile\u00a0and\u00a0Adult\u00a0Koi,\u00a0a\u00a0Strain\u00a0of\u00a0\nCommon\u00a0Carp.\u00a0J\u00a0Aquat\u00a0Anim\u00a0Health,\u00a012(1),\u00a044\u201057.\u00a0doi:10.1577/1548 \u2010\n8667(2000)012<0044:AHAWMM>2.0.CO;2 \u00a0\nHedrick,\u00a0R.\u00a0P.,\u00a0Groff,\u00a0J.\u00a0M.,\u00a0Okihiro,\u00a0M.\u00a0S.,\u00a0&\u00a0McDowell, \u00a0T.\u00a0S.\u00a0(1990).\u00a0Herpesviruses \u00a0detected\u00a0in\u00a0\npapillomatous \u00a0skin\u00a0growths\u00a0of\u00a0koi\u00a0carp\u00a0(Cyprinus \u00a0carpio).\u00a0J\u00a0Wildl\u00a0Dis,\u00a026(4),\u00a0578\u2010581.\u00a0\ndoi:10.7589/0090 \u20103558\u201026.4.578\u00a0\nHedrick,\u00a0R.\u00a0P.,\u00a0Waltzek,\u00a0T.\u00a0B.,\u00a0&\u00a0Mcdowell, \u00a0T.\u00a0S.\u00a0(2006).\u00a0Susceptibility \u00a0of\u00a0Koi\u00a0Carp,\u00a0Common\u00a0Carp,\u00a0\nGoldfish,\u00a0and\u00a0Goldfish3 \u00a0Common\u00a0Carp\u00a0Hybrids\u00a0to\u00a0Cyprinid\u00a0Herpesvirus \u20102\u00a0andHerpesvirus \u20103.\u00a0\nJournal\u00a0of\u00a0Aquatic\u00a0Animal\u00a0Health,\u00a018,\u00a026\u201034.\u00a0\u00a0\nHeldwein, \u00a0E.\u00a0E.,\u00a0&\u00a0Krummenacher, \u00a0C.\u00a0(2008).\u00a0Entry\u00a0of\u00a0herpesviruses \u00a0into\u00a0mammalian \u00a0cells.\u00a0Cell\u00a0Mol\u00a0\nLife\u00a0Sci,\u00a065(11),\u00a01653\u20101668.\u00a0doi:10.1007/s00018 \u2010008\u20107570\u2010z\u00a0\nHoma,\u00a0F.\u00a0L.,\u00a0Huffman, \u00a0J.\u00a0B.,\u00a0Toropova, \u00a0K.,\u00a0Lopez,\u00a0H.\u00a0R.,\u00a0Makhov,\u00a0A.\u00a0M.,\u00a0&\u00a0Conway,\u00a0J.\u00a0F.\u00a0(2013).\u00a0\nStructure \u00a0of\u00a0the\u00a0pseudorabies \u00a0virus\u00a0capsid:\u00a0comparison \u00a0with\u00a0herpes\u00a0simplex\u00a0virus\u00a0type\u00a01\u00a0and\u00a0\ndifferential \u00a0binding\u00a0of\u00a0essential\u00a0minor\u00a0proteins.\u00a0J\u00a0Mol\u00a0Biol,\u00a0425(18),\u00a03415\u20103428.\u00a0\ndoi:10.1016/j.jmb.2013.06.034 \u00a0\nHoness,\u00a0R.\u00a0W.,\u00a0&\u00a0Roizman, \u00a0B.\u00a0(1974).\u00a0Regulation \u00a0of\u00a0herpesvirus \u00a0macromolecular \u00a0synthesis. \u00a0I.\u00a0Cascade\u00a0\nregulation \u00a0of\u00a0the\u00a0synthesis\u00a0of\u00a0three\u00a0groups\u00a0of\u00a0viral\u00a0proteins.\u00a0J\u00a0Virol,\u00a014(1),\u00a08\u201019.\u00a0\u00a0\nHoness,\u00a0R.\u00a0W.,\u00a0&\u00a0Roizman, \u00a0B.\u00a0(1975).\u00a0Regulation \u00a0of\u00a0herpesvirus \u00a0macromolecular \u00a0synthesis: \u00a0sequential \u00a0\ntransition \u00a0of\u00a0polypeptide \u00a0synthesis\u00a0requires\u00a0functional \u00a0viral\u00a0polypeptides. \u00a0Proc\u00a0Natl\u00a0Acad\u00a0Sci\u00a0\nU\u00a0S\u00a0A,\u00a072(4),\u00a01276\u20101280.\u00a0\u00a0\nHordvik,\u00a0I.\u00a0(2015).\u00a0Immunoglobulin \u00a0isotypes\u00a0in\u00a0Atlantic\u00a0salmon,\u00a0Salmo\u00a0salar.\u00a0Biomolecules, \u00a05(1),\u00a0166\u2010\n177.\u00a0doi:10.3390/biom5010166 \u00a0\nHuang,\u00a0C.,\u00a0&\u00a0Wu,\u00a0C.\u00a0Y.\u00a0(2004).\u00a0Characterization \u00a0and\u00a0expression \u00a0of\u00a0the\u00a0pseudorabies \u00a0virus\u00a0early\u00a0gene\u00a0\nUL54.\u00a0J\u00a0Virol\u00a0Methods, \u00a0119(2),\u00a0129\u2010136.\u00a0doi:10.1016/j.jviromet.2004.03.013 \u00a0\nIhara,\u00a0S.,\u00a0Feldman, \u00a0L.,\u00a0Watanabe, \u00a0S.,\u00a0&\u00a0Ben\u2010Porat,\u00a0T.\u00a0(1983).\u00a0Characterization \u00a0of\u00a0the\u00a0immediate \u2010early\u00a0\nfunctions \u00a0of\u00a0pseudorabies \u00a0virus.\u00a0Virology,\u00a0131(2),\u00a0437\u2010454.\u00a0\u00a0\nJinek,\u00a0M.,\u00a0Chylinski, \u00a0K.,\u00a0Fonfara,\u00a0I.,\u00a0Hauer,\u00a0M.,\u00a0Doudna,\u00a0J.\u00a0A.,\u00a0&\u00a0Charpentier, \u00a0E.\u00a0(2012).\u00a0A\u00a0\nprogrammable \u00a0dual\u2010RNA\u2010guided\u00a0DNA\u00a0endonuclease \u00a0in\u00a0adaptive\u00a0bacterial\u00a0immunity. \u00a0Science,\u00a0\n337(6096),\u00a0816\u2010821.\u00a0doi:10.1126/science.1225829 \u00a0Quellen\u00a0\n96\u00a0\n\u00a0\u00a0Johannsen, \u00a0E.,\u00a0Luftig,\u00a0M.,\u00a0Chase,\u00a0M.\u00a0R.,\u00a0Weicksel, \u00a0S.,\u00a0Cahir\u2010McFarland, \u00a0E.,\u00a0Illanes,\u00a0D.,\u00a0.\u00a0.\u00a0.\u00a0Kieff,\u00a0E.\u00a0\n(2004).\u00a0Proteins\u00a0of\u00a0purified\u00a0Epstein\u2010Barr\u00a0virus.\u00a0Proc\u00a0Natl\u00a0Acad\u00a0Sci\u00a0U\u00a0S\u00a0A,\u00a0101(46),\u00a016286\u2010\n16291.\u00a0doi:10.1073/pnas.0407320101 \u00a0\nJohnson,\u00a0P.\u00a0A.,\u00a0&\u00a0Everett,\u00a0R.\u00a0D.\u00a0(1986).\u00a0DNA\u00a0replication \u00a0is\u00a0required\u00a0for\u00a0abundant \u00a0expression \u00a0of\u00a0a\u00a0\nplasmid\u2010borne\u00a0late\u00a0US11\u00a0gene\u00a0of\u00a0herpes\u00a0simplex\u00a0virus\u00a0type\u00a01.\u00a0Nucleic\u00a0Acids\u00a0Res,\u00a014(9),\u00a03609\u2010\n3625.\u00a0\u00a0\nJ\u00f6ns,\u00a0A.,\u00a0Gerdts,\u00a0V.,\u00a0Lange,\u00a0E.,\u00a0Kaden,\u00a0V.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(1997).\u00a0Attenuation \u00a0of\u00a0dUTPase\u2010\ndeficient\u00a0pseudorabies \u00a0virus\u00a0for\u00a0the\u00a0natural\u00a0host.\u00a0Vet\u00a0Microbiol, \u00a056(1\u20102),\u00a047\u201054.\u00a0\ndoi:10.1016/S0378 \u20101135(96)01353 \u20103\u00a0\nJons,\u00a0A.,\u00a0&\u00a0Mettenleiter, \u00a0T.\u00a0C.\u00a0(1996).\u00a0Identification \u00a0and\u00a0characterization \u00a0of\u00a0pseudorabies \u00a0virus\u00a0\ndUTPase. \u00a0J\u00a0Virol,\u00a070(2),\u00a01242\u20101245.\u00a0\u00a0\nKatan,\u00a0M.,\u00a0Haigh,\u00a0A.,\u00a0Verrijzer,\u00a0C.\u00a0P.,\u00a0van\u00a0der\u00a0Vliet,\u00a0P.\u00a0C.,\u00a0&\u00a0O'Hare,\u00a0P.\u00a0(1990).\u00a0Characterization \u00a0of\u00a0a\u00a0\ncellular\u00a0factor\u00a0which\u00a0interacts\u00a0functionally \u00a0with\u00a0Oct\u20101\u00a0in\u00a0the\u00a0assembly \u00a0of\u00a0a\u00a0multicomponent \u00a0\ntranscription \u00a0complex.\u00a0Nucleic\u00a0Acids\u00a0Res,\u00a018(23),\u00a06871\u20106880.\u00a0\u00a0\nKeystone, \u00a0J.\u00a0S.,\u00a0Kozarsky, \u00a0P.\u00a0E.,\u00a0Freedman, \u00a0D.\u00a0O.,\u00a0Nothdruft, \u00a0H.\u00a0D.,\u00a0&\u00a0and\u00a0\u00a0Conno,\u00a0B.\u00a0A.\u00a0(2013).\u00a0Travel\u00a0\nMedicine\u00a0(Vol.\u00a03).\u00a0\nKit,\u00a0S.\u00a0(1989).\u00a0Recombinant \u2010derived\u00a0modified\u2010live\u00a0herpesvirus \u00a0vaccines.\u00a0Adv\u00a0Exp\u00a0Med\u00a0Biol,\u00a0251,\u00a0219\u2010\n236.\u00a0\u00a0\nKit,\u00a0S.,\u00a0Kit,\u00a0M.,\u00a0&\u00a0Pirtle,\u00a0E.\u00a0C.\u00a0(1985).\u00a0Attenuated \u00a0properties \u00a0of\u00a0thymidine \u00a0kinase\u2010negative\u00a0deletion\u00a0\nmutant\u00a0of\u00a0pseudorabies \u00a0virus.\u00a0Am\u00a0J\u00a0Vet\u00a0Res,\u00a046(6),\u00a01359\u20101367.\u00a0\u00a0\nKlafack,\u00a0S.,\u00a0Wang,\u00a0Q.,\u00a0Zeng,\u00a0W.\u00a0W.,\u00a0Wang,\u00a0Y.\u00a0Y.,\u00a0Li,\u00a0Y.\u00a0Y.,\u00a0Zheng,\u00a0S.\u00a0C.,\u00a0.\u00a0.\u00a0.\u00a0Bergmann, \u00a0S.\u00a0M.\u00a0(2017).\u00a0\nGenetic\u00a0Variability \u00a0of\u00a0Koi\u00a0Herpesvirus \u00a0In\u00a0vitro\u2010A\u00a0Natural\u00a0Event?\u00a0.\u00a0Front\u00a0Microbiol, \u00a08.\u00a0\u00a0\nKrishnan, \u00a0B.\u00a0R.\u00a0(2000).\u00a0Current\u00a0status\u00a0of\u00a0DNA\u00a0vaccines\u00a0in\u00a0veterinary \u00a0medicine. \u00a0Adv\u00a0Drug\u00a0Deliv\u00a0Rev,\u00a0\n43(1),\u00a03\u201011.\u00a0\u00a0\nLitman,\u00a0G.\u00a0W.,\u00a0Cannon,\u00a0J.\u00a0P.,\u00a0&\u00a0Dishaw,\u00a0L.\u00a0J.\u00a0(2005).\u00a0Reconstructing \u00a0immune\u00a0phylogeny: \u00a0new\u00a0\nperspectives. \u00a0Nat\u00a0Rev\u00a0Immunol, \u00a05(11),\u00a0866\u2010879.\u00a0doi:10.1038/nri1712 \u00a0\nLuttmann, \u00a0W.,\u00a0Bratke,\u00a0K.,\u00a0K\u00fcpper,\u00a0M.,\u00a0&\u00a0Myrtek,\u00a0D.\u00a0(2006).\u00a0Der\u00a0Experimentator: \u00a0Immunologie \u00a0(Vol.\u00a02).\u00a0\nM\u00fcnchen: \u00a0Elsevier\u00a0Gmbh.\u00a0\nM.,\u00a0J.\u00a0H.\u00a0a.\u00a0M.\u00a0(2006).\u00a0Tier\u00e4rtzliche \u00a0Impfpraxis \u00a0(Vol.\u00a03):\u00a0Joachim\u00a0H.\u00a0\nMashoof, \u00a0S.,\u00a0&\u00a0Criscitiello, \u00a0M.\u00a0F.\u00a0(2016).\u00a0Fish\u00a0Immunoglobulins. \u00a0Biology\u00a0(Basel),\u00a05(4).\u00a0\ndoi:10.3390/biology5040045 \u00a0\nMcGeoch, \u00a0D.\u00a0J.,\u00a0Rixon,\u00a0F.\u00a0J.,\u00a0&\u00a0Davison,\u00a0A.\u00a0J.\u00a0(2006).\u00a0Topics\u00a0in\u00a0herpesvirus \u00a0genomics \u00a0and\u00a0evolution. \u00a0\nVirus\u00a0Res,\u00a0117(1),\u00a090\u2010104.\u00a0doi:10.1016/j.virusres.2006.01.002 \u00a0\nMeeusen, \u00a0E.\u00a0N.,\u00a0Walker,\u00a0J.,\u00a0Peters,\u00a0A.,\u00a0Pastoret,\u00a0P.\u00a0P.,\u00a0&\u00a0Jungersen, \u00a0G.\u00a0(2007).\u00a0Current\u00a0status\u00a0of\u00a0\nveterinary \u00a0vaccines.\u00a0Clin\u00a0Microbiol \u00a0Rev,\u00a020(3),\u00a0489\u2010510,\u00a0table\u00a0of\u00a0contents. \u00a0\ndoi:10.1128/CMR.00005 \u201007\u00a0\nMettenleiter, \u00a0T.\u00a0C.\u00a0(1989).\u00a0Glycoprotein \u00a0gIII\u00a0deletion\u00a0mutants\u00a0of\u00a0pseudorabies \u00a0virus\u00a0are\u00a0impaired\u00a0in\u00a0\nvirus\u00a0entry.\u00a0Virology,\u00a0171(2),\u00a0623\u2010625.\u00a0\u00a0\nMettenleiter, \u00a0T.\u00a0C.\u00a0(2002).\u00a0Herpesvirus \u00a0assembly \u00a0and\u00a0egress.\u00a0J\u00a0Virol,\u00a076(4),\u00a01537\u20101547.\u00a0\u00a0\nMettenleiter, \u00a0T.\u00a0C.\u00a0(2008).\u00a0Pseudorabies \u00a0Virus.\u00a0Encyclopedia \u00a0of\u00a0Virology\u00a0(B.\u00a0W.\u00a0J.\u00a0Mahy\u00a0&\u00a0M.\u00a0H.\u00a0V.\u00a0van\u00a0\nRegenmortel \u00a0Eds.\u00a0\u00a0Vol.\u00a03).\u00a0Oxford:\u00a0Academic \u00a0Press.\u00a0\nMettenleiter, \u00a0T.\u00a0C.,\u00a0Klupp,\u00a0B.\u00a0G.,\u00a0&\u00a0Granzow, \u00a0H.\u00a0(2009).\u00a0Herpesvirus \u00a0assembly: \u00a0an\u00a0update.\u00a0Virus\u00a0Res,\u00a0\n143(2),\u00a0222\u2010234.\u00a0doi:10.1016/j.virusres.2009.03.018 \u00a0\nMeyer,\u00a0K.\u00a0(2007).\u00a0Untersuchungen \u00a0zur\u00a0\u00dcbertragung \u00a0von\u00a0Koi\u2010Herpesvirus \u2010Infektionen \u00a0durch\u00a0\nsymptomlose \u00a0Carrierfische. \u00a0Dissertation \u00a0Tier\u00e4rztlichen \u00a0Hochschule \u00a0Hannover. \u00a0\u00a0\u00a0\u00a0\nMichel,\u00a0B.,\u00a0Leroy,\u00a0B.,\u00a0Stalin\u00a0Raj,\u00a0V.,\u00a0Lieffrig,\u00a0F.,\u00a0Mast,\u00a0J.,\u00a0Wattiez,\u00a0R.,\u00a0.\u00a0.\u00a0.\u00a0Costes,\u00a0B.\u00a0(2010).\u00a0The\u00a0genome\u00a0\nof\u00a0cyprinid\u00a0herpesvirus \u00a03\u00a0encodes\u00a040\u00a0proteins\u00a0incorporated \u00a0in\u00a0mature\u00a0virions.\u00a0J\u00a0Gen\u00a0Virol,\u00a0\n91(Pt\u00a02),\u00a0452\u2010462.\u00a0doi:10.1099/vir.0.015198 \u20100\u00a0\nMletzko,\u00a0A.,\u00a0Amtmann, \u00a0A.,\u00a0Bergmann, \u00a0S.,\u00a0Lee,\u00a0P.,\u00a0Christian, \u00a0J.,\u00a0Buchholz, \u00a0R.,\u00a0&\u00a0Becker,\u00a0A.\u00a0(2017).\u00a0\nInoculation \u00a0of\u00a0cyprinid\u00a0herpesvirus \u00a03\u00a0(CyHV\u20103)\u00a0on\u00a0common\u00a0carp\u00a0brain\u00a0cells\u2010influence \u00a0of\u00a0\nprocess\u00a0parameters \u00a0on\u00a0virus\u00a0yield.\u00a0In\u00a0Vitro\u00a0Cell\u00a0Dev\u00a0Biol\u00a0Anim,\u00a053(7),\u00a0579\u2010585.\u00a0\ndoi:10.1007/s11626 \u2010017\u20100170\u20101\u00a0\u00a0 Quellen\u00a0\n97\u00a0\n\u00a0Murphy,\u00a0K.\u00a0(2012).\u00a0Janeway\u00b4s \u00a0\u2010\u00a0Immuno\u00a0Biology\u00a0(Vol.\u00a08):\u00a0Garland\u00a0Science.\u00a0\nNakao,\u00a0M.,\u00a0Tsujikura, \u00a0M.,\u00a0Ichiki,\u00a0S.,\u00a0Vo,\u00a0T.\u00a0K.,\u00a0&\u00a0Somamoto, \u00a0T.\u00a0(2011).\u00a0The\u00a0complement \u00a0system\u00a0in\u00a0\nteleost\u00a0fish:\u00a0progress\u00a0of\u00a0post\u2010homolog\u2010hunting\u00a0researches. \u00a0Dev\u00a0Comp\u00a0Immunol, \u00a035(12),\u00a01296\u2010\n1308.\u00a0doi:10.1016/j.dci.2011.03.003 \u00a0\nParra,\u00a0D.,\u00a0Korytar,\u00a0T.,\u00a0Takizawa, \u00a0F.,\u00a0&\u00a0Sunyer,\u00a0J.\u00a0O.\u00a0(2016).\u00a0B\u00a0cells\u00a0and\u00a0their\u00a0role\u00a0in\u00a0the\u00a0teleost\u00a0gut.\u00a0\nDevelopmental \u00a0and\u00a0Comparative \u00a0Immunology, \u00a064,\u00a0150\u2010166.\u00a0\u00a0\nPerelberg, \u00a0A.,\u00a0Ronen,\u00a0A.,\u00a0Hutoran,\u00a0M.,\u00a0Smith,\u00a0Y.,\u00a0&\u00a0Kotler,\u00a0M.\u00a0(2005).\u00a0Protection \u00a0of\u00a0cultured\u00a0Cyprinus\u00a0\ncarpio\u00a0against\u00a0a\u00a0lethal\u00a0viral\u00a0disease\u00a0by\u00a0an\u00a0attenuated \u00a0virus\u00a0vaccine.\u00a0Vaccine,\u00a023(26),\u00a03396\u2010\n3403.\u00a0doi:10.1016/j.vaccine.2005.01.096 \u00a0\nPerelberg, \u00a0A.,\u00a0Smirnov,\u00a0M.,\u00a0Hutoran,\u00a0M.,\u00a0Diamant,\u00a0A.,\u00a0Bejerano, \u00a0Y.,\u00a0&\u00a0Kotler,\u00a0M.\u00a0(2003).\u00a0\nEpidemiological \u00a0description \u00a0of\u00a0an\u00a0new\u00a0viral\u00a0disease\u00a0afflicting\u00a0cultured\u00a0Cyprinus\u00a0carpio\u00a0in\u00a0\nIsrael.\u00a0The\u00a0Israeli\u00a0Journal\u00a0of\u00a0Aquaculture, \u00a01(55),\u00a05\u201012.\u00a0\u00a0\nPradipta,\u00a0R.\u00a0R.,\u00a0Bismita,\u00a0N.,\u00a0&\u00a0Surajit,\u00a0D.\u00a0(2012).\u00a0Immune\u00a0system\u00a0and\u00a0immune\u00a0responses \u00a0in\u00a0fish\u00a0and\u00a0\ntheir\u00a0role\u00a0in\u00a0comparative \u00a0immunity \u00a0study:\u00a0A\u00a0model\u00a0for\u00a0higher\u00a0organisms. \u00a0Immunology \u00a0Letters,\u00a0\n148,\u00a023\u201033.\u00a0\u00a0\nRauh,\u00a0T.\u00a0C.\u00a0M.\u00a0a.\u00a0I.\u00a0(1990).\u00a0A\u00a0glycoprotein \u00a0gX\u2010\u00df\u2010galactosidasee \u00a0fusion\u00a0gene\u00a0as\u00a0insertional \u00a0marker\u00a0for\u00a0\nrapid\u00a0identification \u00a0of\u00a0pseudorabies \u00a0virus\u00a0mutants.pdf. \u00a0Journal\u00a0of\u00a0Virological .\u00a0\u00a0\nReske,\u00a0A.,\u00a0Pollara,\u00a0G.,\u00a0Krummenacher, \u00a0C.,\u00a0Chain,\u00a0B.\u00a0M.,\u00a0&\u00a0Katz,\u00a0D.\u00a0R.\u00a0(2007).\u00a0Understanding \u00a0HSV\u20101\u00a0\nentry\u00a0glycoproteins. \u00a0Rev\u00a0Med\u00a0Virol,\u00a017(3),\u00a0205\u2010215.\u00a0doi:10.1002/rmv.531 \u00a0\nRoizman,\u00a0B.,\u00a0and\u00a0Knipe,\u00a0D.M.\u00a0(2001).\u00a0Herpes\u00a0simplex\u00a0viruses\u00a0and\u00a0their\u00a0replication. \u00a0Fields\u00a0Virology,\u00a04th\u00a0\ned\u00a02,\u00a02399\u20132460. \u00a0\u00a0\nRona,\u00a0G.,\u00a0Marfori,\u00a0M.,\u00a0Borsos,\u00a0M.,\u00a0Scheer,\u00a0I.,\u00a0Takacs,\u00a0E.,\u00a0Toth,\u00a0J.,\u00a0.\u00a0.\u00a0.\u00a0Vertessy,\u00a0B.\u00a0G.\u00a0(2013).\u00a0\nPhosphorylation \u00a0adjacent\u00a0to\u00a0the\u00a0nuclear\u00a0localization \u00a0signal\u00a0of\u00a0human\u00a0dUTPase\u00a0abolishes \u00a0\nnuclear\u00a0import:\u00a0structural \u00a0and\u00a0mechanistic \u00a0insights.\u00a0Acta\u00a0Crystallogr \u00a0D\u00a0Biol\u00a0Crystallogr, \u00a069(Pt\u00a0\n12),\u00a02495\u20102505.\u00a0doi:10.1107/S0907444913023354 \u00a0\nRonen,\u00a0A.,\u00a0Perelberg, \u00a0A.,\u00a0Abramowitz, \u00a0J.,\u00a0Hutoran,\u00a0M.,\u00a0Tinman,\u00a0S.,\u00a0Bejerano, \u00a0I.,\u00a0.\u00a0.\u00a0.\u00a0Kotler,\u00a0M.\u00a0(2003).\u00a0\nEfficient\u00a0vaccine\u00a0against\u00a0the\u00a0virus\u00a0causing\u00a0a\u00a0lethal\u00a0disease\u00a0in\u00a0cultured\u00a0Cyprinus\u00a0carpio.\u00a0\nVaccine,\u00a021(32),\u00a04677\u20104684.\u00a0doi:10.1016/s0264 \u2010410x(03)00523 \u20101\u00a0\nRosenkranz, \u00a0D.,\u00a0Klupp,\u00a0B.\u00a0G.,\u00a0Teifke,\u00a0J.\u00a0P.,\u00a0Granzow, \u00a0H.,\u00a0Fichtner,\u00a0D.,\u00a0Mettenleiter, \u00a0T.\u00a0C.,\u00a0&\u00a0Fuchs,\u00a0W.\u00a0\n(2008).\u00a0Identification \u00a0of\u00a0envelope \u00a0protein\u00a0pORF81\u00a0of\u00a0koi\u00a0herpesvirus. \u00a0J\u00a0Gen\u00a0Virol,\u00a089(Pt\u00a04),\u00a0\n896\u2010900.\u00a0doi:10.1099/vir.0.83565 \u20100\u00a0\nSano,\u00a0M.,\u00a0Ito,\u00a0T.,\u00a0Kurita,\u00a0J.,\u00a0Yanai,\u00a0T.,\u00a0Watanabe, \u00a0N.,\u00a0Miwa,\u00a0S.,\u00a0&\u00a0Iida,\u00a0T.\u00a0(2004).\u00a0First\u00a0Detection \u00a0of\u00a0Koi\u00a0\nHerpesvirus \u00a0in\u00a0Cultured\u00a0Common\u00a0Carp\u00a0Cyprinus\u00a0carpio\u00a0in\u00a0Japan.\u00a0Fish\u00a0Pathology, \u00a03(39),\u00a0165\u2010\n167.\u00a0\u00a0\nSathiyamoorthy, \u00a0K.,\u00a0Chen,\u00a0J.,\u00a0Longnecker, \u00a0R.,\u00a0&\u00a0Jardetzky, \u00a0T.\u00a0S.\u00a0(2017).\u00a0The\u00a0COMPLEXity \u00a0in\u00a0herpesvirus \u00a0\nentry.\u00a0Curr\u00a0Opin\u00a0Virol,\u00a024,\u00a097\u2010104.\u00a0doi:10.1016/j.coviro.2017.04.006 \u00a0\nSchnitzlein, \u00a0W.\u00a0M.,\u00a0Winans,\u00a0R.,\u00a0Ellsworth, \u00a0S.,\u00a0&\u00a0Tripathy,\u00a0D.\u00a0N.\u00a0(1995).\u00a0Generation \u00a0of\u00a0thymidine \u00a0\nkinase\u2010deficient\u00a0mutants\u00a0of\u00a0infectious \u00a0laryngotracheitis \u00a0virus.\u00a0Virology,\u00a0209(2),\u00a0304\u2010314.\u00a0\ndoi:10.1006/viro.1995.1262 \u00a0\nSecombes, \u00a0C.\u00a0J.\u00a0(1996).\u00a0The\u00a0nonspecific \u00a0immune\u00a0system:\u00a0celluar\u00a0defens.\u00a0In\u00a0the\u00a0Fish\u00a0Immune\u00a0System:\u00a0\nOrganism, \u00a0Pathogen, \u00a0and\u00a0Enviroment \u00a0(Vol.\u00a015).\u00a0\nSoleto,\u00a0I.,\u00a0Fischer,\u00a0U.,\u00a0Tafalla,\u00a0C.,\u00a0&\u00a0Granja,\u00a0A.\u00a0G.\u00a0(2018).\u00a0Identification \u00a0of\u00a0a\u00a0Potential\u00a0Common\u00a0\nAncestor\u00a0for\u00a0Mammalian \u00a0Cross\u2010Presenting \u00a0Dendritic\u00a0Cells\u00a0in\u00a0Teleost\u00a0Respiratory \u00a0Surfaces.\u00a0\nFront\u00a0Immunol, \u00a09,\u00a059.\u00a0doi:10.3389/fimmu.2018.00059 \u00a0\nSt\u2010Hilaire,\u00a0S.,\u00a0Beevers,\u00a0N.,\u00a0Way,\u00a0K.,\u00a0Le\u00a0Deuff,\u00a0R.\u00a0M.,\u00a0Martin,\u00a0P.,\u00a0&\u00a0Joiner,\u00a0C.\u00a0(2005).\u00a0Reactivation \u00a0of\u00a0koi\u00a0\nherpesvirus \u00a0infections \u00a0in\u00a0common\u00a0carp\u00a0Cyprinus\u00a0carpio.\u00a0Dis\u00a0Aquat\u00a0Organ,\u00a067(1\u20102),\u00a015\u201023.\u00a0\ndoi:10.3354/dao067015 \u00a0\nStrang,\u00a0B.\u00a0L.,\u00a0&\u00a0Stow,\u00a0N.\u00a0D.\u00a0(2005).\u00a0Circularization \u00a0of\u00a0the\u00a0herpes\u00a0simplex\u00a0virus\u00a0type\u00a01\u00a0genome\u00a0upon\u00a0\nlytic\u00a0infection. \u00a0J\u00a0Virol,\u00a079(19),\u00a012487\u201012494.\u00a0doi:10.1128/JVI.79.19.12487 \u201012494.2005 \u00a0\nSunyer,\u00a0J.\u00a0O.\u00a0(2013).\u00a0Fishing\u00a0for\u00a0mammalian \u00a0paradigms \u00a0in\u00a0the\u00a0teleost\u00a0immune\u00a0system.\u00a0Nat\u00a0Immunol, \u00a0\n14(4),\u00a0320\u2010326.\u00a0doi:10.1038/ni.2549 \u00a0Quellen\u00a0\n98\u00a0\n\u00a0\u00a0Taharaguchi, \u00a0S.,\u00a0Inoue,\u00a0H.,\u00a0Ono,\u00a0E.,\u00a0Kida,\u00a0H.,\u00a0Yamada,\u00a0S.,\u00a0&\u00a0Shimizu,\u00a0Y.\u00a0(1994).\u00a0Mapping\u00a0of\u00a0\ntranscriptional \u00a0regulatory \u00a0domains\u00a0of\u00a0pseudorabies \u00a0virus\u00a0immediate \u2010early\u00a0protein.\u00a0Arch\u00a0Virol,\u00a0\n137(3\u20104),\u00a0289\u2010302.\u00a0\u00a0\nTombacz, \u00a0D.,\u00a0Toth,\u00a0J.\u00a0S.,\u00a0Petrovszki, \u00a0P.,\u00a0&\u00a0Boldogkoi, \u00a0Z.\u00a0(2009).\u00a0Whole\u2010genome\u00a0analysis\u00a0of\u00a0\npseudorabies \u00a0virus\u00a0gene\u00a0expression \u00a0by\u00a0real\u2010time\u00a0quantitative \u00a0RT\u2010PCR\u00a0assay.\u00a0BMC\u00a0Genomics, \u00a0\n10,\u00a0491.\u00a0doi:10.1186/1471 \u20102164\u201010\u2010491\u00a0\nTurcotte,\u00a0S.,\u00a0Letellier,\u00a0J.,\u00a0&\u00a0Lippe,\u00a0R.\u00a0(2005).\u00a0Herpes\u00a0simplex\u00a0virus\u00a0type\u00a01\u00a0capsids\u00a0transit\u00a0by\u00a0the\u00a0trans\u2010\nGolgi\u00a0network,\u00a0where\u00a0viral\u00a0glycoproteins \u00a0accumulate \u00a0independently \u00a0of\u00a0capsid\u00a0egress.\u00a0J\u00a0Virol,\u00a0\n79(14),\u00a08847\u20108860.\u00a0doi:10.1128/JVI.79.14.8847 \u20108860.2005 \u00a0\nVallejo,\u00a0A.\u00a0N.,\u00a0Miller,\u00a0N.\u00a0W.,\u00a0Harvey,\u00a0N.\u00a0E.,\u00a0Cuchens,\u00a0M.\u00a0A.,\u00a0Warr,\u00a0G.\u00a0W.,\u00a0&\u00a0Clem,\u00a0L.\u00a0W.\u00a0(1992).\u00a0Cellular\u00a0\npathway(s) \u00a0of\u00a0antigen\u00a0processing \u00a0and\u00a0presentation \u00a0in\u00a0fish\u00a0APC:\u00a0endosomal \u00a0involvement \u00a0and\u00a0\ncell\u2010free\u00a0antigen\u00a0presentation. \u00a0Dev\u00a0Immunol, \u00a03(1),\u00a051\u201065.\u00a0\u00a0\nvan\u00a0Oirschot,\u00a0J.\u00a0T.\u00a0(1999).\u00a0Diva\u00a0vaccines\u00a0that\u00a0reduce\u00a0virus\u00a0transmission. \u00a0J\u00a0Biotechnol, \u00a073(2\u20103),\u00a0195\u2010205.\u00a0\u00a0\nvan\u00a0Oirschot,\u00a0J.\u00a0T.,\u00a0Rziha,\u00a0H.\u00a0J.,\u00a0Moonen,\u00a0P.\u00a0J.,\u00a0Pol,\u00a0J.\u00a0M.,\u00a0&\u00a0van\u00a0Zaane,\u00a0D.\u00a0(1986).\u00a0Differentiation \u00a0of\u00a0\nserum\u00a0antibodies \u00a0from\u00a0pigs\u00a0vaccinated \u00a0or\u00a0infected\u00a0with\u00a0Aujeszky's \u00a0disease\u00a0virus\u00a0by\u00a0a\u00a0\ncompetitive \u00a0enzyme\u00a0immunoassay. \u00a0J\u00a0Gen\u00a0Virol,\u00a067\u00a0(\u00a0Pt\u00a06),\u00a01179\u20101182.\u00a0doi:10.1099/0022 \u2010\n1317\u201067\u20106\u20101179\u00a0\nVancsok,\u00a0C.,\u00a0Penaranda, \u00a0M.\u00a0M.\u00a0D.,\u00a0Raj,\u00a0V.\u00a0S.,\u00a0Leroy,\u00a0B.,\u00a0Jazowiecka \u2010Rakus,\u00a0J.,\u00a0Boutier,\u00a0M.,\u00a0.\u00a0.\u00a0.\u00a0\nVanderplasschen, \u00a0A.\u00a0F.\u00a0C.\u00a0(2017).\u00a0Proteomic \u00a0and\u00a0Functional \u00a0Analyses\u00a0of\u00a0the\u00a0Virion\u00a0\nTransmembrane \u00a0Proteome \u00a0of\u00a0Cyprinid\u00a0Herpesvirus \u00a03.\u00a0J\u00a0Virol,\u00a091(21).\u00a0doi:10.1128/JVI.01209 \u2010\n17\u00a0\nWakae,\u00a0K.,\u00a0Magor,\u00a0B.\u00a0G.,\u00a0Saunders, \u00a0H.,\u00a0Nagaoka, \u00a0H.,\u00a0Kawamura, \u00a0A.,\u00a0Kinoshita, \u00a0K.,\u00a0.\u00a0.\u00a0.\u00a0Muramatsu, \u00a0M.\u00a0\n(2006).\u00a0Evolution \u00a0of\u00a0class\u00a0switch\u00a0recombination \u00a0function\u00a0in\u00a0fish\u00a0activation \u2010induced\u00a0cytidine\u00a0\ndeaminase, \u00a0AID.\u00a0Int\u00a0Immunol, \u00a018(1),\u00a041\u201047.\u00a0doi:10.1093/intimm/dxh347 \u00a0\nWalster,\u00a0C.\u00a0I.\u00a0(1999).\u00a0Clinical\u00a0observations \u00a0of\u00a0severe\u00a0mortalities \u00a0in\u00a0koi\u00a0carp,\u00a0Cyprinus\u00a0carpio,\u00a0with\u00a0gill\u00a0\ndisease.\u00a0Fish\u00a0Veterinary \u00a0Journal,\u00a03,\u00a054\u201058.\u00a0\u00a0\nWaltzek,\u00a0T.\u00a0B.,\u00a0Kelley,\u00a0G.\u00a0O.,\u00a0Stone,\u00a0D.\u00a0M.,\u00a0Way,\u00a0K.,\u00a0Hanson,\u00a0L.,\u00a0Fukuda,\u00a0H.,\u00a0.\u00a0.\u00a0.\u00a0Hedrick,\u00a0R.\u00a0P.\u00a0(2005).\u00a0\nKoi\u00a0herpesvirus \u00a0represents \u00a0a\u00a0third\u00a0cyprinid\u00a0herpesvirus \u00a0(CyHV\u20103)\u00a0in\u00a0the\u00a0family\u00a0Herpesviridae. \u00a0J\u00a0\nGen\u00a0Virol,\u00a086(Pt\u00a06),\u00a01659\u20101667.\u00a0doi:10.1099/vir.0.80982 \u20100\u00a0\nWatanabe, \u00a0S.,\u00a0Ono,\u00a0E.,\u00a0Nikami,\u00a0H.,\u00a0&\u00a0Kida,\u00a0H.\u00a0(1998).\u00a0Promoter \u00a0activity\u00a0of\u00a0sequence \u00a0located\u00a0upstream \u00a0\nof\u00a0the\u00a0pseudorabies \u00a0virus\u00a0early\u00a0protein\u00a00\u00a0gene.\u00a0Vet\u00a0Microbiol, \u00a061(1\u20102),\u00a07\u201019.\u00a0\u00a0\nWhyte,\u00a0S.\u00a0K.\u00a0(2007).\u00a0The\u00a0innate\u00a0immune\u00a0response\u00a0of\u00a0finfish\u2010\u2010a\u00a0review\u00a0of\u00a0current\u00a0knowledge. \u00a0Fish\u00a0\nShellfish\u00a0Immunol, \u00a023(6),\u00a01127\u20101151.\u00a0doi:10.1016/j.fsi.2007.06.005 \u00a0\nWintersberger, \u00a0E.\u00a0(1997).\u00a0Regulation \u00a0and\u00a0biological \u00a0function\u00a0of\u00a0thymidine \u00a0kinase.\u00a0Biochem\u00a0Soc\u00a0Trans,\u00a0\n25(1),\u00a0303\u2010308.\u00a0\u00a0\nZhang,\u00a0H.\u00a0G.,\u00a0&\u00a0Hanson,\u00a0L.\u00a0A.\u00a0(1995).\u00a0Deletion\u00a0of\u00a0thymidine \u00a0kinase\u00a0gene\u00a0attenuates \u00a0channel\u00a0catfish\u00a0\nherpesvirus \u00a0while\u00a0maintaining \u00a0infectivity. \u00a0Virology,\u00a0209(2),\u00a0658\u2010663.\u00a0\ndoi:10.1006/viro.1995.1300 \u00a0\nZhou,\u00a0J.\u00a0X.,\u00a0Wang,\u00a0H.,\u00a0Li,\u00a0X.\u00a0W.,\u00a0Zhu,\u00a0X.,\u00a0Lu,\u00a0W.\u00a0L.,\u00a0&\u00a0Zhang,\u00a0D.\u00a0M.\u00a0(2014b).\u00a0Construction \u00a0of\u00a0KHV\u2010CJ\u00a0\nORF25\u00a0DNA\u00a0vaccine\u00a0and\u00a0immune\u00a0challenge \u00a0test.\u00a0J\u00a0Fish\u00a0Dis,\u00a037(4),\u00a0319\u2010325.\u00a0\ndoi:10.1111/jfd.12105 \u00a0\nZwollo,\u00a0P.,\u00a0Cole,\u00a0S.,\u00a0Bromage, \u00a0E.,\u00a0&\u00a0Kaattari,\u00a0S.\u00a0(2005).\u00a0B\u00a0cell\u00a0heterogeneity \u00a0in\u00a0the\u00a0teleost\u00a0kidney:\u00a0\nevidence\u00a0for\u00a0a\u00a0maturation \u00a0gradient\u00a0from\u00a0anterior\u00a0to\u00a0posterior\u00a0kidney.\u00a0J\u00a0Immunol, \u00a0174(11),\u00a0\n6608\u20106616.\u00a0\u00a0\nZwollo,\u00a0P.,\u00a0Haines,\u00a0A.,\u00a0Rosato,\u00a0P.,\u00a0&\u00a0Gumulak\u2010Smith,\u00a0J.\u00a0(2008).\u00a0Molecular \u00a0and\u00a0cellular\u00a0analysis\u00a0of\u00a0B\u2010cell\u00a0\npopulations \u00a0in\u00a0the\u00a0rainbow\u00a0trout\u00a0using\u00a0Pax5\u00a0and\u00a0immunoglobulin \u00a0markers.\u00a0Dev\u00a0Comp\u00a0\nImmunol, \u00a032(12),\u00a01482\u20101496.\u00a0doi:10.1016/j.dci.2008.06.008 \u00a0\n \n   \u00a0 Zusammenfassung \u00a0der\u00a0Dissertation \u00a0\n99\u00a0\n\u00a07. Zusammenfassung der Dissertation \n\u00a0\nHerstellung sichererer und wi rksamer Lebendvakzine gegen \ndie Koi Herpesvirus Infektion von Karpfen  \nVorgelegt von Lars Schr\u00f6der \n \nDas Koi Herpesvirus (KHV, Cyprinid herpesvirus 3 ) verursacht eine t\u00f6dliche \nErkrankung bei Kois und Karpfen. Um sichere und wirksame Lebendvirusimpfstoffe \nzu erhalten, haben wir Einzel- und Doppeldeletionsmutanten von KHV erzeugt, aus deren Genom die f\u00fcr die beiden Nukleotids toffwechselenzyme Thymidinkinase (TK, \nORF55) und Desoxyuridin-Triphosphatase (DUT, ORF123) codierenden Leserahmen \ngezielt entfernt worden waren. Die Mutationen wurden durch homologe \nRekombination in den zellkulturadaptierten\n\u00a0aber noch virulenten Stamm KHV-T \neingef\u00fchrt. Umfangreiche in vitro  Tests zeigten, dass die Deletion der TK- und DUT-\nGene die KHV-Replikation in Zellkultur (CCB Zellen) nicht erkennbar beeintr\u00e4chtigt. In vivo  Tests an Jungkarpfen zeigten jedoch eine im Vergleich zum Ausgangsvirus \nsignifikant reduzierte Virulenz der Ei nzelgen-Deletionsmutanten eine fast \nvollst\u00e4ndige Attenuierung der Doppelmutante. Dennoch waren alle immunisierten Karpfen gegen eine letale Belastungsinfektion mit virulentem KHV gesch\u00fctzt. Mittels \neiner neu entwickelten Triplex-Real-Time-PCR und aus Kiementupferproben \nisolierter DNA war es m\u00f6glich, mit TK-negativem KHV immunisierte und Wildtyp-infizierte Karpfen zu differenzieren.  Daher k\u00f6nnte die Doppelmutante KHV-\nT\u0394DUT/TK als genetischer Marker-Impfstoff geeignet sein.  \n In einer zweiten  Studie wurde die Funktion von vier immunogenen \nH\u00fcllglykoproteinen der ORF25-Genfamilie (ORF25, ORF65, ORF148 und ORF149) von \nKHV untersucht. Hierbei wurde festgest ellt, dass alle vier Gene f\u00fcr die \nVirusreplikation in Zellkultur entbehrlic h sind. W\u00e4hrend die Deletion von ORF65 \nkeinen erkennbaren Einfluss auf die Virusv ermehrung hatte, f\u00fchrte die Deletion von \nORF148 sogar zu einer leicht erh\u00f6hten Replikationsrate. Im Gegensatz dazu \nbewirkten Deletionen von ORF25 oder OR F149 einen verz\u00f6gerten Eintritt in die \nWirtszellen und damit auch eine verlan gsamte Vermehrung und Ausbreitung der \nViren. Interessanterweise f\u00fchrte die gemeinsame Deletion der Gene ORF148 und \nORF149 zu einem wildtyp\u00e4hnlichen Wachst umsverhalten, das auf gegens\u00e4tzliche Zusammenfassung \u00a0der\u00a0Dissertation \u00a0\n100\u00a0\n\u00a0\u00a0Funktionen der beiden Proteine hindeutete. Elektronenmikroskopische \nUntersuchungen von CCB-Zellen, die mit den verschiedenen \nGlykoproteindeletionsmutanten infiziert waren, zeigten keine Auswirkungen auf die \nBildung und Reifung der Virionen im Ze llkern oder im Zytoplasma, oder die \nVirusfreisetzung. Im Tierversuch erwiesen  sich KHV-Mutanten mit Deletionen der \nGene ORF148 und/oder ORF149 als geringf\u00fc gig, aber f\u00fcr eine Verwendung als \nLebendvirus-Impfstoff nicht ausreichend abgeschw\u00e4cht. \u00dcberlebende Fische waren \njedoch gegen Belastungsinfektionen ebenso  gut gesch\u00fctzt wie Wildtyp-infizierte \nKarpfen, so dass die Deletion dieser antik\u00f6rperinduzierenden Proteine zur \nEntwicklung von KHV-Markerimpfstoffen beitragen k\u00f6nnte, die eine serologische Differenzierung von Wildtyp-infizierten und geimpften Fischen erlauben (DIVA-\nPrinzip). In einer dritten Studie wurden  durch serielle Zellkulturpassage von \nvirulentem KHV und anschlie\u00dfende in vivo  Infektionsversuche Hinweise darauf \ngefunden, dass das bislang nicht n\u00e4her charakterisierte, neben dem ORF149 Gen \nlokalisierte ORF150 f\u00fcr einen weiteren Virulenzfaktor von KHV codiert. \nM\u00f6glicherweise k\u00f6nnte also durch eine kombinierte Deletion der im Rahmen dieser Arbeit untersuchten KHV-Gene ein sicherer und wirksamer, genetisch und serologisch \ndifferenzierbarer Markerimpfstoff hergestellt werden. \n \n  \u00a0 Summary \u00a0\n101\u00a0\n\u00a08. Summary  \nKoi herpesvirus (KHV, Cyprinid herpesvirus 3 ) causes a fatal disease of koi and \ncommon carp. To obtain safe and efficacious live virus va ccines, we generated single \nand double deletion mutants of KHV lacking the genes encoding the nucleotide \nmetabolism enzymes  thymidine kinase (TK, ORF55) and deoxyuridine triphosphatase (DUT, ORF123). The mutations were introduc ed by homologous re combination in the \ncell culture adapted, but still virulent strain KHV-T. In vitro  tests showed that \ndeletion of the TK and DUT genes does not affect KHV replication in CCB cell cultures. \nIn vivo  tests using juvenile carp revealed th at virulence of the single deletion \nmutants was significantly reduced compared to parental wild type virus, and that \nthe double mutant was almost completely  attenuated. Nevertheless, all immunized \ncarp were protected against lethal challeng e infections with virulent KHV. Using a \nnovel triplex-real-time PCR and isolated DN A from gill swab samples, carp immunized \nwith TK-deleted KHV could be differentiated  from wild-type infected fish. Therefore, \nthe double mutant KHV-T \u0394DUT/TK might be suitable as  a genetic marker vaccine. \nIn a second study the functions of four immunogenic envelope glycoproteins, \nencoded by the ORF25 gene family (ORF25, ORF65, ORF148, and ORF149) of KHV. It \nwas observed that the four genes are not essential for in vitro  virus replication. \nWhereas deletion of ORF65 did not detectably  affect replication, deletion of ORF148 \neven slightly enhanced virus growth. In contrast, deletions of ORF25 or ORF149 led \nto delayed entry into host cells, resulting in decelerated replication and spread of \nthe virus. Interestingly, double deletion  of the genes ORF148 and ORF149 restored \nwild-type-like growth properties, indicating  opposite functions of the two proteins. \nElectron microscopy of CCB cells infected  with the different glycoprotein gene \ndeletion mutants showed no effect on the formation and maturation of the virions in \nthe cell nucleus or in the cytoplasm, nor on  virus release. In animal experiments the \nvirus mutants lacking ORF148 and/or ORF149 pr oved to be slightly but insufficiently \nattenuated for use as a live virus vaccines. However, surviving carp were completely \nprotected against lethal challenge infections , and, thus, deletion of these antibody-\ninducing proteins might contribute to  development of vaccines which permit \nserological differentiation of immunized from wild-type infected animals (DIVA \nprinciple). Summary \u00a0\n102\u00a0\n\u00a0\u00a0In a third study serial cell culture passages of virulent KHV-T and subsequent animal \nexperiments indicated that the uncharacter ised ORF150, which is located upstream \nof ORF149, might encode another virulence factor of KHV. Thus, combined deletion \nof the KHV genes analysed in the different pa rts of this thesis might result in a safe \nand efficacious genetic, und serological DIVA vaccine. \n  \u00a0 Anhang\u00a0\n103\u00a0\n\u00a09. Anhang \n9.1. Eigenst\u00e4ndigkeitserkl\u00e4rung \n\u00a0\nHiermit erkl\u00e4re ich, dass diese Arbeit bisher von mir weder an der Mathematisch-\nNaturwissenschaftlichen Fakult\u00e4t der Univ ersit\u00e4t Greifswald noch einer anderen \nwissenschaftlichen Einrichtung zum Zwecke der Promotion eingereicht wurde. \nFerner erkl\u00e4re ich, dass ich diese Arbeit selbstst\u00e4ndig verfasst und keine anderen \nals die darin angegebenen Hilfsmittel und Hilfen benutzt und keine Textabschnitte eines Dritten ohne Kennzeichnung \u00fcbernommen habe. \n   \n___________________\n\u00a0\nLars Schr\u00f6der \n\u00a0\n\u00a0\u00a0\n  Anhang\u00a0\n104\u00a0\n\u00a0\u00a09.2. Publikationen und Tagungsbeitr\u00e4ge \n9.2.1.  Tagungsbeitr\u00e4ge  \n\u00a0\n14.03.-17.03.2018  28th Annual Meeting of the Society for Virology , W\u00fcrzburg \n\u00a0\u201cGeneration of potential live vaccines against koi herpesvirus \ninfection by deletion of nonessential viral genes\u201d \n(Vortrag)  \n29.07.-02.08.2017  42nd International Herpesvirus Workshop , Ghent \n\u201cGeneration of potential live vaccines against koi herpesvirus \nby deletion of nonessential genes encoding enzymes of \nnucleotide metabolism\u201d \n(Vortrag) \n 20.09-22.09.2017 Junior Scientist Symposium FLI , Braunschweig  \n\u201cGeneration of potential live vaccines against koi herpesvirus \nby deletion of nonessential genes encoding enzymes of \nnucleotide metabolism\u201d \n(Poster)  \n28.09.-30.09.2016 1st SUMMER SCHOOL \u201cINFECTION BIOLOGY\u201d, Greifswald \n\u201cDevelopment of recombinant live virus vaccines against koi \nherpesvirus\u201d \n(Poster)  \n21.09.-23.09.2016 Junior Scientist Symposium FLI , Jena \n\u201cDevelopment of recombinant live virus vaccines against koi \nherpesvirus\u201d \n(Poster) \n\u00a0\n\u00a0\u00a0\n\u00a0\u00a0 Anhang\u00a0\n105\u00a0\n\u00a0\u00a0\n9.2.2.  Publikationen  \n\u00a0\nGeneration of a potential koi herpesvirus live vaccine by simultaneous deletion \nof the viral thymdine ki nase and dUTPase genes\u201d \nLars Schr\u00f6der, Sandro Klafack, Sven M. Be rgmann, Dieter Fichtner, Yeonhwa Jin, Pei-\nYu Lee, Dirk H\u00f6per, Thomas C. Mettenleiter, Walter Fuchs \n \nPubliziert in Journal of General Virology  \nCharacterization of gene deletion mu tants of Cyprinid herpesvirus 3 (koi \nherpesvirus) lacking the immunogenic en velope glycoproteins pORF25, pORF65, \npORF148 and pORF149\u201d \nLars Schr\u00f6der, Sandro Klafack, Sven M.  Bergmann, Pei-Yu Alison Lee, Kati \nFranzke, Dirk H\u00f6per, Thomas C. Mettenleiter, Walter Fuchs \n Publiziert in Virus Research  In cellulo evolution of Cyprinid herpesvirus 3 seems to follow a viral \nquasispecies-like model  \nSandro Klafack, Anna-Sophie Fiston-Lavier, Sven M. Bergmann, Saliha Hammoumi, \nLars Schr\u00f6der, Walter Fuchs, Angela Lusiastuti, Pei-Yu Lee, Master students, Anne-\nSophie Gosselin-Grenet and Jean-Christophe Avarre \u00a0\n \nEingereicht bei Viruses - Animal Viruses \n  Anhang\u00a0\n106\u00a0\n\u00a0\u00a0\u00a0  \u00a0 Anhang\u00a0\n107\u00a0\n\u00a09.3 Lebenslauf  \n\u00a0\nLars Schr\u00f6der \nFriedrich-Loeffler-Stra\u00dfe 24 \n17489 Greifswald Lars.schroeder2588@web.de \nGeboren am 25.02.1988 in Schwerin \n Akademische Ausbildung \nSeit 09/2015   Doktorand am Friedrich - Loeffler- Institut Riems \nInstitut Molekulare Virologie und Zellbiologie In der Arbeitsgruppe von Dr. Walter Fuchs \nDoktorvater: Prof. Dr. Dr. h.c. Thomas C. Mettenleiter \n \n10/2012 - 03/2015   Molekular Biologie Master of Science \nUniversit\u00e4t Hamburg \nIn der Arbeitsgruppe von Pr of. Dr. Wolfgang Streit \nMikrobiologie \n \n10/2009 - 09/2012   Biologie Bachelor of Science \nUniversit\u00e4t Hamburg \nIn der Arbeitsgruppe von Pr of. Dr. Wolfgang Streit \nMikrobiologie  \nSchulausbildung \n09/2001 - 06/2008   Sportgymnasium Schwerin  \n09/1998 - 06/2001   J.-R.-Becher Schule Schwerin  \n09/1994 - 06/1998   Heinrich Heine, Grundschule Schwerin \n  \n \n  \n Anhang\u00a0\n108\u00a0\n\u00a0\u00a0Sonstiges \n10/2010 - 03/2015   Studentische Hilfskraft \nIm Fachbereich Mikrobiologie, Universit\u00e4t Hamburg \nAufgabenbereiche : \n\u2022 Vorbereitung der Versuchsprotokolle \n\u2022 Betreuung und Beaufsichtigung der Versuche \n\u2022 Anlegen von Tabellen und \u00dcbersichten zur Auswertung  \n11/2013 - 02/2014   Hilfswissenschaftler \nIm Heinrich-Pette-Institute Hamburg Aufgabenbereiche : \n\u2022 Protein/Protein Interaktionsstudien \n\u2022 Herstellung kompetenter Zellen \u2022 Transfektion/Transformation \n \n01/2012 - 02/2012   Praktikum \nIm Fachbereich Mikrobiologie, Helios Klinikum Schwerin \nAufgabenbereiche : \n\u2022 ELISA-Techniken \u2022 Resistenzbestimmung von Erregern \n\u2022 Auftragserfassung mikrobiologischer \nUntersuchungsproben\n\u00a0  \u00a0 Anhang\u00a0\n109\u00a0\n\u00a09.4 Danksagung \nIch danke Herrn Professor Dr. Dr. h.c. Thomas C. Mettenleiter f\u00fcr die M\u00f6glichkeit, \nmeine Dissertation am Friedrich-Loeffl er-Institut anzufertigen und f\u00fcr die \n\u00dcberlassung des spannenden Themas. Dr. Walter Fuchs m\u00f6chte ich f\u00fcr die stets hilfreichen Besprechungen, die sehr gute \nBetreuung und herzliche Aufnahme in das Labor Fuchs bedanken. \nEin gro\u00dfes Dankesch\u00f6n geht an Dr . Dr. habil. S. M. Bergmann  f\u00fcr die ausgezeichnete \nBetreuung bei allen Tierversuchen und f\u00fcr die sehr gute Zusammenarbeit zwischen \nden Laboren, sowie f\u00fcr manches offene Ohr bei Problemstellungen. \nEin gro\u00dfes Dankesch\u00f6n geht auch an Anja  Landmesser f\u00fcr die hervorragend fachliche \nBetreuung und Unterst\u00fctzung im Laboralltag, sowie die vielen hilfreichen \nAnmerkungen und wertvollen Anregungen . Danke f\u00fcr deine Geduld und deine \naufmunternden Worte. Allen Mitarbeitern des Labor Fuchs (Anja Landmesser, Alexandra H\u00fcbner und Tonny \nKabuuka ) danke ich f\u00fcr die super Arbeitsatmosph\u00e4re, sowie f\u00fcr die praktische \nUnterst\u00fctzung! Danke, dass ihr immer ein offenes Ohr f\u00fcr mich hattet und mir mit \nRat und Tat zur Seite standet. \nWeiterhin m\u00f6chte ich allen Mitarbeiten der 2. Etage in Geb\u00e4ude 40.1 danken: f\u00fcr die \nVersorgung mit Ratschl\u00e4gen, Chemikal ien und Zelllinien in jedem Labor! \nMeiner \u201eMittagsrunde\u201c danke ich f\u00fcr die exzellente Pausenbespa\u00dfung! Vor allem \nVicky, Stephie, Svenja und Melina danke ich f\u00fcr die Erfahrung, sowie die teils sehr \nspannenden und anregenden Gespr\u00e4chsthemen, die so manchen schlechten Tag wieder gut gemacht haben.  \nIch danke Sandro f\u00fcr seine fachliche Unterst\u00fctzung im Tierversuch und f\u00fcr so manche \nAushilfe speziell am Wochenenden oder beim Austausch von Erfahrungen und Anregungen f\u00fcr neue Ideen.    \nMein gr\u00f6\u00dfter Dank gilt nat\u00fcrlich meiner Freundin Vicky. Ich danke dir von ganzem \nHerzen f\u00fcr deine unendliche Geduld und Unte rst\u00fctzung, sowohl auf privater Ebene, \nals auch bei der Anfertigung dieser Do ktorarbeit und den Publikationen.  \nZu guter Letzt m\u00f6chte ich meiner Famili e danken, die mir in all den Jahren den \nR\u00fccken gest\u00e4rkt hat und immer an mich gegl aubt haben. Und ich m\u00f6chte hier speziell \nmeiner kleinen Tochter Neele danken, die mich  inspiriert und mir die Motivation gibt \nimmer weiter zu machen, in der Hoffnung,  dass sie mal stolz au f ihren Papa sein \nkann.  ", "language": "PDF", "image": "PDF", "pagetype": "PDF", "links": "PDF"}